lithium carbonate toxicity|Disease|0|[4, 7]|500|-1|_|_|_|_|_|_|_|6794356
congestive heart failure|Disease|1|[10, 13]|501|-1|_|_|_|_|_|_|_|6794356
massive tricuspid regurgitation|Disease|1|[3, 6]|3|-1|_|_|_|_|_|_|_|6794356
atrial flutter|Disease|1|[7, 9]|500|-1|_|_|_|_|_|_|_|6794356
cyanosis|Disease|5|[6, 7]|501|-1|_|_|_|_|_|_|_|6794356
neurologic depression|Disease|5|[3, 5]|8|-1|_|_|_|_|_|_|_|6794356
cardiac arrhythmia|Disease|5|[9, 11]|9|H|_|_|_|_|_|_|_|6794356
lithium carbonate|Chemical|0|[4, 6]|1|-1|_|_|_|_|_|_|_|6794356
lithium carbonate|Chemical|4|[0, 2]|1|-1|_|_|_|_|_|_|_|6794356
lithium|Chemical|1|[18, 19]|5|-1|_|_|_|_|_|_|_|6794356
dyskinesia|Disease|0|[3, 4]|0|-1|_|_|_|_|_|_|_|6504332
seizures|Disease|1|[20, 21]|2|-1|_|_|_|_|_|_|_|6504332
phenobarbital|Chemical|0|[0, 1]|1|-1|_|_|_|_|_|_|_|6504332
phenobarbital|Chemical|4|[0, 1]|1|-1|_|_|_|_|_|_|_|6504332
phenobarbital therapy|Treat|1|[17, 19]|3|-1|_|_|_|_|_|_|_|6504332
blood ammonia|Physiology|0|[3, 5]|0|-1|_|_|_|_|_|_|_|6436733
valproic acid|Chemical|0|[13, 15]|500|-1|_|_|_|_|_|_|_|6436733
valproic acid|Chemical|1|[0, 2]|500|-1|_|_|_|_|_|_|_|6436733
vpa|Chemical|1|[3, 4]|500|-1|_|_|_|_|_|_|_|6436733
vpa|Chemical|2|[5, 6]|500|-1|_|_|_|_|_|_|_|6436733
vpa|Chemical|3|[35, 36]|500|-1|_|_|_|_|_|_|_|6436733
vpa|Chemical|4|[2, 3]|500|-1|_|_|_|_|_|_|_|6436733
vpa|Chemical|4|[24, 25]|500|-1|_|_|_|_|_|_|_|6436733
ammonia|Chemical|3|[0, 1]|6|H|_|_|_|_|_|_|_|6436733
nh3|Chemical|3|[2, 3]|500|-1|_|_|_|_|_|_|_|6436733
nh3|Chemical|4|[8, 9]|500|-1|_|_|_|_|_|_|_|6436733
drowsiness|Disease|3|[16, 17]|5|-1|_|_|_|_|_|_|_|6436733
extrapyramidal motor system|Physiology|0|[5, 8]|0|-1|_|_|_|_|_|_|_|6293644
salmon calcitonin|Chemical|1|[13, 15]|1|-1|_|_|_|_|_|_|_|6293644
haloperidol|Chemical|2|[7, 8]|500|-1|_|_|_|_|_|_|_|6293644
apomorphine|Chemical|2|[16, 17]|3|-1|_|_|_|_|_|_|_|6293644
dopac|Chemical|3|[17, 18]|500|-1|_|_|_|_|_|_|_|6293644
catalepsy|Disease|2|[10, 11]|4|-1|_|_|_|_|_|_|_|6293644
hyperactivity|Disease|2|[19, 20]|5|-1|_|_|_|_|_|_|_|6293644
calcitonin injection|Treat|2|[0, 2]|6|-1|_|_|_|_|_|_|_|6293644
cardiac hypertrophy|Disease|0|[5, 7]|0|H|_|_|_|_|_|_|_|6203632
hypertrophic growth|Disease|7|[16, 18]|7|H|_|_|_|_|_|_|_|6203632
hypertrophic|Disease|10|[12, 13]|13|H|_|_|_|_|_|_|_|6203632
cellular hypertrophy|Disease|11|[18, 20]|14|-1|_|_|_|_|_|_|_|6203632
hyperplasia|Disease|11|[21, 22]|15|-1|_|_|_|_|_|_|_|6203632
isoproterenol|Chemical|0|[2, 3]|501|-1|_|_|_|_|_|_|_|6203632
iso|Chemical|1|[19, 20]|501|-1|_|_|_|_|_|_|_|6203632
iso|Chemical|9|[7, 8]|501|-1|_|_|_|_|_|_|_|6203632
iso|Chemical|10|[8, 9]|501|-1|_|_|_|_|_|_|_|6203632
hydroxyproline|Chemical|2|[20, 21]|4|-1|_|_|_|_|_|_|_|6203632
body weight|Physiology|1|[28, 30]|3|-1|_|_|_|_|_|_|_|6203632
tissue mass|Physiology|2|[9, 11]|5|-1|_|_|_|_|_|_|_|6203632
heart weight|Physiology|3|[0, 2]|6|-1|_|_|_|_|_|_|_|6203632
intraventricular pressures|Physiology|8|[0, 2]|8|-1|_|_|_|_|_|_|_|6203632
coronary flow measures|Physiology|8|[3, 6]|9|-1|_|_|_|_|_|_|_|6203632
dp/dt|Physiology|9|[2, 5]|11|-1|_|_|_|_|_|_|_|6203632
forestomach carcinogenesis|Disease|0|[8, 10]|0|-1|_|_|_|_|_|_|_|3131282
forestomach tumorigenesis|Disease|1|[19, 21]|2|-1|_|_|_|_|_|_|_|3131282
forestomach tumors|Disease|3|[41, 43]|5|-1|_|_|_|_|_|_|_|3131282
butylated hydroxyanisole|Chemical|0|[16, 18]|501|-1|_|_|_|_|_|_|_|3131282
bha|Chemical|1|[14, 15]|501|-1|_|_|_|_|_|_|_|3131282
bha|Chemical|2|[17, 18]|501|-1|_|_|_|_|_|_|_|3131282
bha|Chemical|3|[4, 5]|501|-1|_|_|_|_|_|_|_|3131282
bha|Chemical|4|[4, 5]|501|-1|_|_|_|_|_|_|_|3131282
bha|Chemical|4|[41, 42]|501|-1|_|_|_|_|_|_|_|3131282
bha|Chemical|7|[13, 14]|501|-1|_|_|_|_|_|_|_|3131282
muscle rigidity|Disease|0|[6, 8]|0|-1|_|_|_|_|_|_|_|3115150
muscle rigidity|Disease|1|[18, 20]|0|-1|_|_|_|_|_|_|_|3115150
muscle rigidity|Disease|7|[11, 13]|0|-1|_|_|_|_|_|_|_|3115150
rigidity|Disease|4|[14, 15]|7|H|_|_|_|_|_|_|_|3115150
cardiovascular, and respiratory depression|Disease|8|[33, 38]|9|-1|_|_|_|_|_|_|_|3115150
ketanserin|Chemical|0|[0, 1]|1|-1|_|_|_|_|_|_|_|3115150
alfentanil|Chemical|0|[3, 4]|2|-1|_|_|_|_|_|_|_|3115150
serotonin|Chemical|1|[11, 12]|501|-1|_|_|_|_|_|_|_|3115150
chlordiazepoxide|Chemical|4|[0, 1]|501|-1|_|_|_|_|_|_|_|3115150
electromyographic activity|Physiology|3|[23, 25]|5|-1|_|_|_|_|_|_|_|3115150
glycopyrronium|Chemical|0|[0, 1]|0|-1|_|_|_|_|_|_|_|2917114
edrophonium|Chemical|0|[10, 11]|1|-1|_|_|_|_|_|_|_|2917114
cardiovascular effects|Physiology|1|[10, 12]|2|-1|_|_|_|_|_|_|_|2917114
heart rate|Physiology|3|[11, 13]|3|-1|_|_|_|_|_|_|_|2917114
cardiovascular stability|Physiology|4|[10, 12]|4|-1|_|_|_|_|_|_|_|2917114
muscular rigidity|Disease|0|[11, 13]|0|-1|_|_|_|_|_|_|_|2564649
muscular rigidity|Disease|1|[1, 3]|0|-1|_|_|_|_|_|_|_|2564649
muscular rigidity|Disease|4|[3, 5]|0|-1|_|_|_|_|_|_|_|2564649
muscular rigidity|Disease|6|[7, 9]|0|-1|_|_|_|_|_|_|_|2564649
fentanyl|Chemical|0|[8, 9]|501|-1|_|_|_|_|_|_|_|2564649
ketamine|Chemical|2|[26, 27]|5|-1|_|_|_|_|_|_|_|2564649
co2|Chemical|3|[12, 13]|501|-1|_|_|_|_|_|_|_|2564649
prazosin|Chemical|4|[32, 33]|501|-1|_|_|_|_|_|_|_|2564649
noradrenergic neurotransmission|Physiology|0|[5, 7]|2|-1|_|_|_|_|_|_|_|2564649
respiration|Physiology|3|[4, 5]|6|-1|_|_|_|_|_|_|_|2564649
body temperature|Physiology|3|[6, 8]|7|-1|_|_|_|_|_|_|_|2564649
electromyographic activity|Physiology|3|[31, 33]|8|-1|_|_|_|_|_|_|_|2564649
electromyographic excitation|Physiology|5|[25, 27]|12|-1|_|_|_|_|_|_|_|2564649
anesthesia|Treat|1|[18, 19]|4|-1|_|_|_|_|_|_|_|2564649
menorrhagia|Disease|0|[11, 12]|0|-1|_|_|_|_|_|_|_|2339463
left transverse sinus thrombosis|Disease|1|[14, 18]|1|-1|_|_|_|_|_|_|_|2339463
blood loss|Disease|2|[15, 17]|500|-1|_|_|_|_|_|_|_|2339463
thromboembolic disease|Disease|3|[4, 6]|500|H|_|_|_|_|_|_|_|2339463
epsilon-aminocaproic acid|Chemical|1|[21, 25]|2|-1|_|_|_|_|_|_|_|2339463
epsilon-aminocaproic acid therapy|Treat|1|[21, 26]|3|-1|_|_|_|_|_|_|_|2339463
clotting|Physiology|2|[12, 13]|5|-1|_|_|_|_|_|_|_|2339463
hemorrhagic cystitis|Disease|0|[0, 2]|0|-1|_|_|_|_|_|_|_|1545575
hemorrhagic cystitis|Disease|0|[0, 2]|0|-1|_|_|_|_|_|_|_|1545575
hemorrhagic cystitis|Disease|1|[0, 2]|0|-1|_|_|_|_|_|_|_|1545575
hemorrhagic cystitis|Disease|1|[0, 2]|0|-1|_|_|_|_|_|_|_|1545575
hemorrhagic cystitis|Disease|3|[30, 32]|0|-1|_|_|_|_|_|_|_|1545575
hemorrhagic cystitis|Disease|4|[11, 13]|0|-1|_|_|_|_|_|_|_|1545575
hemorrhagic cystitis|Disease|5|[19, 21]|0|-1|_|_|_|_|_|_|_|1545575
hemorrhagic cystitis|Disease|6|[21, 23]|0|-1|_|_|_|_|_|_|_|1545575
bone marrow transplantation|Treat|0|[3, 6]|2|-1|_|_|_|_|_|_|_|1545575
bone marrow transplant|Treat|2|[14, 17]|6|-1|_|_|_|_|_|_|_|1545575
forced hydration|Treat|2|[21, 23]|7|-1|_|_|_|_|_|_|_|1545575
bladder irrigation|Treat|2|[24, 26]|8|-1|_|_|_|_|_|_|_|1545575
uroprophylaxis|Treat|3|[17, 18]|11|-1|_|_|_|_|_|_|_|1545575
standard prophylaxis|Treat|4|[5, 7]|13|-1|_|_|_|_|_|_|_|1545575
cyclophosphamide|Chemical|1|[11, 12]|5|-1|_|_|_|_|_|_|_|1545575
mesna|Chemical|3|[19, 20]|10|-1|_|_|_|_|_|_|_|1545575
diazepam|Chemical|0|[32, 33]|0|-1|_|_|_|_|_|_|_|1286498
diazepam|Chemical|0|[12, 13]|0|-1|_|_|_|_|_|_|_|1286498
diazepam|Chemical|2|[36, 37]|0|-1|_|_|_|_|_|_|_|1286498
diazepam|Chemical|10|[9, 10]|0|-1|_|_|_|_|_|_|_|1286498
flumazenil|Chemical|0|[26, 27]|2|-1|_|_|_|_|_|_|_|1286498
flumazenil|Chemical|0|[6, 7]|2|-1|_|_|_|_|_|_|_|1286498
flumazenil|Chemical|2|[0, 1]|2|-1|_|_|_|_|_|_|_|1286498
flumazenil|Chemical|6|[0, 1]|2|-1|_|_|_|_|_|_|_|1286498
flumazenil|Chemical|7|[0, 1]|2|-1|_|_|_|_|_|_|_|1286498
flumazenil|Chemical|10|[0, 1]|2|-1|_|_|_|_|_|_|_|1286498
fentanyl|Chemical|2|[43, 44]|8|-1|_|_|_|_|_|_|_|1286498
meperidine|Chemical|2|[45, 46]|9|-1|_|_|_|_|_|_|_|1286498
morphine|Chemical|2|[48, 49]|10|-1|_|_|_|_|_|_|_|1286498
intravenous conscious sedation|Treat|0|[28, 31]|4|-1|_|_|_|_|_|_|_|1286498
intravenous conscious sedation|Treat|0|[8, 11]|4|-1|_|_|_|_|_|_|_|1286498
alertness|Physiology|5|[25, 26]|11|-1|_|_|_|_|_|_|_|1286498
vomiting|Disease|9|[8, 9]|501|-1|_|_|_|_|_|_|_|1286498
nausea|Disease|9|[6, 7]|15|-1|_|_|_|_|_|_|_|1286498
nausea|Disease|9|[14, 15]|15|-1|_|_|_|_|_|_|_|1286498
injection-site pain|Disease|9|[16, 20]|501|-1|_|_|_|_|_|_|_|1286498
oral contraceptives|Chemical|0|[13, 15]|0|-1|_|_|_|_|_|_|_|839274
adenoma|Disease|1|[4, 5]|1|-1|_|_|_|_|_|_|_|839274
adenoma|Disease|4|[7, 8]|1|-1|_|_|_|_|_|_|_|839274
focal nodular hyperplasia|Disease|1|[8, 11]|2|-1|_|_|_|_|_|_|_|839274
thrombocytopenia|Disease|0|[16, 17]|500|-1|_|_|_|_|_|_|_|591536
thrombocytopenia|Disease|0|[16, 17]|500|-1|_|_|_|_|_|_|_|591536
thrombocytopenia|Disease|2|[30, 31]|500|-1|_|_|_|_|_|_|_|591536
thrombocytopenia|Disease|5|[6, 7]|500|-1|_|_|_|_|_|_|_|591536
arterial occlusion|Disease|2|[5, 7]|500|-1|_|_|_|_|_|_|_|591536
distal ischemia|Disease|2|[13, 15]|5|-1|_|_|_|_|_|_|_|591536
occlusion|Disease|3|[3, 4]|500|-1|_|_|_|_|_|_|_|591536
platelet aggregation|Disease|5|[11, 13]|500|-1|_|_|_|_|_|_|_|591536
thromboembolism|Disease|5|[4, 5]|11|H|_|_|_|_|_|_|_|591536
systemic heparin therapy|Treat|0|[5, 8]|2|-1|_|_|_|_|_|_|_|591536
heparin therapy|Treat|2|[24, 26]|6|-1|_|_|_|_|_|_|_|591536
discontinuation of heparin|Treat|6|[4, 7]|15|-1|_|_|_|_|_|_|_|591536
anticoagulation with sodium warfarin|Treat|6|[9, 13]|16|-1|_|_|_|_|_|_|_|591536
platelet counts|Physiology|2|[32, 34]|7|-1|_|_|_|_|_|_|_|591536
platelet aggregation|Physiology|5|[11, 13]|12|-1|_|_|_|_|_|_|_|591536
warfarin|Chemical|6|[12, 13]|502|-1|_|_|_|_|_|_|_|591536
sodium warfarin|Chemical|6|[11, 13]|502|-1|_|_|_|_|_|_|_|591536
paracetamol|Chemical|0|[10, 11]|0|-1|_|_|_|_|_|_|_|20735774
paracetamol|Chemical|1|[10, 11]|0|-1|_|_|_|_|_|_|_|20735774
paracetamol|Chemical|2|[5, 6]|0|-1|_|_|_|_|_|_|_|20735774
paracetamol|Chemical|3|[11, 12]|0|-1|_|_|_|_|_|_|_|20735774
paracetamol|Chemical|6|[16, 17]|0|-1|_|_|_|_|_|_|_|20735774
paracetamol|Chemical|9|[2, 3]|0|-1|_|_|_|_|_|_|_|20735774
paracetamol|Chemical|9|[2, 3]|0|-1|_|_|_|_|_|_|_|20735774
liver failure|Disease|0|[14, 16]|501|-1|_|_|_|_|_|_|_|20735774
liver injury|Disease|3|[15, 17]|501|-1|_|_|_|_|_|_|_|20735774
liver disease|Disease|6|[65, 67]|7|H|_|_|_|_|_|_|_|20735774
transplant|Treat|0|[5, 6]|2|-1|_|_|_|_|_|_|_|20735774
psychosis|Disease|0|[10, 11]|500|-1|_|_|_|_|_|_|_|20705401
psychotic disorders|Disease|1|[14, 16]|500|-1|_|_|_|_|_|_|_|20705401
hyperactivity|Disease|2|[30, 31]|6|-1|_|_|_|_|_|_|_|20705401
serotonin|Chemical|0|[0, 1]|1|-1|_|_|_|_|_|_|_|20705401
methamphetamine|Chemical|0|[7, 8]|502|-1|_|_|_|_|_|_|_|20705401
clozapine|Chemical|2|[20, 21]|7|-1|_|_|_|_|_|_|_|20705401
olanzapine|Chemical|2|[22, 23]|8|-1|_|_|_|_|_|_|_|20705401
phencyclidine|Chemical|3|[13, 14]|9|-1|_|_|_|_|_|_|_|20705401
meth|Chemical|5|[5, 6]|502|-1|_|_|_|_|_|_|_|20705401
meth|Chemical|5|[5, 6]|502|-1|_|_|_|_|_|_|_|20705401
meth|Chemical|6|[19, 20]|502|-1|_|_|_|_|_|_|_|20705401
meth|Chemical|6|[19, 20]|502|-1|_|_|_|_|_|_|_|20705401
meth|Chemical|7|[31, 32]|502|-1|_|_|_|_|_|_|_|20705401
meth|Chemical|7|[31, 32]|502|-1|_|_|_|_|_|_|_|20705401
meth|Chemical|9|[6, 7]|502|-1|_|_|_|_|_|_|_|20705401
meth|Chemical|9|[6, 7]|502|-1|_|_|_|_|_|_|_|20705401
meth|Chemical|11|[32, 33]|502|-1|_|_|_|_|_|_|_|20705401
meth|Chemical|11|[32, 33]|502|-1|_|_|_|_|_|_|_|20705401
meth|Chemical|12|[12, 13]|502|-1|_|_|_|_|_|_|_|20705401
meth|Chemical|12|[12, 13]|502|-1|_|_|_|_|_|_|_|20705401
serotonin 6 receptor gene|Gene|0|[0, 4]|3|-1|_|_|_|_|_|_|_|20705401
5-ht6 gene (htr6)|Gene|6|[11, 18]|15|-1|_|_|_|_|_|_|_|20705401
htr6|Gene|11|[30, 31]|22|-1|_|_|_|_|_|_|_|20705401
htr6|Gene|12|[2, 3]|22|-1|_|_|_|_|_|_|_|20705401
neural transmission|Physiology|1|[4, 6]|5|-1|_|_|_|_|_|_|_|20705401
prepulse inhibition|Physiology|3|[5, 7]|10|-1|_|_|_|_|_|_|_|20705401
seizures|Disease|0|[11, 12]|0|H|_|_|_|_|_|_|_|19105845
convulsions|Disease|3|[38, 39]|4|-1|_|_|_|_|_|_|_|19105845
bupropion hydrochloride|Chemical|0|[7, 9]|501|-1|_|_|_|_|_|_|_|19105845
bupropion|Chemical|1|[17, 18]|501|-1|_|_|_|_|_|_|_|19105845
bupropion hcl|Chemical|3|[13, 15]|501|-1|_|_|_|_|_|_|_|19105845
bupropion hcl|Chemical|4|[26, 28]|501|-1|_|_|_|_|_|_|_|19105845
bupropion hcl|Chemical|5|[0, 2]|501|-1|_|_|_|_|_|_|_|19105845
bupropion hcl|Chemical|7|[9, 11]|501|-1|_|_|_|_|_|_|_|19105845
bupropion hcl|Chemical|8|[30, 32]|501|-1|_|_|_|_|_|_|_|19105845
infusion rates|Physiology|0|[4, 6]|2|-1|_|_|_|_|_|_|_|19105845
epileptiform activity|Disease|0|[8, 10]|0|-1|_|_|_|_|_|_|_|18657397
epilepsy|Disease|1|[9, 10]|500|-1|_|_|_|_|_|_|_|18657397
epileptic focus|Disease|4|[9, 11]|3|-1|_|_|_|_|_|_|_|18657397
epilepsies|Disease|8|[39, 40]|500|-1|_|_|_|_|_|_|_|18657397
urethane|Chemical|3|[10, 11]|2|-1|_|_|_|_|_|_|_|18657397
penicillin-g potassium|Chemical|4|[19, 23]|4|-1|_|_|_|_|_|_|_|18657397
basal activity|Physiology|4|[5, 7]|5|-1|_|_|_|_|_|_|_|18657397
cortical activity|Physiology|4|[30, 32]|6|-1|_|_|_|_|_|_|_|18657397
dexmedetomidine|Chemical|0|[2, 3]|0|-1|_|_|_|_|_|_|_|18363626
dexmedetomidine|Chemical|3|[2, 3]|0|-1|_|_|_|_|_|_|_|18363626
dexmedetomidine|Chemical|10|[2, 3]|0|-1|_|_|_|_|_|_|_|18363626
dexmedetomidine|Chemical|12|[0, 1]|0|-1|_|_|_|_|_|_|_|18363626
pentobarbital|Chemical|8|[44, 45]|4|-1|_|_|_|_|_|_|_|18363626
hemodynamic responses|Physiology|2|[5, 7]|1|-1|_|_|_|_|_|_|_|18363626
recovery time|Physiology|8|[58, 60]|6|-1|_|_|_|_|_|_|_|18363626
heart rate|Physiology|11|[11, 13]|9|-1|_|_|_|_|_|_|_|18363626
blood pressure|Physiology|11|[14, 16]|10|-1|_|_|_|_|_|_|_|18363626
sedation|Treat|6|[13, 14]|3|-1|_|_|_|_|_|_|_|18363626
sedation protocol|Treat|8|[2, 4]|5|-1|_|_|_|_|_|_|_|18363626
bradycardia|Disease|9|[10, 11]|7|-1|_|_|_|_|_|_|_|18363626
aggressiveness|Disease|0|[18, 19]|0|-1|_|_|_|_|_|_|_|16192988
aggressiveness|Disease|2|[16, 17]|0|-1|_|_|_|_|_|_|_|16192988
aggressiveness|Disease|3|[3, 4]|0|-1|_|_|_|_|_|_|_|16192988
psychiatric disorders|Disease|1|[11, 13]|3|-1|_|_|_|_|_|_|_|16192988
methamphetamine|Chemical|0|[0, 1]|1|-1|_|_|_|_|_|_|_|16192988
meth|Chemical|1|[20, 21]|2|-1|_|_|_|_|_|_|_|16192988
meth|Chemical|1|[20, 21]|2|-1|_|_|_|_|_|_|_|16192988
meth|Chemical|2|[13, 14]|2|-1|_|_|_|_|_|_|_|16192988
meth|Chemical|2|[13, 14]|2|-1|_|_|_|_|_|_|_|16192988
meth|Chemical|3|[8, 9]|2|-1|_|_|_|_|_|_|_|16192988
meth|Chemical|3|[8, 9]|2|-1|_|_|_|_|_|_|_|16192988
meth|Chemical|4|[23, 24]|2|-1|_|_|_|_|_|_|_|16192988
meth|Chemical|4|[23, 24]|2|-1|_|_|_|_|_|_|_|16192988
meth|Chemical|5|[34, 35]|2|-1|_|_|_|_|_|_|_|16192988
meth|Chemical|5|[34, 35]|2|-1|_|_|_|_|_|_|_|16192988
meth|Chemical|6|[10, 11]|2|-1|_|_|_|_|_|_|_|16192988
meth|Chemical|6|[23, 24]|2|-1|_|_|_|_|_|_|_|16192988
meth|Chemical|6|[10, 11]|2|-1|_|_|_|_|_|_|_|16192988
meth|Chemical|6|[23, 24]|2|-1|_|_|_|_|_|_|_|16192988
meth|Chemical|7|[22, 23]|2|-1|_|_|_|_|_|_|_|16192988
meth|Chemical|7|[22, 23]|2|-1|_|_|_|_|_|_|_|16192988
hyperactivity|Physiology|3|[11, 12]|11|-1|_|_|_|_|_|_|_|16192988
map kinase|Gene|4|[14, 16]|14|-1|_|_|_|_|_|_|_|16192988
map kinase|Gene|8|[6, 8]|14|-1|_|_|_|_|_|_|_|16192988
mek1|Gene|5|[11, 12]|16|-1|_|_|_|_|_|_|_|16192988
mek1|Gene|6|[0, 1]|16|-1|_|_|_|_|_|_|_|16192988
erk2p|Gene|5|[13, 14]|17|-1|_|_|_|_|_|_|_|16192988
gsk3alpha|Gene|5|[15, 16]|18|-1|_|_|_|_|_|_|_|16192988
gsk3alpha|Gene|7|[12, 13]|18|-1|_|_|_|_|_|_|_|16192988
14-3-3e|Gene|5|[17, 22]|19|-1|_|_|_|_|_|_|_|16192988
mek7|Gene|5|[24, 25]|20|-1|_|_|_|_|_|_|_|16192988
lamotrigine|Chemical|0|[0, 1]|500|-1|_|_|_|_|_|_|_|16157917
ltg|Chemical|1|[13, 14]|500|-1|_|_|_|_|_|_|_|16157917
ltg|Chemical|2|[4, 5]|500|-1|_|_|_|_|_|_|_|16157917
ltg|Chemical|3|[3, 4]|500|-1|_|_|_|_|_|_|_|16157917
ltg|Chemical|4|[4, 5]|500|-1|_|_|_|_|_|_|_|16157917
ltg|Chemical|4|[22, 23]|500|-1|_|_|_|_|_|_|_|16157917
idiopathic generalized epilepsies|Disease|0|[9, 12]|502|-1|_|_|_|_|_|_|_|16157917
myoclonus|Disease|0|[7, 8]|502|-1|_|_|_|_|_|_|_|16157917
ige|Disease|1|[7, 8]|502|-1|_|_|_|_|_|_|_|16157917
myoclonic jerks|Disease|1|[22, 24]|502|-1|_|_|_|_|_|_|_|16157917
mj|Disease|2|[6, 7]|502|-1|_|_|_|_|_|_|_|16157917
mj|Disease|4|[6, 7]|502|-1|_|_|_|_|_|_|_|16157917
myoclonic status|Disease|4|[16, 18]|502|-1|_|_|_|_|_|_|_|16157917
parkinson disease|Disease|0|[11, 13]|500|-1|_|_|_|_|_|_|_|16116131
parkinson disease|Disease|2|[23, 25]|500|-1|_|_|_|_|_|_|_|16116131
dyskinesias|Disease|0|[9, 10]|500|-1|_|_|_|_|_|_|_|16116131
dyskinesia|Disease|1|[10, 11]|500|H|_|_|_|_|_|_|_|16116131
dyskinetic|Disease|2|[41, 42]|7|H|_|_|_|_|_|_|_|16116131
drug-induced dyskinesias|Disease|3|[9, 13]|500|-1|_|_|_|_|_|_|_|16116131
rtms|Treat|0|[0, 1]|2|-1|_|_|_|_|_|_|_|16116131
rtms|Treat|3|[0, 1]|2|-1|_|_|_|_|_|_|_|16116131
rtms|Treat|3|[18, 19]|2|-1|_|_|_|_|_|_|_|16116131
repetitive transcranial magnetic stimulation|Treat|2|[1, 5]|8|-1|_|_|_|_|_|_|_|16116131
continuous apomorphine infusion|Treat|2|[45, 48]|9|-1|_|_|_|_|_|_|_|16116131
levodopa|Chemical|1|[7, 8]|3|-1|_|_|_|_|_|_|_|16116131
apomorphine|Chemical|2|[46, 47]|5|-1|_|_|_|_|_|_|_|16116131
amnesia|Disease|0|[7, 8]|0|H|_|_|_|_|_|_|_|15930398
amnesia|Disease|19|[26, 27]|0|H|_|_|_|_|_|_|_|15930398
retrograde amnesia|Disease|19|[25, 27]|15|-1|_|_|_|_|_|_|_|15930398
propofol|Chemical|0|[12, 13]|1|-1|_|_|_|_|_|_|_|15930398
procedural sedation|Treat|2|[16, 18]|2|-1|_|_|_|_|_|_|_|15930398
sedations|Treat|8|[9, 10]|4|-1|_|_|_|_|_|_|_|15930398
bis score|Physiology|5|[1, 3]|3|-1|_|_|_|_|_|_|_|15930398
bis score|Physiology|10|[6, 8]|3|-1|_|_|_|_|_|_|_|15930398
bis score|Physiology|11|[3, 5]|3|-1|_|_|_|_|_|_|_|15930398
bis score|Physiology|12|[3, 5]|3|-1|_|_|_|_|_|_|_|15930398
bis score|Physiology|13|[3, 5]|3|-1|_|_|_|_|_|_|_|15930398
bis score|Physiology|14|[2, 4]|3|-1|_|_|_|_|_|_|_|15930398
bis score|Physiology|15|[2, 4]|3|-1|_|_|_|_|_|_|_|15930398
bis score|Physiology|17|[35, 37]|3|-1|_|_|_|_|_|_|_|15930398
bis score|Physiology|17|[3, 5]|3|-1|_|_|_|_|_|_|_|15930398
bis scores|Physiology|18|[7, 9]|13|-1|_|_|_|_|_|_|_|15930398
bis|Physiology|19|[14, 15]|16|-1|_|_|_|_|_|_|_|15930398
hepatitis b|Disease|0|[3, 5]|0|-1|_|_|_|_|_|_|_|15867025
hepatitis b|Disease|1|[9, 11]|0|-1|_|_|_|_|_|_|_|15867025
hepatitis b|Disease|3|[29, 31]|0|-1|_|_|_|_|_|_|_|15867025
hepatitis b|Disease|3|[39, 41]|0|-1|_|_|_|_|_|_|_|15867025
hepatitis b|Disease|3|[10, 12]|0|-1|_|_|_|_|_|_|_|15867025
hepatitis b|Disease|3|[18, 20]|0|-1|_|_|_|_|_|_|_|15867025
hepatitis b|Disease|4|[6, 8]|0|-1|_|_|_|_|_|_|_|15867025
hepatitis b|Disease|5|[0, 2]|0|-1|_|_|_|_|_|_|_|15867025
hepatitis b|Disease|6|[15, 17]|0|-1|_|_|_|_|_|_|_|15867025
hepatitis b|Disease|6|[6, 8]|0|-1|_|_|_|_|_|_|_|15867025
hepatitis b|Disease|7|[17, 19]|0|-1|_|_|_|_|_|_|_|15867025
hepatitis b|Disease|11|[19, 21]|0|-1|_|_|_|_|_|_|_|15867025
rubella|Disease|0|[6, 7]|1|-1|_|_|_|_|_|_|_|15867025
hepatitis b vaccine|Chemical|3|[18, 21]|501|-1|_|_|_|_|_|_|_|15867025
hepatitis b vaccine|Chemical|3|[18, 21]|501|-1|_|_|_|_|_|_|_|15867025
hepatitis b vaccine|Chemical|5|[0, 3]|501|-1|_|_|_|_|_|_|_|15867025
rubella vaccine|Chemical|3|[57, 59]|501|-1|_|_|_|_|_|_|_|15867025
rubella immunity|Immune|3|[47, 49]|10|-1|_|_|_|_|_|_|_|15867025
rubella nonimmune|Immune|3|[60, 62]|11|-1|_|_|_|_|_|_|_|15867025
rubella nonimmunity|Immune|9|[13, 15]|21|-1|_|_|_|_|_|_|_|15867025
hepatitis b vaccine|Treat|5|[0, 3]|15|-1|_|_|_|_|_|_|_|15867025
hepatitis b vaccination|Treat|7|[17, 20]|19|-1|_|_|_|_|_|_|_|15867025
rubella vaccine|Treat|10|[4, 6]|22|-1|_|_|_|_|_|_|_|15867025
infant birth weight|Physiology|7|[10, 13]|20|-1|_|_|_|_|_|_|_|15867025
p300|Gene|0|[2, 3]|0|-1|_|_|_|_|_|_|_|14975762
alpha-sarcomeric actin|Gene|5|[25, 29]|9|-1|_|_|_|_|_|_|_|14975762
bcl-2|Gene|7|[26, 29]|12|-1|_|_|_|_|_|_|_|14975762
bcl-2|Gene|7|[8, 11]|12|-1|_|_|_|_|_|_|_|14975762
mdm-2|Gene|7|[12, 15]|14|-1|_|_|_|_|_|_|_|14975762
p53|Gene|7|[20, 21]|15|-1|_|_|_|_|_|_|_|14975762
doxorubicin|Chemical|1|[0, 1]|1|-1|_|_|_|_|_|_|_|14975762
doxorubicin|Chemical|1|[0, 1]|1|-1|_|_|_|_|_|_|_|14975762
doxorubicin|Chemical|2|[0, 1]|1|-1|_|_|_|_|_|_|_|14975762
doxorubicin|Chemical|2|[0, 1]|1|-1|_|_|_|_|_|_|_|14975762
doxorubicin|Chemical|3|[9, 10]|1|-1|_|_|_|_|_|_|_|14975762
doxorubicin|Chemical|4|[15, 16]|1|-1|_|_|_|_|_|_|_|14975762
doxorubicin|Chemical|6|[0, 1]|1|-1|_|_|_|_|_|_|_|14975762
doxorubicin|Chemical|6|[0, 1]|1|-1|_|_|_|_|_|_|_|14975762
doxorubicin|Chemical|8|[11, 12]|1|-1|_|_|_|_|_|_|_|14975762
survival rate|Physiology|5|[11, 13]|7|-1|_|_|_|_|_|_|_|14975762
left ventricular function|Physiology|5|[18, 21]|8|-1|_|_|_|_|_|_|_|14975762
heart failure|Disease|8|[21, 23]|17|-1|_|_|_|_|_|_|_|14975762
doxorubicin|Chemical|0|[10, 11]|0|-1|_|_|_|_|_|_|_|14736955
doxorubicin|Chemical|1|[2, 3]|0|-1|_|_|_|_|_|_|_|14736955
doxorubicin|Chemical|1|[2, 3]|0|-1|_|_|_|_|_|_|_|14736955
doxorubicin|Chemical|3|[7, 8]|0|-1|_|_|_|_|_|_|_|14736955
doxorubicin|Chemical|13|[29, 30]|0|-1|_|_|_|_|_|_|_|14736955
nadh|Chemical|8|[22, 23]|8|-1|_|_|_|_|_|_|_|14736955
nephrosis|Disease|0|[11, 12]|1|H|_|_|_|_|_|_|_|14736955
nephropathy|Disease|1|[8, 9]|3|H|_|_|_|_|_|_|_|14736955
mitochondrial injury|Disease|2|[6, 8]|501|-1|_|_|_|_|_|_|_|14736955
tubular lesions|Disease|8|[13, 15]|7|-1|_|_|_|_|_|_|_|14736955
glomerular lesions|Disease|10|[18, 20]|10|-1|_|_|_|_|_|_|_|14736955
renal lesions|Disease|13|[32, 34]|501|H|_|_|_|_|_|_|_|14736955
cox subunit i|Gene|9|[9, 12]|9|-1|_|_|_|_|_|_|_|14736955
cox-i|Gene|11|[33, 36]|11|-1|_|_|_|_|_|_|_|14736955
respiratory chain function|Physiology|13|[21, 24]|14|-1|_|_|_|_|_|_|_|14736955
seizures|Disease|0|[4, 5]|500|H|_|_|_|_|_|_|_|11573852
aids|Disease|0|[9, 10]|500|-1|_|_|_|_|_|_|_|11573852
aids|Disease|1|[14, 15]|500|-1|_|_|_|_|_|_|_|11573852
aids|Disease|5|[2, 3]|500|-1|_|_|_|_|_|_|_|11573852
aids|Disease|9|[17, 18]|500|-1|_|_|_|_|_|_|_|11573852
grand mal seizures|Disease|2|[15, 18]|501|-1|_|_|_|_|_|_|_|11573852
petit mal seizures|Disease|2|[26, 29]|500|-1|_|_|_|_|_|_|_|11573852
cryptococcal meningitis|Disease|5|[4, 6]|500|-1|_|_|_|_|_|_|_|11573852
alcohol abuse|Disease|6|[6, 8]|18|-1|_|_|_|_|_|_|_|11573852
withdrawal|Disease|6|[14, 15]|501|-1|_|_|_|_|_|_|_|11573852
seizure|Disease|8|[7, 8]|500|H|_|_|_|_|_|_|_|11573852
amphotericin b|Chemical|0|[0, 2]|1|-1|_|_|_|_|_|_|_|11573852
amphotericin b|Chemical|1|[17, 19]|1|-1|_|_|_|_|_|_|_|11573852
amphotericin b|Chemical|2|[22, 24]|1|-1|_|_|_|_|_|_|_|11573852
amphotericin b|Chemical|9|[7, 9]|1|-1|_|_|_|_|_|_|_|11573852
amphotericin b|Chemical|10|[2, 4]|1|-1|_|_|_|_|_|_|_|11573852
amphotericin b|Chemical|11|[10, 12]|1|-1|_|_|_|_|_|_|_|11573852
didanosine|Chemical|3|[5, 6]|503|-1|_|_|_|_|_|_|_|11573852
didanosine|Chemical|7|[0, 1]|503|-1|_|_|_|_|_|_|_|11573852
hydroxyzine|Chemical|3|[7, 8]|504|-1|_|_|_|_|_|_|_|11573852
promethazine|Chemical|3|[9, 10]|505|-1|_|_|_|_|_|_|_|11573852
hydrocortisone|Chemical|3|[11, 12]|505|-1|_|_|_|_|_|_|_|11573852
prochlorperazine|Chemical|3|[14, 15]|505|-1|_|_|_|_|_|_|_|11573852
phenytoin|Chemical|4|[3, 4]|505|-1|_|_|_|_|_|_|_|11573852
lorazepam|Chemical|4|[5, 6]|505|-1|_|_|_|_|_|_|_|11573852
amphotercin b|Chemical|4|[14, 16]|504|-1|_|_|_|_|_|_|_|11573852
alcohol|Chemical|6|[9, 10]|505|-1|_|_|_|_|_|_|_|11573852
alcohol|Chemical|6|[6, 7]|505|-1|_|_|_|_|_|_|_|11573852
tobramycin|Chemical|0|[4, 5]|0|H|_|_|_|_|_|_|_|9875685
tobramycin|Chemical|4|[0, 1]|0|H|_|_|_|_|_|_|_|9875685
tobramicyn|Chemical|1|[20, 21]|1|-1|_|_|_|_|_|_|_|9875685
steady-state serum concentrations|Physiology|1|[22, 27]|2|-1|_|_|_|_|_|_|_|9875685
concentrations|Physiology|4|[2, 3]|4|-1|_|_|_|_|_|_|_|9875685
renal function|Physiology|6|[17, 19]|5|-1|_|_|_|_|_|_|_|9875685
body weight|Physiology|6|[14, 16]|6|-1|_|_|_|_|_|_|_|9875685
peak concentrations|Physiology|9|[0, 2]|7|-1|_|_|_|_|_|_|_|9875685
auditory function|Physiology|13|[8, 10]|12|-1|_|_|_|_|_|_|_|9875685
auditory function|Physiology|13|[34, 36]|12|-1|_|_|_|_|_|_|_|9875685
nephrotoxicity|Disease|12|[21, 22]|8|-1|_|_|_|_|_|_|_|9875685
decreased auditory function|Disease|13|[7, 10]|501|-1|_|_|_|_|_|_|_|9875685
decreased auditory function|Disease|13|[33, 36]|501|-1|_|_|_|_|_|_|_|9875685
auditory loss|Disease|13|[17, 19]|501|-1|_|_|_|_|_|_|_|9875685
single-dose therapy|Treat|15|[2, 6]|14|-1|_|_|_|_|_|_|_|9875685
doxorubicin|Chemical|0|[17, 18]|0|-1|_|_|_|_|_|_|_|9848575
doxorubicin|Chemical|1|[32, 33]|0|-1|_|_|_|_|_|_|_|9848575
doxorubicin|Chemical|2|[23, 24]|0|-1|_|_|_|_|_|_|_|9848575
doxorubicin|Chemical|4|[7, 8]|0|-1|_|_|_|_|_|_|_|9848575
doxorubicin|Chemical|5|[24, 25]|0|-1|_|_|_|_|_|_|_|9848575
doxorubicin|Chemical|6|[14, 15]|0|-1|_|_|_|_|_|_|_|9848575
doxorubicin|Chemical|7|[11, 12]|0|-1|_|_|_|_|_|_|_|9848575
doxorubicin|Chemical|9|[18, 19]|0|-1|_|_|_|_|_|_|_|9848575
sm-5887|Chemical|0|[9, 12]|2|-1|_|_|_|_|_|_|_|9848575
sm-5887|Chemical|1|[20, 23]|2|-1|_|_|_|_|_|_|_|9848575
sm-5887|Chemical|1|[11, 14]|2|-1|_|_|_|_|_|_|_|9848575
sm-5887|Chemical|2|[33, 36]|2|-1|_|_|_|_|_|_|_|9848575
sm-5887|Chemical|4|[35, 38]|2|-1|_|_|_|_|_|_|_|9848575
sm-5887|Chemical|5|[8, 11]|2|-1|_|_|_|_|_|_|_|9848575
sm-5887|Chemical|6|[24, 27]|2|-1|_|_|_|_|_|_|_|9848575
sm-5887|Chemical|9|[3, 6]|2|-1|_|_|_|_|_|_|_|9848575
cardiomyopathy|Disease|0|[20, 21]|1|-1|_|_|_|_|_|_|_|9848575
cardiotoxic|Disease|1|[8, 9]|3|H|_|_|_|_|_|_|_|9848575
cardiotoxic|Disease|5|[5, 6]|3|H|_|_|_|_|_|_|_|9848575
cardiotoxic|Disease|7|[4, 5]|3|H|_|_|_|_|_|_|_|9848575
chronic cardiotoxicity|Disease|9|[12, 14]|23|-1|_|_|_|_|_|_|_|9848575
blood pressure|Physiology|4|[47, 49]|11|-1|_|_|_|_|_|_|_|9848575
blood pressure|Physiology|4|[18, 20]|11|-1|_|_|_|_|_|_|_|9848575
doxorubicin treatment|Treat|7|[11, 13]|20|-1|_|_|_|_|_|_|_|9848575
sm-5887|Treat|8|[5, 8]|21|-1|_|_|_|_|_|_|_|9848575
posteroventral medial pallidotomy|Treat|0|[0, 3]|0|-1|_|_|_|_|_|_|_|9321531
posteroventral medial pallidotomy|Treat|1|[2, 5]|0|-1|_|_|_|_|_|_|_|9321531
surgery|Treat|7|[24, 25]|11|-1|_|_|_|_|_|_|_|9321531
surgery|Treat|7|[20, 21]|11|-1|_|_|_|_|_|_|_|9321531
pallidotomy|Treat|9|[11, 12]|14|-1|_|_|_|_|_|_|_|9321531
dopaminergic therapy|Treat|11|[9, 11]|15|-1|_|_|_|_|_|_|_|9321531
dyskinesias|Disease|4|[75, 76]|2|H|_|_|_|_|_|_|_|9321531
dyskinesias|Disease|4|[98, 99]|2|H|_|_|_|_|_|_|_|9321531
parkinsonism|Disease|5|[12, 13]|500|H|_|_|_|_|_|_|_|9321531
bradykinesia|Disease|5|[15, 16]|6|-1|_|_|_|_|_|_|_|9321531
rigidity|Disease|5|[18, 19]|500|-1|_|_|_|_|_|_|_|9321531
ipsilateral dyskinesias|Disease|6|[3, 5]|8|-1|_|_|_|_|_|_|_|9321531
motor function|Physiology|4|[18, 20]|4|-1|_|_|_|_|_|_|_|9321531
postural stability|Physiology|6|[15, 17]|9|-1|_|_|_|_|_|_|_|9321531
gait|Physiology|6|[18, 19]|10|-1|_|_|_|_|_|_|_|9321531
levodopa|Chemical|9|[14, 15]|13|-1|_|_|_|_|_|_|_|9321531
pilocarpine|Chemical|0|[6, 7]|500|-1|_|_|_|_|_|_|_|9305828
pilocarpine|Chemical|3|[1, 2]|500|-1|_|_|_|_|_|_|_|9305828
neuropeptide-y|Chemical|0|[0, 3]|2|-1|_|_|_|_|_|_|_|9305828
neuropeptide-y|Chemical|1|[0, 3]|2|-1|_|_|_|_|_|_|_|9305828
pilo|Chemical|3|[3, 4]|500|-1|_|_|_|_|_|_|_|9305828
pilo|Chemical|5|[0, 1]|500|-1|_|_|_|_|_|_|_|9305828
pilo|Chemical|7|[3, 4]|500|-1|_|_|_|_|_|_|_|9305828
pilo|Chemical|8|[30, 31]|500|-1|_|_|_|_|_|_|_|9305828
peroxidase-antiperoxidase|Chemical|4|[2, 5]|13|-1|_|_|_|_|_|_|_|9305828
temporal lobe epilepsy|Disease|0|[9, 12]|502|-1|_|_|_|_|_|_|_|9305828
seizure-like events|Disease|2|[15, 19]|502|-1|_|_|_|_|_|_|_|9305828
epilepsy|Disease|3|[7, 8]|502|-1|_|_|_|_|_|_|_|9305828
status epilepticus|Disease|3|[15, 17]|9|-1|_|_|_|_|_|_|_|9305828
spontaneous recurrent seizures|Disease|3|[19, 22]|502|-1|_|_|_|_|_|_|_|9305828
brain damage|Disease|3|[24, 26]|502|-1|_|_|_|_|_|_|_|9305828
tle|Disease|8|[33, 34]|502|-1|_|_|_|_|_|_|_|9305828
npy|Gene|1|[4, 5]|4|-1|_|_|_|_|_|_|_|9305828
npy|Gene|2|[9, 10]|4|-1|_|_|_|_|_|_|_|9305828
npy|Gene|4|[7, 8]|4|-1|_|_|_|_|_|_|_|9305828
npy|Gene|5|[5, 6]|4|-1|_|_|_|_|_|_|_|9305828
npy|Gene|6|[0, 1]|4|-1|_|_|_|_|_|_|_|9305828
npy|Gene|7|[13, 14]|4|-1|_|_|_|_|_|_|_|9305828
npy|Gene|8|[6, 7]|4|-1|_|_|_|_|_|_|_|9305828
npy|Gene|8|[23, 24]|4|-1|_|_|_|_|_|_|_|9305828
npy|Gene|9|[9, 10]|4|-1|_|_|_|_|_|_|_|9305828
myopic|Disease|0|[2, 3]|0|-1|_|_|_|_|_|_|_|9041081
elevated intraocular pressure|Disease|6|[15, 18]|5|-1|_|_|_|_|_|_|_|9041081
photorefractive keratectomy|Treat|0|[5, 7]|1|-1|_|_|_|_|_|_|_|9041081
prk|Treat|3|[32, 33]|3|-1|_|_|_|_|_|_|_|9041081
corticosteroid therapy|Treat|6|[24, 26]|7|-1|_|_|_|_|_|_|_|9041081
excimer laser prk|Treat|8|[3, 6]|9|-1|_|_|_|_|_|_|_|9041081
electrophysiologic function|Physiology|0|[9, 11]|2|-1|_|_|_|_|_|_|_|9041081
intraocular pressure|Physiology|6|[16, 18]|8|-1|_|_|_|_|_|_|_|9041081
iop|Physiology|9|[5, 6]|11|-1|_|_|_|_|_|_|_|9041081
steroid|Chemical|6|[12, 13]|4|H|_|_|_|_|_|_|_|9041081
steroid|Chemical|9|[2, 3]|4|H|_|_|_|_|_|_|_|9041081
corticosteroid|Chemical|6|[24, 25]|6|-1|_|_|_|_|_|_|_|9041081
sarcoma|Disease|0|[7, 8]|500|H|_|_|_|_|_|_|_|8305357
sarcoma|Disease|1|[31, 32]|500|H|_|_|_|_|_|_|_|8305357
sarcoma|Disease|2|[8, 9]|500|H|_|_|_|_|_|_|_|8305357
sarcoma|Disease|7|[5, 6]|500|H|_|_|_|_|_|_|_|8305357
sarcoma|Disease|11|[22, 23]|500|H|_|_|_|_|_|_|_|8305357
kaposi's sarcoma|Disease|0|[4, 8]|1|-1|_|_|_|_|_|_|_|8305357
kaposi's sarcoma|Disease|1|[28, 32]|1|-1|_|_|_|_|_|_|_|8305357
kaposi's sarcoma|Disease|2|[5, 9]|1|-1|_|_|_|_|_|_|_|8305357
kaposi's sarcoma|Disease|7|[2, 6]|1|-1|_|_|_|_|_|_|_|8305357
kaposi's sarcoma|Disease|11|[19, 23]|1|-1|_|_|_|_|_|_|_|8305357
aids|Disease|1|[26, 27]|500|-1|_|_|_|_|_|_|_|8305357
neutropenia|Disease|9|[13, 14]|11|-1|_|_|_|_|_|_|_|8305357
daunorubicin|Chemical|0|[1, 2]|2|-1|_|_|_|_|_|_|_|8305357
daunorubicin|Treat|1|[18, 19]|6|-1|_|_|_|_|_|_|_|8305357
thrombosis|Disease|1|[9, 10]|0|-1|_|_|_|_|_|_|_|8012887
platelet aggregation|Disease|2|[16, 18]|1|-1|_|_|_|_|_|_|_|8012887
ancrod treatment|Treat|3|[8, 10]|2|-1|_|_|_|_|_|_|_|8012887
seizure|Disease|0|[0, 1]|500|-1|_|_|_|_|_|_|_|7651879
seizures|Disease|2|[0, 1]|500|-1|_|_|_|_|_|_|_|7651879
cardiac arrhythmias|Disease|2|[2, 4]|4|-1|_|_|_|_|_|_|_|7651879
overdose|Disease|3|[0, 1]|5|-1|_|_|_|_|_|_|_|7651879
generalized tonic-clonic seizure|Disease|5|[6, 11]|500|-1|_|_|_|_|_|_|_|7651879
flumazenil|Chemical|0|[2, 3]|1|-1|_|_|_|_|_|_|_|7651879
flumazenil|Chemical|1|[0, 1]|1|-1|_|_|_|_|_|_|_|7651879
neuropathy|Disease|0|[7, 8]|0|-1|_|_|_|_|_|_|_|3015327
isoniazid|Chemical|0|[6, 7]|1|-1|_|_|_|_|_|_|_|3015327
iopentol|Chemical|0|[3, 4]|0|-1|_|_|_|_|_|_|_|2980315
iopentol|Chemical|4|[0, 1]|0|-1|_|_|_|_|_|_|_|2980315
iohexol|Chemical|0|[5, 6]|1|-1|_|_|_|_|_|_|_|2980315
metrizoate|Chemical|0|[7, 8]|2|-1|_|_|_|_|_|_|_|2980315
ventricular fibrillation|Disease|0|[19, 21]|3|-1|_|_|_|_|_|_|_|2980315
aortic pressure|Physiology|0|[24, 26]|4|-1|_|_|_|_|_|_|_|2980315
blood pressure|Physiology|4|[10, 12]|6|-1|_|_|_|_|_|_|_|2980315
deep venous thrombosis|Disease|1|[7, 10]|0|-1|_|_|_|_|_|_|_|2819587
oral contraceptive|Chemical|3|[11, 13]|1|-1|_|_|_|_|_|_|_|2819587
coronary stenosis|Disease|0|[13, 15]|500|-1|_|_|_|_|_|_|_|1564236
coronary occlusion|Disease|1|[21, 23]|1|-1|_|_|_|_|_|_|_|1564236
coronary stenoses|Disease|1|[26, 28]|500|-1|_|_|_|_|_|_|_|1564236
partial coronary stenosis|Disease|6|[13, 16]|500|-1|_|_|_|_|_|_|_|1564236
dipyridamole|Chemical|6|[1, 2]|3|-1|_|_|_|_|_|_|_|1564236
dipyridamole|Chemical|7|[22, 23]|3|-1|_|_|_|_|_|_|_|1564236
dipyridamole|Chemical|9|[14, 15]|3|-1|_|_|_|_|_|_|_|1564236
hyperemia|Physiology|6|[4, 5]|5|-1|_|_|_|_|_|_|_|1564236
furosemide|Chemical|0|[4, 5]|0|-1|_|_|_|_|_|_|_|1300436
furosemide|Chemical|1|[11, 12]|0|-1|_|_|_|_|_|_|_|1300436
furosemide|Chemical|3|[9, 10]|0|-1|_|_|_|_|_|_|_|1300436
furosemide|Chemical|6|[9, 10]|0|-1|_|_|_|_|_|_|_|1300436
furosemide|Chemical|7|[9, 10]|0|-1|_|_|_|_|_|_|_|1300436
furosemide|Chemical|8|[0, 1]|0|-1|_|_|_|_|_|_|_|1300436
furosemide|Chemical|8|[0, 1]|0|-1|_|_|_|_|_|_|_|1300436
radiocontrast|Chemical|2|[6, 7]|3|-1|_|_|_|_|_|_|_|1300436
intravenous fluids|Treat|1|[15, 17]|2|-1|_|_|_|_|_|_|_|1300436
renal function significantly deteriorated|Disease|6|[0, 4]|6|-1|_|_|_|_|_|_|_|1300436
weight loss|Disease|7|[5, 7]|8|-1|_|_|_|_|_|_|_|1300436
renal pathology|Disease|0|[1, 3]|0|-1|_|_|_|_|_|_|_|1141447
diabetes insipidus|Disease|0|[10, 12]|1|-1|_|_|_|_|_|_|_|1141447
lithium|Chemical|0|[7, 8]|2|-1|_|_|_|_|_|_|_|1141447
liver tumors|Disease|0|[6, 8]|500|H|_|_|_|_|_|_|_|188339
liver tumors|Disease|2|[3, 5]|500|H|_|_|_|_|_|_|_|188339
adenoma|Disease|4|[15, 16]|500|-1|_|_|_|_|_|_|_|188339
focal nodular hyperplasia|Disease|4|[11, 14]|6|-1|_|_|_|_|_|_|_|188339
hepatoma|Disease|4|[20, 21]|500|-1|_|_|_|_|_|_|_|188339
oral contraceptives|Chemical|0|[10, 12]|502|-1|_|_|_|_|_|_|_|188339
oral contraceptives|Chemical|2|[7, 9]|502|-1|_|_|_|_|_|_|_|188339
oral contraceptive|Chemical|1|[17, 19]|502|-1|_|_|_|_|_|_|_|188339
oral contraceptive|Chemical|5|[9, 11]|502|-1|_|_|_|_|_|_|_|188339
graft-versus-host disease|Disease|0|[0, 6]|500|H|_|_|_|_|_|_|_|19135948
sinusoidal obstruction syndrome|Disease|0|[18, 21]|501|H|_|_|_|_|_|_|_|19135948
microangiopathy|Disease|0|[22, 23]|502|H|_|_|_|_|_|_|_|19135948
myelodysplastic syndrome|Disease|3|[21, 23]|503|-1|_|_|_|_|_|_|_|19135948
mds|Disease|3|[24, 25]|503|-1|_|_|_|_|_|_|_|19135948
myeloid leukemia|Disease|3|[32, 34]|501|H|_|_|_|_|_|_|_|19135948
aml|Disease|3|[35, 36]|503|-1|_|_|_|_|_|_|_|19135948
mucositis|Disease|4|[11, 12]|503|-1|_|_|_|_|_|_|_|19135948
grade ii-iv gvhd|Disease|5|[7, 12]|503|-1|_|_|_|_|_|_|_|19135948
transplantation-associated microangiopathy|Disease|6|[0, 4]|503|-1|_|_|_|_|_|_|_|19135948
tma|Disease|6|[5, 6]|503|-1|_|_|_|_|_|_|_|19135948
tma|Disease|9|[19, 20]|503|-1|_|_|_|_|_|_|_|19135948
sos|Disease|7|[18, 19]|503|-1|_|_|_|_|_|_|_|19135948
sos|Disease|9|[21, 22]|503|-1|_|_|_|_|_|_|_|19135948
gvhd|Disease|9|[14, 15]|503|-1|_|_|_|_|_|_|_|19135948
everolimus|Chemical|0|[8, 9]|3|-1|_|_|_|_|_|_|_|19135948
everolimus|Chemical|2|[0, 1]|3|-1|_|_|_|_|_|_|_|19135948
tacrolimus|Chemical|0|[10, 11]|4|-1|_|_|_|_|_|_|_|19135948
methotrexate|Chemical|1|[5, 6]|6|-1|_|_|_|_|_|_|_|19135948
sirolimus|Chemical|2|[5, 6]|9|-1|_|_|_|_|_|_|_|19135948
graft-versus-host disease prophylaxis|Treat|0|[0, 7]|5|-1|_|_|_|_|_|_|_|19135948
allogeneic hematopoietic stem cell transplantation|Treat|1|[21, 26]|7|-1|_|_|_|_|_|_|_|19135948
hsct|Treat|3|[46, 47]|14|-1|_|_|_|_|_|_|_|19135948
loreclezole|Chemical|0|[9, 10]|500|-1|_|_|_|_|_|_|_|14704468
loreclezole|Chemical|1|[0, 1]|500|-1|_|_|_|_|_|_|_|14704468
valproate|Chemical|0|[14, 15]|1|-1|_|_|_|_|_|_|_|14704468
clonazepam|Chemical|0|[16, 17]|2|-1|_|_|_|_|_|_|_|14704468
carbamazepine|Chemical|2|[18, 19]|500|-1|_|_|_|_|_|_|_|14704468
bicuculline|Chemical|4|[4, 5]|500|-1|_|_|_|_|_|_|_|14704468
bay k-8644|Chemical|4|[15, 19]|8|-1|_|_|_|_|_|_|_|14704468
bay k-8644|Chemical|5|[9, 13]|8|-1|_|_|_|_|_|_|_|14704468
aminophylline|Chemical|5|[7, 8]|9|-1|_|_|_|_|_|_|_|14704468
antiepileptics|Chemical|6|[16, 17]|11|-1|_|_|_|_|_|_|_|14704468
gabaergic neurotransmission|Chemical|6|[21, 23]|12|-1|_|_|_|_|_|_|_|14704468
seizure|Disease|1|[20, 21]|4|-1|_|_|_|_|_|_|_|14704468
afterdischarge|Physiology|1|[22, 23]|5|-1|_|_|_|_|_|_|_|14704468
acute liver failure|Disease|0|[0, 3]|500|-1|_|_|_|_|_|_|_|12549952
liver failure|Disease|1|[8, 10]|500|-1|_|_|_|_|_|_|_|12549952
hyperthyroidism|Disease|2|[15, 16]|500|-1|_|_|_|_|_|_|_|12549952
deterioration of renal function|Disease|4|[7, 11]|501|-1|_|_|_|_|_|_|_|12549952
liver injury|Disease|5|[10, 12]|500|H|_|_|_|_|_|_|_|12549952
sepsis|Disease|6|[6, 7]|500|-1|_|_|_|_|_|_|_|12549952
coagulopathy|Disease|6|[8, 9]|500|-1|_|_|_|_|_|_|_|12549952
hepatotoxicity|Disease|8|[5, 6]|500|-1|_|_|_|_|_|_|_|12549952
liver insult|Disease|10|[11, 13]|500|-1|_|_|_|_|_|_|_|12549952
hepatotoxic|Disease|10|[20, 21]|501|H|_|_|_|_|_|_|_|12549952
bupropion|Chemical|0|[5, 6]|1|-1|_|_|_|_|_|_|_|12549952
carbimazole|Chemical|0|[7, 8]|2|-1|_|_|_|_|_|_|_|12549952
propranolol|Chemical|2|[22, 23]|5|-1|_|_|_|_|_|_|_|12549952
hormone therapy|Treat|0|[2, 4]|0|-1|_|_|_|_|_|_|_|19370593
hormone therapy|Treat|1|[2, 4]|0|-1|_|_|_|_|_|_|_|19370593
ht|Treat|3|[10, 11]|7|-1|_|_|_|_|_|_|_|19370593
ht|Treat|6|[9, 10]|7|-1|_|_|_|_|_|_|_|19370593
ht|Treat|10|[7, 8]|7|-1|_|_|_|_|_|_|_|19370593
ht|Treat|11|[6, 7]|7|-1|_|_|_|_|_|_|_|19370593
ht|Treat|12|[6, 7]|7|-1|_|_|_|_|_|_|_|19370593
ht|Treat|12|[17, 18]|7|-1|_|_|_|_|_|_|_|19370593
ht|Treat|18|[4, 5]|7|-1|_|_|_|_|_|_|_|19370593
ht|Treat|19|[8, 9]|7|-1|_|_|_|_|_|_|_|19370593
placebo|Treat|6|[11, 12]|10|-1|_|_|_|_|_|_|_|19370593
continuous combined ht|Treat|13|[23, 26]|24|-1|_|_|_|_|_|_|_|19370593
combined continuous ht|Treat|14|[11, 14]|25|-1|_|_|_|_|_|_|_|19370593
combined continuous ht|Treat|15|[15, 18]|25|-1|_|_|_|_|_|_|_|19370593
combined continuous ht|Treat|16|[15, 18]|25|-1|_|_|_|_|_|_|_|19370593
oestrogen-only ht|Treat|15|[21, 25]|28|-1|_|_|_|_|_|_|_|19370593
dementia|Disease|1|[30, 31]|500|-1|_|_|_|_|_|_|_|19370593
dementia|Disease|13|[37, 38]|500|-1|_|_|_|_|_|_|_|19370593
menopausal symptoms|Disease|1|[12, 14]|501|-1|_|_|_|_|_|_|_|19370593
cardiovascular disease|Disease|1|[25, 27]|502|H|_|_|_|_|_|_|_|19370593
osteoporosis|Disease|1|[28, 29]|502|-1|_|_|_|_|_|_|_|19370593
gallbladder disease|Disease|3|[19, 21]|501|-1|_|_|_|_|_|_|_|19370593
menstrual disorders|Disease|4|[17, 19]|501|-1|_|_|_|_|_|_|_|19370593
stroke|Disease|10|[29, 30]|501|-1|_|_|_|_|_|_|_|19370593
stroke|Disease|11|[17, 18]|501|-1|_|_|_|_|_|_|_|19370593
venous thrombo-embolism|Disease|10|[13, 17]|14|-1|_|_|_|_|_|_|_|19370593
fractures|Disease|12|[12, 13]|502|-1|_|_|_|_|_|_|_|19370593
colon cancer|Disease|12|[19, 21]|501|-1|_|_|_|_|_|_|_|19370593
progestogens|Chemical|7|[7, 8]|11|-1|_|_|_|_|_|_|_|19370593
oestrogens|Chemical|7|[2, 3]|504|-1|_|_|_|_|_|_|_|19370593
oestrogen|Chemical|11|[3, 4]|504|-1|_|_|_|_|_|_|_|19370593
oestrogen|Chemical|15|[21, 22]|504|-1|_|_|_|_|_|_|_|19370593
gliomas|Disease|0|[7, 8]|500|-1|_|_|_|_|_|_|_|17019386
elevated icp|Disease|1|[12, 14]|2|H|_|_|_|_|_|_|_|17019386
elevated icp|Disease|1|[12, 14]|2|H|_|_|_|_|_|_|_|17019386
brain tumor|Disease|1|[15, 17]|500|-1|_|_|_|_|_|_|_|17019386
brain tumor|Disease|4|[22, 24]|500|-1|_|_|_|_|_|_|_|17019386
edema|Disease|1|[9, 10]|501|H|_|_|_|_|_|_|_|17019386
edema|Disease|9|[38, 39]|501|H|_|_|_|_|_|_|_|17019386
brain edema|Disease|1|[8, 10]|501|H|_|_|_|_|_|_|_|17019386
metastases|Disease|5|[27, 28]|10|-1|_|_|_|_|_|_|_|17019386
metastases|Disease|8|[3, 4]|10|-1|_|_|_|_|_|_|_|17019386
malignant glioma|Disease|5|[22, 24]|500|-1|_|_|_|_|_|_|_|17019386
meningioma|Disease|5|[30, 31]|12|-1|_|_|_|_|_|_|_|17019386
edematous|Disease|6|[8, 9]|15|H|_|_|_|_|_|_|_|17019386
glioma|Disease|7|[26, 27]|500|-1|_|_|_|_|_|_|_|17019386
neoplastic|Disease|8|[22, 23]|20|-1|_|_|_|_|_|_|_|17019386
peritumoral edema|Disease|9|[37, 39]|501|-1|_|_|_|_|_|_|_|17019386
mannitol|Chemical|0|[2, 3]|1|-1|_|_|_|_|_|_|_|17019386
mannitol|Chemical|5|[2, 3]|1|-1|_|_|_|_|_|_|_|17019386
mannitol|Chemical|7|[0, 1]|1|-1|_|_|_|_|_|_|_|17019386
mannitol|Chemical|7|[29, 30]|1|-1|_|_|_|_|_|_|_|17019386
icp|Physiology|1|[13, 14]|7|-1|_|_|_|_|_|_|_|17019386
icp|Physiology|9|[43, 44]|7|-1|_|_|_|_|_|_|_|17019386
osmotic gradient|Physiology|2|[15, 17]|8|-1|_|_|_|_|_|_|_|17019386
craniotomy|Treat|5|[36, 37]|14|-1|_|_|_|_|_|_|_|17019386
postoperative myalgia|Disease|0|[5, 7]|500|-1|_|_|_|_|_|_|_|12452237
postoperative myalgia|Disease|13|[21, 23]|500|-1|_|_|_|_|_|_|_|12452237
myalgia|Disease|0|[6, 7]|500|-1|_|_|_|_|_|_|_|12452237
fasciculation|Disease|6|[12, 13]|501|-1|_|_|_|_|_|_|_|12452237
muscle fasciculation|Disease|9|[4, 6]|501|-1|_|_|_|_|_|_|_|12452237
muscle fasciculation|Disease|9|[23, 25]|501|-1|_|_|_|_|_|_|_|12452237
lidocaine|Chemical|0|[1, 2]|2|-1|_|_|_|_|_|_|_|12452237
succinylcholine|Chemical|0|[3, 4]|3|-1|_|_|_|_|_|_|_|12452237
rocuronium|Chemical|3|[56, 57]|5|-1|_|_|_|_|_|_|_|12452237
morphine|Chemical|4|[0, 1]|6|-1|_|_|_|_|_|_|_|12452237
thiopental|Chemical|5|[12, 13]|8|-1|_|_|_|_|_|_|_|12452237
general anesthesia|Treat|1|[21, 23]|4|-1|_|_|_|_|_|_|_|12452237
blood pressure|Physiology|4|[24, 26]|7|-1|_|_|_|_|_|_|_|12452237
heart rate|Physiology|7|[4, 6]|10|-1|_|_|_|_|_|_|_|12452237
sinusitis|Disease|0|[12, 13]|500|-1|_|_|_|_|_|_|_|9564988
sinusitis|Disease|1|[29, 30]|500|-1|_|_|_|_|_|_|_|9564988
sinusitis|Disease|14|[23, 24]|500|-1|_|_|_|_|_|_|_|9564988
sinus|Disease|4|[12, 13]|500|-1|_|_|_|_|_|_|_|9564988
nausea|Disease|13|[14, 15]|6|-1|_|_|_|_|_|_|_|9564988
diarrhea|Disease|13|[9, 10]|7|-1|_|_|_|_|_|_|_|9564988
levofloxacin|Chemical|0|[5, 6]|1|-1|_|_|_|_|_|_|_|9564988
therapy|Treat|3|[6, 7]|3|-1|_|_|_|_|_|_|_|9564988
treatment|Treat|8|[9, 10]|5|-1|_|_|_|_|_|_|_|9564988
prostacyclin|Chemical|0|[7, 8]|500|-1|_|_|_|_|_|_|_|7596955
prostacyclin|Chemical|1|[10, 11]|500|-1|_|_|_|_|_|_|_|7596955
beraprost|Chemical|0|[9, 10]|500|-1|_|_|_|_|_|_|_|7596955
cilostazol|Chemical|0|[13, 14]|501|-1|_|_|_|_|_|_|_|7596955
bpt|Chemical|3|[15, 16]|500|-1|_|_|_|_|_|_|_|7596955
bpt|Chemical|3|[7, 8]|500|-1|_|_|_|_|_|_|_|7596955
bpt|Chemical|12|[7, 8]|500|-1|_|_|_|_|_|_|_|7596955
clz|Chemical|3|[9, 10]|501|-1|_|_|_|_|_|_|_|7596955
clz|Chemical|4|[6, 7]|501|-1|_|_|_|_|_|_|_|7596955
clz|Chemical|8|[25, 26]|501|-1|_|_|_|_|_|_|_|7596955
clz|Chemical|12|[9, 10]|501|-1|_|_|_|_|_|_|_|7596955
agents|Chemical|9|[14, 15]|501|H|_|_|_|_|_|_|_|7596955
platelet aggregation|Disease|6|[13, 15]|8|-1|_|_|_|_|_|_|_|7596955
facial flush|Disease|8|[12, 14]|11|-1|_|_|_|_|_|_|_|7596955
headache|Disease|8|[6, 7]|12|H|_|_|_|_|_|_|_|7596955
nausea|Disease|8|[17, 18]|13|-1|_|_|_|_|_|_|_|7596955
platelet aggregation|Physiology|6|[13, 15]|9|-1|_|_|_|_|_|_|_|7596955
vital signs|Physiology|7|[9, 11]|10|-1|_|_|_|_|_|_|_|7596955
platelet aggregability|Physiology|11|[1, 3]|16|-1|_|_|_|_|_|_|_|7596955
arthritis|Disease|0|[6, 7]|0|H|_|_|_|_|_|_|_|17965424
arthritis|Disease|1|[29, 30]|0|H|_|_|_|_|_|_|_|17965424
rheumatoid arthritis|Disease|0|[5, 7]|500|-1|_|_|_|_|_|_|_|17965424
ra|Disease|2|[19, 20]|500|-1|_|_|_|_|_|_|_|17965424
gi adverse experiences|Disease|4|[18, 21]|501|-1|_|_|_|_|_|_|_|17965424
thrombotic cardiovascular|Disease|5|[8, 10]|10|-1|_|_|_|_|_|_|_|17965424
gi aes|Disease|8|[6, 8]|501|-1|_|_|_|_|_|_|_|17965424
gi aes|Disease|11|[15, 17]|501|-1|_|_|_|_|_|_|_|17965424
gi aes|Disease|12|[11, 13]|501|-1|_|_|_|_|_|_|_|17965424
hypertension|Disease|9|[45, 46]|12|-1|_|_|_|_|_|_|_|17965424
hypertension|Disease|9|[5, 6]|12|-1|_|_|_|_|_|_|_|17965424
oedema|Disease|9|[9, 10]|14|-1|_|_|_|_|_|_|_|17965424
oedema|Disease|9|[51, 52]|14|-1|_|_|_|_|_|_|_|17965424
etoricoxib|Chemical|0|[12, 13]|2|-1|_|_|_|_|_|_|_|17965424
etoricoxib|Chemical|0|[3, 4]|2|-1|_|_|_|_|_|_|_|17965424
etoricoxib|Chemical|10|[0, 1]|2|-1|_|_|_|_|_|_|_|17965424
etoricoxib|Chemical|11|[2, 3]|2|-1|_|_|_|_|_|_|_|17965424
diclofenac sodium|Chemical|0|[14, 16]|503|-1|_|_|_|_|_|_|_|17965424
diclofenac|Chemical|1|[24, 25]|503|-1|_|_|_|_|_|_|_|17965424
diclofenac|Chemical|10|[2, 3]|503|-1|_|_|_|_|_|_|_|17965424
diclofenac|Chemical|11|[19, 20]|503|-1|_|_|_|_|_|_|_|17965424
aspirin|Chemical|3|[8, 9]|8|-1|_|_|_|_|_|_|_|17965424
eps|Disease|0|[8, 9]|500|H|_|_|_|_|_|_|_|17042884
eps|Disease|1|[7, 8]|500|H|_|_|_|_|_|_|_|17042884
eps|Disease|6|[5, 6]|500|H|_|_|_|_|_|_|_|17042884
eps|Disease|7|[2, 3]|500|H|_|_|_|_|_|_|_|17042884
eps|Disease|8|[42, 43]|500|H|_|_|_|_|_|_|_|17042884
eps|Disease|8|[4, 5]|500|H|_|_|_|_|_|_|_|17042884
eps|Disease|8|[42, 43]|500|H|_|_|_|_|_|_|_|17042884
eps|Disease|8|[4, 5]|500|H|_|_|_|_|_|_|_|17042884
eps|Disease|14|[9, 10]|500|H|_|_|_|_|_|_|_|17042884
eps|Disease|14|[9, 10]|500|H|_|_|_|_|_|_|_|17042884
bipolar mania|Disease|0|[18, 20]|1|H|_|_|_|_|_|_|_|17042884
extrapyramidal symptoms (eps)|Disease|0|[5, 10]|500|H|_|_|_|_|_|_|_|17042884
akathisia|Disease|1|[11, 12]|5|-1|_|_|_|_|_|_|_|17042884
akathisia|Disease|5|[16, 17]|5|-1|_|_|_|_|_|_|_|17042884
extrapyramidal symptoms|Disease|5|[0, 2]|500|H|_|_|_|_|_|_|_|17042884
eps-related adverse events|Disease|7|[2, 7]|500|H|_|_|_|_|_|_|_|17042884
tremor|Disease|10|[50, 51]|24|-1|_|_|_|_|_|_|_|17042884
tremor|Disease|10|[16, 17]|24|-1|_|_|_|_|_|_|_|17042884
tremor|Disease|10|[31, 32]|24|-1|_|_|_|_|_|_|_|17042884
tremor|Disease|11|[25, 26]|24|-1|_|_|_|_|_|_|_|17042884
extrapyramidal syndrome|Disease|11|[37, 39]|500|H|_|_|_|_|_|_|_|17042884
quetiapine|Chemical|0|[11, 12]|502|-1|_|_|_|_|_|_|_|17042884
haloperidol|Chemical|3|[29, 30]|6|-1|_|_|_|_|_|_|_|17042884
haloperidol|Chemical|8|[14, 15]|6|-1|_|_|_|_|_|_|_|17042884
haloperidol|Chemical|11|[0, 1]|6|-1|_|_|_|_|_|_|_|17042884
haloperidol|Chemical|11|[0, 1]|6|-1|_|_|_|_|_|_|_|17042884
lithium|Chemical|3|[27, 28]|7|H|_|_|_|_|_|_|_|17042884
divalproex|Chemical|4|[21, 22]|8|-1|_|_|_|_|_|_|_|17042884
qtp|Chemical|7|[8, 9]|502|-1|_|_|_|_|_|_|_|17042884
li|Chemical|7|[10, 11]|15|-1|_|_|_|_|_|_|_|17042884
li|Chemical|7|[25, 26]|15|-1|_|_|_|_|_|_|_|17042884
dvp|Chemical|7|[12, 13]|17|-1|_|_|_|_|_|_|_|17042884
dvp|Chemical|7|[27, 28]|17|-1|_|_|_|_|_|_|_|17042884
hypertensive|Disease|0|[16, 17]|0|-1|_|_|_|_|_|_|_|8586822
hypertensive|Disease|1|[28, 29]|0|-1|_|_|_|_|_|_|_|8586822
hypertensive|Disease|1|[14, 15]|0|-1|_|_|_|_|_|_|_|8586822
increase in map|Disease|5|[22, 25]|7|-1|_|_|_|_|_|_|_|8586822
captopril|Chemical|0|[12, 13]|1|-1|_|_|_|_|_|_|_|8586822
dietary sodium chloride|Chemical|1|[31, 34]|2|-1|_|_|_|_|_|_|_|8586822
dietary sodium chloride|Chemical|5|[17, 20]|2|-1|_|_|_|_|_|_|_|8586822
clonidine|Chemical|3|[19, 20]|501|-1|_|_|_|_|_|_|_|8586822
hexamethonium|Chemical|5|[6, 7]|9|-1|_|_|_|_|_|_|_|8586822
alpha2-adrenergic receptor agonist|Chemical|6|[6, 11]|501|-1|_|_|_|_|_|_|_|8586822
lifetime captopril treatment|Treat|4|[2, 5]|6|-1|_|_|_|_|_|_|_|8586822
infusion|Treat|6|[0, 1]|11|-1|_|_|_|_|_|_|_|8586822
captopril-treated|Treat|7|[5, 8]|13|-1|_|_|_|_|_|_|_|8586822
map|Physiology|6|[19, 20]|12|-1|_|_|_|_|_|_|_|8586822
corticosterone|Chemical|0|[9, 10]|0|-1|_|_|_|_|_|_|_|3961813
tri-ortho-tolyl phosphate (totp)|Chemical|1|[0, 9]|500|-1|_|_|_|_|_|_|_|3961813
0,0'-diisopropyl phosphorofluoridate (dfp)|Chemical|1|[18, 28]|501|-1|_|_|_|_|_|_|_|3961813
totp|Chemical|3|[37, 38]|500|-1|_|_|_|_|_|_|_|3961813
totp|Chemical|3|[18, 19]|500|-1|_|_|_|_|_|_|_|3961813
totp|Chemical|4|[6, 7]|500|-1|_|_|_|_|_|_|_|3961813
totp|Chemical|5|[6, 7]|500|-1|_|_|_|_|_|_|_|3961813
totp|Chemical|6|[16, 17]|500|-1|_|_|_|_|_|_|_|3961813
dfp|Chemical|3|[39, 40]|501|-1|_|_|_|_|_|_|_|3961813
dfp|Chemical|4|[8, 9]|501|-1|_|_|_|_|_|_|_|3961813
dfp|Chemical|5|[8, 9]|501|-1|_|_|_|_|_|_|_|3961813
dfp|Chemical|6|[18, 19]|501|-1|_|_|_|_|_|_|_|3961813
neuropathy|Disease|3|[21, 22]|3|H|_|_|_|_|_|_|_|3961813
degenerating myelinated fibers|Disease|6|[0, 3]|11|-1|_|_|_|_|_|_|_|3961813
adenosine|Chemical|0|[6, 7]|0|-1|_|_|_|_|_|_|_|20973483
compound 1|Chemical|2|[7, 9]|1|-1|_|_|_|_|_|_|_|20973483
haloperidol|Chemical|3|[73, 74]|3|-1|_|_|_|_|_|_|_|20973483
reserpine|Chemical|3|[81, 82]|4|-1|_|_|_|_|_|_|_|20973483
6-hydroxydopamine|Chemical|3|[87, 90]|5|H|_|_|_|_|_|_|_|20973483
mptp|Chemical|3|[104, 105]|6|-1|_|_|_|_|_|_|_|20973483
6-hydroxydopamine (6-ohda)|Chemical|3|[87, 95]|7|-1|_|_|_|_|_|_|_|20973483
akinesia|Disease|3|[84, 85]|2|-1|_|_|_|_|_|_|_|20973483
chronic hepatitis c|Disease|0|[9, 12]|500|-1|_|_|_|_|_|_|_|17511042
chronic hepatitis c|Disease|1|[3, 6]|500|-1|_|_|_|_|_|_|_|17511042
chronic hepatitis c|Disease|1|[3, 6]|500|-1|_|_|_|_|_|_|_|17511042
hepatitis c|Disease|0|[10, 12]|500|-1|_|_|_|_|_|_|_|17511042
hepatitis c|Disease|0|[10, 12]|500|-1|_|_|_|_|_|_|_|17511042
hepatitis c|Disease|1|[4, 6]|500|-1|_|_|_|_|_|_|_|17511042
delusional parasitosis|Disease|0|[5, 7]|501|-1|_|_|_|_|_|_|_|17511042
depression|Disease|2|[9, 10]|10|H|_|_|_|_|_|_|_|17511042
psychosis|Disease|3|[6, 7]|11|H|_|_|_|_|_|_|_|17511042
psychogenic parasitosis|Disease|4|[10, 12]|501|-1|_|_|_|_|_|_|_|17511042
pegylated interferon alpha-2b|Chemical|0|[14, 19]|4|-1|_|_|_|_|_|_|_|17511042
ribavirin|Chemical|0|[20, 21]|5|-1|_|_|_|_|_|_|_|17511042
pegylated interferon alpha-2b and ribavirin treatment|Treat|0|[14, 22]|6|-1|_|_|_|_|_|_|_|17511042
interferon therapy|Treat|4|[14, 16]|13|-1|_|_|_|_|_|_|_|17511042
neuroleptic malignant syndrome|Disease|0|[1, 4]|500|H|_|_|_|_|_|_|_|16720068
depressive|Disease|1|[8, 9]|501|H|_|_|_|_|_|_|_|16720068
depressive|Disease|11|[10, 11]|501|H|_|_|_|_|_|_|_|16720068
depressive symptoms|Disease|1|[8, 10]|501|H|_|_|_|_|_|_|_|16720068
insomnia|Disease|1|[18, 19]|5|-1|_|_|_|_|_|_|_|16720068
loss of appetite|Disease|1|[20, 23]|6|-1|_|_|_|_|_|_|_|16720068
tremors|Disease|3|[24, 25]|502|-1|_|_|_|_|_|_|_|16720068
muscle rigidity|Disease|3|[21, 23]|502|-1|_|_|_|_|_|_|_|16720068
psychomotor retardation|Disease|3|[14, 16]|9|-1|_|_|_|_|_|_|_|16720068
muscle rigidity with tremors|Disease|3|[21, 25]|502|-1|_|_|_|_|_|_|_|16720068
fever|Disease|4|[4, 5]|11|-1|_|_|_|_|_|_|_|16720068
extrapyramidal symptoms|Disease|4|[32, 34]|502|H|_|_|_|_|_|_|_|16720068
nms|Disease|9|[25, 26]|500|H|_|_|_|_|_|_|_|16720068
nms|Disease|11|[4, 5]|500|H|_|_|_|_|_|_|_|16720068
dehydration|Disease|11|[16, 17]|20|-1|_|_|_|_|_|_|_|16720068
malnutrition|Disease|11|[20, 21]|23|H|_|_|_|_|_|_|_|16720068
depression|Disease|12|[13, 14]|501|H|_|_|_|_|_|_|_|16720068
paroxetine|Chemical|0|[9, 10]|1|-1|_|_|_|_|_|_|_|16720068
alprazolam|Chemical|0|[11, 12]|2|-1|_|_|_|_|_|_|_|16720068
creatine|Chemical|5|[6, 7]|14|-1|_|_|_|_|_|_|_|16720068
diazepam|Chemical|6|[5, 6]|15|-1|_|_|_|_|_|_|_|16720068
bromocriptine|Chemical|6|[3, 4]|16|-1|_|_|_|_|_|_|_|16720068
blood pressure|Physiology|4|[14, 16]|12|-1|_|_|_|_|_|_|_|16720068
physiologic|Physiology|10|[3, 4]|19|-1|_|_|_|_|_|_|_|16720068
combined treatment|Treat|9|[32, 34]|18|-1|_|_|_|_|_|_|_|16720068
pilocarpine|Chemical|0|[0, 1]|0|-1|_|_|_|_|_|_|_|16596970
pilocarpine|Chemical|4|[22, 23]|0|-1|_|_|_|_|_|_|_|16596970
pilocarpine|Chemical|5|[0, 1]|0|-1|_|_|_|_|_|_|_|16596970
seizures|Disease|0|[1, 2]|1|H|_|_|_|_|_|_|_|16596970
status epilepticus|Disease|1|[3, 5]|2|-1|_|_|_|_|_|_|_|16596970
status epilepticus|Disease|9|[0, 2]|2|-1|_|_|_|_|_|_|_|16596970
impaired auditory location discrimination|Disease|11|[7, 11]|7|-1|_|_|_|_|_|_|_|16596970
auditory discrimination|Physiology|2|[9, 11]|3|-1|_|_|_|_|_|_|_|16596970
cyclooxygenase inhibitors|Chemical|0|[3, 5]|0|-1|_|_|_|_|_|_|_|16586083
cyclooxygenase inhibitors|Chemical|3|[0, 2]|0|-1|_|_|_|_|_|_|_|16586083
nt-probnp|Chemical|6|[12, 15]|8|-1|_|_|_|_|_|_|_|16586083
stroke|Disease|1|[15, 16]|1|-1|_|_|_|_|_|_|_|16586083
myocardial infarction|Disease|1|[12, 14]|2|-1|_|_|_|_|_|_|_|16586083
hypertension|Disease|1|[17, 18]|3|-1|_|_|_|_|_|_|_|16586083
heart failure|Disease|1|[19, 21]|4|-1|_|_|_|_|_|_|_|16586083
vascular resistance|Physiology|3|[15, 17]|6|-1|_|_|_|_|_|_|_|16586083
fluid retention|Physiology|3|[18, 20]|7|-1|_|_|_|_|_|_|_|16586083
left ventricular dysfunction|Disease|0|[23, 26]|500|-1|_|_|_|_|_|_|_|10539815
left ventricular dysfunction|Disease|4|[9, 12]|500|-1|_|_|_|_|_|_|_|10539815
heart failure|Disease|0|[8, 10]|501|H|_|_|_|_|_|_|_|10539815
congestive heart failure|Disease|1|[15, 18]|501|H|_|_|_|_|_|_|_|10539815
congestive heart failure (chf)|Disease|1|[15, 21]|501|H|_|_|_|_|_|_|_|10539815
chf|Disease|3|[15, 16]|501|H|_|_|_|_|_|_|_|10539815
chf|Disease|4|[33, 34]|501|H|_|_|_|_|_|_|_|10539815
chf|Disease|14|[18, 19]|501|H|_|_|_|_|_|_|_|10539815
chf|Disease|16|[14, 15]|501|H|_|_|_|_|_|_|_|10539815
decreased renal function|Disease|6|[0, 3]|502|-1|_|_|_|_|_|_|_|10539815
hypertension|Disease|7|[39, 40]|11|-1|_|_|_|_|_|_|_|10539815
diabetes|Disease|7|[41, 42]|12|-1|_|_|_|_|_|_|_|10539815
diabetes|Disease|16|[0, 1]|12|-1|_|_|_|_|_|_|_|10539815
renal impairment|Disease|13|[4, 6]|502|-1|_|_|_|_|_|_|_|10539815
renal impairment|Disease|16|[8, 10]|502|-1|_|_|_|_|_|_|_|10539815
renal function|Physiology|0|[3, 5]|2|-1|_|_|_|_|_|_|_|10539815
systolic blood pressure|Physiology|7|[28, 31]|13|-1|_|_|_|_|_|_|_|10539815
ejection fraction|Physiology|9|[33, 35]|15|-1|_|_|_|_|_|_|_|10539815
enalapril|Chemical|4|[28, 29]|8|-1|_|_|_|_|_|_|_|10539815
enalapril|Chemical|14|[2, 3]|8|-1|_|_|_|_|_|_|_|10539815
diuretic|Chemical|7|[48, 49]|10|-1|_|_|_|_|_|_|_|10539815
diuretic|Chemical|9|[14, 15]|10|-1|_|_|_|_|_|_|_|10539815
diuretic|Chemical|11|[0, 1]|10|-1|_|_|_|_|_|_|_|10539815
diuretic|Chemical|15|[0, 1]|10|-1|_|_|_|_|_|_|_|10539815
beta-blocker therapy|Treat|17|[0, 4]|24|-1|_|_|_|_|_|_|_|10539815
choreoathetosis|Disease|0|[3, 4]|500|-1|_|_|_|_|_|_|_|9022662
attention deficit disorder|Disease|1|[19, 22]|2|-1|_|_|_|_|_|_|_|9022662
choreoathetoid movements|Disease|7|[1, 3]|500|-1|_|_|_|_|_|_|_|9022662
pemoline associated movement disorder|Disease|12|[2, 6]|500|-1|_|_|_|_|_|_|_|9022662
overdose|Disease|13|[13, 14]|12|H|_|_|_|_|_|_|_|9022662
pemoline|Chemical|0|[0, 1]|1|-1|_|_|_|_|_|_|_|9022662
pemoline|Chemical|1|[2, 3]|1|-1|_|_|_|_|_|_|_|9022662
pemoline|Chemical|2|[0, 1]|1|-1|_|_|_|_|_|_|_|9022662
pemoline|Chemical|12|[2, 3]|1|-1|_|_|_|_|_|_|_|9022662
methylphenidate|Chemical|5|[14, 15]|5|-1|_|_|_|_|_|_|_|9022662
therapy|Treat|6|[7, 8]|6|-1|_|_|_|_|_|_|_|9022662
gastrointestinal decontamination|Treat|9|[3, 5]|8|-1|_|_|_|_|_|_|_|9022662
treatment|Treat|10|[1, 2]|9|-1|_|_|_|_|_|_|_|9022662
hemorrhagic cystitis|Disease|0|[10, 12]|0|-1|_|_|_|_|_|_|_|8677458
hemorrhagic cystitis|Disease|1|[0, 2]|0|-1|_|_|_|_|_|_|_|8677458
hemorrhagic cystitis|Disease|1|[0, 2]|0|-1|_|_|_|_|_|_|_|8677458
emesis|Disease|4|[36, 37]|8|-1|_|_|_|_|_|_|_|8677458
mesna|Chemical|0|[4, 5]|1|-1|_|_|_|_|_|_|_|8677458
mesna|Chemical|2|[0, 1]|1|-1|_|_|_|_|_|_|_|8677458
ifosfamide|Chemical|0|[7, 8]|2|-1|_|_|_|_|_|_|_|8677458
continuous subcutaneous administration|Treat|0|[0, 3]|3|-1|_|_|_|_|_|_|_|8677458
subcutaneous administration|Treat|3|[2, 4]|7|-1|_|_|_|_|_|_|_|8677458
outpatient setting|Treat|5|[31, 33]|9|-1|_|_|_|_|_|_|_|8677458
hyperammonemia|Disease|0|[5, 6]|0|-1|_|_|_|_|_|_|_|6323692
incoordination|Disease|1|[34, 35]|1|-1|_|_|_|_|_|_|_|6323692
incoordination|Disease|7|[24, 25]|1|-1|_|_|_|_|_|_|_|6323692
liver disease|Disease|2|[24, 26]|5|H|_|_|_|_|_|_|_|6323692
diazepam|Chemical|1|[36, 37]|2|-1|_|_|_|_|_|_|_|6323692
diazepam|Chemical|7|[20, 21]|2|-1|_|_|_|_|_|_|_|6323692
ammonium acetate|Chemical|1|[2, 4]|501|-1|_|_|_|_|_|_|_|6323692
morphine|Chemical|1|[21, 22]|4|-1|_|_|_|_|_|_|_|6323692
nh4ac|Chemical|3|[42, 43]|501|-1|_|_|_|_|_|_|_|6323692
nh4ac|Chemical|3|[25, 26]|501|-1|_|_|_|_|_|_|_|6323692
nh4ac|Chemical|6|[5, 6]|501|-1|_|_|_|_|_|_|_|6323692
nh4ac|Chemical|7|[13, 14]|501|-1|_|_|_|_|_|_|_|6323692
nh4ac|Chemical|7|[37, 38]|501|-1|_|_|_|_|_|_|_|6323692
catecholamine|Chemical|3|[8, 9]|8|-1|_|_|_|_|_|_|_|6323692
acetaldehyde|Chemical|4|[18, 19]|9|-1|_|_|_|_|_|_|_|6323692
ammonia|Chemical|5|[4, 5]|501|-1|_|_|_|_|_|_|_|6323692
verapamil|Chemical|6|[11, 12]|12|-1|_|_|_|_|_|_|_|6323692
amphetamine|Chemical|7|[27, 28]|15|-1|_|_|_|_|_|_|_|6323692
metrazol|Chemical|7|[43, 44]|16|-1|_|_|_|_|_|_|_|6323692
nephropathy|Disease|0|[2, 3]|500|-1|_|_|_|_|_|_|_|20195852
cin|Disease|1|[11, 12]|500|-1|_|_|_|_|_|_|_|20195852
cin|Disease|2|[7, 8]|500|-1|_|_|_|_|_|_|_|20195852
cin|Disease|6|[34, 35]|500|-1|_|_|_|_|_|_|_|20195852
cin|Disease|7|[5, 6]|500|-1|_|_|_|_|_|_|_|20195852
cin|Disease|8|[42, 43]|500|-1|_|_|_|_|_|_|_|20195852
cin|Disease|8|[8, 9]|500|-1|_|_|_|_|_|_|_|20195852
cin|Disease|9|[5, 6]|500|-1|_|_|_|_|_|_|_|20195852
cin|Disease|10|[4, 5]|500|-1|_|_|_|_|_|_|_|20195852
cin|Disease|11|[24, 25]|500|-1|_|_|_|_|_|_|_|20195852
cyanosis|Disease|2|[48, 49]|4|-1|_|_|_|_|_|_|_|20195852
cyanosis|Disease|11|[20, 21]|4|-1|_|_|_|_|_|_|_|20195852
injury to the kidney|Disease|6|[5, 9]|500|-1|_|_|_|_|_|_|_|20195852
renal injury|Disease|7|[46, 48]|500|-1|_|_|_|_|_|_|_|20195852
renal injury|Disease|7|[30, 32]|500|-1|_|_|_|_|_|_|_|20195852
congenital heart diseases|Disease|9|[10, 13]|22|-1|_|_|_|_|_|_|_|20195852
cardiac angiography|Treat|0|[12, 14]|1|-1|_|_|_|_|_|_|_|20195852
contrast media|Chemical|1|[5, 7]|502|-1|_|_|_|_|_|_|_|20195852
iopromide|Chemical|2|[17, 18]|502|-1|_|_|_|_|_|_|_|20195852
iohexol|Chemical|2|[19, 20]|502|-1|_|_|_|_|_|_|_|20195852
sodium (na)|Chemical|4|[1, 5]|503|-1|_|_|_|_|_|_|_|20195852
potassium (k)|Chemical|4|[6, 10]|9|-1|_|_|_|_|_|_|_|20195852
creatinine (cr)|Chemical|4|[12, 16]|504|-1|_|_|_|_|_|_|_|20195852
na|Chemical|5|[3, 4]|503|-1|_|_|_|_|_|_|_|20195852
cr|Chemical|5|[5, 6]|504|-1|_|_|_|_|_|_|_|20195852
cm|Chemical|8|[49, 50]|502|-1|_|_|_|_|_|_|_|20195852
cm|Chemical|8|[18, 19]|502|-1|_|_|_|_|_|_|_|20195852
cm|Chemical|11|[13, 14]|502|-1|_|_|_|_|_|_|_|20195852
ventricular tachycardia|Disease|0|[3, 5]|500|-1|_|_|_|_|_|_|_|18997632
ventricular tachycardia|Disease|3|[22, 24]|500|-1|_|_|_|_|_|_|_|18997632
seizure|Disease|1|[17, 18]|2|H|_|_|_|_|_|_|_|18997632
seizure|Disease|1|[1, 2]|2|H|_|_|_|_|_|_|_|18997632
electroconvulsive therapy|Disease|1|[7, 9]|4|-1|_|_|_|_|_|_|_|18997632
ventricular ectopy|Disease|2|[26, 28]|500|-1|_|_|_|_|_|_|_|18997632
arrhythmia|Disease|3|[12, 13]|500|-1|_|_|_|_|_|_|_|18997632
ventricular arrhythmias|Disease|4|[20, 22]|500|-1|_|_|_|_|_|_|_|18997632
caffeine|Chemical|0|[7, 8]|1|-1|_|_|_|_|_|_|_|18997632
optic neuropathy|Disease|0|[13, 15]|500|-1|_|_|_|_|_|_|_|15565293
tuberculosis|Disease|2|[9, 10]|2|-1|_|_|_|_|_|_|_|15565293
visual deficits|Disease|5|[27, 29]|500|-1|_|_|_|_|_|_|_|15565293
visual deficits|Disease|9|[48, 50]|500|-1|_|_|_|_|_|_|_|15565293
visual deficits|Disease|9|[59, 61]|500|-1|_|_|_|_|_|_|_|15565293
visual deficits|Disease|11|[13, 15]|500|-1|_|_|_|_|_|_|_|15565293
hereditary optic neuropathies|Disease|13|[32, 35]|500|-1|_|_|_|_|_|_|_|15565293
optic neuropathies|Disease|14|[11, 13]|500|-1|_|_|_|_|_|_|_|15565293
renal impairment|Disease|15|[24, 26]|13|-1|_|_|_|_|_|_|_|15565293
ethambutol|Chemical|0|[10, 11]|502|-1|_|_|_|_|_|_|_|15565293
ethambutol|Chemical|2|[0, 1]|502|-1|_|_|_|_|_|_|_|15565293
ethambutol (emb)|Chemical|5|[8, 12]|502|-1|_|_|_|_|_|_|_|15565293
emb|Chemical|9|[6, 7]|502|-1|_|_|_|_|_|_|_|15565293
emb|Chemical|12|[9, 10]|502|-1|_|_|_|_|_|_|_|15565293
arthritis|Disease|0|[22, 23]|0|H|_|_|_|_|_|_|_|15266215
arthritis|Disease|2|[24, 25]|0|H|_|_|_|_|_|_|_|15266215
arthritis|Disease|3|[60, 61]|0|H|_|_|_|_|_|_|_|15266215
arthritis|Disease|9|[47, 48]|0|H|_|_|_|_|_|_|_|15266215
osteoarthritis|Disease|2|[21, 22]|6|-1|_|_|_|_|_|_|_|15266215
rheumatoid arthritis|Disease|2|[23, 25]|7|-1|_|_|_|_|_|_|_|15266215
cerebrovascular|Disease|3|[9, 10]|9|-1|_|_|_|_|_|_|_|15266215
peripheral vascular|Disease|3|[11, 13]|10|-1|_|_|_|_|_|_|_|15266215
arterial thrombotic|Disease|3|[15, 17]|11|-1|_|_|_|_|_|_|_|15266215
valdecoxib|Chemical|0|[8, 9]|501|-1|_|_|_|_|_|_|_|15266215
nonsteroidal antiinflammatory agents|Chemical|0|[10, 13]|502|H|_|_|_|_|_|_|_|15266215
cyclooxygenase (cox)-2-specific inhibitors|Chemical|1|[15, 24]|501|-1|_|_|_|_|_|_|_|15266215
nonsteroidal antiinflammatory drugs (nsaids)|Chemical|1|[26, 32]|502|H|_|_|_|_|_|_|_|15266215
diclofenac|Chemical|3|[35, 36]|12|-1|_|_|_|_|_|_|_|15266215
ibuprofen|Chemical|3|[40, 41]|13|-1|_|_|_|_|_|_|_|15266215
naproxen|Chemical|3|[46, 47]|14|-1|_|_|_|_|_|_|_|15266215
aspirin|Chemical|4|[38, 39]|15|-1|_|_|_|_|_|_|_|15266215
aspirin|Chemical|4|[29, 30]|15|-1|_|_|_|_|_|_|_|15266215
ephedrine|Chemical|0|[10, 11]|0|-1|_|_|_|_|_|_|_|14742097
fluoxetine|Chemical|2|[6, 7]|4|-1|_|_|_|_|_|_|_|14742097
sertraline|Chemical|2|[8, 9]|5|-1|_|_|_|_|_|_|_|14742097
paroxetine|Chemical|2|[11, 12]|6|-1|_|_|_|_|_|_|_|14742097
sexual dysfunction|Disease|1|[37, 39]|1|H|_|_|_|_|_|_|_|14742097
sexually dysfunctional|Disease|2|[1, 3]|3|-1|_|_|_|_|_|_|_|14742097
genital blood flow|Physiology|1|[23, 26]|2|-1|_|_|_|_|_|_|_|14742097
erectile dysfunction|Disease|0|[0, 2]|0|-1|_|_|_|_|_|_|_|11890511
6-hydroxydopamine|Chemical|1|[13, 16]|1|-1|_|_|_|_|_|_|_|11890511
apomorphine|Chemical|2|[1, 2]|4|-1|_|_|_|_|_|_|_|11890511
dopamine|Chemical|5|[2, 3]|7|H|_|_|_|_|_|_|_|11890511
injections|Treat|1|[11, 12]|2|-1|_|_|_|_|_|_|_|11890511
erectile function|Physiology|1|[0, 2]|3|-1|_|_|_|_|_|_|_|11890511
penile erections|Physiology|2|[4, 6]|5|-1|_|_|_|_|_|_|_|11890511
intracavernous pressures|Physiology|3|[0, 2]|6|-1|_|_|_|_|_|_|_|11890511
parkinsonian|Disease|0|[19, 20]|500|H|_|_|_|_|_|_|_|9270571
dyskinesias|Disease|3|[42, 43]|7|-1|_|_|_|_|_|_|_|9270571
parkinsonism|Disease|5|[14, 15]|500|-1|_|_|_|_|_|_|_|9270571
pd|Disease|7|[30, 31]|500|H|_|_|_|_|_|_|_|9270571
levodopa|Chemical|0|[20, 21]|1|-1|_|_|_|_|_|_|_|9270571
levodopa|Chemical|3|[39, 40]|1|-1|_|_|_|_|_|_|_|9270571
levodopa|Chemical|4|[0, 1]|1|-1|_|_|_|_|_|_|_|9270571
levodopa|Chemical|4|[0, 1]|1|-1|_|_|_|_|_|_|_|9270571
levodopa|Chemical|5|[46, 47]|1|-1|_|_|_|_|_|_|_|9270571
levodopa|Chemical|5|[16, 17]|1|-1|_|_|_|_|_|_|_|9270571
levodopa|Chemical|5|[29, 30]|1|-1|_|_|_|_|_|_|_|9270571
levodopa|Chemical|6|[34, 35]|1|-1|_|_|_|_|_|_|_|9270571
a-86929|Chemical|0|[11, 14]|502|-1|_|_|_|_|_|_|_|9270571
a-86929|Chemical|3|[69, 72]|502|-1|_|_|_|_|_|_|_|9270571
a-86929|Chemical|5|[3, 6]|502|-1|_|_|_|_|_|_|_|9270571
a-86929|Chemical|7|[13, 16]|502|-1|_|_|_|_|_|_|_|9270571
dopamine|Chemical|0|[6, 7]|3|H|_|_|_|_|_|_|_|9270571
skf-82958|Chemical|2|[11, 14]|502|-1|_|_|_|_|_|_|_|9270571
skf-82958|Chemical|2|[108, 111]|502|-1|_|_|_|_|_|_|_|9270571
mptp|Chemical|3|[30, 31]|8|-1|_|_|_|_|_|_|_|9270571
da d1-like receptor agonist|Chemical|3|[131, 137]|502|H|_|_|_|_|_|_|_|9270571
ly-171555|Chemical|4|[10, 13]|503|-1|_|_|_|_|_|_|_|9270571
ly-171555|Chemical|5|[18, 21]|503|-1|_|_|_|_|_|_|_|9270571
ly-171555|Chemical|5|[39, 42]|503|-1|_|_|_|_|_|_|_|9270571
d1 receptor|Chemical|6|[5, 7]|22|H|_|_|_|_|_|_|_|9270571
da d2 receptor agonist|Chemical|6|[37, 41]|503|-1|_|_|_|_|_|_|_|9270571
convulsions|Disease|0|[6, 7]|0|-1|_|_|_|_|_|_|_|7189975
bupivacaine|Chemical|2|[19, 20]|1|-1|_|_|_|_|_|_|_|7189975
lidocaine|Chemical|2|[32, 33]|2|-1|_|_|_|_|_|_|_|7189975
chloroprocaine|Chemical|2|[46, 47]|3|-1|_|_|_|_|_|_|_|7189975
carbamazepine|Chemical|0|[10, 11]|0|-1|_|_|_|_|_|_|_|6415512
myoclonic, atypical absence and/or atonic (minor motor) seizures|Disease|1|[25, 38]|501|-1|_|_|_|_|_|_|_|6415512
epilepsy|Disease|1|[13, 14]|2|H|_|_|_|_|_|_|_|6415512
seizures|Disease|2|[35, 36]|501|-1|_|_|_|_|_|_|_|6415512
seizures|Disease|2|[23, 24]|501|-1|_|_|_|_|_|_|_|6415512
ceroid lipofuscinosis|Disease|3|[12, 14]|5|-1|_|_|_|_|_|_|_|6415512
overdose|Disease|0|[7, 8]|0|-1|_|_|_|_|_|_|_|1928887
overdose|Disease|3|[8, 9]|0|-1|_|_|_|_|_|_|_|1928887
hypotension|Disease|0|[3, 4]|1|H|_|_|_|_|_|_|_|1928887
hypotension|Disease|3|[13, 14]|1|H|_|_|_|_|_|_|_|1928887
hypotension|Disease|4|[14, 15]|1|H|_|_|_|_|_|_|_|1928887
hypotension|Disease|5|[12, 13]|1|H|_|_|_|_|_|_|_|1928887
hypotensive|Disease|2|[12, 13]|6|-1|_|_|_|_|_|_|_|1928887
naloxone|Chemical|0|[0, 1]|2|-1|_|_|_|_|_|_|_|1928887
captopril|Chemical|0|[6, 7]|3|-1|_|_|_|_|_|_|_|1928887
hypotension|Physiology|0|[3, 4]|4|-1|_|_|_|_|_|_|_|1928887
hemodynamic effects|Physiology|1|[1, 3]|5|-1|_|_|_|_|_|_|_|1928887
hypotensive actions|Physiology|2|[12, 14]|7|-1|_|_|_|_|_|_|_|1928887
cardiac dysfunction|Disease|0|[3, 5]|0|H|_|_|_|_|_|_|_|1728915
bradycardia|Disease|1|[4, 5]|500|H|_|_|_|_|_|_|_|1728915
atrioventricular block|Disease|1|[6, 8]|3|-1|_|_|_|_|_|_|_|1728915
overdose|Disease|3|[13, 14]|4|H|_|_|_|_|_|_|_|1728915
sinus tachycardias|Disease|3|[4, 6]|5|-1|_|_|_|_|_|_|_|1728915
bradyarrhythmias|Disease|4|[15, 16]|500|H|_|_|_|_|_|_|_|1728915
atrioventricular conduction delay|Disease|4|[17, 20]|7|H|_|_|_|_|_|_|_|1728915
psychiatric conditions|Disease|5|[12, 14]|8|-1|_|_|_|_|_|_|_|1728915
carbamazepine|Chemical|0|[0, 1]|1|-1|_|_|_|_|_|_|_|1728915
haloperidol|Chemical|0|[12, 13]|0|-1|_|_|_|_|_|_|_|20558148
haloperidol|Chemical|4|[25, 26]|0|-1|_|_|_|_|_|_|_|20558148
haloperidol|Chemical|5|[0, 1]|0|-1|_|_|_|_|_|_|_|20558148
haloperidol|Chemical|5|[0, 1]|0|-1|_|_|_|_|_|_|_|20558148
haloperidol|Chemical|6|[17, 18]|0|-1|_|_|_|_|_|_|_|20558148
haloperidol|Chemical|8|[17, 18]|0|-1|_|_|_|_|_|_|_|20558148
excitatory amino acid|Chemical|2|[21, 24]|2|H|_|_|_|_|_|_|_|20558148
ap7|Chemical|5|[31, 32]|6|-1|_|_|_|_|_|_|_|20558148
ap7|Chemical|6|[11, 12]|6|-1|_|_|_|_|_|_|_|20558148
catalepsy|Disease|0|[15, 16]|1|-1|_|_|_|_|_|_|_|20558148
symptomatic treatment|Treat|1|[20, 22]|0|-1|_|_|_|_|_|_|_|19940105
antiparkinsonian therapeutic strategies|Treat|10|[17, 20]|21|-1|_|_|_|_|_|_|_|19940105
pd|Disease|2|[28, 29]|500|H|_|_|_|_|_|_|_|19940105
pd|Disease|3|[37, 38]|500|H|_|_|_|_|_|_|_|19940105
pd|Disease|6|[13, 14]|500|H|_|_|_|_|_|_|_|19940105
pd|Disease|8|[24, 25]|500|H|_|_|_|_|_|_|_|19940105
catalepsy|Disease|4|[31, 32]|5|-1|_|_|_|_|_|_|_|19940105
akinetic symptoms of pd|Disease|6|[10, 14]|500|H|_|_|_|_|_|_|_|19940105
n,n'-dibenzhydrylethane-1,2-diamine dihydrochloride (amn082)|Chemical|3|[3, 19]|502|-1|_|_|_|_|_|_|_|19940105
haloperidol|Chemical|4|[28, 29]|4|-1|_|_|_|_|_|_|_|19940105
haloperidol|Chemical|7|[8, 9]|4|-1|_|_|_|_|_|_|_|19940105
amn082|Chemical|4|[26, 27]|502|-1|_|_|_|_|_|_|_|19940105
amn082|Chemical|5|[0, 1]|502|-1|_|_|_|_|_|_|_|19940105
amn082|Chemical|6|[20, 21]|502|-1|_|_|_|_|_|_|_|19940105
amn082|Chemical|8|[3, 4]|502|-1|_|_|_|_|_|_|_|19940105
apomorphine|Chemical|5|[12, 13]|7|-1|_|_|_|_|_|_|_|19940105
6-hydroxydopamine|Chemical|5|[18, 21]|8|-1|_|_|_|_|_|_|_|19940105
mglu7 receptor|Chemical|9|[5, 7]|502|-1|_|_|_|_|_|_|_|19940105
dopamine|Chemical|9|[15, 16]|19|-1|_|_|_|_|_|_|_|19940105
mglu7 receptor subtypes|Chemical|10|[3, 6]|502|-1|_|_|_|_|_|_|_|19940105
mglu7|Gene|7|[14, 15]|14|-1|_|_|_|_|_|_|_|19940105
mglu7|Gene|7|[25, 26]|14|-1|_|_|_|_|_|_|_|19940105
hypotension|Disease|0|[9, 10]|500|-1|_|_|_|_|_|_|_|19923525
hypotension|Disease|1|[2, 3]|500|-1|_|_|_|_|_|_|_|19923525
hypotension|Disease|2|[20, 21]|500|-1|_|_|_|_|_|_|_|19923525
hypotension|Disease|7|[3, 4]|500|-1|_|_|_|_|_|_|_|19923525
hypotension|Disease|16|[31, 32]|500|-1|_|_|_|_|_|_|_|19923525
hypotension|Disease|17|[23, 24]|500|-1|_|_|_|_|_|_|_|19923525
hypotension|Disease|18|[16, 17]|500|-1|_|_|_|_|_|_|_|19923525
cognitive dysfunction|Disease|1|[18, 20]|5|H|_|_|_|_|_|_|_|19923525
hypotensive|Disease|9|[3, 4]|500|-1|_|_|_|_|_|_|_|19923525
hypotensive episodes|Disease|9|[3, 5]|500|-1|_|_|_|_|_|_|_|19923525
ntg|Disease|14|[33, 34]|500|-1|_|_|_|_|_|_|_|19923525
ntg|Disease|14|[64, 65]|500|-1|_|_|_|_|_|_|_|19923525
nimodipine|Chemical|0|[0, 1]|502|-1|_|_|_|_|_|_|_|19923525
nitroglycerin|Chemical|0|[6, 7]|503|-1|_|_|_|_|_|_|_|19923525
ntg|Chemical|6|[33, 34]|503|-1|_|_|_|_|_|_|_|19923525
ntg|Chemical|6|[48, 49]|503|-1|_|_|_|_|_|_|_|19923525
ntg|Chemical|6|[40, 41]|503|-1|_|_|_|_|_|_|_|19923525
ntg|Chemical|9|[33, 34]|503|-1|_|_|_|_|_|_|_|19923525
ntg|Chemical|9|[27, 28]|503|-1|_|_|_|_|_|_|_|19923525
ntg|Chemical|11|[23, 24]|503|-1|_|_|_|_|_|_|_|19923525
ntg|Chemical|11|[16, 17]|503|-1|_|_|_|_|_|_|_|19923525
ntg|Chemical|16|[11, 12]|503|-1|_|_|_|_|_|_|_|19923525
ntg|Chemical|17|[13, 14]|503|-1|_|_|_|_|_|_|_|19923525
nimo|Chemical|6|[59, 60]|502|-1|_|_|_|_|_|_|_|19923525
nimo|Chemical|6|[50, 51]|502|-1|_|_|_|_|_|_|_|19923525
nimo|Chemical|9|[29, 30]|502|-1|_|_|_|_|_|_|_|19923525
nimo|Chemical|11|[25, 26]|502|-1|_|_|_|_|_|_|_|19923525
nimo|Chemical|12|[8, 9]|502|-1|_|_|_|_|_|_|_|19923525
nimo|Chemical|14|[66, 67]|502|-1|_|_|_|_|_|_|_|19923525
nimo|Chemical|17|[0, 1]|502|-1|_|_|_|_|_|_|_|19923525
hypotension|Physiology|0|[9, 10]|3|-1|_|_|_|_|_|_|_|19923525
cerebral blood flow|Physiology|1|[8, 11]|6|-1|_|_|_|_|_|_|_|19923525
brain tissue oxygenation|Physiology|7|[7, 10]|14|-1|_|_|_|_|_|_|_|19923525
blood pressure|Physiology|11|[34, 36]|20|-1|_|_|_|_|_|_|_|19923525
homeostasis|Physiology|18|[14, 15]|34|-1|_|_|_|_|_|_|_|19923525
warfarin|Chemical|0|[13, 14]|0|-1|_|_|_|_|_|_|_|19058474
warfarin|Chemical|1|[26, 27]|0|-1|_|_|_|_|_|_|_|19058474
warfarin|Chemical|2|[31, 32]|0|-1|_|_|_|_|_|_|_|19058474
warfarin|Chemical|2|[22, 23]|0|-1|_|_|_|_|_|_|_|19058474
flavonoids|Chemical|2|[8, 9]|5|-1|_|_|_|_|_|_|_|19058474
gastrointestinal haemorrhage|Disease|0|[3, 5]|1|-1|_|_|_|_|_|_|_|19058474
myocardial injury|Disease|0|[12, 14]|500|-1|_|_|_|_|_|_|_|18808529
hypotension|Disease|1|[22, 23]|3|H|_|_|_|_|_|_|_|18808529
myocardial damage|Disease|1|[6, 8]|500|-1|_|_|_|_|_|_|_|18808529
alterations in the structural integrity of the sarcolemma|Disease|2|[1, 9]|500|-1|_|_|_|_|_|_|_|18808529
ischaemic injury|Disease|9|[5, 7]|500|-1|_|_|_|_|_|_|_|18808529
isoproterenol|Chemical|0|[0, 1]|1|-1|_|_|_|_|_|_|_|18808529
dystrophin|Gene|0|[5, 6]|2|-1|_|_|_|_|_|_|_|18808529
oxygen supply|Physiology|1|[15, 17]|5|-1|_|_|_|_|_|_|_|18808529
coronary hypotension|Physiology|1|[21, 23]|6|-1|_|_|_|_|_|_|_|18808529
myocardial hyperactivity|Physiology|1|[24, 26]|7|-1|_|_|_|_|_|_|_|18808529
sarcolemmal stability|Physiology|3|[41, 43]|9|-1|_|_|_|_|_|_|_|18808529
obese|Disease|0|[5, 6]|500|-1|_|_|_|_|_|_|_|18674790
obese|Disease|5|[40, 41]|500|-1|_|_|_|_|_|_|_|18674790
obese|Disease|9|[6, 7]|500|-1|_|_|_|_|_|_|_|18674790
obesity|Disease|4|[23, 24]|500|-1|_|_|_|_|_|_|_|18674790
renal or hepatic toxicity|Disease|5|[51, 55]|11|-1|_|_|_|_|_|_|_|18674790
cardiac dysfunction|Disease|5|[29, 31]|14|-1|_|_|_|_|_|_|_|18674790
fat|Chemical|0|[1, 2]|1|-1|_|_|_|_|_|_|_|18674790
fat|Chemical|4|[15, 16]|1|-1|_|_|_|_|_|_|_|18674790
doxorubicin|Chemical|0|[11, 12]|502|-1|_|_|_|_|_|_|_|18674790
doxorubicin|Chemical|1|[4, 5]|502|-1|_|_|_|_|_|_|_|18674790
doxorubicin|Chemical|2|[12, 13]|502|-1|_|_|_|_|_|_|_|18674790
doxorubicin|Chemical|4|[39, 40]|502|-1|_|_|_|_|_|_|_|18674790
doxorubicin|Chemical|5|[9, 10]|502|-1|_|_|_|_|_|_|_|18674790
doxorubicin|Chemical|6|[0, 1]|502|-1|_|_|_|_|_|_|_|18674790
doxorubicin|Chemical|6|[9, 10]|502|-1|_|_|_|_|_|_|_|18674790
doxorubicin|Chemical|7|[124, 125]|502|-1|_|_|_|_|_|_|_|18674790
doxorubicin|Chemical|9|[12, 13]|502|-1|_|_|_|_|_|_|_|18674790
adriamycin|Chemical|1|[6, 7]|502|-1|_|_|_|_|_|_|_|18674790
amp|Chemical|7|[100, 101]|17|-1|_|_|_|_|_|_|_|18674790
atp synthesis|Physiology|3|[19, 21]|6|-1|_|_|_|_|_|_|_|18674790
jak/stat3|Gene|3|[24, 27]|7|-1|_|_|_|_|_|_|_|18674790
jak/stat3|Gene|9|[30, 33]|7|-1|_|_|_|_|_|_|_|18674790
cardiac|'Disease'|8|[1, 2]|19|-1|_|_|_|_|_|_|_|18674790
erythropoietin|'Chemical'|8|[2, 3]|20|-1|_|_|_|_|_|_|_|18674790
lithium|Chemical|0|[5, 6]|0|-1|_|_|_|_|_|_|_|18441470
sinus node dysfunction|Disease|1|[0, 3]|1|-1|_|_|_|_|_|_|_|18441470
atrioventricular (av) block|Disease|2|[6, 11]|2|-1|_|_|_|_|_|_|_|18441470
atrioventricular (av) block|Disease|2|[6, 11]|2|-1|_|_|_|_|_|_|_|18441470
syncopal attacks|Disease|3|[12, 14]|5|-1|_|_|_|_|_|_|_|18441470
permanent pacemaker implantation|Treat|2|[21, 24]|4|-1|_|_|_|_|_|_|_|18441470
ziprasidone|Chemical|0|[5, 6]|0|-1|_|_|_|_|_|_|_|17366349
ziprasidone|Chemical|2|[16, 17]|0|-1|_|_|_|_|_|_|_|17366349
ziprasidone|Chemical|3|[14, 15]|0|-1|_|_|_|_|_|_|_|17366349
ziprasidone|Chemical|4|[38, 39]|0|-1|_|_|_|_|_|_|_|17366349
ziprasidone|Chemical|5|[14, 15]|0|-1|_|_|_|_|_|_|_|17366349
neuroleptic malignant syndrome|Disease|0|[0, 3]|501|-1|_|_|_|_|_|_|_|17366349
neuroleptic malignant syndrome|Disease|1|[0, 3]|501|-1|_|_|_|_|_|_|_|17366349
nms|Disease|3|[8, 9]|501|-1|_|_|_|_|_|_|_|17366349
nms|Disease|4|[21, 22]|501|-1|_|_|_|_|_|_|_|17366349
nms|Disease|5|[11, 12]|501|-1|_|_|_|_|_|_|_|17366349
myocardial infarction|Disease|0|[13, 15]|500|-1|_|_|_|_|_|_|_|16584858
mi|Disease|2|[14, 15]|500|-1|_|_|_|_|_|_|_|16584858
mi|Disease|5|[41, 42]|500|-1|_|_|_|_|_|_|_|16584858
mi|Disease|6|[25, 26]|500|-1|_|_|_|_|_|_|_|16584858
mi|Disease|7|[24, 25]|500|-1|_|_|_|_|_|_|_|16584858
mi|Disease|8|[17, 18]|500|-1|_|_|_|_|_|_|_|16584858
myocardial damage|Disease|3|[23, 25]|500|-1|_|_|_|_|_|_|_|16584858
ischemic myocardium|Disease|4|[23, 25]|500|-1|_|_|_|_|_|_|_|16584858
cardiac damage|Disease|8|[31, 33]|500|-1|_|_|_|_|_|_|_|16584858
isoproterenol|Chemical|0|[10, 11]|502|-1|_|_|_|_|_|_|_|16584858
mangiferin|Chemical|0|[2, 3]|503|-1|_|_|_|_|_|_|_|16584858
polyphenol|Chemical|1|[12, 13]|503|H|_|_|_|_|_|_|_|16584858
creatine|Chemical|3|[44, 45]|5|H|_|_|_|_|_|_|_|16584858
isph|Chemical|3|[3, 4]|502|-1|_|_|_|_|_|_|_|16584858
lactate dehydrogenase (ldh)|Chemical|3|[38, 43]|8|-1|_|_|_|_|_|_|_|16584858
creatine phosphokinase isoenzymes (ck-mb)|Chemical|3|[44, 52]|9|-1|_|_|_|_|_|_|_|16584858
ttc|Chemical|4|[12, 13]|504|-1|_|_|_|_|_|_|_|16584858
triphenyl tetrazolium chloride (ttc)|Chemical|4|[8, 14]|504|-1|_|_|_|_|_|_|_|16584858
vitamin c|Chemical|5|[30, 32]|14|-1|_|_|_|_|_|_|_|16584858
vitamin e|Chemical|5|[33, 35]|15|-1|_|_|_|_|_|_|_|16584858
glutathione|Chemical|5|[15, 16]|16|-1|_|_|_|_|_|_|_|16584858
glutathione|Chemical|5|[12, 13]|16|-1|_|_|_|_|_|_|_|16584858
glutathione|Chemical|5|[36, 37]|16|-1|_|_|_|_|_|_|_|16584858
glutathione|Chemical|5|[18, 19]|16|-1|_|_|_|_|_|_|_|16584858
dimethyl sulphoxide|Chemical|6|[16, 18]|21|-1|_|_|_|_|_|_|_|16584858
intraperitoneally|Treat|6|[20, 21]|22|-1|_|_|_|_|_|_|_|16584858
myoclonus|Disease|0|[3, 4]|0|-1|_|_|_|_|_|_|_|16563323
myoclonus|Disease|6|[2, 3]|0|-1|_|_|_|_|_|_|_|16563323
nausea|Disease|7|[14, 15]|4|-1|_|_|_|_|_|_|_|16563323
nausea|Disease|9|[9, 10]|4|-1|_|_|_|_|_|_|_|16563323
nausea|Disease|11|[23, 24]|4|-1|_|_|_|_|_|_|_|16563323
pruritus|Disease|7|[16, 17]|5|-1|_|_|_|_|_|_|_|16563323
pruritus|Disease|9|[12, 13]|5|-1|_|_|_|_|_|_|_|16563323
pruritus|Disease|11|[26, 27]|5|-1|_|_|_|_|_|_|_|16563323
remifentanil|Chemical|1|[16, 17]|1|-1|_|_|_|_|_|_|_|16563323
etomidate|Chemical|1|[35, 36]|2|-1|_|_|_|_|_|_|_|16563323
choline|Chemical|0|[2, 3]|0|-1|_|_|_|_|_|_|_|16428827
choline|Chemical|1|[1, 2]|0|-1|_|_|_|_|_|_|_|16428827
mc|Chemical|0|[5, 6]|1|H|_|_|_|_|_|_|_|16428827
daidzein|Chemical|0|[0, 1]|500|-1|_|_|_|_|_|_|_|16428827
acetylcholine (ach)|Chemical|1|[20, 24]|6|-1|_|_|_|_|_|_|_|16428827
4',7-dihydroxy-isoflavone|Chemical|3|[17, 25]|500|-1|_|_|_|_|_|_|_|16428827
scopolamine|Chemical|4|[12, 13]|8|-1|_|_|_|_|_|_|_|16428827
scopolamine|Chemical|5|[20, 21]|8|-1|_|_|_|_|_|_|_|16428827
scopolamine|Chemical|6|[2, 3]|8|-1|_|_|_|_|_|_|_|16428827
scopolamine|Chemical|7|[12, 13]|8|-1|_|_|_|_|_|_|_|16428827
scopolamine|Chemical|8|[22, 23]|8|-1|_|_|_|_|_|_|_|16428827
amnesia|Disease|0|[14, 15]|2|-1|_|_|_|_|_|_|_|16428827
amnesia|Disease|5|[23, 24]|2|-1|_|_|_|_|_|_|_|16428827
amnesia|Disease|8|[25, 26]|2|-1|_|_|_|_|_|_|_|16428827
alzheimer's disease (ad)|Disease|1|[33, 40]|5|-1|_|_|_|_|_|_|_|16428827
performance impairment|Disease|7|[19, 21]|13|-1|_|_|_|_|_|_|_|16428827
hiccups|Disease|0|[4, 5]|0|-1|_|_|_|_|_|_|_|15985056
pharyngitis|Disease|2|[21, 22]|2|-1|_|_|_|_|_|_|_|15985056
azithromycin|Chemical|0|[1, 2]|1|-1|_|_|_|_|_|_|_|15985056
baclofen|Chemical|4|[6, 7]|3|-1|_|_|_|_|_|_|_|15985056
dexamethasone|Chemical|7|[2, 3]|5|-1|_|_|_|_|_|_|_|15985056
methylprednisolone|Chemical|7|[4, 5]|6|-1|_|_|_|_|_|_|_|15985056
midazolam|Chemical|7|[9, 10]|7|-1|_|_|_|_|_|_|_|15985056
therapy|Treat|4|[4, 5]|4|-1|_|_|_|_|_|_|_|15985056
warfarin|Chemical|0|[3, 4]|0|-1|_|_|_|_|_|_|_|15276120
warfarin|Chemical|1|[4, 5]|0|-1|_|_|_|_|_|_|_|15276120
hemorrhage|Disease|0|[6, 7]|501|-1|_|_|_|_|_|_|_|15276120
bleeding|Disease|1|[7, 8]|501|-1|_|_|_|_|_|_|_|15276120
intracranial bleeding|Disease|2|[7, 9]|501|-1|_|_|_|_|_|_|_|15276120
haemorrhagic myocarditis|Disease|0|[1, 3]|0|-1|_|_|_|_|_|_|_|11271907
haemorrhagic myocarditis|Disease|1|[0, 2]|0|-1|_|_|_|_|_|_|_|11271907
cyclophosphamide|Chemical|0|[5, 6]|1|-1|_|_|_|_|_|_|_|11271907
migraine without aura|Disease|0|[5, 8]|500|-1|_|_|_|_|_|_|_|10524660
headache|Disease|3|[21, 22]|500|-1|_|_|_|_|_|_|_|10524660
headache|Disease|7|[0, 1]|500|-1|_|_|_|_|_|_|_|10524660
headache|Disease|8|[8, 9]|500|-1|_|_|_|_|_|_|_|10524660
headache|Disease|8|[16, 17]|500|-1|_|_|_|_|_|_|_|10524660
headache|Disease|9|[5, 6]|500|-1|_|_|_|_|_|_|_|10524660
headache|Disease|9|[22, 23]|500|-1|_|_|_|_|_|_|_|10524660
headache|Disease|11|[27, 28]|500|-1|_|_|_|_|_|_|_|10524660
migraine|Disease|4|[15, 16]|500|-1|_|_|_|_|_|_|_|10524660
nitric oxide (no)|Chemical|2|[12, 17]|502|-1|_|_|_|_|_|_|_|10524660
glyceryl trinitrate (gtn)|Chemical|3|[27, 32]|502|-1|_|_|_|_|_|_|_|10524660
gtn|Chemical|7|[14, 15]|502|-1|_|_|_|_|_|_|_|10524660
gtn|Chemical|8|[5, 6]|502|-1|_|_|_|_|_|_|_|10524660
no|Chemical|10|[5, 6]|502|-1|_|_|_|_|_|_|_|10524660
no|Chemical|11|[9, 10]|502|-1|_|_|_|_|_|_|_|10524660
stroke|Disease|0|[0, 1]|0|-1|_|_|_|_|_|_|_|9799166
stroke|Disease|1|[11, 12]|0|-1|_|_|_|_|_|_|_|9799166
stroke|Disease|2|[7, 8]|0|-1|_|_|_|_|_|_|_|9799166
stroke|Disease|7|[4, 5]|0|-1|_|_|_|_|_|_|_|9799166
stroke|Disease|8|[6, 7]|0|-1|_|_|_|_|_|_|_|9799166
stroke|Disease|10|[14, 15]|0|-1|_|_|_|_|_|_|_|9799166
cocaine|Chemical|0|[2, 3]|1|-1|_|_|_|_|_|_|_|9799166
cocaine|Chemical|1|[3, 4]|1|-1|_|_|_|_|_|_|_|9799166
cocaine|Chemical|2|[11, 12]|1|-1|_|_|_|_|_|_|_|9799166
cocaine|Chemical|8|[13, 14]|1|-1|_|_|_|_|_|_|_|9799166
cocaine|Chemical|9|[15, 16]|1|-1|_|_|_|_|_|_|_|9799166
cocaine|Chemical|10|[3, 4]|1|-1|_|_|_|_|_|_|_|9799166
amphetamine|Chemical|0|[4, 5]|2|-1|_|_|_|_|_|_|_|9799166
tamoxifen|Chemical|0|[19, 20]|0|-1|_|_|_|_|_|_|_|9672273
tamoxifen|Chemical|0|[5, 6]|0|-1|_|_|_|_|_|_|_|9672273
tamoxifen|Chemical|1|[2, 3]|0|-1|_|_|_|_|_|_|_|9672273
endometrial cancer|Disease|1|[22, 24]|2|-1|_|_|_|_|_|_|_|9672273
breast-cancer|Disease|12|[5, 8]|5|-1|_|_|_|_|_|_|_|9672273
vascular events|Disease|14|[13, 15]|7|H|_|_|_|_|_|_|_|9672273
hypertriglyceridaemia|Disease|14|[16, 17]|8|-1|_|_|_|_|_|_|_|9672273
intention-to-treat|Treat|9|[7, 12]|4|-1|_|_|_|_|_|_|_|9672273
hormone-replacement therapy|Treat|13|[16, 20]|6|-1|_|_|_|_|_|_|_|9672273
pupillary oscillation|Disease|0|[3, 5]|0|-1|_|_|_|_|_|_|_|8854309
pupillary oscillation|Disease|2|[2, 4]|0|-1|_|_|_|_|_|_|_|8854309
paranoia|Disease|0|[12, 13]|500|-1|_|_|_|_|_|_|_|8854309
cip|Disease|2|[33, 34]|500|-1|_|_|_|_|_|_|_|8854309
cip|Disease|2|[18, 19]|500|-1|_|_|_|_|_|_|_|8854309
cocaine|Chemical|0|[9, 10]|1|-1|_|_|_|_|_|_|_|8854309
cocaine|Chemical|1|[0, 1]|1|-1|_|_|_|_|_|_|_|8854309
cocaine|Chemical|2|[14, 15]|1|-1|_|_|_|_|_|_|_|8854309
pupillary oscillation|Physiology|0|[3, 5]|3|-1|_|_|_|_|_|_|_|8854309
levomepromazine|Chemical|0|[4, 5]|0|-1|_|_|_|_|_|_|_|8473723
levomepromazine|Chemical|1|[6, 7]|0|-1|_|_|_|_|_|_|_|8473723
fluvoxamine|Chemical|0|[6, 7]|1|-1|_|_|_|_|_|_|_|8473723
fluvoxamine|Chemical|1|[8, 9]|1|-1|_|_|_|_|_|_|_|8473723
fluvoxamine|Chemical|2|[6, 7]|1|-1|_|_|_|_|_|_|_|8473723
seizures|Disease|0|[0, 1]|2|-1|_|_|_|_|_|_|_|8473723
combined levomepromazine-fluvoxamine treatment|Treat|1|[5, 10]|5|-1|_|_|_|_|_|_|_|8473723
eaca|Chemical|0|[7, 8]|500|-1|_|_|_|_|_|_|_|6674249
eaca|Chemical|1|[14, 15]|500|-1|_|_|_|_|_|_|_|6674249
epsilon-aminocaproic acid (eaca)|Chemical|0|[2, 9]|500|-1|_|_|_|_|_|_|_|6674249
epsilon-aminocaproic acid (eaca)|Chemical|1|[9, 16]|500|-1|_|_|_|_|_|_|_|6674249
myopathy|Disease|0|[10, 11]|502|-1|_|_|_|_|_|_|_|6674249
myopathy|Disease|1|[4, 5]|502|-1|_|_|_|_|_|_|_|6674249
sah|Disease|1|[28, 29]|503|-1|_|_|_|_|_|_|_|6674249
necrotizing myopathy|Disease|1|[3, 5]|502|-1|_|_|_|_|_|_|_|6674249
subarachnoid haemorrhage (sah)|Disease|1|[25, 30]|503|-1|_|_|_|_|_|_|_|6674249
gastric hypersecretory states|Disease|0|[15, 18]|500|H|_|_|_|_|_|_|_|6150641
gastric acid hypersecretory states|Disease|1|[32, 36]|500|H|_|_|_|_|_|_|_|6150641
zollinger-ellison syndrome|Disease|2|[3, 7]|4|-1|_|_|_|_|_|_|_|6150641
systemic mastocytosis|Disease|2|[11, 13]|5|-1|_|_|_|_|_|_|_|6150641
impotence|Disease|6|[9, 10]|7|-1|_|_|_|_|_|_|_|6150641
hepatic or hematologic toxicity|Disease|7|[34, 38]|8|H|_|_|_|_|_|_|_|6150641
hematologic toxicity|Disease|7|[36, 38]|9|-1|_|_|_|_|_|_|_|6150641
ranitidine|Chemical|0|[5, 6]|1|-1|_|_|_|_|_|_|_|6150641
cimetidine|Chemical|0|[7, 8]|2|-1|_|_|_|_|_|_|_|6150641
acid secretion|Physiology|4|[28, 30]|6|-1|_|_|_|_|_|_|_|6150641
gastrin concentrations|Physiology|7|[42, 44]|10|-1|_|_|_|_|_|_|_|6150641
reye syndrome|Disease|1|[5, 7]|0|-1|_|_|_|_|_|_|_|3670965
reye syndrome|Disease|2|[20, 22]|0|-1|_|_|_|_|_|_|_|3670965
reye syndrome|Disease|4|[6, 8]|0|-1|_|_|_|_|_|_|_|3670965
reye syndrome|Disease|5|[3, 5]|0|-1|_|_|_|_|_|_|_|3670965
reye syndrome|Disease|6|[4, 6]|0|-1|_|_|_|_|_|_|_|3670965
reye syndrome|Disease|8|[0, 2]|0|-1|_|_|_|_|_|_|_|3670965
paracetamol|Chemical|3|[18, 19]|501|-1|_|_|_|_|_|_|_|3670965
paracetamol|Chemical|7|[29, 30]|501|-1|_|_|_|_|_|_|_|3670965
aspirin|Chemical|3|[0, 1]|502|-1|_|_|_|_|_|_|_|3670965
salicylate|Chemical|3|[2, 3]|502|-1|_|_|_|_|_|_|_|3670965
acetaminophen|Chemical|3|[20, 21]|501|-1|_|_|_|_|_|_|_|3670965
salicylates|Chemical|8|[14, 15]|502|-1|_|_|_|_|_|_|_|3670965
st. anthony's fire|Disease|0|[0, 6]|500|-1|_|_|_|_|_|_|_|3300918
st. anthony's fire|Disease|0|[0, 6]|500|-1|_|_|_|_|_|_|_|3300918
st. anthony's fire|Disease|4|[30, 36]|500|-1|_|_|_|_|_|_|_|3300918
vasospasm|Disease|1|[5, 6]|500|-1|_|_|_|_|_|_|_|3300918
headache|Disease|3|[34, 35]|4|H|_|_|_|_|_|_|_|3300918
gangrene|Disease|3|[15, 16]|500|-1|_|_|_|_|_|_|_|3300918
migraine|Disease|4|[22, 23]|10|H|_|_|_|_|_|_|_|3300918
methysergide|Chemical|1|[20, 21]|502|-1|_|_|_|_|_|_|_|3300918
ergot|Chemical|3|[6, 7]|502|-1|_|_|_|_|_|_|_|3300918
ergot|Chemical|4|[13, 14]|502|-1|_|_|_|_|_|_|_|3300918
calcium channel blockers|Chemical|4|[4, 7]|11|-1|_|_|_|_|_|_|_|3300918
beta-adrenergic antagonists|Chemical|4|[8, 12]|12|-1|_|_|_|_|_|_|_|3300918
ergot preparations|Chemical|4|[13, 15]|502|-1|_|_|_|_|_|_|_|3300918
management of migraine headache|Treat|3|[31, 35]|7|-1|_|_|_|_|_|_|_|3300918
hypokalemia|Disease|0|[7, 8]|0|-1|_|_|_|_|_|_|_|2826064
oxprenolol|Chemical|0|[12, 13]|1|-1|_|_|_|_|_|_|_|2826064
oxprenolol|Chemical|6|[0, 1]|1|-1|_|_|_|_|_|_|_|2826064
terbutaline|Chemical|1|[9, 10]|3|-1|_|_|_|_|_|_|_|2826064
hypokalemia|Physiology|0|[7, 8]|2|-1|_|_|_|_|_|_|_|2826064
plasma potassium levels|Physiology|4|[17, 20]|4|-1|_|_|_|_|_|_|_|2826064
potassium effects|Physiology|5|[15, 17]|5|-1|_|_|_|_|_|_|_|2826064
hypotensive|Disease|0|[10, 11]|500|-1|_|_|_|_|_|_|_|2422478
hypotensive|Disease|1|[25, 26]|500|-1|_|_|_|_|_|_|_|2422478
hypotensive|Disease|6|[33, 34]|500|-1|_|_|_|_|_|_|_|2422478
hypotension|Disease|3|[29, 30]|500|-1|_|_|_|_|_|_|_|2422478
hypotension|Disease|4|[29, 30]|500|-1|_|_|_|_|_|_|_|2422478
hypotension|Disease|6|[17, 18]|500|-1|_|_|_|_|_|_|_|2422478
hypertensive|Disease|3|[2, 3]|6|-1|_|_|_|_|_|_|_|2422478
stroke|Disease|3|[4, 5]|7|-1|_|_|_|_|_|_|_|2422478
serotonin|Chemical|0|[2, 3]|1|H|_|_|_|_|_|_|_|2422478
methyldopa|Chemical|0|[13, 14]|3|-1|_|_|_|_|_|_|_|2422478
5,7-dht|Chemical|3|[59, 64]|502|-1|_|_|_|_|_|_|_|2422478
5,7-dht|Chemical|4|[5, 10]|502|-1|_|_|_|_|_|_|_|2422478
5,7-dht|Chemical|4|[5, 10]|502|-1|_|_|_|_|_|_|_|2422478
5,7-dht|Chemical|5|[2, 7]|502|-1|_|_|_|_|_|_|_|2422478
5,7-dihydroxytryptamine (5,7-dht)|Chemical|3|[53, 65]|502|-1|_|_|_|_|_|_|_|2422478
hypotensive effect|Physiology|0|[10, 12]|2|-1|_|_|_|_|_|_|_|2422478
hypotension|Physiology|4|[29, 30]|13|-1|_|_|_|_|_|_|_|2422478
blood pressure|Physiology|5|[36, 38]|15|-1|_|_|_|_|_|_|_|2422478
sexual side effects|Disease|0|[3, 6]|0|-1|_|_|_|_|_|_|_|1535072
male impotence|Disease|1|[20, 22]|3|-1|_|_|_|_|_|_|_|1535072
obsessive compulsive disorder|Disease|4|[6, 9]|6|H|_|_|_|_|_|_|_|1535072
trichotillomania|Disease|4|[10, 11]|7|-1|_|_|_|_|_|_|_|1535072
anxiety|Disease|4|[12, 13]|8|H|_|_|_|_|_|_|_|1535072
serotonin|Chemical|0|[8, 9]|1|H|_|_|_|_|_|_|_|1535072
yohimbine|Chemical|0|[0, 1]|2|-1|_|_|_|_|_|_|_|1535072
clomipramine|Chemical|2|[17, 18]|5|-1|_|_|_|_|_|_|_|1535072
treatment of male impotence|Treat|1|[18, 22]|4|-1|_|_|_|_|_|_|_|1535072
yohimbine treatment|Treat|7|[7, 9]|10|-1|_|_|_|_|_|_|_|1535072
sexual functioning|Physiology|6|[9, 11]|9|-1|_|_|_|_|_|_|_|1535072
hepatitis|Disease|0|[10, 11]|0|-1|_|_|_|_|_|_|_|1504402
liver injury|Disease|1|[26, 28]|3|H|_|_|_|_|_|_|_|1504402
dilevalol|Chemical|0|[7, 8]|1|-1|_|_|_|_|_|_|_|1504402
hypersensitivity immune reaction|Immune|0|[0, 3]|2|-1|_|_|_|_|_|_|_|1504402
healthy|Immune|4|[9, 10]|4|-1|_|_|_|_|_|_|_|1504402
lymphocyte sensitization|Immune|8|[9, 11]|5|-1|_|_|_|_|_|_|_|1504402
myocardial hypertrophy|Disease|0|[1, 3]|500|-1|_|_|_|_|_|_|_|19917396
myocardial hypertrophy|Disease|7|[0, 2]|500|-1|_|_|_|_|_|_|_|19917396
edema|Disease|5|[15, 16]|6|H|_|_|_|_|_|_|_|19917396
interstitial edema|Disease|5|[14, 16]|7|-1|_|_|_|_|_|_|_|19917396
mild myocardial hypertrophy|Disease|5|[17, 20]|500|-1|_|_|_|_|_|_|_|19917396
tacrolimus|Chemical|0|[5, 6]|1|-1|_|_|_|_|_|_|_|19917396
tacrolimus|Chemical|1|[0, 1]|1|-1|_|_|_|_|_|_|_|19917396
organ transplantation|Treat|1|[10, 12]|3|-1|_|_|_|_|_|_|_|19917396
heart transplantation|Treat|3|[10, 12]|5|-1|_|_|_|_|_|_|_|19917396
immunosuppressant|Immune|1|[4, 5]|4|-1|_|_|_|_|_|_|_|19917396
humoral rejection|Immune|5|[24, 26]|9|-1|_|_|_|_|_|_|_|19917396
blood tacrolimus concentration|Physiology|6|[1, 4]|10|-1|_|_|_|_|_|_|_|19917396
blood concentration|Physiology|9|[6, 8]|12|-1|_|_|_|_|_|_|_|19917396
idiopathic parkinson's disease|Disease|0|[9, 14]|500|H|_|_|_|_|_|_|_|19234905
parkinson's disease (pd)|Disease|1|[23, 30]|500|H|_|_|_|_|_|_|_|19234905
dyskinesias|Disease|2|[70, 71]|5|-1|_|_|_|_|_|_|_|19234905
parkinsonian|Disease|6|[9, 10]|500|-1|_|_|_|_|_|_|_|19234905
hoehn _ yahr|Disease|8|[4, 7]|10|-1|_|_|_|_|_|_|_|19234905
schwab england adl|Disease|8|[8, 11]|11|-1|_|_|_|_|_|_|_|19234905
homonymous hemianopsia|Disease|10|[11, 13]|13|-1|_|_|_|_|_|_|_|19234905
pd|Disease|11|[22, 23]|500|H|_|_|_|_|_|_|_|19234905
pallidotomy|Treat|0|[3, 4]|1|-1|_|_|_|_|_|_|_|19234905
subthalamotomy|Treat|0|[5, 6]|2|-1|_|_|_|_|_|_|_|19234905
lesions of the unilateral stn and gpi|Treat|11|[7, 14]|16|-1|_|_|_|_|_|_|_|19234905
levodopa|Chemical|2|[67, 68]|4|-1|_|_|_|_|_|_|_|19234905
levodopa|Chemical|3|[7, 8]|4|-1|_|_|_|_|_|_|_|19234905
levodopa|Chemical|7|[0, 1]|4|-1|_|_|_|_|_|_|_|19234905
levodopa|Chemical|7|[0, 1]|4|-1|_|_|_|_|_|_|_|19234905
valproate|Chemical|10|[33, 34]|14|-1|_|_|_|_|_|_|_|19234905
cognitive functions|Physiology|9|[0, 2]|12|-1|_|_|_|_|_|_|_|19234905
nephrosis|Disease|0|[7, 8]|500|-1|_|_|_|_|_|_|_|18541230
nephrosis|Disease|1|[21, 22]|500|-1|_|_|_|_|_|_|_|18541230
nephrotic syndrome|Disease|1|[30, 32]|500|-1|_|_|_|_|_|_|_|18541230
hematological abnormalities|Disease|3|[9, 11]|5|H|_|_|_|_|_|_|_|18541230
renal dysfunction|Disease|4|[4, 6]|6|-1|_|_|_|_|_|_|_|18541230
hyperlipidemia|Disease|4|[7, 8]|7|-1|_|_|_|_|_|_|_|18541230
renal damage|Disease|5|[4, 6]|9|-1|_|_|_|_|_|_|_|18541230
puromycin aminonucleoside|Chemical|2|[29, 31]|3|-1|_|_|_|_|_|_|_|18541230
puromycin aminonucleoside|Chemical|4|[0, 2]|3|-1|_|_|_|_|_|_|_|18541230
antithrombin|Treat|2|[0, 1]|4|-1|_|_|_|_|_|_|_|18541230
antithrombin-treated|Treat|5|[31, 34]|10|-1|_|_|_|_|_|_|_|18541230
antithrombin treatment|Treat|6|[3, 5]|11|-1|_|_|_|_|_|_|_|18541230
takotsubo cardiomyopathy|Disease|0|[10, 12]|500|-1|_|_|_|_|_|_|_|18177388
takotsubo cardiomyopathy|Disease|0|[10, 12]|500|-1|_|_|_|_|_|_|_|18177388
takotsubo cardiomyopathy|Disease|1|[13, 15]|500|-1|_|_|_|_|_|_|_|18177388
takotsubo cardiomyopathy|Disease|1|[13, 15]|500|-1|_|_|_|_|_|_|_|18177388
akinesia|Disease|3|[17, 18]|5|-1|_|_|_|_|_|_|_|18177388
apical ballooning|Disease|3|[27, 29]|500|-1|_|_|_|_|_|_|_|18177388
reverse apical ballooning syndrome|Disease|4|[20, 24]|500|-1|_|_|_|_|_|_|_|18177388
amphetamine|Chemical|0|[21, 22]|2|-1|_|_|_|_|_|_|_|18177388
adolescent corticosterone treatment|Treat|0|[12, 15]|0|-1|_|_|_|_|_|_|_|17490864
amphetamine treatment|Treat|4|[0, 2]|6|-1|_|_|_|_|_|_|_|17490864
prepulse inhibition|Physiology|0|[3, 5]|1|-1|_|_|_|_|_|_|_|17490864
prepulse inhibition (ppi)|Physiology|3|[7, 12]|4|-1|_|_|_|_|_|_|_|17490864
ppi|Physiology|4|[4, 5]|7|-1|_|_|_|_|_|_|_|17490864
dopaminergic regulation of ppi|Physiology|7|[28, 32]|12|-1|_|_|_|_|_|_|_|17490864
sensory gating|Physiology|8|[24, 26]|14|-1|_|_|_|_|_|_|_|17490864
corticosterone|Chemical|2|[26, 27]|2|-1|_|_|_|_|_|_|_|17490864
apomorphine|Chemical|3|[3, 4]|3|-1|_|_|_|_|_|_|_|17490864
apomorphine|Chemical|8|[4, 5]|3|-1|_|_|_|_|_|_|_|17490864
amphetamine|Chemical|4|[0, 1]|5|-1|_|_|_|_|_|_|_|17490864
8-oh-dpat|Chemical|5|[7, 12]|8|-1|_|_|_|_|_|_|_|17490864
8-oh-dpat|Chemical|5|[7, 12]|8|-1|_|_|_|_|_|_|_|17490864
serotonin|Chemical|5|[1, 2]|10|H|_|_|_|_|_|_|_|17490864
locomotor hyperactivity|Disease|6|[3, 5]|11|-1|_|_|_|_|_|_|_|17490864
degeneration of dopaminergic neurons|Disease|0|[4, 8]|0|H|_|_|_|_|_|_|_|17490790
degeneration of dopaminergic neurons|Disease|2|[53, 57]|0|H|_|_|_|_|_|_|_|17490790
degeneration of dopaminergic neurons|Disease|6|[21, 25]|0|H|_|_|_|_|_|_|_|17490790
chronic overload|Disease|5|[7, 9]|6|-1|_|_|_|_|_|_|_|17490790
iron dextran|Chemical|0|[1, 3]|1|-1|_|_|_|_|_|_|_|17490790
tyrosine|Chemical|2|[30, 31]|3|-1|_|_|_|_|_|_|_|17490790
dopamine|Chemical|4|[4, 5]|5|-1|_|_|_|_|_|_|_|17490790
tyrosine hydroxylase (th)|Gene|2|[30, 35]|4|-1|_|_|_|_|_|_|_|17490790
warfarin|Chemical|0|[0, 1]|0|-1|_|_|_|_|_|_|_|16047871
warfarin|Chemical|0|[0, 1]|0|-1|_|_|_|_|_|_|_|16047871
warfarin|Chemical|3|[12, 13]|0|-1|_|_|_|_|_|_|_|16047871
warfarin|Chemical|4|[11, 12]|0|-1|_|_|_|_|_|_|_|16047871
warfarin|Chemical|5|[21, 22]|0|-1|_|_|_|_|_|_|_|16047871
warfarin|Chemical|6|[9, 10]|0|-1|_|_|_|_|_|_|_|16047871
warfarin|Chemical|7|[11, 12]|0|-1|_|_|_|_|_|_|_|16047871
cutaneous small vessel vasculitis|Disease|2|[8, 12]|501|-1|_|_|_|_|_|_|_|16047871
vasculitis|Disease|2|[11, 12]|501|-1|_|_|_|_|_|_|_|16047871
vasculitis|Disease|2|[1, 2]|501|-1|_|_|_|_|_|_|_|16047871
eruptions|Disease|4|[6, 7]|501|-1|_|_|_|_|_|_|_|16047871
skin eruptions|Disease|4|[5, 7]|501|-1|_|_|_|_|_|_|_|16047871
lv cutaneous lesions|Disease|5|[13, 16]|501|-1|_|_|_|_|_|_|_|16047871
degeneration of spinal motor neurons|Disease|0|[15, 20]|500|-1|_|_|_|_|_|_|_|15673851
aortic occlusion|Disease|1|[33, 35]|2|-1|_|_|_|_|_|_|_|15673851
aortic occlusion|Disease|2|[6, 8]|2|-1|_|_|_|_|_|_|_|15673851
spastic paraparesis|Disease|5|[27, 29]|500|-1|_|_|_|_|_|_|_|15673851
morphine|Chemical|0|[23, 24]|1|-1|_|_|_|_|_|_|_|15673851
n-methyl-d-aspartate (nmda)|Chemical|1|[14, 24]|3|-1|_|_|_|_|_|_|_|15673851
cerebrospinal fluid (csf) glutamate concentration|Physiology|6|[5, 12]|6|-1|_|_|_|_|_|_|_|15673851
seizures|Disease|0|[15, 16]|0|-1|_|_|_|_|_|_|_|12481039
sodium channel beta 2-subunits|Gene|0|[19, 25]|1|-1|_|_|_|_|_|_|_|12481039
sodium channel beta-subunits|Gene|1|[0, 5]|2|-1|_|_|_|_|_|_|_|12481039
beta2|Gene|2|[2, 3]|3|-1|_|_|_|_|_|_|_|12481039
beta2|Gene|2|[14, 15]|3|-1|_|_|_|_|_|_|_|12481039
stx|Chemical|3|[10, 11]|501|-1|_|_|_|_|_|_|_|12481039
saxitoxin (stx)|Chemical|3|[8, 12]|501|-1|_|_|_|_|_|_|_|12481039
pilocarpine|Chemical|7|[21, 22]|9|-1|_|_|_|_|_|_|_|12481039
action potential generation|Physiology|5|[18, 21]|7|-1|_|_|_|_|_|_|_|12481039
conduction velocity|Physiology|6|[4, 6]|8|-1|_|_|_|_|_|_|_|12481039
seizure|Disease|0|[8, 9]|0|-1|_|_|_|_|_|_|_|11185967
cocaine or amphetamine abuse|Disease|5|[26, 30]|500|-1|_|_|_|_|_|_|_|11185967
cocaine or amphetamine abuse|Disease|7|[17, 21]|500|-1|_|_|_|_|_|_|_|11185967
drug abuse|Disease|9|[24, 26]|500|-1|_|_|_|_|_|_|_|11185967
cocaine|Chemical|1|[18, 19]|1|H|_|_|_|_|_|_|_|11185967
cocaine|Chemical|3|[7, 8]|1|H|_|_|_|_|_|_|_|11185967
cocaine|Chemical|5|[26, 27]|1|H|_|_|_|_|_|_|_|11185967
cocaine|Chemical|7|[17, 18]|1|H|_|_|_|_|_|_|_|11185967
cocaine|Chemical|8|[11, 12]|1|H|_|_|_|_|_|_|_|11185967
amphetamine|Chemical|1|[20, 21]|2|-1|_|_|_|_|_|_|_|11185967
benzoylecgonine|Chemical|3|[9, 10]|4|-1|_|_|_|_|_|_|_|11185967
alcohol|Chemical|5|[8, 9]|7|-1|_|_|_|_|_|_|_|11185967
parkinsonian|Disease|1|[27, 28]|500|H|_|_|_|_|_|_|_|11099450
parkinsonian|Disease|3|[54, 55]|500|H|_|_|_|_|_|_|_|11099450
parkinsonian|Disease|4|[21, 22]|500|H|_|_|_|_|_|_|_|11099450
parkinsonian|Disease|5|[11, 12]|500|H|_|_|_|_|_|_|_|11099450
parkinsonian|Disease|5|[48, 49]|500|H|_|_|_|_|_|_|_|11099450
parkinsonian|Disease|5|[29, 30]|500|H|_|_|_|_|_|_|_|11099450
lid|Disease|2|[52, 53]|501|-1|_|_|_|_|_|_|_|11099450
lid|Disease|3|[35, 36]|501|-1|_|_|_|_|_|_|_|11099450
lid|Disease|6|[26, 27]|501|-1|_|_|_|_|_|_|_|11099450
dyskinesias|Disease|4|[19, 20]|501|-1|_|_|_|_|_|_|_|11099450
parkinsonism|Disease|6|[13, 14]|500|H|_|_|_|_|_|_|_|11099450
gpi|Disease|8|[13, 14]|16|H|_|_|_|_|_|_|_|11099450
levodopa|Chemical|1|[33, 34]|1|-1|_|_|_|_|_|_|_|11099450
levodopa|Chemical|2|[15, 16]|1|-1|_|_|_|_|_|_|_|11099450
levodopa|Chemical|2|[8, 9]|1|-1|_|_|_|_|_|_|_|11099450
levodopa|Chemical|5|[5, 6]|1|-1|_|_|_|_|_|_|_|11099450
pallidotomy|Treat|1|[25, 26]|2|-1|_|_|_|_|_|_|_|11099450
methadone|Chemical|0|[3, 4]|500|-1|_|_|_|_|_|_|_|11027904
methadone|Chemical|2|[19, 20]|500|-1|_|_|_|_|_|_|_|11027904
hydromorphone|Chemical|3|[38, 39]|7|-1|_|_|_|_|_|_|_|11027904
ketorolac|Chemical|3|[48, 49]|8|-1|_|_|_|_|_|_|_|11027904
mm opioid|Chemical|6|[4, 6]|500|H|_|_|_|_|_|_|_|11027904
opioid abusers|Disease|0|[6, 8]|502|-1|_|_|_|_|_|_|_|11027904
opioid addicts|Disease|2|[15, 17]|502|-1|_|_|_|_|_|_|_|11027904
pain|Disease|3|[21, 22]|6|H|_|_|_|_|_|_|_|11027904
cp pain|Disease|4|[10, 12]|9|-1|_|_|_|_|_|_|_|11027904
pain-intolerant|Disease|6|[9, 12]|10|-1|_|_|_|_|_|_|_|11027904
pain management|Treat|1|[1, 3]|2|-1|_|_|_|_|_|_|_|11027904
pain experience|Physiology|1|[21, 23]|3|-1|_|_|_|_|_|_|_|11027904
n-acetyl-beta-d-glucosaminidase (nag)|Chemical|1|[13, 25]|0|-1|_|_|_|_|_|_|_|10193809
puromycin aminonucleoside (pan)|Chemical|2|[2, 7]|500|-1|_|_|_|_|_|_|_|10193809
pan|Chemical|5|[4, 5]|500|-1|_|_|_|_|_|_|_|10193809
proteinuria|Disease|2|[15, 16]|1|-1|_|_|_|_|_|_|_|10193809
proteinuria|Disease|9|[16, 17]|1|-1|_|_|_|_|_|_|_|10193809
protein electrophoretic pattern|Physiology|3|[8, 11]|3|-1|_|_|_|_|_|_|_|10193809
pituitary tumors|Disease|0|[18, 20]|0|-1|_|_|_|_|_|_|_|9214597
vascular endothelial growth factor|Gene|0|[3, 7]|1|-1|_|_|_|_|_|_|_|9214597
vegfr-2/flk-1/kdr|Gene|4|[6, 15]|4|-1|_|_|_|_|_|_|_|9214597
vegf|Gene|6|[10, 11]|6|-1|_|_|_|_|_|_|_|9214597
vegfr-2|Gene|10|[6, 9]|8|-1|_|_|_|_|_|_|_|9214597
vegfr-2|Gene|11|[12, 15]|8|-1|_|_|_|_|_|_|_|9214597
flk-1|Gene|10|[10, 13]|9|-1|_|_|_|_|_|_|_|9214597
kdr|Gene|10|[14, 15]|10|-1|_|_|_|_|_|_|_|9214597
estrogens|Chemical|1|[0, 1]|501|-1|_|_|_|_|_|_|_|9214597
17beta-estradiol (e2)|Chemical|5|[4, 10]|501|-1|_|_|_|_|_|_|_|9214597
e2|Chemical|10|[32, 33]|501|-1|_|_|_|_|_|_|_|9214597
angiogenesis|Physiology|3|[11, 12]|3|-1|_|_|_|_|_|_|_|9214597
myopathy|Disease|0|[3, 4]|500|-1|_|_|_|_|_|_|_|7604176
myopathy|Disease|1|[5, 6]|500|-1|_|_|_|_|_|_|_|7604176
myopathy|Disease|4|[5, 6]|500|-1|_|_|_|_|_|_|_|7604176
myopathy|Disease|7|[9, 10]|500|-1|_|_|_|_|_|_|_|7604176
myopathy|Disease|7|[14, 15]|500|-1|_|_|_|_|_|_|_|7604176
inflammatory myopathy|Disease|1|[4, 6]|500|-1|_|_|_|_|_|_|_|7604176
non-insulin-dependent diabetes mellitus|Disease|2|[13, 20]|4|-1|_|_|_|_|_|_|_|7604176
hypertension|Disease|2|[21, 22]|5|-1|_|_|_|_|_|_|_|7604176
hypercholesterolemia|Disease|3|[11, 12]|6|-1|_|_|_|_|_|_|_|7604176
autoimmune thyroiditis|Disease|5|[9, 11]|8|H|_|_|_|_|_|_|_|7604176
hypothyroidism|Disease|5|[3, 4]|9|-1|_|_|_|_|_|_|_|7604176
pravastatin|Chemical|0|[0, 1]|1|-1|_|_|_|_|_|_|_|7604176
lovastatin|Chemical|7|[1, 2]|13|-1|_|_|_|_|_|_|_|7604176
simvastatin|Chemical|7|[3, 4]|14|-1|_|_|_|_|_|_|_|7604176
cd4+ lymphocytes|Immune|6|[17, 20]|10|-1|_|_|_|_|_|_|_|7604176
doxorubicin|Chemical|0|[9, 10]|500|-1|_|_|_|_|_|_|_|7282516
doxorubicin|Chemical|1|[10, 11]|500|-1|_|_|_|_|_|_|_|7282516
adriamycin|Chemical|1|[15, 16]|500|-1|_|_|_|_|_|_|_|7282516
dxr|Chemical|2|[26, 27]|500|-1|_|_|_|_|_|_|_|7282516
dxr|Chemical|3|[11, 12]|500|-1|_|_|_|_|_|_|_|7282516
dxr|Chemical|6|[15, 16]|500|-1|_|_|_|_|_|_|_|7282516
dxr|Chemical|6|[1, 2]|500|-1|_|_|_|_|_|_|_|7282516
cardiomyopathy|Disease|1|[1, 2]|502|-1|_|_|_|_|_|_|_|7282516
myocardial damage|Disease|6|[4, 6]|502|-1|_|_|_|_|_|_|_|7282516
exercise hemodynamics|Physiology|5|[25, 27]|6|-1|_|_|_|_|_|_|_|7282516
myocardial function|Physiology|6|[19, 21]|10|-1|_|_|_|_|_|_|_|7282516
aplastic anemia|Disease|0|[1, 3]|0|-1|_|_|_|_|_|_|_|7072798
cataract|Disease|1|[17, 18]|2|-1|_|_|_|_|_|_|_|7072798
pancytopenia|Disease|2|[4, 5]|4|H|_|_|_|_|_|_|_|7072798
chloramphenicol|Chemical|0|[8, 9]|1|-1|_|_|_|_|_|_|_|7072798
cataract extraction|Treat|1|[17, 19]|3|-1|_|_|_|_|_|_|_|7072798
topical treatment|Treat|4|[10, 12]|5|-1|_|_|_|_|_|_|_|7072798
bradycardia|Disease|0|[0, 1]|0|-1|_|_|_|_|_|_|_|3769769
bradycardia|Disease|0|[0, 1]|0|-1|_|_|_|_|_|_|_|3769769
bradycardia|Disease|2|[7, 8]|0|-1|_|_|_|_|_|_|_|3769769
schizophrenic|Disease|1|[2, 3]|3|-1|_|_|_|_|_|_|_|3769769
trihexyphenidyl hydrochloride|Chemical|0|[3, 5]|501|-1|_|_|_|_|_|_|_|3769769
trihexyphenidyl|Chemical|3|[5, 6]|501|-1|_|_|_|_|_|_|_|3769769
antidyskinetic drug|Chemical|4|[1, 3]|501|-1|_|_|_|_|_|_|_|3769769
nephrotoxicity|Disease|0|[2, 3]|500|-1|_|_|_|_|_|_|_|3708922
nephrotoxicity|Disease|4|[9, 10]|500|-1|_|_|_|_|_|_|_|3708922
nephrotoxicity|Disease|5|[3, 4]|500|-1|_|_|_|_|_|_|_|3708922
renal toxicity|Disease|1|[18, 20]|500|-1|_|_|_|_|_|_|_|3708922
nephrotoxic|Disease|3|[11, 12]|500|-1|_|_|_|_|_|_|_|3708922
cyclosporine|Chemical|0|[1, 2]|502|-1|_|_|_|_|_|_|_|3708922
csa|Chemical|2|[8, 9]|502|-1|_|_|_|_|_|_|_|3708922
csa|Chemical|3|[4, 5]|502|-1|_|_|_|_|_|_|_|3708922
csa|Chemical|3|[40, 41]|502|-1|_|_|_|_|_|_|_|3708922
csa|Chemical|4|[8, 9]|502|-1|_|_|_|_|_|_|_|3708922
csa|Chemical|5|[6, 7]|502|-1|_|_|_|_|_|_|_|3708922
gentamicin|Chemical|3|[16, 17]|8|-1|_|_|_|_|_|_|_|3708922
gentamicin|Chemical|4|[0, 1]|8|-1|_|_|_|_|_|_|_|3708922
amphothericin b|Chemical|3|[23, 25]|9|-1|_|_|_|_|_|_|_|3708922
ketoconazole|Chemical|3|[26, 27]|10|-1|_|_|_|_|_|_|_|3708922
chemotherapy|Treat|0|[7, 8]|2|-1|_|_|_|_|_|_|_|3708922
locomotor hyperactivity|Disease|0|[6, 8]|0|-1|_|_|_|_|_|_|_|3220106
locomotor hyperactivity|Disease|8|[10, 12]|0|-1|_|_|_|_|_|_|_|3220106
hyperactivity|Disease|0|[7, 8]|3|H|_|_|_|_|_|_|_|3220106
nicotine|Chemical|0|[10, 11]|501|H|_|_|_|_|_|_|_|3220106
nicotine|Chemical|0|[3, 4]|501|H|_|_|_|_|_|_|_|3220106
spiperone|Chemical|2|[54, 55]|5|H|_|_|_|_|_|_|_|3220106
spiperone|Chemical|3|[22, 23]|5|H|_|_|_|_|_|_|_|3220106
spiperone|Chemical|5|[7, 8]|5|H|_|_|_|_|_|_|_|3220106
spiperone|Chemical|7|[15, 16]|5|H|_|_|_|_|_|_|_|3220106
l-[3h]nicotine|Chemical|2|[44, 50]|501|-1|_|_|_|_|_|_|_|3220106
[3h]spiperone|Chemical|2|[51, 55]|7|-1|_|_|_|_|_|_|_|3220106
[3h]spiperone|Chemical|3|[19, 23]|7|-1|_|_|_|_|_|_|_|3220106
[3h]spiperone|Chemical|5|[4, 8]|7|-1|_|_|_|_|_|_|_|3220106
[3h]spiperone|Chemical|7|[12, 16]|7|-1|_|_|_|_|_|_|_|3220106
[3h]nicotine|Chemical|3|[14, 18]|9|H|_|_|_|_|_|_|_|3220106
[3h]nicotine|Chemical|7|[26, 30]|9|H|_|_|_|_|_|_|_|3220106
dopamine (da)|Chemical|4|[46, 50]|11|-1|_|_|_|_|_|_|_|3220106
subcutaneously implanting each animal with an alzet osmotic mini-pump|Treat|1|[18, 29]|4|-1|_|_|_|_|_|_|_|3220106
chronic nicotine-treated|Treat|8|[4, 8]|18|-1|_|_|_|_|_|_|_|3220106
hypertension|Disease|0|[3, 4]|0|-1|_|_|_|_|_|_|_|2722224
increased cardiac output|Disease|3|[37, 40]|500|-1|_|_|_|_|_|_|_|2722224
increased cardiac output|Disease|9|[12, 15]|500|-1|_|_|_|_|_|_|_|2722224
rise in resting blood pressure|Disease|9|[1, 6]|500|-1|_|_|_|_|_|_|_|2722224
hydrocortisone|Chemical|0|[0, 1]|1|-1|_|_|_|_|_|_|_|2722224
blood pressure|Physiology|1|[3, 5]|2|-1|_|_|_|_|_|_|_|2722224
cardiac output|Physiology|2|[20, 22]|3|-1|_|_|_|_|_|_|_|2722224
total peripheral resistance|Physiology|2|[23, 26]|4|-1|_|_|_|_|_|_|_|2722224
forearm vascular resistance|Physiology|2|[27, 30]|5|-1|_|_|_|_|_|_|_|2722224
vascular resistance|Physiology|6|[4, 6]|9|-1|_|_|_|_|_|_|_|2722224
threshold|Physiology|7|[14, 15]|12|-1|_|_|_|_|_|_|_|2722224
sympathetic nervous system activity|Physiology|8|[15, 19]|13|-1|_|_|_|_|_|_|_|2722224
treatment|Treat|5|[42, 43]|7|-1|_|_|_|_|_|_|_|2722224
treatment|Treat|5|[50, 51]|7|-1|_|_|_|_|_|_|_|2722224
hydrocortisone|Treat|6|[60, 61]|10|-1|_|_|_|_|_|_|_|2722224
hydrocortisone|Treat|6|[27, 28]|10|-1|_|_|_|_|_|_|_|2722224
suprofen|Chemical|0|[2, 3]|0|-1|_|_|_|_|_|_|_|1636026
nephrotoxic|Disease|2|[2, 3]|1|H|_|_|_|_|_|_|_|1636026
decline in glomerular filtration rate|Disease|4|[5, 10]|501|-1|_|_|_|_|_|_|_|1636026
declines in renal function|Disease|7|[6, 10]|501|-1|_|_|_|_|_|_|_|1636026
renal sodium excretion|Physiology|3|[6, 9]|2|-1|_|_|_|_|_|_|_|1636026
oxygen consumption|Physiology|3|[10, 12]|3|-1|_|_|_|_|_|_|_|1636026
urinary flow rates|Physiology|3|[14, 17]|4|-1|_|_|_|_|_|_|_|1636026
baseline excretion rate of uric acid|Physiology|5|[5, 11]|6|-1|_|_|_|_|_|_|_|1636026
renal function|Physiology|7|[8, 10]|8|-1|_|_|_|_|_|_|_|1636026
cocaine|Chemical|0|[0, 1]|0|-1|_|_|_|_|_|_|_|1610717
cocaine|Chemical|1|[41, 42]|0|-1|_|_|_|_|_|_|_|1610717
cocaine|Chemical|3|[0, 1]|0|-1|_|_|_|_|_|_|_|1610717
cocaine|Chemical|3|[0, 1]|0|-1|_|_|_|_|_|_|_|1610717
cocaine|Chemical|4|[0, 1]|0|-1|_|_|_|_|_|_|_|1610717
cocaine|Chemical|9|[0, 1]|0|-1|_|_|_|_|_|_|_|1610717
seizures|Disease|0|[4, 5]|1|H|_|_|_|_|_|_|_|1610717
hyperactivity|Disease|5|[8, 9]|6|H|_|_|_|_|_|_|_|1610717
hypersensitivity|Disease|5|[10, 11]|7|H|_|_|_|_|_|_|_|1610717
hypersensitivity|Disease|7|[0, 1]|7|H|_|_|_|_|_|_|_|1610717
"beating drum" behavior|Disease|5|[12, 17]|8|-1|_|_|_|_|_|_|_|1610717
sniffing|Disease|5|[25, 26]|9|-1|_|_|_|_|_|_|_|1610717
power frequency spectra|Physiology|6|[3, 6]|10|-1|_|_|_|_|_|_|_|1610717
brainstem ambient power spectral frequency|Physiology|7|[16, 21]|12|-1|_|_|_|_|_|_|_|1610717
cholestasis|Disease|0|[15, 16]|0|-1|_|_|_|_|_|_|_|873132
ethinyl estradiol|Chemical|0|[11, 13]|1|-1|_|_|_|_|_|_|_|873132
taurodeoxycholic acid|Chemical|2|[14, 16]|2|H|_|_|_|_|_|_|_|873132
[24-14c]sodium deoxycholate|Chemical|3|[1, 8]|3|-1|_|_|_|_|_|_|_|873132
[14c]biliary bile acid|Chemical|3|[10, 16]|4|H|_|_|_|_|_|_|_|873132
taurocholic acid|Chemical|4|[10, 12]|5|-1|_|_|_|_|_|_|_|873132
chronic coronary artery disease|Disease|0|[12, 16]|0|H|_|_|_|_|_|_|_|783197
obstructive coronary artery disease|Disease|1|[19, 23]|2|H|_|_|_|_|_|_|_|783197
congestive heart failure|Disease|2|[35, 38]|4|-1|_|_|_|_|_|_|_|783197
congestive heart failure|Disease|9|[15, 18]|4|-1|_|_|_|_|_|_|_|783197
left ventricular end-diastolic volume falls|Disease|9|[18, 25]|9|-1|_|_|_|_|_|_|_|783197
ouabain|Chemical|0|[2, 3]|501|-1|_|_|_|_|_|_|_|783197
digitalis glycosides|Chemical|1|[3, 5]|501|-1|_|_|_|_|_|_|_|783197
contractility|Physiology|6|[51, 52]|5|-1|_|_|_|_|_|_|_|783197
myocardial oxygen consumption|Physiology|8|[4, 7]|6|-1|_|_|_|_|_|_|_|783197
mean arterial pressure|Physiology|8|[21, 24]|7|-1|_|_|_|_|_|_|_|783197
left ventricular end-diastolic volume|Physiology|9|[18, 24]|10|-1|_|_|_|_|_|_|_|783197
wall tension|Physiology|10|[10, 12]|11|-1|_|_|_|_|_|_|_|783197
myocardial metabolism|Physiology|11|[9, 11]|12|-1|_|_|_|_|_|_|_|783197
prolongation of the qt interval|Disease|0|[0, 5]|500|H|_|_|_|_|_|_|_|9545159
gastrointestinal motility disorders|Disease|1|[18, 21]|3|H|_|_|_|_|_|_|_|9545159
torsades de pointes|Disease|2|[5, 8]|7|-1|_|_|_|_|_|_|_|9545159
sudden cardiac death|Disease|2|[10, 13]|8|H|_|_|_|_|_|_|_|9545159
gastroesophageal reflux disorder|Disease|3|[18, 21]|9|-1|_|_|_|_|_|_|_|9545159
qt-interval prolongation|Disease|4|[8, 12]|500|H|_|_|_|_|_|_|_|9545159
syncope|Disease|4|[5, 6]|12|-1|_|_|_|_|_|_|_|9545159
cisapride|Chemical|0|[7, 8]|1|-1|_|_|_|_|_|_|_|9545159
cisapride|Chemical|1|[0, 1]|1|-1|_|_|_|_|_|_|_|9545159
diltiazem|Chemical|0|[9, 10]|2|-1|_|_|_|_|_|_|_|9545159
azole|Chemical|2|[22, 23]|5|-1|_|_|_|_|_|_|_|9545159
erythromycin|Chemical|2|[20, 21]|6|-1|_|_|_|_|_|_|_|9545159
hypertension|Physiology|3|[34, 35]|10|-1|_|_|_|_|_|_|_|9545159
ovarian cancer|Disease|0|[12, 14]|0|-1|_|_|_|_|_|_|_|8643973
thrombocytopenia|Disease|5|[16, 17]|5|-1|_|_|_|_|_|_|_|8643973
leukopenia|Disease|5|[11, 12]|6|H|_|_|_|_|_|_|_|8643973
granulocytopenia|Disease|5|[13, 14]|7|H|_|_|_|_|_|_|_|8643973
neurotoxicity|Disease|6|[0, 1]|8|-1|_|_|_|_|_|_|_|8643973
neurotoxicity|Disease|6|[0, 1]|8|-1|_|_|_|_|_|_|_|8643973
paclitaxel|Chemical|0|[0, 1]|1|-1|_|_|_|_|_|_|_|8643973
carboplatin|Chemical|0|[3, 4]|2|-1|_|_|_|_|_|_|_|8643973
infusion|Treat|1|[32, 33]|3|-1|_|_|_|_|_|_|_|8643973
calvert formula|Treat|2|[29, 31]|4|-1|_|_|_|_|_|_|_|8643973
tacrolimus|Chemical|0|[2, 3]|0|-1|_|_|_|_|_|_|_|10743694
cyclosporine|Chemical|0|[10, 11]|1|-1|_|_|_|_|_|_|_|10743694
conversion|Treat|0|[8, 9]|2|-1|_|_|_|_|_|_|_|10743694
liver recipients|Treat|3|[2, 4]|4|-1|_|_|_|_|_|_|_|10743694
immunosuppression|Immune|1|[14, 15]|3|-1|_|_|_|_|_|_|_|10743694
blood level|Physiology|3|[36, 38]|5|-1|_|_|_|_|_|_|_|10743694
iddm|Disease|5|[54, 55]|501|-1|_|_|_|_|_|_|_|10743694
iddm|Disease|5|[18, 19]|501|-1|_|_|_|_|_|_|_|10743694
gi toxicity|Disease|5|[64, 66]|502|-1|_|_|_|_|_|_|_|10743694
ptld|Disease|5|[81, 82]|9|-1|_|_|_|_|_|_|_|10743694
neurotoxicity|Disease|5|[5, 6]|10|-1|_|_|_|_|_|_|_|10743694
neurotoxicity|Disease|5|[49, 50]|10|-1|_|_|_|_|_|_|_|10743694
hemolytic anemia|Disease|5|[92, 94]|12|-1|_|_|_|_|_|_|_|10743694
pruritus|Disease|5|[99, 100]|13|-1|_|_|_|_|_|_|_|10743694
nephrotoxicity|Disease|5|[24, 25]|14|-1|_|_|_|_|_|_|_|10743694
nephrotoxicity|Disease|5|[59, 60]|14|-1|_|_|_|_|_|_|_|10743694
(insulin-dependent) diabetes mellitus (iddm)|Disease|5|[10, 20]|501|-1|_|_|_|_|_|_|_|10743694
gastrointestinal (gi) toxicity|Disease|5|[29, 34]|502|-1|_|_|_|_|_|_|_|10743694
cardiomyopathy|Disease|5|[39, 40]|18|-1|_|_|_|_|_|_|_|10743694
cardiomyopathy|Disease|5|[87, 88]|18|-1|_|_|_|_|_|_|_|10743694
hepatotoxicity|Disease|5|[70, 71]|20|-1|_|_|_|_|_|_|_|10743694
netilmicin|Chemical|0|[5, 6]|500|-1|_|_|_|_|_|_|_|3535719
tobramycin|Chemical|0|[7, 8]|501|-1|_|_|_|_|_|_|_|3535719
netilmicin sulfate|Chemical|1|[8, 10]|500|-1|_|_|_|_|_|_|_|3535719
tobramycin sulfate|Chemical|1|[11, 13]|501|-1|_|_|_|_|_|_|_|3535719
piperacillin sodium|Chemical|1|[16, 18]|502|-1|_|_|_|_|_|_|_|3535719
piperacillin|Chemical|4|[13, 14]|502|-1|_|_|_|_|_|_|_|3535719
piperacillin|Chemical|4|[24, 25]|502|-1|_|_|_|_|_|_|_|3535719
treatment regimens|Treat|2|[2, 4]|5|-1|_|_|_|_|_|_|_|3535719
nephrotoxicity|Disease|3|[0, 1]|6|-1|_|_|_|_|_|_|_|3535719
ototoxicity|Disease|4|[0, 1]|7|-1|_|_|_|_|_|_|_|3535719
auditory thresholds|Disease|5|[17, 19]|10|-1|_|_|_|_|_|_|_|3535719
convulsions|Disease|0|[8, 9]|0|-1|_|_|_|_|_|_|_|6433367
flurothyl|Chemical|1|[24, 25]|1|-1|_|_|_|_|_|_|_|6433367
flurothyl|Chemical|2|[21, 22]|1|-1|_|_|_|_|_|_|_|6433367
picrotoxin|Chemical|1|[26, 27]|2|-1|_|_|_|_|_|_|_|6433367
picrotoxin|Chemical|2|[31, 32]|2|-1|_|_|_|_|_|_|_|6433367
pentetrazol|Chemical|1|[28, 29]|501|-1|_|_|_|_|_|_|_|6433367
bicuculline|Chemical|1|[35, 36]|4|-1|_|_|_|_|_|_|_|6433367
bicuculline|Chemical|2|[33, 34]|4|-1|_|_|_|_|_|_|_|6433367
ibuprofen|Chemical|2|[0, 1]|5|-1|_|_|_|_|_|_|_|6433367
sulindac|Chemical|2|[2, 3]|6|-1|_|_|_|_|_|_|_|6433367
mefenamic acid|Chemical|2|[4, 6]|7|-1|_|_|_|_|_|_|_|6433367
meclofenamic acid|Chemical|2|[10, 12]|8|-1|_|_|_|_|_|_|_|6433367
ptz|Chemical|2|[25, 26]|501|-1|_|_|_|_|_|_|_|6433367
ptz|Chemical|3|[17, 18]|501|-1|_|_|_|_|_|_|_|6433367
pgs|Chemical|3|[4, 5]|13|H|_|_|_|_|_|_|_|6433367
fluorthyl|Chemical|3|[14, 15]|14|H|_|_|_|_|_|_|_|6433367
angioedema|Disease|0|[10, 11]|500|-1|_|_|_|_|_|_|_|17285209
hypertension|Disease|1|[18, 19]|501|-1|_|_|_|_|_|_|_|17285209
vomiting|Disease|2|[20, 21]|5|-1|_|_|_|_|_|_|_|17285209
nausea|Disease|2|[18, 19]|6|H|_|_|_|_|_|_|_|17285209
abdominal pain|Disease|2|[15, 17]|7|H|_|_|_|_|_|_|_|17285209
hypertensive|Disease|8|[17, 18]|501|H|_|_|_|_|_|_|_|17285209
ascites|Disease|9|[27, 28]|12|-1|_|_|_|_|_|_|_|17285209
stomach and small bowel thickening|Disease|9|[19, 24]|500|-1|_|_|_|_|_|_|_|17285209
intestinal angioedema|Disease|10|[17, 19]|500|-1|_|_|_|_|_|_|_|17285209
angiotensin-converting enzyme (ace) inhibitor|Chemical|0|[0, 8]|503|-1|_|_|_|_|_|_|_|17285209
amlodipine|Chemical|1|[28, 29]|2|-1|_|_|_|_|_|_|_|17285209
benazapril|Chemical|1|[30, 31]|503|-1|_|_|_|_|_|_|_|17285209
analgesics|Chemical|4|[15, 16]|8|-1|_|_|_|_|_|_|_|17285209
fluid|Treat|4|[13, 14]|9|-1|_|_|_|_|_|_|_|17285209
anti-hypertensive medications|Treat|8|[15, 19]|11|-1|_|_|_|_|_|_|_|17285209
liver toxicity|Disease|0|[11, 13]|500|H|_|_|_|_|_|_|_|15858223
liver toxicity|Disease|7|[0, 2]|500|H|_|_|_|_|_|_|_|15858223
hepatotoxicity|Disease|2|[15, 16]|500|H|_|_|_|_|_|_|_|15858223
necrosis|Disease|8|[29, 30]|21|-1|_|_|_|_|_|_|_|15858223
steatosis|Disease|8|[32, 33]|22|-1|_|_|_|_|_|_|_|15858223
valproic acid|Chemical|0|[15, 17]|502|H|_|_|_|_|_|_|_|15858223
valproic acid|Chemical|0|[0, 2]|502|H|_|_|_|_|_|_|_|15858223
15-f(2t)-isop|Chemical|1|[42, 50]|503|-1|_|_|_|_|_|_|_|15858223
15-f(2t)-isop|Chemical|3|[11, 19]|503|-1|_|_|_|_|_|_|_|15858223
15-f(2t)-isop|Chemical|3|[11, 19]|503|-1|_|_|_|_|_|_|_|15858223
15-f(2t)-isop|Chemical|4|[3, 11]|503|-1|_|_|_|_|_|_|_|15858223
15-f(2t)-isop|Chemical|4|[3, 11]|503|-1|_|_|_|_|_|_|_|15858223
15-f(2t)-isop|Chemical|10|[18, 26]|503|-1|_|_|_|_|_|_|_|15858223
15-f(2t)-isoprostane|Chemical|1|[33, 41]|503|-1|_|_|_|_|_|_|_|15858223
vpa|Chemical|2|[9, 10]|502|H|_|_|_|_|_|_|_|15858223
vpa|Chemical|2|[27, 28]|502|H|_|_|_|_|_|_|_|15858223
vpa|Chemical|4|[21, 22]|502|H|_|_|_|_|_|_|_|15858223
vpa|Chemical|9|[9, 10]|502|H|_|_|_|_|_|_|_|15858223
vpa|Chemical|9|[24, 25]|502|H|_|_|_|_|_|_|_|15858223
vpa|Chemical|9|[36, 37]|502|H|_|_|_|_|_|_|_|15858223
vpa|Chemical|10|[6, 7]|502|H|_|_|_|_|_|_|_|15858223
tbars|Chemical|3|[32, 33]|504|H|_|_|_|_|_|_|_|15858223
tbars|Chemical|6|[3, 4]|504|H|_|_|_|_|_|_|_|15858223
tbars|Chemical|6|[3, 4]|504|H|_|_|_|_|_|_|_|15858223
lipid hydroperoxides (lpo)|Chemical|3|[20, 25]|505|H|_|_|_|_|_|_|_|15858223
thiobarbituric acid reactive substances (tbars)|Chemical|3|[27, 34]|504|H|_|_|_|_|_|_|_|15858223
lpo|Chemical|5|[1, 2]|505|H|_|_|_|_|_|_|_|15858223
alpha-glutathione s-transferase (alpha-gst)|Chemical|7|[9, 20]|20|-1|_|_|_|_|_|_|_|15858223
4-ene-vpa|Chemical|9|[20, 25]|23|-1|_|_|_|_|_|_|_|15858223
4-ene-vpa|Chemical|9|[20, 25]|23|-1|_|_|_|_|_|_|_|15858223
2,4-diene-vpa|Chemical|9|[30, 37]|24|H|_|_|_|_|_|_|_|15858223
(e)-2,4-diene-vpa|Chemical|9|[26, 37]|29|-1|_|_|_|_|_|_|_|15858223
pheochromocytoma|Disease|0|[0, 1]|0|-1|_|_|_|_|_|_|_|15811908
headache|Disease|2|[16, 17]|3|-1|_|_|_|_|_|_|_|15811908
vomiting|Disease|2|[18, 19]|4|-1|_|_|_|_|_|_|_|15811908
hypertension|Disease|2|[13, 14]|5|H|_|_|_|_|_|_|_|15811908
hypertensive|Disease|6|[16, 17]|9|-1|_|_|_|_|_|_|_|15811908
hypertensive|Disease|7|[22, 23]|9|-1|_|_|_|_|_|_|_|15811908
amisulpride|Chemical|0|[3, 4]|1|-1|_|_|_|_|_|_|_|15811908
tiapride|Chemical|0|[5, 6]|2|-1|_|_|_|_|_|_|_|15811908
nicardipine|Chemical|3|[12, 13]|6|-1|_|_|_|_|_|_|_|15811908
verapamil|Chemical|3|[14, 15]|7|-1|_|_|_|_|_|_|_|15811908
substituted benzamide drugs|Chemical|5|[15, 18]|8|H|_|_|_|_|_|_|_|15811908
hypertensive crisis|Physiology|7|[22, 24]|11|-1|_|_|_|_|_|_|_|15811908
cocaine|Chemical|1|[30, 31]|0|-1|_|_|_|_|_|_|_|15764424
amphetamine|Chemical|1|[27, 28]|2|H|_|_|_|_|_|_|_|15764424
methamphetamine|Chemical|2|[0, 1]|3|-1|_|_|_|_|_|_|_|15764424
psychosis|Disease|1|[33, 34]|501|H|_|_|_|_|_|_|_|15764424
hyperkinesia|Disease|3|[6, 7]|4|-1|_|_|_|_|_|_|_|15764424
psychotic symptoms|Disease|4|[17, 19]|501|H|_|_|_|_|_|_|_|15764424
overdose|Disease|0|[6, 7]|0|H|_|_|_|_|_|_|_|12101159
overdose|Disease|1|[8, 9]|0|H|_|_|_|_|_|_|_|12101159
overdose|Disease|3|[4, 5]|0|H|_|_|_|_|_|_|_|12101159
overdose|Disease|7|[17, 18]|0|H|_|_|_|_|_|_|_|12101159
overdose|Disease|8|[12, 13]|0|H|_|_|_|_|_|_|_|12101159
hypotension|Disease|2|[10, 11]|7|-1|_|_|_|_|_|_|_|12101159
tonic-clonic seizures|Disease|3|[9, 13]|500|-1|_|_|_|_|_|_|_|12101159
generalised tonic-clonic seizures|Disease|3|[8, 13]|500|-1|_|_|_|_|_|_|_|12101159
bradycardia|Disease|4|[6, 7]|13|-1|_|_|_|_|_|_|_|12101159
asystole|Disease|7|[24, 25]|17|-1|_|_|_|_|_|_|_|12101159
cardiac arrest|Disease|8|[8, 10]|20|H|_|_|_|_|_|_|_|12101159
diltiazem|Chemical|0|[5, 6]|1|-1|_|_|_|_|_|_|_|12101159
nitrate|Chemical|1|[26, 27]|3|-1|_|_|_|_|_|_|_|12101159
paracetamol|Chemical|1|[21, 22]|4|-1|_|_|_|_|_|_|_|12101159
aspirin|Chemical|1|[23, 24]|5|-1|_|_|_|_|_|_|_|12101159
alcohol|Chemical|1|[29, 30]|6|-1|_|_|_|_|_|_|_|12101159
activated charcoal|Chemical|2|[15, 17]|8|-1|_|_|_|_|_|_|_|12101159
adrenaline (epinephrine)|Chemical|5|[15, 19]|15|-1|_|_|_|_|_|_|_|12101159
intravenous fluids|Treat|2|[18, 20]|9|-1|_|_|_|_|_|_|_|12101159
intravenous calcium therapy|Treat|7|[11, 14]|18|-1|_|_|_|_|_|_|_|12101159
whole bowel irrigation|Treat|9|[10, 13]|21|-1|_|_|_|_|_|_|_|12101159
blood pressure|Physiology|4|[9, 11]|14|-1|_|_|_|_|_|_|_|12101159
renal papillary necrosis|Disease|0|[0, 3]|0|-1|_|_|_|_|_|_|_|6699841
renal papillary necrosis|Disease|0|[0, 3]|0|-1|_|_|_|_|_|_|_|6699841
renal papillary necrosis|Disease|1|[30, 33]|0|-1|_|_|_|_|_|_|_|6699841
arthritis|Disease|1|[9, 10]|3|H|_|_|_|_|_|_|_|6699841
rheumatoid arthritis|Disease|1|[8, 10]|6|-1|_|_|_|_|_|_|_|6699841
renal toxicity|Disease|4|[21, 23]|11|H|_|_|_|_|_|_|_|6699841
naproxen|Chemical|0|[5, 6]|2|-1|_|_|_|_|_|_|_|6699841
gold|Chemical|1|[26, 27]|4|-1|_|_|_|_|_|_|_|6699841
sulindac|Chemical|1|[17, 18]|7|-1|_|_|_|_|_|_|_|6699841
sulindac|Chemical|3|[0, 1]|7|-1|_|_|_|_|_|_|_|6699841
fenoprofen calcium|Chemical|1|[19, 21]|8|-1|_|_|_|_|_|_|_|6699841
salicylates|Chemical|1|[24, 25]|9|-1|_|_|_|_|_|_|_|6699841
hypotension|Disease|1|[11, 12]|0|-1|_|_|_|_|_|_|_|6127992
bradycardia|Disease|1|[13, 14]|1|-1|_|_|_|_|_|_|_|6127992
ischaemic heart disease|Disease|1|[3, 6]|2|-1|_|_|_|_|_|_|_|6127992
left ventricular function|Disease|3|[1, 4]|9|-1|_|_|_|_|_|_|_|6127992
verapamil|Chemical|1|[18, 19]|3|-1|_|_|_|_|_|_|_|6127992
beta-adrenergic blocking drugs|Chemical|1|[20, 25]|4|-1|_|_|_|_|_|_|_|6127992
cardiac failure|Physiology|1|[8, 10]|5|-1|_|_|_|_|_|_|_|6127992
hypotension|Physiology|1|[11, 12]|6|-1|_|_|_|_|_|_|_|6127992
bradycardia|Physiology|1|[13, 14]|7|-1|_|_|_|_|_|_|_|6127992
combined therapy|Treat|2|[9, 11]|8|-1|_|_|_|_|_|_|_|6127992
mild hypertension|Disease|0|[10, 12]|0|-1|_|_|_|_|_|_|_|6115999
hypertension|Disease|1|[10, 11]|5|H|_|_|_|_|_|_|_|6115999
impotence|Disease|4|[9, 10]|6|-1|_|_|_|_|_|_|_|6115999
impotence|Disease|4|[12, 13]|6|-1|_|_|_|_|_|_|_|6115999
impaired glucose tolerance|Disease|5|[9, 12]|8|-1|_|_|_|_|_|_|_|6115999
gout|Disease|5|[17, 18]|9|-1|_|_|_|_|_|_|_|6115999
raynaud's phenomenon|Disease|5|[27, 31]|10|-1|_|_|_|_|_|_|_|6115999
dyspnoea|Disease|5|[32, 33]|11|-1|_|_|_|_|_|_|_|6115999
corneal disease|Disease|6|[1, 3]|12|-1|_|_|_|_|_|_|_|6115999
bendrofluazide|Chemical|0|[3, 4]|1|-1|_|_|_|_|_|_|_|6115999
propranolol|Chemical|0|[5, 6]|2|-1|_|_|_|_|_|_|_|6115999
hypertension|Physiology|0|[11, 12]|3|-1|_|_|_|_|_|_|_|6115999
hypertension|Physiology|0|[24, 25]|3|-1|_|_|_|_|_|_|_|6115999
potassium level|Physiology|7|[2, 4]|13|-1|_|_|_|_|_|_|_|6115999
uric acid levels|Physiology|7|[9, 12]|14|-1|_|_|_|_|_|_|_|6115999
urea level|Physiology|8|[18, 20]|15|-1|_|_|_|_|_|_|_|6115999
dexmedetomidine|Chemical|0|[0, 1]|0|-1|_|_|_|_|_|_|_|18086064
dexmedetomidine|Chemical|6|[0, 1]|0|-1|_|_|_|_|_|_|_|18086064
myocardial infarction|Disease|6|[41, 43]|1|-1|_|_|_|_|_|_|_|18086064
myocardial ischaemia|Disease|6|[67, 69]|2|H|_|_|_|_|_|_|_|18086064
hypotension|Disease|7|[3, 4]|4|-1|_|_|_|_|_|_|_|18086064
bradycardia|Disease|7|[29, 30]|5|-1|_|_|_|_|_|_|_|18086064
bradycardia|Disease|8|[8, 9]|5|-1|_|_|_|_|_|_|_|18086064
creatine|Chemical|0|[5, 6]|0|-1|_|_|_|_|_|_|_|12739036
creatine|Chemical|4|[7, 8]|0|-1|_|_|_|_|_|_|_|12739036
chloroquine|Chemical|1|[17, 18]|500|-1|_|_|_|_|_|_|_|12739036
chloroquine|Chemical|3|[3, 4]|500|-1|_|_|_|_|_|_|_|12739036
chloroquine|Chemical|10|[3, 4]|500|-1|_|_|_|_|_|_|_|12739036
azathioprine|Chemical|2|[23, 24]|6|-1|_|_|_|_|_|_|_|12739036
cyclophosphamide|Chemical|2|[25, 26]|7|-1|_|_|_|_|_|_|_|12739036
(cq)|Chemical|3|[4, 7]|500|-1|_|_|_|_|_|_|_|12739036
creatine kinase (ck)|Chemical|4|[7, 12]|13|-1|_|_|_|_|_|_|_|12739036
systemic lupus erythematosus|Disease|0|[9, 12]|502|H|_|_|_|_|_|_|_|12739036
myopathy|Disease|1|[20, 21]|3|H|_|_|_|_|_|_|_|12739036
myopathy|Disease|9|[17, 18]|3|H|_|_|_|_|_|_|_|12739036
myopathy|Disease|10|[6, 7]|3|H|_|_|_|_|_|_|_|12739036
renal involvement|Disease|2|[15, 17]|4|-1|_|_|_|_|_|_|_|12739036
systemic lupus erythematosus (sle)|Disease|2|[8, 14]|502|H|_|_|_|_|_|_|_|12739036
arthralgia|Disease|3|[11, 12]|8|H|_|_|_|_|_|_|_|12739036
slightly increased creatine kinase (ck) levels|Disease|4|[5, 13]|12|-1|_|_|_|_|_|_|_|12739036
myositis|Disease|5|[0, 1]|503|-1|_|_|_|_|_|_|_|12739036
atrophy|Disease|6|[15, 16]|504|-1|_|_|_|_|_|_|_|12739036
muscular weakness|Disease|6|[11, 13]|17|H|_|_|_|_|_|_|_|12739036
muscular atrophy|Disease|6|[14, 16]|504|-1|_|_|_|_|_|_|_|12739036
polymyositis|Disease|9|[14, 15]|503|-1|_|_|_|_|_|_|_|12739036
sle|Disease|11|[23, 24]|502|H|_|_|_|_|_|_|_|12739036
sle|Disease|11|[3, 4]|502|H|_|_|_|_|_|_|_|12739036
steroids|Treat|5|[10, 11]|15|-1|_|_|_|_|_|_|_|12739036
adenovirus disease|Disease|0|[5, 7]|500|H|_|_|_|_|_|_|_|12093990
adenovirus|Disease|1|[2, 3]|500|H|_|_|_|_|_|_|_|12093990
hepatitis c|Disease|7|[23, 25]|8|-1|_|_|_|_|_|_|_|12093990
hepatitis c|Disease|7|[23, 25]|8|-1|_|_|_|_|_|_|_|12093990
infection with hemorrhagic fever viruses|Disease|7|[34, 39]|501|H|_|_|_|_|_|_|_|12093990
respiratory syncytial virus infection|Disease|7|[10, 14]|10|-1|_|_|_|_|_|_|_|12093990
hemorrhagic fever viruses|Disease|7|[36, 39]|501|H|_|_|_|_|_|_|_|12093990
anemia|Disease|8|[11, 12]|13|-1|_|_|_|_|_|_|_|12093990
nephrotoxicity|Disease|9|[21, 22]|14|H|_|_|_|_|_|_|_|12093990
adenovirus infection|Disease|9|[6, 8]|500|H|_|_|_|_|_|_|_|12093990
hemorrhagic cystitis|Disease|12|[4, 6]|18|-1|_|_|_|_|_|_|_|12093990
hemorrhagic cystitis|Disease|17|[22, 24]|18|-1|_|_|_|_|_|_|_|12093990
adenovirus pneumonia|Disease|14|[5, 7]|21|-1|_|_|_|_|_|_|_|12093990
digeorge syndrome|Disease|14|[17, 19]|22|-1|_|_|_|_|_|_|_|12093990
cardiac transplant|Disease|15|[7, 9]|23|-1|_|_|_|_|_|_|_|12093990
progressive renal failure|Disease|20|[9, 12]|27|-1|_|_|_|_|_|_|_|12093990
neutropenia|Disease|20|[13, 14]|28|-1|_|_|_|_|_|_|_|12093990
immunodeficiency|Disease|21|[37, 38]|29|H|_|_|_|_|_|_|_|12093990
ribavirin|Chemical|0|[1, 2]|1|-1|_|_|_|_|_|_|_|12093990
ribavirin|Chemical|6|[0, 1]|1|-1|_|_|_|_|_|_|_|12093990
cidofovir|Chemical|5|[7, 8]|5|-1|_|_|_|_|_|_|_|12093990
polymerase chain reaction|Chemical|23|[5, 8]|30|-1|_|_|_|_|_|_|_|12093990
intravenous ribavirin treatment|Treat|0|[0, 3]|2|-1|_|_|_|_|_|_|_|12093990
intravenous ribavirin therapy|Treat|10|[7, 10]|16|-1|_|_|_|_|_|_|_|12093990
intravenous ribavirin therapy|Treat|19|[0, 3]|16|-1|_|_|_|_|_|_|_|12093990
intravenous ribavirin|Treat|11|[15, 17]|17|-1|_|_|_|_|_|_|_|12093990
bone marrow transplants|Treat|12|[9, 12]|19|-1|_|_|_|_|_|_|_|12093990
bone marrow transplant|Treat|13|[1, 4]|20|-1|_|_|_|_|_|_|_|12093990
compassionate-use protocol|Treat|16|[6, 10]|24|-1|_|_|_|_|_|_|_|12093990
antiviral treatment|Treat|23|[20, 22]|31|-1|_|_|_|_|_|_|_|12093990
treatment|Treat|25|[20, 21]|32|-1|_|_|_|_|_|_|_|12093990
immunocompromised|Immune|1|[13, 14]|4|-1|_|_|_|_|_|_|_|12093990
guanosine|Gene|6|[3, 4]|7|-1|_|_|_|_|_|_|_|12093990
hepatotoxicity|Disease|0|[0, 1]|0|H|_|_|_|_|_|_|_|3962737
cholestatic hepatitis|Disease|3|[3, 5]|3|-1|_|_|_|_|_|_|_|3962737
cirrhosis of the liver|Disease|4|[27, 31]|4|H|_|_|_|_|_|_|_|3962737
steatosis|Disease|4|[16, 17]|5|H|_|_|_|_|_|_|_|3962737
alcoholic hepatitis|Disease|4|[20, 22]|6|-1|_|_|_|_|_|_|_|3962737
cholestatic injury|Disease|6|[8, 10]|7|-1|_|_|_|_|_|_|_|3962737
hepatomegaly|Disease|6|[11, 12]|8|-1|_|_|_|_|_|_|_|3962737
amiodarone|Chemical|0|[2, 3]|1|-1|_|_|_|_|_|_|_|3962737
amiodarone|Chemical|1|[0, 1]|1|-1|_|_|_|_|_|_|_|3962737
ketamine|Chemical|0|[5, 6]|0|-1|_|_|_|_|_|_|_|2716967
ketamine|Chemical|1|[5, 6]|0|-1|_|_|_|_|_|_|_|2716967
ketamine|Chemical|2|[4, 5]|0|-1|_|_|_|_|_|_|_|2716967
ketamine|Chemical|2|[23, 24]|0|-1|_|_|_|_|_|_|_|2716967
ketamine|Chemical|3|[19, 20]|0|-1|_|_|_|_|_|_|_|2716967
ketamine|Chemical|4|[10, 11]|0|-1|_|_|_|_|_|_|_|2716967
ketamine|Chemical|4|[20, 21]|0|-1|_|_|_|_|_|_|_|2716967
ketamine|Chemical|5|[19, 20]|0|-1|_|_|_|_|_|_|_|2716967
ketamine|Chemical|7|[19, 20]|0|-1|_|_|_|_|_|_|_|2716967
ketamine|Chemical|8|[4, 5]|0|-1|_|_|_|_|_|_|_|2716967
ketamine|Chemical|8|[43, 44]|0|-1|_|_|_|_|_|_|_|2716967
morphine|Chemical|0|[7, 8]|2|-1|_|_|_|_|_|_|_|2716967
naloxone|Chemical|6|[0, 1]|11|-1|_|_|_|_|_|_|_|2716967
catalepsy|Disease|0|[0, 1]|1|-1|_|_|_|_|_|_|_|2716967
loss of righting reflex|Disease|3|[8, 12]|7|-1|_|_|_|_|_|_|_|2716967
osteomyelitis|Disease|0|[15, 16]|0|-1|_|_|_|_|_|_|_|19642243
aids|Disease|0|[6, 7]|1|-1|_|_|_|_|_|_|_|19642243
acute renal failure|Disease|0|[0, 3]|2|-1|_|_|_|_|_|_|_|19642243
nephrotoxicity|Disease|3|[1, 2]|5|-1|_|_|_|_|_|_|_|19642243
vancomycin|Chemical|0|[12, 13]|3|-1|_|_|_|_|_|_|_|19642243
vancomycin|Chemical|3|[0, 1]|3|-1|_|_|_|_|_|_|_|19642243
tenofovir disoproxil fumarate|Chemical|1|[16, 19]|4|-1|_|_|_|_|_|_|_|19642243
stroke|Disease|0|[3, 4]|500|-1|_|_|_|_|_|_|_|17682013
stroke|Disease|3|[17, 18]|500|-1|_|_|_|_|_|_|_|17682013
leukaemia|Disease|1|[26, 27]|2|-1|_|_|_|_|_|_|_|17682013
stroke-like episodes|Disease|3|[17, 21]|500|-1|_|_|_|_|_|_|_|17682013
cerebrovascular accidents|Disease|5|[2, 4]|500|-1|_|_|_|_|_|_|_|17682013
white matter abnormalities|Disease|10|[13, 16]|500|-1|_|_|_|_|_|_|_|17682013
leukoencephalopathy|Disease|11|[7, 8]|500|-1|_|_|_|_|_|_|_|17682013
cytotoxic oedema within cerebral white matter|Disease|12|[8, 14]|500|-1|_|_|_|_|_|_|_|17682013
cytotoxic oedema|Disease|12|[8, 10]|500|-1|_|_|_|_|_|_|_|17682013
chemotherapy|Treat|0|[8, 9]|1|-1|_|_|_|_|_|_|_|17682013
methotrexate|Chemical|1|[23, 24]|3|-1|_|_|_|_|_|_|_|17682013
5-fluorouracil|Chemical|6|[20, 23]|8|H|_|_|_|_|_|_|_|17682013
carmofur|Chemical|6|[26, 27]|9|-1|_|_|_|_|_|_|_|17682013
capecitabine|Chemical|6|[29, 30]|10|-1|_|_|_|_|_|_|_|17682013
pathophysiology|Physiology|2|[7, 8]|4|-1|_|_|_|_|_|_|_|17682013
desipramine|Chemical|0|[12, 13]|0|-1|_|_|_|_|_|_|_|16725121
cocaine|Chemical|1|[21, 22]|1|-1|_|_|_|_|_|_|_|16725121
cocaine|Chemical|4|[3, 4]|1|-1|_|_|_|_|_|_|_|16725121
cocaine|Chemical|5|[18, 19]|1|-1|_|_|_|_|_|_|_|16725121
cocaine|Chemical|6|[16, 17]|1|-1|_|_|_|_|_|_|_|16725121
cocaine|Chemical|9|[3, 4]|1|-1|_|_|_|_|_|_|_|16725121
cocaine|Chemical|10|[19, 20]|1|-1|_|_|_|_|_|_|_|16725121
lidocaine|Chemical|3|[4, 5]|3|-1|_|_|_|_|_|_|_|16725121
bupivacaine|Chemical|3|[6, 7]|4|-1|_|_|_|_|_|_|_|16725121
na(+)|Chemical|8|[2, 6]|10|-1|_|_|_|_|_|_|_|16725121
seizures|Disease|1|[18, 19]|2|H|_|_|_|_|_|_|_|16725121
convulsions|Disease|5|[13, 14]|7|-1|_|_|_|_|_|_|_|16725121
convulsions|Disease|5|[21, 22]|7|-1|_|_|_|_|_|_|_|16725121
hepatitis c|Disease|0|[9, 11]|500|H|_|_|_|_|_|_|_|16629641
hepatitis c|Disease|0|[9, 11]|500|H|_|_|_|_|_|_|_|16629641
hepatitis c|Disease|1|[3, 5]|500|H|_|_|_|_|_|_|_|16629641
hepatitis c|Disease|8|[31, 33]|500|H|_|_|_|_|_|_|_|16629641
anemia|Disease|0|[4, 5]|1|H|_|_|_|_|_|_|_|16629641
liver disease|Disease|1|[21, 23]|4|H|_|_|_|_|_|_|_|16629641
cirrhosis|Disease|1|[12, 13]|5|-1|_|_|_|_|_|_|_|16629641
hepatocellular carcinoma|Disease|1|[14, 16]|6|-1|_|_|_|_|_|_|_|16629641
end-stage liver disease|Disease|1|[18, 23]|7|H|_|_|_|_|_|_|_|16629641
chronic infection with hepatitis c virus (hcv)|Disease|1|[0, 9]|500|H|_|_|_|_|_|_|_|16629641
hcv infection|Disease|2|[5, 7]|500|H|_|_|_|_|_|_|_|16629641
hcv infection|Disease|4|[22, 24]|500|H|_|_|_|_|_|_|_|16629641
hemolytic anemia|Disease|3|[26, 28]|12|-1|_|_|_|_|_|_|_|16629641
hemolytic anemia|Disease|8|[25, 27]|12|-1|_|_|_|_|_|_|_|16629641
renal or cardiovascular disorders|Disease|4|[30, 34]|13|-1|_|_|_|_|_|_|_|16629641
chronic hepatitis c|Disease|8|[30, 33]|500|H|_|_|_|_|_|_|_|16629641
chronic hepatitis c|Disease|8|[30, 33]|500|H|_|_|_|_|_|_|_|16629641
ribavirin|Chemical|2|[14, 15]|10|-1|_|_|_|_|_|_|_|16629641
viramidine|Chemical|8|[0, 1]|20|-1|_|_|_|_|_|_|_|16629641
combination therapy|Treat|2|[8, 10]|11|-1|_|_|_|_|_|_|_|16629641
cerebral function|Physiology|5|[19, 21]|15|-1|_|_|_|_|_|_|_|16629641
milk-alkali syndrome|Disease|0|[6, 10]|0|-1|_|_|_|_|_|_|_|16006300
milk-alkali syndrome|Disease|9|[2, 6]|0|-1|_|_|_|_|_|_|_|16006300
hypercalcemia|Disease|1|[11, 12]|2|H|_|_|_|_|_|_|_|16006300
metabolic alkalosis|Disease|3|[11, 13]|4|H|_|_|_|_|_|_|_|16006300
hypocalcemia|Disease|6|[24, 25]|9|-1|_|_|_|_|_|_|_|16006300
calcium carbonate|Chemical|0|[0, 2]|1|-1|_|_|_|_|_|_|_|16006300
1,25-dihydroxyvitamin d|Chemical|3|[28, 34]|3|-1|_|_|_|_|_|_|_|16006300
1,25-dihydroxyvitamin d|Chemical|3|[28, 34]|3|-1|_|_|_|_|_|_|_|16006300
parathyroid hormone (pth)|Chemical|3|[16, 21]|5|-1|_|_|_|_|_|_|_|16006300
furosemide|Chemical|5|[8, 9]|7|-1|_|_|_|_|_|_|_|16006300
furosemide|Chemical|10|[4, 5]|7|-1|_|_|_|_|_|_|_|16006300
pamidronate|Chemical|6|[10, 11]|10|-1|_|_|_|_|_|_|_|16006300
pamidronate|Chemical|11|[0, 1]|10|-1|_|_|_|_|_|_|_|16006300
aggressive hydration|Treat|5|[2, 4]|8|-1|_|_|_|_|_|_|_|16006300
hydration, furosemide|Treat|10|[2, 5]|13|-1|_|_|_|_|_|_|_|16006300
hepatitis c|Disease|0|[12, 14]|500|H|_|_|_|_|_|_|_|11705128
hepatitis c|Disease|0|[12, 14]|500|H|_|_|_|_|_|_|_|11705128
hepatitis c|Disease|1|[35, 37]|500|H|_|_|_|_|_|_|_|11705128
hemolytic anemia|Disease|0|[6, 8]|1|H|_|_|_|_|_|_|_|11705128
hemolytic anemia|Disease|2|[14, 16]|1|H|_|_|_|_|_|_|_|11705128
chronic hepatitis c|Disease|1|[34, 37]|500|H|_|_|_|_|_|_|_|11705128
chronic hepatitis c|Disease|1|[34, 37]|500|H|_|_|_|_|_|_|_|11705128
riha|Disease|3|[17, 18]|10|-1|_|_|_|_|_|_|_|11705128
riha|Disease|4|[17, 18]|10|-1|_|_|_|_|_|_|_|11705128
riha|Disease|5|[12, 13]|10|-1|_|_|_|_|_|_|_|11705128
riha|Disease|7|[2, 3]|10|-1|_|_|_|_|_|_|_|11705128
riha|Disease|8|[7, 8]|10|-1|_|_|_|_|_|_|_|11705128
riha|Disease|9|[9, 10]|10|-1|_|_|_|_|_|_|_|11705128
riha|Disease|12|[9, 10]|10|-1|_|_|_|_|_|_|_|11705128
riha|Disease|13|[12, 13]|10|-1|_|_|_|_|_|_|_|11705128
riha|Disease|14|[13, 14]|10|-1|_|_|_|_|_|_|_|11705128
chc|Disease|3|[21, 22]|500|H|_|_|_|_|_|_|_|11705128
ribavirin|Chemical|0|[3, 4]|3|-1|_|_|_|_|_|_|_|11705128
interferon-alpha|Chemical|1|[26, 29]|6|-1|_|_|_|_|_|_|_|11705128
combination therapy|Treat|1|[14, 16]|8|-1|_|_|_|_|_|_|_|11705128
treating|Treat|12|[6, 7]|18|-1|_|_|_|_|_|_|_|11705128
ketamine|Chemical|0|[5, 6]|0|-1|_|_|_|_|_|_|_|6540303
ketamine|Chemical|1|[15, 16]|0|-1|_|_|_|_|_|_|_|6540303
ketamine|Chemical|2|[17, 18]|0|-1|_|_|_|_|_|_|_|6540303
ketamine|Chemical|4|[8, 9]|0|-1|_|_|_|_|_|_|_|6540303
ketamine|Chemical|4|[27, 28]|0|-1|_|_|_|_|_|_|_|6540303
ketamine|Chemical|5|[0, 1]|0|-1|_|_|_|_|_|_|_|6540303
ketamine|Chemical|5|[27, 28]|0|-1|_|_|_|_|_|_|_|6540303
ketamine|Chemical|7|[16, 17]|0|-1|_|_|_|_|_|_|_|6540303
ketamine|Chemical|8|[15, 16]|0|-1|_|_|_|_|_|_|_|6540303
dopamine|Chemical|2|[7, 8]|4|-1|_|_|_|_|_|_|_|6540303
serotonin|Chemical|4|[0, 1]|7|-1|_|_|_|_|_|_|_|6540303
serotonin|Chemical|4|[5, 6]|7|-1|_|_|_|_|_|_|_|6540303
melatonin|Chemical|4|[24, 25]|9|-1|_|_|_|_|_|_|_|6540303
catatonia|Disease|0|[6, 7]|1|-1|_|_|_|_|_|_|_|6540303
blood-brain barrier|Physiology|6|[22, 26]|12|-1|_|_|_|_|_|_|_|6540303
allergic rhinitis|Disease|0|[29, 31]|500|H|_|_|_|_|_|_|_|3057041
major symptoms|Disease|6|[7, 9]|5|H|_|_|_|_|_|_|_|3057041
altered taste perception|Disease|13|[2, 5]|10|-1|_|_|_|_|_|_|_|3057041
drowsiness|Disease|13|[0, 1]|11|-1|_|_|_|_|_|_|_|3057041
seasonal allergic rhinitis|Disease|14|[10, 13]|500|H|_|_|_|_|_|_|_|3057041
azelastine|Chemical|0|[18, 19]|1|-1|_|_|_|_|_|_|_|3057041
chlorpheniramine|Chemical|0|[20, 21]|502|-1|_|_|_|_|_|_|_|3057041
chlorpheniramine maleate|Chemical|1|[10, 12]|502|-1|_|_|_|_|_|_|_|3057041
study medications|Treat|5|[25, 27]|4|-1|_|_|_|_|_|_|_|3057041
treatment|Treat|12|[10, 11]|9|-1|_|_|_|_|_|_|_|3057041
vital signs|Physiology|8|[0, 2]|6|-1|_|_|_|_|_|_|_|3057041
body weights|Physiology|8|[3, 5]|7|-1|_|_|_|_|_|_|_|3057041
electrocardiograms|Physiology|8|[19, 20]|8|-1|_|_|_|_|_|_|_|3057041
calcium carbon-ate|Chemical|1|[21, 25]|500|-1|_|_|_|_|_|_|_|625456
sodium bicarbonate|Chemical|1|[26, 28]|500|-1|_|_|_|_|_|_|_|625456
powders|Chemical|3|[18, 19]|500|-1|_|_|_|_|_|_|_|625456
hypercalcaemia|Disease|1|[4, 5]|2|-1|_|_|_|_|_|_|_|625456
nephrolithiasis|Disease|1|[9, 10]|3|-1|_|_|_|_|_|_|_|625456
corticosteroids|Chemical|0|[9, 10]|0|-1|_|_|_|_|_|_|_|7910951
nondepolarizing neuromuscular blocking agents|Chemical|0|[4, 8]|500|-1|_|_|_|_|_|_|_|7910951
nondepolarizing neuromuscular blocking agents (nd-nmba)|Chemical|1|[6, 15]|500|-1|_|_|_|_|_|_|_|7910951
nd-nmbas|Chemical|2|[23, 26]|500|-1|_|_|_|_|_|_|_|7910951
muscle weakness|Disease|1|[24, 26]|502|H|_|_|_|_|_|_|_|7910951
prolonged muscle weakness|Disease|1|[23, 26]|502|H|_|_|_|_|_|_|_|7910951
respiratory insufficiency|Disease|2|[13, 15]|5|H|_|_|_|_|_|_|_|7910951
low amplitude compound motor action potentials|Disease|5|[3, 9]|8|H|_|_|_|_|_|_|_|7910951
loss of thick, myosin filaments|Disease|7|[29, 35]|502|-1|_|_|_|_|_|_|_|7910951
pathology at both the neuromuscular junction|Disease|8|[8, 14]|502|H|_|_|_|_|_|_|_|7910951
hepatic dysfunction|Disease|9|[0, 2]|11|-1|_|_|_|_|_|_|_|7910951
corticosteroids|Treat|3|[5, 6]|7|-1|_|_|_|_|_|_|_|7910951
bladder hyperactivity|Disease|0|[4, 6]|500|-1|_|_|_|_|_|_|_|7752389
bladder hyperactivity|Disease|8|[13, 15]|500|-1|_|_|_|_|_|_|_|7752389
inflammatory conditions of the lower urinary tract|Disease|8|[17, 24]|500|-1|_|_|_|_|_|_|_|7752389
prostaglandin e2|Chemical|0|[0, 2]|502|-1|_|_|_|_|_|_|_|7752389
prostaglandin e2|Chemical|0|[0, 2]|502|-1|_|_|_|_|_|_|_|7752389
prostaglandin (pg) e2|Chemical|1|[11, 16]|502|-1|_|_|_|_|_|_|_|7752389
rp 67,580|Chemical|2|[11, 15]|5|-1|_|_|_|_|_|_|_|7752389
rp 67,580|Chemical|2|[11, 15]|5|-1|_|_|_|_|_|_|_|7752389
rp 67,580|Chemical|4|[15, 19]|5|-1|_|_|_|_|_|_|_|7752389
rp 67,580|Chemical|4|[15, 19]|5|-1|_|_|_|_|_|_|_|7752389
sr 48,968|Chemical|2|[21, 25]|6|-1|_|_|_|_|_|_|_|7752389
sr 48,968|Chemical|2|[21, 25]|6|-1|_|_|_|_|_|_|_|7752389
sr 48,968|Chemical|4|[20, 24]|6|-1|_|_|_|_|_|_|_|7752389
sr 48,968|Chemical|4|[20, 24]|6|-1|_|_|_|_|_|_|_|7752389
pge2|Chemical|3|[4, 5]|502|-1|_|_|_|_|_|_|_|7752389
pge2|Chemical|4|[6, 7]|502|-1|_|_|_|_|_|_|_|7752389
pge2|Chemical|4|[38, 39]|502|-1|_|_|_|_|_|_|_|7752389
pge2|Chemical|5|[9, 10]|502|-1|_|_|_|_|_|_|_|7752389
pge2|Chemical|6|[6, 7]|502|-1|_|_|_|_|_|_|_|7752389
nk1|Chemical|7|[12, 13]|20|H|_|_|_|_|_|_|_|7752389
nk2|Chemical|7|[14, 15]|21|H|_|_|_|_|_|_|_|7752389
prostanoids|Chemical|8|[0, 1]|502|H|_|_|_|_|_|_|_|7752389
basal intravesical pressure|Physiology|1|[20, 23]|4|-1|_|_|_|_|_|_|_|7752389
bladder pressure|Physiology|3|[10, 12]|9|-1|_|_|_|_|_|_|_|7752389
micturition|Physiology|5|[18, 19]|18|-1|_|_|_|_|_|_|_|7752389
thiazide|Chemical|0|[0, 1]|500|-1|_|_|_|_|_|_|_|6942642
thiazide|Chemical|1|[0, 1]|500|-1|_|_|_|_|_|_|_|6942642
thiazide|Chemical|2|[9, 10]|500|-1|_|_|_|_|_|_|_|6942642
thiazide|Chemical|11|[5, 6]|500|-1|_|_|_|_|_|_|_|6942642
hydrochlorothiazide|Chemical|3|[18, 19]|500|-1|_|_|_|_|_|_|_|6942642
hctz|Chemical|5|[30, 31]|500|-1|_|_|_|_|_|_|_|6942642
hctz|Chemical|7|[8, 9]|500|-1|_|_|_|_|_|_|_|6942642
hctz|Chemical|9|[3, 4]|500|-1|_|_|_|_|_|_|_|6942642
k+|Chemical|10|[13, 15]|17|-1|_|_|_|_|_|_|_|6942642
hypokalemia|Disease|0|[3, 4]|1|H|_|_|_|_|_|_|_|6942642
hypokalemia|Disease|2|[0, 1]|1|H|_|_|_|_|_|_|_|6942642
cardiac arrhythmias|Disease|0|[5, 7]|502|-1|_|_|_|_|_|_|_|6942642
diastolic hypertension|Disease|3|[15, 17]|7|-1|_|_|_|_|_|_|_|6942642
hypertension|Disease|3|[16, 17]|8|H|_|_|_|_|_|_|_|6942642
pvc's|Disease|7|[19, 22]|502|-1|_|_|_|_|_|_|_|6942642
pvc's|Disease|10|[3, 6]|502|-1|_|_|_|_|_|_|_|6942642
pvc's|Disease|12|[13, 16]|502|-1|_|_|_|_|_|_|_|6942642
antihypertensive treatment programs|Treat|1|[9, 12]|4|-1|_|_|_|_|_|_|_|6942642
blood pressure|Physiology|4|[24, 26]|10|-1|_|_|_|_|_|_|_|6942642
k|Physiology|5|[2, 3]|12|-1|_|_|_|_|_|_|_|6942642
potassium|Physiology|11|[13, 14]|19|-1|_|_|_|_|_|_|_|6942642
hypertensive|Disease|0|[6, 7]|0|H|_|_|_|_|_|_|_|3732088
coronary disease|Disease|0|[7, 9]|500|H|_|_|_|_|_|_|_|3732088
cardiac arrhythmias|Disease|1|[15, 17]|4|H|_|_|_|_|_|_|_|3732088
ventricular ectopic beats|Disease|6|[15, 18]|14|-1|_|_|_|_|_|_|_|3732088
ischaemic heart disease|Disease|7|[19, 22]|500|H|_|_|_|_|_|_|_|3732088
diuretics, potassium|Chemical|0|[0, 3]|2|H|_|_|_|_|_|_|_|3732088
diuretic|Chemical|3|[28, 29]|6|H|_|_|_|_|_|_|_|3732088
diuretic|Chemical|3|[41, 42]|6|H|_|_|_|_|_|_|_|3732088
diuretic|Chemical|7|[9, 10]|6|H|_|_|_|_|_|_|_|3732088
amiloride|Chemical|3|[30, 31]|8|-1|_|_|_|_|_|_|_|3732088
chlorthalidone|Chemical|3|[43, 44]|9|-1|_|_|_|_|_|_|_|3732088
noradrenaline (norepinephrine)|Chemical|5|[13, 17]|12|-1|_|_|_|_|_|_|_|3732088
plasma renin|Chemical|5|[10, 12]|13|-1|_|_|_|_|_|_|_|3732088
arrhythmias|Physiology|0|[4, 5]|3|-1|_|_|_|_|_|_|_|3732088
plasma potassium|Physiology|1|[8, 10]|5|-1|_|_|_|_|_|_|_|3732088
potassium concentrations|Physiology|4|[1, 3]|10|-1|_|_|_|_|_|_|_|3732088
blood pressure|Physiology|5|[0, 2]|11|-1|_|_|_|_|_|_|_|3732088
monophasic action potential|Physiology|6|[37, 40]|15|-1|_|_|_|_|_|_|_|3732088
ventricular effective refractory period|Physiology|6|[42, 46]|16|-1|_|_|_|_|_|_|_|3732088
respiratory paralysis|Disease|0|[7, 9]|0|-1|_|_|_|_|_|_|_|2893236
respiratory paralysis|Disease|1|[7, 9]|0|-1|_|_|_|_|_|_|_|2893236
respiratory paralysis|Disease|2|[5, 7]|0|-1|_|_|_|_|_|_|_|2893236
respiratory paralysis|Disease|6|[15, 17]|0|-1|_|_|_|_|_|_|_|2893236
respiratory paralysis|Disease|7|[5, 7]|0|-1|_|_|_|_|_|_|_|2893236
anesthetic action|Disease|4|[10, 12]|6|H|_|_|_|_|_|_|_|2893236
respiratory depressant action|Disease|4|[16, 19]|7|H|_|_|_|_|_|_|_|2893236
naloxone|Chemical|0|[3, 4]|1|-1|_|_|_|_|_|_|_|2893236
naloxone|Chemical|6|[0, 1]|1|-1|_|_|_|_|_|_|_|2893236
thiopental|Chemical|0|[11, 12]|2|-1|_|_|_|_|_|_|_|2893236
thiosemicarbazide|Chemical|4|[4, 5]|5|-1|_|_|_|_|_|_|_|2893236
amino acids|Chemical|5|[33, 35]|8|-1|_|_|_|_|_|_|_|2893236
hbsag|Chemical|2|[23, 24]|500|H|_|_|_|_|_|_|_|2533791
hbsag|Chemical|5|[12, 13]|500|H|_|_|_|_|_|_|_|2533791
hbsag|Chemical|5|[12, 13]|500|H|_|_|_|_|_|_|_|2533791
hbsag|Chemical|6|[5, 6]|500|H|_|_|_|_|_|_|_|2533791
hbsag|Chemical|7|[1, 2]|500|H|_|_|_|_|_|_|_|2533791
hbeag|Chemical|2|[31, 32]|501|-1|_|_|_|_|_|_|_|2533791
hbeag|Chemical|6|[1, 2]|501|-1|_|_|_|_|_|_|_|2533791
hepatitis b surface antigen (hbsag)|Chemical|2|[18, 25]|500|H|_|_|_|_|_|_|_|2533791
hepatitis b e antigen (hbeag)|Chemical|2|[26, 33]|501|-1|_|_|_|_|_|_|_|2533791
hepatitis b vaccine|Chemical|3|[23, 26]|6|-1|_|_|_|_|_|_|_|2533791
hepatitis b vaccine|Chemical|3|[23, 26]|6|-1|_|_|_|_|_|_|_|2533791
hepatitis b|Disease|2|[26, 28]|2|H|_|_|_|_|_|_|_|2533791
hepatitis b|Disease|2|[18, 20]|2|H|_|_|_|_|_|_|_|2533791
hepatitis b|Disease|3|[8, 10]|2|H|_|_|_|_|_|_|_|2533791
hepatitis b|Disease|3|[23, 25]|2|H|_|_|_|_|_|_|_|2533791
hbsag|Disease|5|[12, 13]|12|H|_|_|_|_|_|_|_|2533791
hbsag|Disease|6|[5, 6]|12|H|_|_|_|_|_|_|_|2533791
hbsag|Disease|7|[1, 2]|12|H|_|_|_|_|_|_|_|2533791
hbeag|Disease|6|[1, 2]|16|-1|_|_|_|_|_|_|_|2533791
injections of hepatitis b immune globulin (hbig) and at least three injections of plasma derived hepatitis b vaccine|Treat|3|[6, 26]|10|-1|_|_|_|_|_|_|_|2533791
prostaglandin d2|Chemical|0|[7, 9]|0|-1|_|_|_|_|_|_|_|2322844
prostaglandin d2|Chemical|2|[0, 2]|0|-1|_|_|_|_|_|_|_|2322844
prostaglandin d2|Chemical|3|[31, 33]|0|-1|_|_|_|_|_|_|_|2322844
prostaglandin d2|Chemical|5|[4, 6]|0|-1|_|_|_|_|_|_|_|2322844
prostaglandin d2|Chemical|8|[5, 7]|0|-1|_|_|_|_|_|_|_|2322844
prostaglandin e2|Chemical|3|[0, 2]|5|-1|_|_|_|_|_|_|_|2322844
prostaglandin e2|Chemical|3|[0, 2]|5|-1|_|_|_|_|_|_|_|2322844
prostaglandin e2|Chemical|6|[2, 4]|5|-1|_|_|_|_|_|_|_|2322844
prostaglandin e2|Chemical|6|[2, 4]|5|-1|_|_|_|_|_|_|_|2322844
prostaglandin e2|Chemical|8|[8, 10]|5|-1|_|_|_|_|_|_|_|2322844
prostaglandin e2|Chemical|8|[8, 10]|5|-1|_|_|_|_|_|_|_|2322844
ah6809|Chemical|5|[28, 29]|10|-1|_|_|_|_|_|_|_|2322844
ah6809|Chemical|6|[10, 11]|10|-1|_|_|_|_|_|_|_|2322844
prostaglandin f2 alpha|Chemical|7|[0, 3]|14|-1|_|_|_|_|_|_|_|2322844
writhing|Disease|1|[22, 23]|1|-1|_|_|_|_|_|_|_|2322844
writhing|Disease|4|[7, 8]|1|-1|_|_|_|_|_|_|_|2322844
pain|Disease|1|[8, 9]|2|H|_|_|_|_|_|_|_|2322844
hyperalgesic|Disease|2|[14, 15]|4|-1|_|_|_|_|_|_|_|2322844
atrial tachyarrhythmia|Disease|0|[3, 5]|500|-1|_|_|_|_|_|_|_|20552622
arrhythmia|Disease|3|[1, 2]|500|H|_|_|_|_|_|_|_|20552622
siat|Disease|6|[8, 9]|500|-1|_|_|_|_|_|_|_|20552622
siat|Disease|7|[5, 6]|500|-1|_|_|_|_|_|_|_|20552622
siat|Disease|8|[19, 20]|500|-1|_|_|_|_|_|_|_|20552622
siat|Disease|9|[14, 15]|500|-1|_|_|_|_|_|_|_|20552622
siat|Disease|10|[11, 12]|500|-1|_|_|_|_|_|_|_|20552622
tachycardia|Disease|11|[28, 29]|13|H|_|_|_|_|_|_|_|20552622
salbutamol|Chemical|0|[7, 8]|1|-1|_|_|_|_|_|_|_|20552622
salbutamol|Chemical|10|[2, 3]|1|-1|_|_|_|_|_|_|_|20552622
inhalator|Treat|4|[12, 13]|3|-1|_|_|_|_|_|_|_|20552622
medications|Treat|9|[22, 23]|8|-1|_|_|_|_|_|_|_|20552622
surgery|Treat|9|[24, 25]|9|-1|_|_|_|_|_|_|_|20552622
radiofrequency catheter ablation (rfca)|Treat|9|[27, 33]|10|-1|_|_|_|_|_|_|_|20552622
nephrotoxicity|Disease|0|[6, 7]|0|-1|_|_|_|_|_|_|_|20510337
nephrotoxicity|Disease|7|[16, 17]|0|-1|_|_|_|_|_|_|_|20510337
renal injury|Disease|1|[12, 14]|500|-1|_|_|_|_|_|_|_|20510337
renal tissue damage|Disease|5|[3, 6]|500|-1|_|_|_|_|_|_|_|20510337
coenzyme q10|Chemical|0|[0, 2]|1|-1|_|_|_|_|_|_|_|20510337
coenzyme q10|Chemical|1|[4, 6]|1|-1|_|_|_|_|_|_|_|20510337
coenzyme q10|Chemical|2|[0, 2]|1|-1|_|_|_|_|_|_|_|20510337
coenzyme q10|Chemical|3|[0, 2]|1|-1|_|_|_|_|_|_|_|20510337
coenzyme q10|Chemical|4|[0, 2]|1|-1|_|_|_|_|_|_|_|20510337
coenzyme q10|Chemical|5|[12, 14]|1|-1|_|_|_|_|_|_|_|20510337
coenzyme q10|Chemical|6|[4, 6]|1|-1|_|_|_|_|_|_|_|20510337
coenzyme q10|Chemical|7|[4, 6]|1|-1|_|_|_|_|_|_|_|20510337
cisplatin|Chemical|0|[5, 6]|2|-1|_|_|_|_|_|_|_|20510337
blood urea nitrogen|Chemical|3|[4, 7]|502|-1|_|_|_|_|_|_|_|20510337
urea nitrogen|Chemical|3|[5, 7]|502|-1|_|_|_|_|_|_|_|20510337
reduced glutathione|Chemical|4|[11, 13]|503|-1|_|_|_|_|_|_|_|20510337
zinc|Chemical|4|[48, 49]|12|-1|_|_|_|_|_|_|_|20510337
glutathione|Chemical|4|[12, 13]|503|-1|_|_|_|_|_|_|_|20510337
nitric oxide|Chemical|4|[34, 36]|15|-1|_|_|_|_|_|_|_|20510337
selenium|Chemical|4|[46, 47]|16|-1|_|_|_|_|_|_|_|20510337
coenzyme q10 treatment|Treat|0|[0, 3]|3|-1|_|_|_|_|_|_|_|20510337
coenzyme q10 treatment|Treat|2|[0, 3]|3|-1|_|_|_|_|_|_|_|20510337
coenzyme q10 treatment|Treat|5|[12, 15]|3|-1|_|_|_|_|_|_|_|20510337
inducible nitric oxide synthase|Gene|6|[14, 18]|21|-1|_|_|_|_|_|_|_|20510337
nuclear factor-kappab|Gene|6|[19, 23]|22|-1|_|_|_|_|_|_|_|20510337
caspase-3|Gene|6|[24, 27]|23|-1|_|_|_|_|_|_|_|20510337
p53|Gene|6|[28, 29]|24|-1|_|_|_|_|_|_|_|20510337
nephropathy|Disease|0|[6, 7]|0|H|_|_|_|_|_|_|_|20164825
vascular dysfunction|Disease|1|[16, 18]|3|-1|_|_|_|_|_|_|_|20164825
nephrotoxicity|Disease|10|[13, 14]|11|-1|_|_|_|_|_|_|_|20164825
metformin|Chemical|0|[0, 1]|1|-1|_|_|_|_|_|_|_|20164825
gentamicin|Chemical|0|[3, 4]|2|-1|_|_|_|_|_|_|_|20164825
cytochrome c|Chemical|3|[16, 18]|6|-1|_|_|_|_|_|_|_|20164825
respiration intensity|Physiology|3|[3, 5]|4|-1|_|_|_|_|_|_|_|20164825
permeability transition|Physiology|3|[12, 14]|5|-1|_|_|_|_|_|_|_|20164825
antioxidant systems|Physiology|5|[28, 30]|7|-1|_|_|_|_|_|_|_|20164825
mitochondrial function|Physiology|7|[19, 21]|8|-1|_|_|_|_|_|_|_|20164825
mitochondrial transition pores|Physiology|8|[21, 24]|9|-1|_|_|_|_|_|_|_|20164825
reactive oxygen species|Physiology|9|[9, 12]|10|-1|_|_|_|_|_|_|_|20164825
postoperative delirium|Disease|0|[9, 11]|0|-1|_|_|_|_|_|_|_|20042557
postoperative delirium|Disease|1|[24, 26]|0|-1|_|_|_|_|_|_|_|20042557
postoperative delirium|Disease|4|[0, 2]|0|-1|_|_|_|_|_|_|_|20042557
postoperative delirium|Disease|6|[3, 5]|0|-1|_|_|_|_|_|_|_|20042557
postoperative delirium|Disease|8|[12, 14]|0|-1|_|_|_|_|_|_|_|20042557
postoperative delirium|Disease|9|[20, 22]|0|-1|_|_|_|_|_|_|_|20042557
delirium|Disease|0|[10, 11]|1|H|_|_|_|_|_|_|_|20042557
dementia|Disease|2|[31, 32]|3|-1|_|_|_|_|_|_|_|20042557
mental disorders|Disease|4|[12, 14]|7|H|_|_|_|_|_|_|_|20042557
confusion|Disease|4|[22, 23]|8|-1|_|_|_|_|_|_|_|20042557
propofol|Chemical|2|[41, 42]|4|-1|_|_|_|_|_|_|_|20042557
hip fracture repair|Treat|2|[34, 37]|5|-1|_|_|_|_|_|_|_|20042557
light sedation|Treat|6|[55, 57]|10|-1|_|_|_|_|_|_|_|20042557
light sedation|Treat|6|[10, 12]|10|-1|_|_|_|_|_|_|_|20042557
deep sedation|Treat|6|[29, 31]|12|-1|_|_|_|_|_|_|_|20042557
sedation|Treat|8|[19, 20]|14|-1|_|_|_|_|_|_|_|20042557
sedation|Treat|8|[7, 8]|14|-1|_|_|_|_|_|_|_|20042557
myocardial infarction|Disease|0|[4, 6]|0|H|_|_|_|_|_|_|_|19944333
coronary artery spasm|Disease|0|[8, 11]|500|H|_|_|_|_|_|_|_|19944333
chest pain|Disease|1|[17, 19]|500|H|_|_|_|_|_|_|_|19944333
renal cell carcinoma|Disease|1|[9, 12]|4|-1|_|_|_|_|_|_|_|19944333
subendocardial infarction|Disease|4|[7, 9]|5|-1|_|_|_|_|_|_|_|19944333
angiography|Disease|5|[10, 11]|6|H|_|_|_|_|_|_|_|19944333
angina|Disease|8|[10, 11]|500|H|_|_|_|_|_|_|_|19944333
sorafenib|Chemical|0|[0, 1]|1|-1|_|_|_|_|_|_|_|19944333
sorafenib|Chemical|10|[0, 1]|1|-1|_|_|_|_|_|_|_|19944333
ca-channel blocker|Chemical|7|[6, 10]|7|H|_|_|_|_|_|_|_|19944333
nicorandil|Chemical|8|[3, 4]|9|-1|_|_|_|_|_|_|_|19944333
cellular proliferation and survival|Physiology|10|[11, 15]|11|-1|_|_|_|_|_|_|_|19944333
rho/rock pathway|Physiology|12|[9, 13]|12|-1|_|_|_|_|_|_|_|19944333
ciprofloxacin|Chemical|0|[3, 4]|0|-1|_|_|_|_|_|_|_|17975693
norfloxacin|Chemical|0|[5, 6]|1|-1|_|_|_|_|_|_|_|17975693
anxious behaviour|Disease|3|[14, 16]|2|-1|_|_|_|_|_|_|_|17975693
cardiomyopathy|Disease|0|[10, 11]|500|H|_|_|_|_|_|_|_|17943461
hiv-infected|Disease|1|[12, 15]|2|H|_|_|_|_|_|_|_|17943461
dilated cardiomyopathy|Disease|1|[2, 4]|500|-1|_|_|_|_|_|_|_|17943461
myocarditis|Disease|1|[8, 9]|4|-1|_|_|_|_|_|_|_|17943461
heart failure|Disease|1|[20, 22]|5|H|_|_|_|_|_|_|_|17943461
immunodeficiency|Disease|2|[15, 16]|6|H|_|_|_|_|_|_|_|17943461
aids|Disease|2|[18, 19]|7|-1|_|_|_|_|_|_|_|17943461
dcm|Disease|3|[47, 48]|500|-1|_|_|_|_|_|_|_|17943461
cardiac dilation|Disease|6|[10, 12]|14|-1|_|_|_|_|_|_|_|17943461
azt|Chemical|0|[7, 8]|502|-1|_|_|_|_|_|_|_|17943461
azt|Chemical|3|[27, 28]|502|-1|_|_|_|_|_|_|_|17943461
azt|Chemical|3|[82, 83]|502|-1|_|_|_|_|_|_|_|17943461
azt|Chemical|6|[3, 4]|502|-1|_|_|_|_|_|_|_|17943461
zidovudine|Chemical|3|[12, 13]|502|-1|_|_|_|_|_|_|_|17943461
cardiac structure|Physiology|5|[12, 14]|12|-1|_|_|_|_|_|_|_|17943461
sarcolemmal integrity|Physiology|8|[18, 20]|17|-1|_|_|_|_|_|_|_|17943461
fasl|Gene|5|[3, 4]|13|-1|_|_|_|_|_|_|_|17943461
dystrophin|Gene|8|[6, 7]|18|-1|_|_|_|_|_|_|_|17943461
troponin i|Gene|8|[9, 11]|19|-1|_|_|_|_|_|_|_|17943461
fas|Gene|9|[5, 6]|21|-1|_|_|_|_|_|_|_|17943461
fasl tg mice|Immune|6|[6, 9]|16|-1|_|_|_|_|_|_|_|17943461
haart|Treat|9|[24, 25]|20|-1|_|_|_|_|_|_|_|17943461
chorea|Disease|0|[3, 4]|0|-1|_|_|_|_|_|_|_|17074608
encephalopathy|Disease|0|[5, 6]|1|H|_|_|_|_|_|_|_|17074608
neonatal apnea|Disease|2|[7, 9]|3|-1|_|_|_|_|_|_|_|17074608
intractable seizures|Disease|2|[10, 12]|4|H|_|_|_|_|_|_|_|17074608
psychomotor retardation|Disease|2|[19, 21]|5|H|_|_|_|_|_|_|_|17074608
language delay|Disease|4|[7, 9]|6|-1|_|_|_|_|_|_|_|17074608
mental retardation|Disease|4|[10, 12]|7|H|_|_|_|_|_|_|_|17074608
valproate|Chemical|0|[0, 1]|2|-1|_|_|_|_|_|_|_|17074608
amnesia|Disease|0|[13, 14]|0|-1|_|_|_|_|_|_|_|16364460
amnesia|Disease|1|[19, 20]|0|-1|_|_|_|_|_|_|_|16364460
amnesia|Disease|9|[19, 20]|0|-1|_|_|_|_|_|_|_|16364460
scopolamine|Chemical|0|[10, 11]|1|-1|_|_|_|_|_|_|_|16364460
scopolamine|Chemical|1|[11, 12]|1|-1|_|_|_|_|_|_|_|16364460
scopolamine|Chemical|3|[60, 61]|1|-1|_|_|_|_|_|_|_|16364460
scopolamine|Chemical|3|[18, 19]|1|-1|_|_|_|_|_|_|_|16364460
scopolamine|Chemical|6|[16, 17]|1|-1|_|_|_|_|_|_|_|16364460
scopolamine|Chemical|8|[2, 3]|1|-1|_|_|_|_|_|_|_|16364460
scopolamine|Chemical|8|[23, 24]|1|-1|_|_|_|_|_|_|_|16364460
scopolamine|Chemical|9|[16, 17]|1|-1|_|_|_|_|_|_|_|16364460
ritanserin|Chemical|0|[2, 3]|2|-1|_|_|_|_|_|_|_|16364460
ritanserin|Chemical|7|[0, 1]|2|-1|_|_|_|_|_|_|_|16364460
dmso|Chemical|3|[11, 12]|7|-1|_|_|_|_|_|_|_|16364460
dmso|Chemical|3|[15, 16]|7|-1|_|_|_|_|_|_|_|16364460
dmso|Chemical|3|[50, 51]|7|-1|_|_|_|_|_|_|_|16364460
dmso|Chemical|3|[86, 87]|7|-1|_|_|_|_|_|_|_|16364460
dmso|Chemical|7|[26, 27]|7|-1|_|_|_|_|_|_|_|16364460
proteinuria|Disease|0|[5, 6]|0|-1|_|_|_|_|_|_|_|15579441
hypoxia|Disease|0|[0, 1]|1|H|_|_|_|_|_|_|_|15579441
nephrotic syndrome|Disease|4|[18, 20]|4|-1|_|_|_|_|_|_|_|15579441
hypoxic|Disease|7|[32, 33]|7|-1|_|_|_|_|_|_|_|15579441
progressive glomerular diseases|Disease|8|[12, 15]|8|H|_|_|_|_|_|_|_|15579441
tissue oxygenation|Physiology|1|[8, 10]|2|-1|_|_|_|_|_|_|_|15579441
vascular endothelial growth factor|Gene|2|[23, 27]|3|-1|_|_|_|_|_|_|_|15579441
hypoxia-responsive transgene|Gene|5|[3, 7]|6|-1|_|_|_|_|_|_|_|15579441
puromycin aminonucleoside|Chemical|4|[14, 16]|5|-1|_|_|_|_|_|_|_|15579441
systemic sclerosis|Disease|0|[21, 23]|0|-1|_|_|_|_|_|_|_|15517007
multiple sclerosis|Disease|0|[24, 26]|1|-1|_|_|_|_|_|_|_|15517007
heart damage|Disease|7|[20, 22]|7|-1|_|_|_|_|_|_|_|15517007
autologous haematopoietic stem cell transplantation|Treat|1|[0, 5]|2|-1|_|_|_|_|_|_|_|15517007
transplanted|Treat|2|[7, 8]|3|-1|_|_|_|_|_|_|_|15517007
transplant|Treat|5|[15, 16]|4|-1|_|_|_|_|_|_|_|15517007
transplantation medicine|Treat|8|[30, 32]|8|-1|_|_|_|_|_|_|_|15517007
cyclophosphamide|Chemical|7|[6, 7]|5|-1|_|_|_|_|_|_|_|15517007
mitoxantrone|Chemical|7|[11, 12]|6|-1|_|_|_|_|_|_|_|15517007
arteritis|Disease|0|[31, 32]|0|-1|_|_|_|_|_|_|_|12180796
fenoldopam|Chemical|0|[36, 37]|1|-1|_|_|_|_|_|_|_|12180796
theophylline|Chemical|0|[38, 39]|2|-1|_|_|_|_|_|_|_|12180796
inos|Gene|0|[9, 10]|3|-1|_|_|_|_|_|_|_|12180796
inos|Gene|1|[24, 25]|3|-1|_|_|_|_|_|_|_|12180796
bfgf|Gene|0|[17, 18]|4|-1|_|_|_|_|_|_|_|12180796
bfgf|Gene|1|[32, 33]|4|-1|_|_|_|_|_|_|_|12180796
tgf-beta1|Gene|0|[26, 29]|5|-1|_|_|_|_|_|_|_|12180796
tgf-beta1|Gene|1|[41, 44]|5|-1|_|_|_|_|_|_|_|12180796
tgf-beta1|Gene|5|[5, 8]|5|-1|_|_|_|_|_|_|_|12180796
low-molecular-weight heparin|Chemical|0|[0, 6]|500|-1|_|_|_|_|_|_|_|12109865
low-molecular-weight heparin|Chemical|3|[0, 6]|500|-1|_|_|_|_|_|_|_|12109865
oral anticoagulant (oac)|Chemical|1|[5, 10]|501|-1|_|_|_|_|_|_|_|12109865
uh|Chemical|2|[3, 4]|501|H|_|_|_|_|_|_|_|12109865
uh|Chemical|3|[13, 14]|501|H|_|_|_|_|_|_|_|12109865
uh|Chemical|3|[27, 28]|501|H|_|_|_|_|_|_|_|12109865
uh|Chemical|11|[17, 18]|501|H|_|_|_|_|_|_|_|12109865
uh|Chemical|11|[17, 18]|501|H|_|_|_|_|_|_|_|12109865
lmwh|Chemical|4|[20, 21]|501|-1|_|_|_|_|_|_|_|12109865
lmwh|Chemical|5|[11, 12]|501|-1|_|_|_|_|_|_|_|12109865
lmwh|Chemical|11|[12, 13]|501|-1|_|_|_|_|_|_|_|12109865
lmwh|Chemical|12|[8, 9]|501|-1|_|_|_|_|_|_|_|12109865
lmwh|Chemical|13|[16, 17]|501|-1|_|_|_|_|_|_|_|12109865
thromboembolism|Disease|10|[4, 5]|8|-1|_|_|_|_|_|_|_|12109865
hemorrhage|Disease|10|[38, 39]|9|-1|_|_|_|_|_|_|_|12109865
mechanical heart valves|Disease|11|[5, 8]|11|-1|_|_|_|_|_|_|_|12109865
nephrolithiasis|Disease|0|[3, 4]|0|-1|_|_|_|_|_|_|_|12042105
refractory seizures|Disease|1|[19, 21]|500|-1|_|_|_|_|_|_|_|12042105
seizures|Disease|1|[20, 21]|500|-1|_|_|_|_|_|_|_|12042105
topiramate|Chemical|0|[0, 1]|1|-1|_|_|_|_|_|_|_|12042105
topiramate|Chemical|1|[0, 1]|1|-1|_|_|_|_|_|_|_|12042105
hypokalemia|Disease|0|[15, 16]|0|-1|_|_|_|_|_|_|_|11868798
nephrotoxicity|Disease|1|[2, 3]|3|H|_|_|_|_|_|_|_|11868798
neutropenic|Disease|4|[19, 20]|7|-1|_|_|_|_|_|_|_|11868798
neutropenic|Disease|9|[20, 21]|7|-1|_|_|_|_|_|_|_|11868798
fungal infection|Disease|5|[34, 36]|10|-1|_|_|_|_|_|_|_|11868798
hematological disorders|Disease|5|[9, 11]|11|H|_|_|_|_|_|_|_|11868798
spironolactone|Chemical|0|[0, 1]|1|-1|_|_|_|_|_|_|_|11868798
amphotericin b|Chemical|0|[11, 13]|501|-1|_|_|_|_|_|_|_|11868798
amphotericin b (amb)|Chemical|1|[9, 14]|501|-1|_|_|_|_|_|_|_|11868798
amb|Chemical|2|[24, 25]|501|-1|_|_|_|_|_|_|_|11868798
amb|Chemical|3|[8, 9]|501|-1|_|_|_|_|_|_|_|11868798
amb|Chemical|4|[22, 23]|501|-1|_|_|_|_|_|_|_|11868798
amb|Chemical|5|[17, 18]|501|-1|_|_|_|_|_|_|_|11868798
amb|Chemical|5|[20, 21]|501|-1|_|_|_|_|_|_|_|11868798
amb|Chemical|6|[17, 18]|501|-1|_|_|_|_|_|_|_|11868798
amb|Chemical|6|[5, 6]|501|-1|_|_|_|_|_|_|_|11868798
amb|Chemical|7|[3, 4]|501|-1|_|_|_|_|_|_|_|11868798
amb|Chemical|8|[11, 12]|501|-1|_|_|_|_|_|_|_|11868798
amb|Chemical|8|[17, 18]|501|-1|_|_|_|_|_|_|_|11868798
amb|Chemical|9|[23, 24]|501|-1|_|_|_|_|_|_|_|11868798
amb treatment|Treat|4|[22, 24]|9|-1|_|_|_|_|_|_|_|11868798
plasma potassium levels|Physiology|6|[11, 14]|16|-1|_|_|_|_|_|_|_|11868798
plasma potassium|Physiology|7|[14, 16]|18|-1|_|_|_|_|_|_|_|11868798
dopamine|Chemical|0|[0, 1]|0|-1|_|_|_|_|_|_|_|11860278
pilocarpine|Chemical|4|[20, 21]|5|-1|_|_|_|_|_|_|_|11860278
pilocarpine|Chemical|7|[2, 3]|5|-1|_|_|_|_|_|_|_|11860278
kainic acid|Chemical|5|[9, 11]|8|-1|_|_|_|_|_|_|_|11860278
d1/d2 receptor|Gene|1|[6, 10]|1|-1|_|_|_|_|_|_|_|11860278
d2r|Gene|4|[10, 11]|6|-1|_|_|_|_|_|_|_|11860278
d2r|Gene|6|[2, 3]|6|-1|_|_|_|_|_|_|_|11860278
seizures|Disease|2|[15, 16]|2|H|_|_|_|_|_|_|_|11860278
epilepsy|Disease|3|[17, 18]|3|H|_|_|_|_|_|_|_|11860278
neurotoxicity|Disease|4|[8, 9]|4|H|_|_|_|_|_|_|_|11860278
neurotoxicity|Disease|6|[24, 25]|4|H|_|_|_|_|_|_|_|11860278
ka|Disease|5|[12, 13]|7|-1|_|_|_|_|_|_|_|11860278
ka|Disease|7|[25, 26]|7|-1|_|_|_|_|_|_|_|11860278
hyperprolactinemia|Disease|0|[5, 6]|0|-1|_|_|_|_|_|_|_|11838826
prolactinomas|Disease|2|[7, 8]|4|-1|_|_|_|_|_|_|_|11838826
delayed puberty|Disease|2|[19, 21]|5|-1|_|_|_|_|_|_|_|11838826
mental disorders|Disease|6|[17, 19]|7|H|_|_|_|_|_|_|_|11838826
bipolar disorder|Disease|6|[23, 25]|8|-1|_|_|_|_|_|_|_|11838826
psychoses|Disease|6|[26, 27]|9|H|_|_|_|_|_|_|_|11838826
risperidone|Chemical|0|[2, 3]|1|-1|_|_|_|_|_|_|_|11838826
risperidone|Chemical|1|[2, 3]|1|-1|_|_|_|_|_|_|_|11838826
cabergoline|Chemical|4|[11, 12]|6|-1|_|_|_|_|_|_|_|11838826
cabergoline|Chemical|9|[0, 1]|6|-1|_|_|_|_|_|_|_|11838826
dopamine agonist|Treat|0|[8, 10]|2|-1|_|_|_|_|_|_|_|11838826
prolactin levels|Physiology|6|[35, 37]|10|-1|_|_|_|_|_|_|_|11838826
cholestatic jaundice|Disease|0|[0, 2]|500|H|_|_|_|_|_|_|_|11467664
edema|Disease|4|[12, 13]|3|H|_|_|_|_|_|_|_|11467664
cholestasis|Disease|4|[8, 9]|500|H|_|_|_|_|_|_|_|11467664
portal edema|Disease|4|[11, 13]|5|H|_|_|_|_|_|_|_|11467664
ductular proliferation|Disease|4|[14, 16]|6|-1|_|_|_|_|_|_|_|11467664
hepatotoxicity|Disease|6|[26, 27]|8|H|_|_|_|_|_|_|_|11467664
metformin|Chemical|0|[7, 8]|502|-1|_|_|_|_|_|_|_|11467664
metformin hydrochloride|Chemical|1|[14, 16]|502|-1|_|_|_|_|_|_|_|11467664
metformin hydrochloride|Chemical|5|[0, 2]|502|-1|_|_|_|_|_|_|_|11467664
vigabatrin|Chemical|0|[16, 17]|0|-1|_|_|_|_|_|_|_|11077455
visual field constriction|Disease|1|[3, 6]|501|-1|_|_|_|_|_|_|_|11077455
field defects|Disease|12|[1, 3]|501|-1|_|_|_|_|_|_|_|11077455
electroretinography|Physiology|5|[6, 7]|2|-1|_|_|_|_|_|_|_|11077455
electroretinography|Physiology|5|[12, 13]|2|-1|_|_|_|_|_|_|_|11077455
electro-oculography|Physiology|5|[21, 24]|4|-1|_|_|_|_|_|_|_|11077455
visual evoked potentials|Physiology|5|[29, 32]|5|-1|_|_|_|_|_|_|_|11077455
rapamycin|Chemical|0|[2, 3]|0|-1|_|_|_|_|_|_|_|11063349
cyclosporine (csa)|Chemical|1|[18, 22]|2|-1|_|_|_|_|_|_|_|11063349
tacrolimus (tac)|Chemical|1|[23, 27]|500|-1|_|_|_|_|_|_|_|11063349
csa|Chemical|4|[15, 16]|10|H|_|_|_|_|_|_|_|11063349
csa|Chemical|4|[6, 7]|10|H|_|_|_|_|_|_|_|11063349
csa|Chemical|13|[9, 10]|10|H|_|_|_|_|_|_|_|11063349
tac|Chemical|4|[17, 18]|500|-1|_|_|_|_|_|_|_|11063349
tac|Chemical|4|[8, 9]|500|-1|_|_|_|_|_|_|_|11063349
immunosuppression|Treat|0|[3, 4]|1|-1|_|_|_|_|_|_|_|11063349
ptld|Disease|4|[34, 35]|502|-1|_|_|_|_|_|_|_|11063349
ptld|Disease|8|[3, 4]|502|-1|_|_|_|_|_|_|_|11063349
ptld|Disease|8|[3, 4]|502|-1|_|_|_|_|_|_|_|11063349
ptld|Disease|9|[15, 16]|502|-1|_|_|_|_|_|_|_|11063349
ptld|Disease|11|[13, 14]|502|-1|_|_|_|_|_|_|_|11063349
ptld|Disease|11|[13, 14]|502|-1|_|_|_|_|_|_|_|11063349
nephrotoxicity|Disease|4|[9, 10]|5|H|_|_|_|_|_|_|_|11063349
nephrotoxicity|Disease|6|[10, 11]|5|H|_|_|_|_|_|_|_|11063349
tac nephrotoxicity|Disease|4|[8, 10]|6|-1|_|_|_|_|_|_|_|11063349
facial dysmorphism|Disease|4|[24, 26]|7|-1|_|_|_|_|_|_|_|11063349
posttransplant lymphoproliferative disorder (ptld)|Disease|4|[30, 36]|502|-1|_|_|_|_|_|_|_|11063349
hepatotoxicity|Disease|4|[43, 44]|9|-1|_|_|_|_|_|_|_|11063349
creatinine|Physiology|6|[18, 19]|15|-1|_|_|_|_|_|_|_|11063349
immunosuppression|Immune|13|[6, 7]|21|-1|_|_|_|_|_|_|_|11063349
over-immunosuppression|Immune|14|[14, 17]|23|-1|_|_|_|_|_|_|_|11063349
levodopa|Chemical|0|[2, 3]|0|-1|_|_|_|_|_|_|_|10091616
apomorphine|Chemical|1|[70, 71]|2|-1|_|_|_|_|_|_|_|10091616
dyskinesias|Disease|0|[5, 6]|501|-1|_|_|_|_|_|_|_|10091616
dyskinesia|Disease|2|[23, 24]|501|-1|_|_|_|_|_|_|_|10091616
score at rest|Physiology|2|[3, 6]|4|-1|_|_|_|_|_|_|_|10091616
cardiomyopathy|Disease|0|[10, 11]|500|H|_|_|_|_|_|_|_|9952311
swelling|Disease|6|[53, 54]|13|-1|_|_|_|_|_|_|_|9952311
bradycardia|Disease|6|[16, 17]|14|-1|_|_|_|_|_|_|_|9952311
cardiovascular arrhythmias|Disease|6|[12, 14]|15|H|_|_|_|_|_|_|_|9952311
mitochondrial structural and functional impairment|Disease|8|[25, 30]|500|H|_|_|_|_|_|_|_|9952311
adr|Disease|8|[20, 21]|22|-1|_|_|_|_|_|_|_|9952311
adriamycin|Chemical|0|[7, 8]|502|-1|_|_|_|_|_|_|_|9952311
adriamycin (adr)|Chemical|1|[3, 7]|502|-1|_|_|_|_|_|_|_|9952311
adr|Chemical|2|[45, 46]|502|-1|_|_|_|_|_|_|_|9952311
adr|Chemical|2|[3, 4]|502|-1|_|_|_|_|_|_|_|9952311
adr|Chemical|2|[22, 23]|502|-1|_|_|_|_|_|_|_|9952311
adr|Chemical|6|[10, 11]|502|-1|_|_|_|_|_|_|_|9952311
adr|Chemical|7|[31, 32]|502|-1|_|_|_|_|_|_|_|9952311
adr|Chemical|8|[20, 21]|502|-1|_|_|_|_|_|_|_|9952311
cytochrome c oxidase ii|Gene|0|[16, 20]|2|-1|_|_|_|_|_|_|_|9952311
coxii|Gene|4|[32, 33]|10|-1|_|_|_|_|_|_|_|9952311
coxii|Gene|7|[25, 26]|10|-1|_|_|_|_|_|_|_|9952311
coxiii|Gene|4|[34, 35]|11|-1|_|_|_|_|_|_|_|9952311
coxiv|Gene|4|[37, 38]|12|-1|_|_|_|_|_|_|_|9952311
cancer chemotherapy|Treat|1|[8, 10]|4|-1|_|_|_|_|_|_|_|9952311
i.p. treated with adr|Treat|2|[39, 46]|8|-1|_|_|_|_|_|_|_|9952311
adr treatment|Treat|7|[31, 33]|19|-1|_|_|_|_|_|_|_|9952311
cardiovascular functions|Physiology|2|[28, 30]|9|-1|_|_|_|_|_|_|_|9952311
ventricular depolarization time|Physiology|6|[20, 23]|17|-1|_|_|_|_|_|_|_|9952311
bradycardia|Disease|0|[1, 2]|0|-1|_|_|_|_|_|_|_|9915601
bradycardia|Disease|1|[16, 17]|0|-1|_|_|_|_|_|_|_|9915601
bradycardia|Disease|2|[11, 12]|0|-1|_|_|_|_|_|_|_|9915601
bradycardia|Disease|3|[3, 4]|0|-1|_|_|_|_|_|_|_|9915601
hypotension|Disease|1|[5, 6]|2|-1|_|_|_|_|_|_|_|9915601
isoniazid|Chemical|0|[12, 13]|1|-1|_|_|_|_|_|_|_|9915601
gamma-aminobutyric acid (gaba)|Chemical|1|[26, 33]|5|-1|_|_|_|_|_|_|_|9915601
chloralose|Chemical|2|[24, 25]|7|-1|_|_|_|_|_|_|_|9915601
urethane|Chemical|2|[26, 27]|8|-1|_|_|_|_|_|_|_|9915601
propranolol|Chemical|3|[5, 6]|11|-1|_|_|_|_|_|_|_|9915601
labetalol|Chemical|3|[9, 10]|12|-1|_|_|_|_|_|_|_|9915601
clonidine|Chemical|3|[17, 18]|13|-1|_|_|_|_|_|_|_|9915601
hexamethonium|Chemical|3|[22, 23]|14|-1|_|_|_|_|_|_|_|9915601
carbachol|Chemical|3|[24, 25]|15|-1|_|_|_|_|_|_|_|9915601
methylatropine|Chemical|4|[8, 9]|16|-1|_|_|_|_|_|_|_|9915601
bradycardia|Physiology|1|[16, 17]|4|-1|_|_|_|_|_|_|_|9915601
tachycardia|Physiology|1|[14, 15]|6|-1|_|_|_|_|_|_|_|9915601
parasympathetic tone|Physiology|5|[13, 15]|17|-1|_|_|_|_|_|_|_|9915601
sle|Disease|0|[8, 9]|500|-1|_|_|_|_|_|_|_|9758264
birth defects|Disease|1|[28, 30]|3|H|_|_|_|_|_|_|_|9758264
epilepsy|Disease|1|[31, 32]|501|H|_|_|_|_|_|_|_|9758264
cleft lip and palate|Disease|4|[7, 11]|7|-1|_|_|_|_|_|_|_|9758264
seizures|Disease|5|[7, 8]|501|H|_|_|_|_|_|_|_|9758264
status epilepticus|Disease|7|[2, 4]|10|-1|_|_|_|_|_|_|_|9758264
systemic lupus erythematodes|Disease|7|[8, 11]|500|-1|_|_|_|_|_|_|_|9758264
stillbirth|Disease|8|[4, 5]|12|-1|_|_|_|_|_|_|_|9758264
lupus|Disease|9|[15, 16]|500|-1|_|_|_|_|_|_|_|9758264
folic acid|Chemical|0|[10, 12]|1|-1|_|_|_|_|_|_|_|9758264
folic acid|Chemical|0|[3, 5]|1|-1|_|_|_|_|_|_|_|9758264
carbamazepine|Chemical|6|[12, 13]|9|-1|_|_|_|_|_|_|_|9758264
multivitamin supplementation|Treat|1|[11, 13]|5|-1|_|_|_|_|_|_|_|9758264
periconception care|Treat|2|[9, 11]|6|-1|_|_|_|_|_|_|_|9758264
blood-brain barrier|Physiology|9|[20, 24]|14|-1|_|_|_|_|_|_|_|9758264
irritable bowel syndrome|Disease|0|[15, 18]|500|H|_|_|_|_|_|_|_|9669632
irritable bowel syndrome|Disease|1|[2, 5]|500|H|_|_|_|_|_|_|_|9669632
disordered gastrointestinal motility|Disease|1|[19, 22]|2|H|_|_|_|_|_|_|_|9669632
abdominal pain|Disease|1|[10, 12]|4|H|_|_|_|_|_|_|_|9669632
irritable bowel syndrome (ibs)|Disease|2|[27, 33]|500|H|_|_|_|_|_|_|_|9669632
ibs|Disease|3|[7, 8]|500|H|_|_|_|_|_|_|_|9669632
ibs|Disease|6|[13, 14]|500|H|_|_|_|_|_|_|_|9669632
ibs|Disease|8|[17, 18]|500|H|_|_|_|_|_|_|_|9669632
ibs|Disease|9|[3, 4]|500|H|_|_|_|_|_|_|_|9669632
ibs|Disease|10|[11, 12]|500|H|_|_|_|_|_|_|_|9669632
diarrhoea|Disease|4|[3, 4]|10|-1|_|_|_|_|_|_|_|9669632
constipation-predominant ibs|Disease|6|[10, 14]|12|-1|_|_|_|_|_|_|_|9669632
constipation|Disease|8|[14, 15]|15|-1|_|_|_|_|_|_|_|9669632
constipation|Disease|8|[7, 8]|15|-1|_|_|_|_|_|_|_|9669632
cisapride|Chemical|0|[2, 3]|1|-1|_|_|_|_|_|_|_|9669632
cisapride|Chemical|10|[2, 3]|1|-1|_|_|_|_|_|_|_|9669632
gastrointestinal motility|Physiology|1|[20, 22]|5|-1|_|_|_|_|_|_|_|9669632
jejunal motility|Physiology|2|[21, 23]|8|-1|_|_|_|_|_|_|_|9669632
contraction characteristics|Physiology|4|[10, 12]|11|-1|_|_|_|_|_|_|_|9669632
long-term treatment with a prokinetic agent|Treat|2|[8, 16]|7|-1|_|_|_|_|_|_|_|9669632
treatment|Treat|7|[12, 13]|14|-1|_|_|_|_|_|_|_|9669632
ventricular tachycardia|Disease|0|[3, 5]|500|-1|_|_|_|_|_|_|_|9326871
gastroenteritis|Disease|3|[12, 13]|5|-1|_|_|_|_|_|_|_|9326871
dysrhythmias|Disease|6|[1, 2]|500|-1|_|_|_|_|_|_|_|9326871
clarithromycin|Chemical|0|[0, 1]|1|-1|_|_|_|_|_|_|_|9326871
clarithromycin|Chemical|1|[0, 1]|1|-1|_|_|_|_|_|_|_|9326871
erythromycin|Chemical|2|[3, 4]|3|-1|_|_|_|_|_|_|_|9326871
erythromycin|Chemical|3|[7, 8]|3|-1|_|_|_|_|_|_|_|9326871
erythromycin|Chemical|4|[11, 12]|3|-1|_|_|_|_|_|_|_|9326871
nephrogenic diabetes insipidus|Disease|0|[1, 4]|500|-1|_|_|_|_|_|_|_|9226773
dehydration|Disease|1|[11, 12]|2|-1|_|_|_|_|_|_|_|9226773
head injury|Disease|1|[14, 16]|3|-1|_|_|_|_|_|_|_|9226773
polyuria|Disease|4|[15, 16]|500|-1|_|_|_|_|_|_|_|9226773
lithium|Chemical|0|[5, 6]|1|-1|_|_|_|_|_|_|_|9226773
vasopressin|Chemical|3|[21, 22]|4|-1|_|_|_|_|_|_|_|9226773
osmoregulated thirst|Physiology|3|[18, 20]|5|-1|_|_|_|_|_|_|_|9226773
vasopressin secretion|Physiology|3|[21, 23]|6|-1|_|_|_|_|_|_|_|9226773
cessation of therapy|Treat|4|[11, 14]|8|-1|_|_|_|_|_|_|_|9226773
malignant bone tumor|Disease|0|[6, 9]|500|-1|_|_|_|_|_|_|_|8600333
bone tumors|Disease|1|[11, 13]|500|-1|_|_|_|_|_|_|_|8600333
ventricular arrhythmias|Disease|5|[26, 28]|501|-1|_|_|_|_|_|_|_|8600333
ventricular dilation|Disease|5|[30, 32]|501|-1|_|_|_|_|_|_|_|8600333
complex ventricular arrhythmias|Disease|5|[25, 28]|501|-1|_|_|_|_|_|_|_|8600333
cardiac abnormalities|Disease|6|[3, 5]|501|-1|_|_|_|_|_|_|_|8600333
cardiac status|Disease|7|[11, 13]|501|-1|_|_|_|_|_|_|_|8600333
doxorubicin|Chemical|1|[28, 29]|2|-1|_|_|_|_|_|_|_|8600333
doxorubicin|Chemical|3|[3, 4]|2|-1|_|_|_|_|_|_|_|8600333
doxorubicin|Chemical|7|[9, 10]|2|-1|_|_|_|_|_|_|_|8600333
doxorubicin|Chemical|9|[3, 4]|2|-1|_|_|_|_|_|_|_|8600333
treatment|Treat|2|[38, 39]|3|-1|_|_|_|_|_|_|_|8600333
age|Physiology|2|[12, 13]|4|-1|_|_|_|_|_|_|_|8600333
age|Physiology|2|[5, 6]|4|-1|_|_|_|_|_|_|_|8600333
heart rate variability|Physiology|7|[16, 19]|13|-1|_|_|_|_|_|_|_|8600333
left ventricular posterior wall thickness|Physiology|8|[8, 13]|14|-1|_|_|_|_|_|_|_|8600333
lvpw index|Physiology|11|[11, 13]|16|-1|_|_|_|_|_|_|_|8600333
diazepam|Chemical|0|[5, 6]|0|-1|_|_|_|_|_|_|_|8514073
diazepam|Chemical|1|[14, 15]|0|-1|_|_|_|_|_|_|_|8514073
diazepam|Chemical|2|[12, 13]|0|-1|_|_|_|_|_|_|_|8514073
diazepam|Chemical|3|[8, 9]|0|-1|_|_|_|_|_|_|_|8514073
diazepam|Chemical|4|[17, 18]|0|-1|_|_|_|_|_|_|_|8514073
diazepam|Chemical|5|[17, 18]|0|-1|_|_|_|_|_|_|_|8514073
midazolam|Chemical|0|[3, 4]|2|-1|_|_|_|_|_|_|_|8514073
alcohol|Chemical|7|[19, 20]|11|-1|_|_|_|_|_|_|_|8514073
nonsteroidal anti-inflammatory drug|Chemical|7|[2, 7]|12|-1|_|_|_|_|_|_|_|8514073
venous complications|Disease|0|[0, 2]|1|-1|_|_|_|_|_|_|_|8514073
pain|Disease|5|[0, 1]|8|-1|_|_|_|_|_|_|_|8514073
swelling|Disease|6|[0, 1]|9|H|_|_|_|_|_|_|_|8514073
warmth|Disease|6|[2, 3]|10|-1|_|_|_|_|_|_|_|8514073
furosemide|Chemical|0|[6, 7]|500|-1|_|_|_|_|_|_|_|8492347
furosemide|Chemical|0|[6, 7]|500|-1|_|_|_|_|_|_|_|8492347
diuretic|Chemical|3|[1, 2]|500|-1|_|_|_|_|_|_|_|8492347
tetany|Disease|0|[0, 1]|502|-1|_|_|_|_|_|_|_|8492347
rhabdomyolysis|Disease|0|[2, 3]|2|-1|_|_|_|_|_|_|_|8492347
hypokalemia|Disease|1|[3, 4]|503|-1|_|_|_|_|_|_|_|8492347
hypocalcemia|Disease|1|[5, 6]|5|-1|_|_|_|_|_|_|_|8492347
muscle weakness|Disease|2|[5, 7]|503|H|_|_|_|_|_|_|_|8492347
muscle spasms|Disease|2|[13, 15]|502|-1|_|_|_|_|_|_|_|8492347
obese|Disease|3|[16, 17]|8|-1|_|_|_|_|_|_|_|8492347
edematous|Disease|3|[18, 19]|9|-1|_|_|_|_|_|_|_|8492347
pilocarpine|Chemical|0|[14, 15]|0|-1|_|_|_|_|_|_|_|8410199
pilocarpine|Chemical|2|[8, 9]|0|-1|_|_|_|_|_|_|_|8410199
pilocarpine|Chemical|2|[29, 30]|0|-1|_|_|_|_|_|_|_|8410199
pilocarpine|Chemical|3|[36, 37]|0|-1|_|_|_|_|_|_|_|8410199
digoxigenin|Chemical|3|[7, 8]|6|-1|_|_|_|_|_|_|_|8410199
cresyl violet|Chemical|4|[5, 7]|10|-1|_|_|_|_|_|_|_|8410199
gad|Chemical|5|[3, 4]|14|-1|_|_|_|_|_|_|_|8410199
gad|Chemical|6|[28, 29]|14|-1|_|_|_|_|_|_|_|8410199
seizures|Disease|0|[17, 18]|1|-1|_|_|_|_|_|_|_|8410199
neuronal loss|Disease|4|[38, 40]|11|-1|_|_|_|_|_|_|_|8410199
glutamate decarboxylase|Gene|0|[2, 4]|2|-1|_|_|_|_|_|_|_|8410199
gad|Gene|1|[13, 14]|3|-1|_|_|_|_|_|_|_|8410199
gad|Gene|3|[10, 11]|3|-1|_|_|_|_|_|_|_|8410199
gad|Gene|3|[22, 23]|3|-1|_|_|_|_|_|_|_|8410199
gad|Gene|4|[46, 47]|3|-1|_|_|_|_|_|_|_|8410199
gad|Gene|4|[30, 31]|3|-1|_|_|_|_|_|_|_|8410199
gad|Gene|5|[3, 4]|3|-1|_|_|_|_|_|_|_|8410199
gad|Gene|8|[12, 13]|3|-1|_|_|_|_|_|_|_|8410199
gaba|Gene|9|[12, 13]|18|-1|_|_|_|_|_|_|_|8410199
renal dysfunction|Disease|0|[7, 9]|500|-1|_|_|_|_|_|_|_|7791169
pain|Disease|4|[13, 14]|10|-1|_|_|_|_|_|_|_|7791169
renal impairment|Disease|9|[6, 8]|500|-1|_|_|_|_|_|_|_|7791169
misoprostol|Chemical|0|[3, 4]|1|-1|_|_|_|_|_|_|_|7791169
misoprostol|Chemical|1|[9, 10]|1|-1|_|_|_|_|_|_|_|7791169
indomethacin|Chemical|0|[5, 6]|2|-1|_|_|_|_|_|_|_|7791169
indomethacin|Chemical|1|[19, 20]|2|-1|_|_|_|_|_|_|_|7791169
blood urea nitrogen|Chemical|3|[9, 12]|502|-1|_|_|_|_|_|_|_|7791169
urea nitrogen|Chemical|3|[10, 12]|502|-1|_|_|_|_|_|_|_|7791169
electrolytes|Chemical|3|[16, 17]|9|H|_|_|_|_|_|_|_|7791169
renal function|Physiology|1|[11, 13]|5|-1|_|_|_|_|_|_|_|7791169
bun|Physiology|5|[20, 21]|11|-1|_|_|_|_|_|_|_|7791169
therapy with nonsteroidal antiinflammatory drugs (nsaid)|Treat|2|[16, 24]|6|-1|_|_|_|_|_|_|_|7791169
treatment|Treat|7|[33, 34]|12|-1|_|_|_|_|_|_|_|7791169
nephrotoxic|Disease|0|[0, 1]|0|H|_|_|_|_|_|_|_|6728084
impairment of renal reabsorption|Disease|8|[15, 19]|11|-1|_|_|_|_|_|_|_|6728084
treatment|Treat|0|[4, 5]|1|-1|_|_|_|_|_|_|_|6728084
renal protein reabsorption and accumulation|Physiology|0|[6, 11]|2|-1|_|_|_|_|_|_|_|6728084
endothelial fenestrae|Physiology|3|[9, 11]|8|-1|_|_|_|_|_|_|_|6728084
gfr|Physiology|5|[4, 5]|9|-1|_|_|_|_|_|_|_|6728084
urinary excretion of sodium|Physiology|5|[7, 11]|10|-1|_|_|_|_|_|_|_|6728084
gentamicin|Chemical|1|[5, 6]|3|-1|_|_|_|_|_|_|_|6728084
gentamicin|Chemical|3|[0, 1]|3|-1|_|_|_|_|_|_|_|6728084
kanamycin|Chemical|1|[7, 8]|4|-1|_|_|_|_|_|_|_|6728084
netilmicin|Chemical|1|[9, 10]|5|-1|_|_|_|_|_|_|_|6728084
n-acetyl-beta-d-glucosaminidase (nag)|Chemical|2|[18, 30]|6|-1|_|_|_|_|_|_|_|6728084
gyki-41 099|Chemical|0|[2, 6]|500|-1|_|_|_|_|_|_|_|6111982
gyki-41 099|Chemical|1|[2, 6]|500|-1|_|_|_|_|_|_|_|6111982
chlorpropanol|Chemical|0|[7, 8]|500|-1|_|_|_|_|_|_|_|6111982
tobanum|Chemical|0|[9, 10]|500|-1|_|_|_|_|_|_|_|6111982
propranolol|Chemical|1|[22, 23]|4|-1|_|_|_|_|_|_|_|6111982
ouabain|Chemical|2|[11, 12]|6|-1|_|_|_|_|_|_|_|6111982
gyki-41 900|Chemical|3|[0, 4]|500|-1|_|_|_|_|_|_|_|6111982
14c-41 099|Chemical|5|[12, 16]|500|-1|_|_|_|_|_|_|_|6111982
arrhythmia|Disease|2|[12, 13]|5|-1|_|_|_|_|_|_|_|6111982
chorea|Disease|0|[0, 1]|0|-1|_|_|_|_|_|_|_|3123611
rheumatic fever|Disease|4|[21, 23]|3|-1|_|_|_|_|_|_|_|3123611
oral contraceptives|Chemical|1|[6, 8]|1|-1|_|_|_|_|_|_|_|3123611
amphetamine|Chemical|3|[5, 6]|2|-1|_|_|_|_|_|_|_|3123611
l-dopa|Chemical|0|[7, 10]|500|-1|_|_|_|_|_|_|_|761833
l-dopa|Chemical|0|[7, 10]|500|-1|_|_|_|_|_|_|_|761833
l-dopa|Chemical|2|[9, 12]|500|-1|_|_|_|_|_|_|_|761833
l-dopa|Chemical|2|[9, 12]|500|-1|_|_|_|_|_|_|_|761833
l-dopa|Chemical|3|[3, 6]|500|-1|_|_|_|_|_|_|_|761833
l-dopa|Chemical|3|[3, 6]|500|-1|_|_|_|_|_|_|_|761833
l-dopa|Chemical|5|[7, 10]|500|-1|_|_|_|_|_|_|_|761833
l-dopa|Chemical|5|[7, 10]|500|-1|_|_|_|_|_|_|_|761833
l-dopa|Chemical|6|[16, 19]|500|-1|_|_|_|_|_|_|_|761833
l-dopa|Chemical|6|[16, 19]|500|-1|_|_|_|_|_|_|_|761833
l-dopa|Chemical|7|[16, 19]|500|-1|_|_|_|_|_|_|_|761833
l-dopa|Chemical|7|[16, 19]|500|-1|_|_|_|_|_|_|_|761833
nh4cl|Chemical|1|[19, 20]|501|-1|_|_|_|_|_|_|_|761833
ammonia|Chemical|3|[15, 16]|501|-1|_|_|_|_|_|_|_|761833
ammonia|Chemical|3|[30, 31]|501|-1|_|_|_|_|_|_|_|761833
dopamine|Chemical|3|[21, 22]|500|-1|_|_|_|_|_|_|_|761833
urea|Chemical|3|[32, 33]|11|-1|_|_|_|_|_|_|_|761833
coma|Disease|1|[1, 2]|2|-1|_|_|_|_|_|_|_|761833
brain ammonia|Physiology|5|[13, 15]|14|-1|_|_|_|_|_|_|_|761833
renal function|Physiology|6|[31, 33]|17|-1|_|_|_|_|_|_|_|761833
thrombocytopenia|Disease|0|[3, 4]|0|-1|_|_|_|_|_|_|_|18589141
thrombocytopenia|Disease|2|[3, 4]|0|-1|_|_|_|_|_|_|_|18589141
thrombosis|Disease|1|[27, 28]|2|-1|_|_|_|_|_|_|_|18589141
hit|Disease|3|[17, 18]|500|-1|_|_|_|_|_|_|_|18589141
hit|Disease|3|[3, 4]|500|-1|_|_|_|_|_|_|_|18589141
hit|Disease|7|[0, 1]|500|-1|_|_|_|_|_|_|_|18589141
hit|Disease|10|[17, 18]|500|-1|_|_|_|_|_|_|_|18589141
hit|Disease|14|[10, 11]|500|-1|_|_|_|_|_|_|_|18589141
hit|Disease|15|[9, 10]|500|-1|_|_|_|_|_|_|_|18589141
platelet aggregation|Disease|12|[4, 6]|16|-1|_|_|_|_|_|_|_|18589141
hit antibody-positive|Disease|13|[3, 7]|500|-1|_|_|_|_|_|_|_|18589141
liver transplantation|Treat|0|[5, 7]|1|-1|_|_|_|_|_|_|_|18589141
surgery|Treat|7|[8, 9]|12|-1|_|_|_|_|_|_|_|18589141
heparin sodium|Chemical|1|[3, 5]|502|H|_|_|_|_|_|_|_|18589141
low-molecular weight heparin|Chemical|1|[9, 14]|503|-1|_|_|_|_|_|_|_|18589141
lmwh|Chemical|5|[2, 3]|503|-1|_|_|_|_|_|_|_|18589141
ufh|Chemical|5|[21, 22]|503|-1|_|_|_|_|_|_|_|18589141
ufh|Chemical|6|[3, 4]|503|-1|_|_|_|_|_|_|_|18589141
ufh|Chemical|14|[7, 8]|503|-1|_|_|_|_|_|_|_|18589141
platelet count|Physiology|8|[0, 2]|13|-1|_|_|_|_|_|_|_|18589141
platelet counts|Physiology|9|[4, 6]|14|-1|_|_|_|_|_|_|_|18589141
graves' disease|Disease|0|[11, 14]|500|-1|_|_|_|_|_|_|_|16418614
graves' disease|Disease|0|[11, 14]|500|-1|_|_|_|_|_|_|_|16418614
graves' disease|Disease|3|[8, 11]|500|-1|_|_|_|_|_|_|_|16418614
graves' disease|Disease|3|[8, 11]|500|-1|_|_|_|_|_|_|_|16418614
turner syndrome|Disease|0|[8, 10]|2|-1|_|_|_|_|_|_|_|16418614
turner syndrome|Disease|3|[5, 7]|2|-1|_|_|_|_|_|_|_|16418614
vasculitis|Disease|2|[7, 8]|4|-1|_|_|_|_|_|_|_|16418614
palpable purpuric lesions|Disease|3|[14, 17]|9|-1|_|_|_|_|_|_|_|16418614
hyperthyroidism|Disease|5|[4, 5]|500|-1|_|_|_|_|_|_|_|16418614
ptu|Chemical|0|[0, 1]|502|-1|_|_|_|_|_|_|_|16418614
ptu|Chemical|4|[5, 6]|502|-1|_|_|_|_|_|_|_|16418614
ptu|Chemical|4|[40, 41]|502|-1|_|_|_|_|_|_|_|16418614
antineutrophil cytoplasmic antibodies (ancas)|Chemical|2|[15, 21]|5|-1|_|_|_|_|_|_|_|16418614
propylthiouracil (ptu)|Chemical|4|[3, 7]|502|-1|_|_|_|_|_|_|_|16418614
ana|Immune|4|[23, 24]|13|-1|_|_|_|_|_|_|_|16418614
anca|Immune|4|[25, 26]|14|-1|_|_|_|_|_|_|_|16418614
radioablation|Treat|5|[6, 7]|16|-1|_|_|_|_|_|_|_|16418614
muscle rigidity|Disease|0|[4, 6]|500|-1|_|_|_|_|_|_|_|15893386
muscle rigidity|Disease|1|[1, 3]|500|-1|_|_|_|_|_|_|_|15893386
muscle rigidity|Disease|2|[20, 22]|500|-1|_|_|_|_|_|_|_|15893386
muscle rigidity|Disease|3|[9, 11]|500|-1|_|_|_|_|_|_|_|15893386
masseter muscle rigidity|Disease|0|[3, 6]|500|-1|_|_|_|_|_|_|_|15893386
hyperthermia|Disease|1|[18, 19]|4|H|_|_|_|_|_|_|_|15893386
hyperthermia|Disease|4|[17, 18]|4|H|_|_|_|_|_|_|_|15893386
malignant hyperthermia|Disease|1|[17, 19]|5|-1|_|_|_|_|_|_|_|15893386
succinylcholine|Chemical|0|[0, 1]|2|-1|_|_|_|_|_|_|_|15893386
propofol|Chemical|4|[5, 6]|11|-1|_|_|_|_|_|_|_|15893386
muscle rigidity|Physiology|1|[1, 3]|6|-1|_|_|_|_|_|_|_|15893386
general anesthetic management|Treat|3|[23, 26]|9|-1|_|_|_|_|_|_|_|15893386
minor neurological dysfunction|Disease|0|[0, 3]|500|-1|_|_|_|_|_|_|_|15814210
asphyxia|Disease|5|[3, 4]|5|-1|_|_|_|_|_|_|_|15814210
malformations|Disease|5|[5, 6]|6|-1|_|_|_|_|_|_|_|15814210
intraventricular haemorrhage grades iii and iv|Disease|5|[16, 22]|7|-1|_|_|_|_|_|_|_|15814210
periventricular leukomalacia|Disease|5|[23, 25]|8|-1|_|_|_|_|_|_|_|15814210
psychomotor retardation|Disease|5|[28, 30]|9|-1|_|_|_|_|_|_|_|15814210
minor neurological dysfunctions|Disease|6|[8, 11]|500|-1|_|_|_|_|_|_|_|15814210
neurological dysfunctions|Disease|11|[11, 13]|500|-1|_|_|_|_|_|_|_|15814210
dexamethasone|Chemical|0|[19, 20]|1|-1|_|_|_|_|_|_|_|15814210
dexamethasone|Chemical|4|[0, 1]|1|-1|_|_|_|_|_|_|_|15814210
dexamethasone treatment|Treat|0|[19, 21]|2|-1|_|_|_|_|_|_|_|15814210
dexamethasone therapy|Treat|1|[19, 21]|3|-1|_|_|_|_|_|_|_|15814210
fine motor skills|Physiology|8|[0, 3]|11|-1|_|_|_|_|_|_|_|15814210
gross motor function|Physiology|8|[4, 7]|12|-1|_|_|_|_|_|_|_|15814210
levodopa|Chemical|0|[3, 4]|0|-1|_|_|_|_|_|_|_|11912119
levodopa|Chemical|1|[24, 25]|0|-1|_|_|_|_|_|_|_|11912119
levodopa|Chemical|1|[19, 20]|0|-1|_|_|_|_|_|_|_|11912119
levodopa|Chemical|2|[25, 26]|0|-1|_|_|_|_|_|_|_|11912119
levodopa|Chemical|3|[29, 30]|0|-1|_|_|_|_|_|_|_|11912119
levodopa|Chemical|5|[22, 23]|0|-1|_|_|_|_|_|_|_|11912119
levodopa therapy|Treat|1|[19, 21]|3|-1|_|_|_|_|_|_|_|11912119
dyskinesias|Disease|2|[28, 29]|501|-1|_|_|_|_|_|_|_|11912119
lid|Disease|4|[17, 18]|501|-1|_|_|_|_|_|_|_|11912119
lid|Disease|7|[14, 15]|501|-1|_|_|_|_|_|_|_|11912119
lid|Disease|8|[23, 24]|501|-1|_|_|_|_|_|_|_|11912119
lid|Disease|8|[31, 32]|501|-1|_|_|_|_|_|_|_|11912119
lid|Disease|11|[8, 9]|501|-1|_|_|_|_|_|_|_|11912119
lid|Disease|13|[4, 5]|501|-1|_|_|_|_|_|_|_|11912119
force|Physiology|5|[9, 10]|9|-1|_|_|_|_|_|_|_|11912119
grip force|Physiology|6|[4, 6]|10|-1|_|_|_|_|_|_|_|11912119
grip force|Physiology|6|[18, 20]|10|-1|_|_|_|_|_|_|_|11912119
motor fluctuations|Physiology|13|[15, 17]|17|-1|_|_|_|_|_|_|_|11912119
steroid|Chemical|0|[9, 10]|0|-1|_|_|_|_|_|_|_|9105126
steroid|Chemical|1|[13, 14]|0|-1|_|_|_|_|_|_|_|9105126
steroid|Chemical|2|[4, 5]|0|-1|_|_|_|_|_|_|_|9105126
septal rupture|Disease|1|[5, 7]|501|-1|_|_|_|_|_|_|_|9105126
septal rupture|Disease|2|[9, 11]|501|-1|_|_|_|_|_|_|_|9105126
postinfarction ventricular septal rupture|Disease|1|[3, 7]|501|-1|_|_|_|_|_|_|_|9105126
angioedema|Disease|0|[0, 1]|500|-1|_|_|_|_|_|_|_|8599504
angioedema|Disease|1|[0, 1]|500|-1|_|_|_|_|_|_|_|8599504
upper-airway obstruction|Disease|1|[28, 32]|2|-1|_|_|_|_|_|_|_|8599504
edema|Disease|1|[6, 7]|500|H|_|_|_|_|_|_|_|8599504
edema|Disease|1|[20, 21]|500|H|_|_|_|_|_|_|_|8599504
quincke's disease|Disease|1|[8, 12]|500|-1|_|_|_|_|_|_|_|8599504
swelling|Disease|2|[25, 26]|500|-1|_|_|_|_|_|_|_|8599504
drug allergies|Disease|2|[17, 19]|8|-1|_|_|_|_|_|_|_|8599504
droperidol|Chemical|0|[3, 4]|1|-1|_|_|_|_|_|_|_|8599504
hallucinations|Disease|0|[4, 5]|500|-1|_|_|_|_|_|_|_|8546130
hallucinations|Disease|1|[1, 2]|500|-1|_|_|_|_|_|_|_|8546130
hallucinations|Disease|2|[6, 7]|500|-1|_|_|_|_|_|_|_|8546130
chronic renal failure|Disease|0|[9, 12]|1|H|_|_|_|_|_|_|_|8546130
uremia|Disease|1|[14, 15]|5|H|_|_|_|_|_|_|_|8546130
visual hallucinations|Disease|2|[5, 7]|500|-1|_|_|_|_|_|_|_|8546130
end-stage renal disease (esrd)|Disease|3|[9, 17]|8|H|_|_|_|_|_|_|_|8546130
continuous ambulatory peritoneal dialysis (capd)|Disease|3|[19, 26]|9|-1|_|_|_|_|_|_|_|8546130
clarithromycin|Chemical|0|[0, 1]|2|-1|_|_|_|_|_|_|_|8546130
continuous ambulatory peritoneal dialysis|Treat|0|[13, 17]|3|-1|_|_|_|_|_|_|_|8546130
renal toxicity|Disease|0|[1, 3]|0|H|_|_|_|_|_|_|_|7724492
renal toxicity|Disease|1|[8, 10]|0|H|_|_|_|_|_|_|_|7724492
renal toxicity|Disease|9|[22, 24]|0|H|_|_|_|_|_|_|_|7724492
glomerulonephritis|Disease|1|[20, 21]|3|-1|_|_|_|_|_|_|_|7724492
glomerulonephritis|Disease|6|[5, 6]|3|-1|_|_|_|_|_|_|_|7724492
proteinuria|Disease|3|[4, 5]|7|-1|_|_|_|_|_|_|_|7724492
proteinuria|Disease|4|[6, 7]|7|-1|_|_|_|_|_|_|_|7724492
proteinuria|Disease|7|[0, 1]|7|-1|_|_|_|_|_|_|_|7724492
nephrosis|Disease|10|[6, 7]|20|H|_|_|_|_|_|_|_|7724492
doxorubicin|Chemical|0|[4, 5]|501|-1|_|_|_|_|_|_|_|7724492
doxorubicin|Chemical|1|[1, 2]|501|-1|_|_|_|_|_|_|_|7724492
doxorubicin|Chemical|2|[10, 11]|501|-1|_|_|_|_|_|_|_|7724492
doxorubicin|Chemical|7|[24, 25]|501|-1|_|_|_|_|_|_|_|7724492
doxorubicin (dx)|Chemical|2|[10, 14]|501|-1|_|_|_|_|_|_|_|7724492
dx|Chemical|3|[16, 17]|501|-1|_|_|_|_|_|_|_|7724492
dx|Chemical|5|[18, 19]|501|-1|_|_|_|_|_|_|_|7724492
dx|Chemical|6|[12, 13]|501|-1|_|_|_|_|_|_|_|7724492
dx|Chemical|9|[16, 17]|501|-1|_|_|_|_|_|_|_|7724492
dxnp|Treat|7|[39, 40]|15|-1|_|_|_|_|_|_|_|7724492
dx|Treat|7|[41, 42]|16|-1|_|_|_|_|_|_|_|7724492
np|Treat|8|[4, 5]|17|-1|_|_|_|_|_|_|_|7724492
myocardial infarction|Disease|0|[3, 5]|0|-1|_|_|_|_|_|_|_|7619765
etoposide|Chemical|0|[0, 1]|1|-1|_|_|_|_|_|_|_|7619765
chemotherapy|Treat|1|[9, 10]|2|-1|_|_|_|_|_|_|_|7619765
sexual dysfunction|Disease|0|[3, 5]|0|-1|_|_|_|_|_|_|_|7416947
rheumatic heart disease|Disease|3|[32, 35]|8|-1|_|_|_|_|_|_|_|7416947
digoxin|Chemical|0|[13, 14]|1|-1|_|_|_|_|_|_|_|7416947
estradiol|Chemical|6|[10, 11]|10|-1|_|_|_|_|_|_|_|7416947
testosterone|Chemical|6|[12, 13]|11|-1|_|_|_|_|_|_|_|7416947
estrogen|Physiology|1|[19, 20]|2|-1|_|_|_|_|_|_|_|7416947
plasma testosterone|Physiology|1|[24, 26]|3|-1|_|_|_|_|_|_|_|7416947
luteinizing hormone (lh)|Physiology|1|[27, 32]|4|-1|_|_|_|_|_|_|_|7416947
estradiol|Physiology|2|[30, 31]|5|-1|_|_|_|_|_|_|_|7416947
testosterone|Physiology|2|[32, 33]|6|-1|_|_|_|_|_|_|_|7416947
lh|Physiology|2|[35, 36]|7|-1|_|_|_|_|_|_|_|7416947
cardiac functional capacity|Physiology|3|[15, 18]|9|-1|_|_|_|_|_|_|_|7416947
aplastic anemia|Disease|0|[1, 3]|0|-1|_|_|_|_|_|_|_|7263204
indomethacin|Chemical|0|[5, 6]|1|-1|_|_|_|_|_|_|_|7263204
indomethacin|Chemical|3|[0, 1]|1|-1|_|_|_|_|_|_|_|7263204
allopurinol|Chemical|2|[14, 15]|3|-1|_|_|_|_|_|_|_|7263204
lymphocyte transformation tests|Treat|0|[8, 11]|2|-1|_|_|_|_|_|_|_|7263204
lymphocyte transformation test|Treat|4|[2, 5]|5|-1|_|_|_|_|_|_|_|7263204
nephrotic syndrome|Disease|0|[10, 12]|0|H|_|_|_|_|_|_|_|7066357
nephrotic|Disease|3|[32, 33]|2|-1|_|_|_|_|_|_|_|7066357
nephrotic|Disease|3|[23, 24]|2|-1|_|_|_|_|_|_|_|7066357
puromycin aminonucleoside|Chemical|0|[17, 19]|1|-1|_|_|_|_|_|_|_|7066357
fatty acids|Chemical|4|[9, 11]|4|-1|_|_|_|_|_|_|_|7066357
triacylglycerol|Chemical|4|[12, 13]|5|H|_|_|_|_|_|_|_|7066357
cholesteryl esters|Chemical|4|[21, 23]|6|-1|_|_|_|_|_|_|_|7066357
ldl|Chemical|8|[3, 4]|7|-1|_|_|_|_|_|_|_|7066357
plasma hdl|Physiology|12|[10, 12]|8|-1|_|_|_|_|_|_|_|7066357
hepatic necrosis|Disease|0|[5, 7]|500|H|_|_|_|_|_|_|_|7007443
fulminant hepatic failure|Disease|1|[26, 29]|500|H|_|_|_|_|_|_|_|7007443
overdose|Disease|2|[27, 28]|2|-1|_|_|_|_|_|_|_|7007443
viral hepatitis|Disease|2|[42, 44]|4|-1|_|_|_|_|_|_|_|7007443
paracetamol|Chemical|2|[26, 27]|3|-1|_|_|_|_|_|_|_|7007443
wernicke's encephalopathy|Disease|0|[6, 10]|500|-1|_|_|_|_|_|_|_|3762968
wernicke's encephalopathy|Disease|1|[18, 22]|500|-1|_|_|_|_|_|_|_|3762968
wernicke's encephalopathy|Disease|2|[19, 23]|500|-1|_|_|_|_|_|_|_|3762968
wernicke's encephalopathy|Disease|3|[18, 22]|500|-1|_|_|_|_|_|_|_|3762968
wernicke's encephalopathy|Disease|4|[18, 22]|500|-1|_|_|_|_|_|_|_|3762968
wernicke-korsakoff syndrome|Disease|1|[54, 58]|500|-1|_|_|_|_|_|_|_|3762968
wernicke-korsakoff syndrome|Disease|4|[7, 11]|500|-1|_|_|_|_|_|_|_|3762968
diabetic|Disease|2|[13, 14]|8|-1|_|_|_|_|_|_|_|3762968
tolazamide|Chemical|0|[3, 4]|1|-1|_|_|_|_|_|_|_|3762968
thiamine|Chemical|1|[42, 43]|502|-1|_|_|_|_|_|_|_|3762968
thiamine|Chemical|1|[3, 4]|502|-1|_|_|_|_|_|_|_|3762968
thiamine pyrophosphate (tpp)|Chemical|1|[42, 47]|502|-1|_|_|_|_|_|_|_|3762968
tpp|Chemical|3|[31, 32]|502|-1|_|_|_|_|_|_|_|3762968
myocardial ischemia|Disease|0|[2, 4]|500|H|_|_|_|_|_|_|_|3413271
myocardial ischemia|Disease|1|[6, 8]|500|H|_|_|_|_|_|_|_|3413271
myocardial ischemia|Disease|3|[5, 7]|500|H|_|_|_|_|_|_|_|3413271
myocardial ischemia|Disease|4|[5, 7]|500|H|_|_|_|_|_|_|_|3413271
myocardial ischemia|Disease|5|[3, 5]|500|H|_|_|_|_|_|_|_|3413271
angina|Disease|3|[14, 15]|7|-1|_|_|_|_|_|_|_|3413271
ischemia|Disease|6|[4, 5]|500|H|_|_|_|_|_|_|_|3413271
epinephrine|Chemical|0|[6, 7]|1|-1|_|_|_|_|_|_|_|3413271
ischemia|Physiology|0|[13, 14]|2|-1|_|_|_|_|_|_|_|3413271
ischemia|Physiology|0|[3, 4]|2|-1|_|_|_|_|_|_|_|3413271
myocardial oxygen consumption|Physiology|2|[7, 10]|5|-1|_|_|_|_|_|_|_|3413271
heart rate|Physiology|5|[46, 48]|10|-1|_|_|_|_|_|_|_|3413271
heart rate|Physiology|5|[10, 12]|10|-1|_|_|_|_|_|_|_|3413271
rate-pressure product|Physiology|5|[49, 53]|12|-1|_|_|_|_|_|_|_|3413271
rate-pressure product|Physiology|5|[13, 17]|12|-1|_|_|_|_|_|_|_|3413271
end-diastolic volume|Physiology|5|[22, 26]|14|-1|_|_|_|_|_|_|_|3413271
contractility|Physiology|5|[39, 40]|15|-1|_|_|_|_|_|_|_|3413271
emotional distress|Physiology|6|[15, 17]|17|-1|_|_|_|_|_|_|_|3413271
contralateral rotation|Disease|0|[1, 3]|0|-1|_|_|_|_|_|_|_|3088349
contralateral rotation|Disease|1|[13, 15]|0|-1|_|_|_|_|_|_|_|3088349
contralateral rotation|Disease|2|[9, 11]|0|-1|_|_|_|_|_|_|_|3088349
contralateral rotation|Disease|4|[1, 3]|0|-1|_|_|_|_|_|_|_|3088349
contralateral rotation|Disease|5|[29, 31]|0|-1|_|_|_|_|_|_|_|3088349
contralateral rotation|Disease|7|[18, 20]|0|-1|_|_|_|_|_|_|_|3088349
sn lesion|Disease|1|[6, 8]|500|H|_|_|_|_|_|_|_|3088349
sn lesion|Disease|1|[6, 8]|500|H|_|_|_|_|_|_|_|3088349
lesioning|Disease|5|[20, 21]|500|H|_|_|_|_|_|_|_|3088349
amphetamine|Chemical|0|[17, 18]|1|-1|_|_|_|_|_|_|_|3088349
lithium|Chemical|0|[8, 9]|0|-1|_|_|_|_|_|_|_|3001299
lithium|Chemical|3|[9, 10]|0|-1|_|_|_|_|_|_|_|3001299
urine-concentrating ability|Physiology|0|[3, 7]|1|-1|_|_|_|_|_|_|_|3001299
nephrogenic diabetes insipidus|Disease|1|[16, 19]|2|-1|_|_|_|_|_|_|_|3001299
hypothyroidism|Disease|1|[20, 21]|501|-1|_|_|_|_|_|_|_|3001299
hypothyroidism|Disease|3|[0, 1]|501|-1|_|_|_|_|_|_|_|3001299
hypothyroid|Disease|4|[8, 9]|501|-1|_|_|_|_|_|_|_|3001299
hypothyroid|Disease|4|[12, 13]|501|-1|_|_|_|_|_|_|_|3001299
immunodeficient|Disease|0|[10, 11]|0|H|_|_|_|_|_|_|_|2004015
anaemia|Disease|1|[1, 2]|3|H|_|_|_|_|_|_|_|2004015
leukaemia|Disease|2|[21, 22]|5|-1|_|_|_|_|_|_|_|2004015
aids|Disease|2|[7, 8]|6|H|_|_|_|_|_|_|_|2004015
azt|Disease|6|[18, 19]|11|-1|_|_|_|_|_|_|_|2004015
reticulocytosis|Disease|10|[2, 3]|18|-1|_|_|_|_|_|_|_|2004015
azidothymidine|Chemical|0|[8, 9]|501|-1|_|_|_|_|_|_|_|2004015
3'-azido-3'dideoxythymidine (azt)|Chemical|1|[4, 15]|501|-1|_|_|_|_|_|_|_|2004015
azt|Chemical|2|[30, 31]|501|-1|_|_|_|_|_|_|_|2004015
azt|Chemical|3|[13, 14]|501|-1|_|_|_|_|_|_|_|2004015
azt|Chemical|4|[0, 1]|501|-1|_|_|_|_|_|_|_|2004015
azt|Chemical|5|[15, 16]|501|-1|_|_|_|_|_|_|_|2004015
azt|Chemical|8|[8, 9]|501|-1|_|_|_|_|_|_|_|2004015
azt|Chemical|9|[17, 18]|501|-1|_|_|_|_|_|_|_|2004015
azt|Chemical|10|[12, 13]|501|-1|_|_|_|_|_|_|_|2004015
azt|Chemical|11|[0, 1]|501|-1|_|_|_|_|_|_|_|2004015
phenylhydrazine (phz)|Chemical|8|[22, 26]|502|-1|_|_|_|_|_|_|_|2004015
phz|Chemical|9|[19, 20]|502|-1|_|_|_|_|_|_|_|2004015
immunodeficient|Immune|0|[10, 11]|2|-1|_|_|_|_|_|_|_|2004015
bone marrow|Treat|7|[9, 11]|12|-1|_|_|_|_|_|_|_|2004015
sensitivity|Physiology|7|[4, 5]|13|-1|_|_|_|_|_|_|_|2004015
plasma epo|Physiology|11|[19, 21]|21|-1|_|_|_|_|_|_|_|2004015
cardiomyopathy|Disease|0|[11, 12]|0|H|_|_|_|_|_|_|_|1732442
vacuolar degeneration|Disease|3|[3, 5]|5|-1|_|_|_|_|_|_|_|1732442
vacuolar degeneration|Disease|10|[19, 21]|5|-1|_|_|_|_|_|_|_|1732442
myocardial impairment|Disease|10|[13, 15]|12|H|_|_|_|_|_|_|_|1732442
adriamycin|Chemical|0|[8, 9]|1|-1|_|_|_|_|_|_|_|1732442
iodine-125-metaiodobenzylguanidine|Chemical|0|[13, 18]|501|-1|_|_|_|_|_|_|_|1732442
metaiodobenzylguanidine (mibg)|Chemical|1|[1, 5]|501|-1|_|_|_|_|_|_|_|1732442
norepinephrine (ne)|Chemical|1|[9, 13]|501|-1|_|_|_|_|_|_|_|1732442
mibg|Chemical|5|[6, 7]|501|-1|_|_|_|_|_|_|_|1732442
mibg|Chemical|7|[7, 8]|501|-1|_|_|_|_|_|_|_|1732442
mibg|Chemical|8|[7, 8]|501|-1|_|_|_|_|_|_|_|1732442
mibg|Chemical|9|[2, 3]|501|-1|_|_|_|_|_|_|_|1732442
adriamycin treatment|Treat|3|[16, 18]|6|-1|_|_|_|_|_|_|_|1732442
amnestic syndrome|Disease|0|[0, 2]|500|-1|_|_|_|_|_|_|_|1423339
dementia|Disease|1|[9, 10]|2|H|_|_|_|_|_|_|_|1423339
impairment of memory|Disease|2|[7, 10]|500|-1|_|_|_|_|_|_|_|1423339
propranolol|Chemical|0|[4, 5]|1|-1|_|_|_|_|_|_|_|1423339
cerebral reactions|Physiology|3|[4, 6]|4|-1|_|_|_|_|_|_|_|1423339
ketamine|Chemical|0|[16, 17]|0|-1|_|_|_|_|_|_|_|921394
ketamine|Chemical|1|[2, 3]|0|-1|_|_|_|_|_|_|_|921394
ketamine|Chemical|2|[2, 3]|0|-1|_|_|_|_|_|_|_|921394
ketamine|Chemical|4|[18, 19]|0|-1|_|_|_|_|_|_|_|921394
ketamine|Chemical|5|[23, 24]|0|-1|_|_|_|_|_|_|_|921394
ganglion blocker|Chemical|4|[9, 11]|10|-1|_|_|_|_|_|_|_|921394
sa node|Physiology|0|[4, 6]|1|-1|_|_|_|_|_|_|_|921394
sa node|Physiology|1|[22, 24]|1|-1|_|_|_|_|_|_|_|921394
sa node|Physiology|1|[5, 7]|1|-1|_|_|_|_|_|_|_|921394
sa nodal activity|Physiology|2|[19, 22]|6|-1|_|_|_|_|_|_|_|921394
tachycardia|Physiology|4|[21, 22]|9|-1|_|_|_|_|_|_|_|921394
peripheral adrenergic mechanism|Physiology|5|[8, 11]|12|-1|_|_|_|_|_|_|_|921394
depression|Disease|3|[1, 2]|7|-1|_|_|_|_|_|_|_|921394
succinylcholine|Chemical|0|[6, 7]|0|-1|_|_|_|_|_|_|_|871943
apnoea|Disease|1|[5, 6]|1|-1|_|_|_|_|_|_|_|871943
respiration|Physiology|2|[2, 3]|2|-1|_|_|_|_|_|_|_|871943
hypotension|Disease|0|[1, 2]|500|-1|_|_|_|_|_|_|_|1355091
hypotension|Disease|4|[1, 2]|500|-1|_|_|_|_|_|_|_|1355091
hypotension|Disease|6|[9, 10]|500|-1|_|_|_|_|_|_|_|1355091
hypotension|Disease|9|[11, 12]|500|-1|_|_|_|_|_|_|_|1355091
hypertensive|Disease|0|[16, 17]|1|H|_|_|_|_|_|_|_|1355091
hypertensive|Disease|2|[26, 27]|1|H|_|_|_|_|_|_|_|1355091
orthostatic hypotension|Disease|0|[0, 2]|500|-1|_|_|_|_|_|_|_|1355091
orthostatic hypotension|Disease|4|[0, 2]|500|-1|_|_|_|_|_|_|_|1355091
shr|Disease|5|[5, 6]|9|-1|_|_|_|_|_|_|_|1355091
shr|Disease|8|[15, 16]|9|-1|_|_|_|_|_|_|_|1355091
shr|Disease|8|[3, 4]|9|-1|_|_|_|_|_|_|_|1355091
shr|Disease|12|[73, 74]|9|-1|_|_|_|_|_|_|_|1355091
bradycardia|Disease|12|[4, 5]|18|-1|_|_|_|_|_|_|_|1355091
bradycardia|Disease|13|[4, 5]|18|-1|_|_|_|_|_|_|_|1355091
bradycardia|Disease|14|[23, 24]|18|-1|_|_|_|_|_|_|_|1355091
bradycardia|Disease|15|[3, 4]|18|-1|_|_|_|_|_|_|_|1355091
prazosin|Chemical|0|[11, 12]|3|-1|_|_|_|_|_|_|_|1355091
cirazoline|Chemical|12|[11, 12]|20|-1|_|_|_|_|_|_|_|1355091
abbott-53693|Chemical|12|[33, 36]|21|-1|_|_|_|_|_|_|_|1355091
abbott-53693|Chemical|14|[9, 12]|21|-1|_|_|_|_|_|_|_|1355091
noradrenaline|Chemical|12|[51, 52]|22|-1|_|_|_|_|_|_|_|1355091
arterial blood pressure|Physiology|2|[20, 23]|5|-1|_|_|_|_|_|_|_|1355091
map|Physiology|5|[2, 3]|10|-1|_|_|_|_|_|_|_|1355091
map|Physiology|5|[34, 35]|10|-1|_|_|_|_|_|_|_|1355091
map|Physiology|5|[22, 23]|10|-1|_|_|_|_|_|_|_|1355091
map|Physiology|8|[0, 1]|10|-1|_|_|_|_|_|_|_|1355091
pressor responses|Physiology|12|[1, 3]|23|-1|_|_|_|_|_|_|_|1355091
bradycardia|Physiology|12|[4, 5]|24|-1|_|_|_|_|_|_|_|1355091
chronic prazosin treatment|Treat|2|[6, 9]|6|-1|_|_|_|_|_|_|_|1355091
headache|Disease|1|[10, 11]|0|H|_|_|_|_|_|_|_|8638876
vomiting|Disease|1|[14, 15]|1|-1|_|_|_|_|_|_|_|8638876
nausea|Disease|1|[12, 13]|2|-1|_|_|_|_|_|_|_|8638876
hemiparesis|Disease|1|[17, 18]|3|H|_|_|_|_|_|_|_|8638876
nausea and vomiting|Disease|1|[12, 15]|4|-1|_|_|_|_|_|_|_|8638876
left hemiparesis|Disease|1|[16, 18]|5|-1|_|_|_|_|_|_|_|8638876
seizure|Disease|1|[19, 20]|6|-1|_|_|_|_|_|_|_|8638876
dm|Disease|2|[3, 4]|500|-1|_|_|_|_|_|_|_|8638876
dm|Disease|7|[17, 18]|500|-1|_|_|_|_|_|_|_|8638876
diabetes mellitus|Disease|2|[0, 2]|500|-1|_|_|_|_|_|_|_|8638876
hemorrhagic infarct|Disease|3|[4, 6]|11|-1|_|_|_|_|_|_|_|8638876
venous sinus thrombosis|Disease|5|[15, 18]|501|H|_|_|_|_|_|_|_|8638876
cerebral artery and the venous sinus occlusion|Disease|6|[3, 10]|13|H|_|_|_|_|_|_|_|8638876
venous sinus occlusion|Disease|6|[7, 10]|501|-1|_|_|_|_|_|_|_|8638876
thrombosis of both the ica and the venous sinus|Disease|7|[28, 37]|15|-1|_|_|_|_|_|_|_|8638876
progesterone|Chemical|1|[26, 27]|7|-1|_|_|_|_|_|_|_|8638876
estradiol|Chemical|1|[28, 29]|8|-1|_|_|_|_|_|_|_|8638876
chloroquine|Chemical|0|[0, 1]|0|-1|_|_|_|_|_|_|_|1628552
chloroquine|Chemical|0|[0, 1]|0|-1|_|_|_|_|_|_|_|1628552
chloroquine|Chemical|1|[11, 12]|0|-1|_|_|_|_|_|_|_|1628552
chloroquine|Chemical|2|[5, 6]|0|-1|_|_|_|_|_|_|_|1628552
chloroquine|Chemical|3|[15, 16]|0|-1|_|_|_|_|_|_|_|1628552
heart block|Disease|0|[3, 5]|1|H|_|_|_|_|_|_|_|1628552
blindness|Disease|0|[6, 7]|3|-1|_|_|_|_|_|_|_|1628552
fatiguability|Disease|1|[21, 22]|5|H|_|_|_|_|_|_|_|1628552
dyspnoea|Disease|1|[23, 24]|6|-1|_|_|_|_|_|_|_|1628552
dizziness|Disease|1|[25, 26]|7|H|_|_|_|_|_|_|_|1628552
syncopal attacks|Disease|1|[28, 30]|8|-1|_|_|_|_|_|_|_|1628552
retinopathy|Disease|2|[6, 7]|10|-1|_|_|_|_|_|_|_|1628552
heart failure|Disease|2|[13, 15]|11|H|_|_|_|_|_|_|_|1628552
right bundle branch block|Disease|2|[21, 25]|12|-1|_|_|_|_|_|_|_|1628552
pacemaker insertion|Treat|3|[6, 8]|14|-1|_|_|_|_|_|_|_|1628552
bupivacaine|Chemical|0|[5, 6]|0|-1|_|_|_|_|_|_|_|11524350
bupivacaine|Chemical|3|[0, 1]|0|-1|_|_|_|_|_|_|_|11524350
levobupivacaine|Chemical|0|[8, 9]|1|-1|_|_|_|_|_|_|_|11524350
levobupivacaine|Chemical|3|[2, 3]|1|-1|_|_|_|_|_|_|_|11524350
ropivacaine|Chemical|0|[12, 13]|2|-1|_|_|_|_|_|_|_|11524350
ropivacaine|Chemical|3|[5, 6]|2|-1|_|_|_|_|_|_|_|11524350
ropivacaine|Chemical|11|[11, 12]|2|-1|_|_|_|_|_|_|_|11524350
epinephrine|Chemical|6|[0, 1]|7|-1|_|_|_|_|_|_|_|11524350
arterial pressure|Physiology|4|[11, 13]|6|-1|_|_|_|_|_|_|_|11524350
cardiac compressions|Physiology|6|[16, 18]|8|-1|_|_|_|_|_|_|_|11524350
systolic arterial pressure|Physiology|7|[6, 9]|9|-1|_|_|_|_|_|_|_|11524350
seizures|Disease|8|[9, 10]|10|-1|_|_|_|_|_|_|_|11524350
dysrhythmias|Disease|9|[7, 8]|11|H|_|_|_|_|_|_|_|11524350
asystole|Disease|9|[9, 10]|12|-1|_|_|_|_|_|_|_|11524350
cardiac arrest|Disease|12|[27, 29]|14|H|_|_|_|_|_|_|_|11524350
treatment|Treat|12|[35, 36]|15|-1|_|_|_|_|_|_|_|11524350
22-oxacalcitriol|Chemical|0|[0, 3]|500|-1|_|_|_|_|_|_|_|10027919
calcitriol|Chemical|1|[2, 3]|3|H|_|_|_|_|_|_|_|10027919
parathyroid hormone (pth)|Chemical|1|[8, 13]|4|-1|_|_|_|_|_|_|_|10027919
oct|Chemical|2|[10, 11]|500|-1|_|_|_|_|_|_|_|10027919
oct|Chemical|10|[7, 8]|500|-1|_|_|_|_|_|_|_|10027919
oct|Chemical|13|[7, 8]|500|-1|_|_|_|_|_|_|_|10027919
oct|Chemical|14|[4, 5]|500|-1|_|_|_|_|_|_|_|10027919
secondary hyperparathyroidism|Disease|0|[4, 6]|1|H|_|_|_|_|_|_|_|10027919
adynamic bone disease|Disease|1|[38, 41]|2|H|_|_|_|_|_|_|_|10027919
impaired renal function|Disease|3|[22, 25]|6|H|_|_|_|_|_|_|_|10027919
hyperparathyroidism|Disease|10|[5, 6]|12|H|_|_|_|_|_|_|_|10027919
hypercalcemia|Disease|12|[7, 8]|14|-1|_|_|_|_|_|_|_|10027919
hyperphosphatemia|Disease|12|[9, 10]|15|-1|_|_|_|_|_|_|_|10027919
normal renal function|Disease|13|[3, 6]|16|H|_|_|_|_|_|_|_|10027919
woven osteoid|Disease|14|[12, 14]|18|-1|_|_|_|_|_|_|_|10027919
fibrosis|Disease|14|[15, 16]|19|H|_|_|_|_|_|_|_|10027919
bone turnover|Physiology|3|[15, 17]|7|-1|_|_|_|_|_|_|_|10027919
bone metabolism|Physiology|8|[7, 9]|11|-1|_|_|_|_|_|_|_|10027919
mineralization lag time|Physiology|15|[5, 8]|21|-1|_|_|_|_|_|_|_|10027919
phosphate supplementation|Treat|6|[6, 8]|8|-1|_|_|_|_|_|_|_|10027919
treatment modalities|Treat|7|[3, 5]|9|-1|_|_|_|_|_|_|_|10027919
oct|Treat|8|[26, 27]|10|-1|_|_|_|_|_|_|_|10027919
non-small cell lung cancer|Disease|0|[4, 10]|500|-1|_|_|_|_|_|_|_|8643966
ovarian and breast carcinoma|Disease|1|[25, 29]|3|H|_|_|_|_|_|_|_|8643966
breast carcinoma|Disease|1|[27, 29]|4|-1|_|_|_|_|_|_|_|8643966
non-small cell lung cancer (nsclc)|Disease|2|[20, 29]|500|-1|_|_|_|_|_|_|_|8643966
leukopenia|Disease|3|[0, 1]|7|H|_|_|_|_|_|_|_|8643966
leukopenia|Disease|3|[16, 17]|7|H|_|_|_|_|_|_|_|8643966
nsclc|Disease|4|[26, 27]|500|-1|_|_|_|_|_|_|_|8643966
nsclc|Disease|6|[10, 11]|500|-1|_|_|_|_|_|_|_|8643966
nsclc|Disease|14|[12, 13]|500|-1|_|_|_|_|_|_|_|8643966
neutropenia|Disease|9|[16, 17]|15|-1|_|_|_|_|_|_|_|8643966
polyneuropathy|Disease|10|[4, 5]|16|-1|_|_|_|_|_|_|_|8643966
polyneuropathy|Disease|10|[17, 18]|16|-1|_|_|_|_|_|_|_|8643966
arthralgia|Disease|11|[8, 9]|18|-1|_|_|_|_|_|_|_|8643966
myalgia|Disease|11|[6, 7]|19|-1|_|_|_|_|_|_|_|8643966
vomiting|Disease|12|[2, 3]|20|-1|_|_|_|_|_|_|_|8643966
nausea|Disease|12|[0, 1]|21|H|_|_|_|_|_|_|_|8643966
paclitaxel|Chemical|0|[11, 12]|1|-1|_|_|_|_|_|_|_|8643966
paclitaxel|Chemical|7|[0, 1]|1|-1|_|_|_|_|_|_|_|8643966
paclitaxel|Chemical|13|[0, 1]|1|-1|_|_|_|_|_|_|_|8643966
chemotherapy|Treat|0|[0, 1]|2|-1|_|_|_|_|_|_|_|8643966
24-hour paclitaxel infusions|Treat|2|[5, 10]|6|-1|_|_|_|_|_|_|_|8643966
infusion|Treat|4|[12, 13]|10|-1|_|_|_|_|_|_|_|8643966
premedication|Treat|7|[16, 17]|14|-1|_|_|_|_|_|_|_|8643966
performance status|Physiology|5|[28, 30]|11|-1|_|_|_|_|_|_|_|8643966
cerebral hemorrhage|Disease|0|[0, 2]|0|H|_|_|_|_|_|_|_|6695415
stroke|Disease|1|[16, 17]|500|H|_|_|_|_|_|_|_|6695415
stroke|Disease|3|[11, 12]|500|H|_|_|_|_|_|_|_|6695415
hypertensive|Disease|3|[17, 18]|501|H|_|_|_|_|_|_|_|6695415
hypertensive|Disease|4|[10, 11]|501|H|_|_|_|_|_|_|_|6695415
hypertensive|Disease|5|[19, 20]|501|H|_|_|_|_|_|_|_|6695415
hypertensive|Disease|6|[14, 15]|501|H|_|_|_|_|_|_|_|6695415
subarachnoid and cerebral hemorrhage|Disease|4|[0, 4]|500|-1|_|_|_|_|_|_|_|6695415
hypertension|Disease|5|[13, 14]|501|-1|_|_|_|_|_|_|_|6695415
phenylpropanolamine|Chemical|0|[4, 5]|503|-1|_|_|_|_|_|_|_|6695415
caffeine|Chemical|0|[8, 9]|503|-1|_|_|_|_|_|_|_|6695415
phenylpropanolamine (ppa)|Chemical|1|[0, 4]|503|-1|_|_|_|_|_|_|_|6695415
ppa/caffeine|Chemical|3|[5, 8]|503|-1|_|_|_|_|_|_|_|6695415
ppa/caffeine|Chemical|5|[2, 5]|503|-1|_|_|_|_|_|_|_|6695415
hypertensive|Physiology|4|[10, 11]|10|-1|_|_|_|_|_|_|_|6695415
blood pressure|Physiology|7|[4, 6]|15|-1|_|_|_|_|_|_|_|6695415
ventricular tachycardia|Disease|0|[13, 15]|500|-1|_|_|_|_|_|_|_|6637851
ventricular tachycardia|Disease|1|[11, 13]|500|-1|_|_|_|_|_|_|_|6637851
ventricular fibrillation|Disease|0|[16, 18]|501|-1|_|_|_|_|_|_|_|6637851
ventricular tachycardia (vt)|Disease|1|[11, 16]|500|-1|_|_|_|_|_|_|_|6637851
vt|Disease|3|[16, 17]|500|-1|_|_|_|_|_|_|_|6637851
vt|Disease|4|[10, 11]|500|-1|_|_|_|_|_|_|_|6637851
vt|Disease|8|[15, 16]|500|-1|_|_|_|_|_|_|_|6637851
vt|Disease|9|[22, 23]|500|-1|_|_|_|_|_|_|_|6637851
vf|Disease|3|[21, 22]|501|-1|_|_|_|_|_|_|_|6637851
vf|Disease|8|[17, 18]|501|-1|_|_|_|_|_|_|_|6637851
vf|Disease|9|[24, 25]|501|-1|_|_|_|_|_|_|_|6637851
nausea|Disease|7|[14, 15]|9|-1|_|_|_|_|_|_|_|6637851
visual halos or blurring|Disease|7|[21, 25]|10|-1|_|_|_|_|_|_|_|6637851
tremor|Disease|7|[7, 8]|11|-1|_|_|_|_|_|_|_|6637851
ataxia|Disease|7|[9, 10]|12|-1|_|_|_|_|_|_|_|6637851
anorexia|Disease|7|[16, 17]|13|-1|_|_|_|_|_|_|_|6637851
thyroid function abnormalities|Disease|7|[29, 32]|14|-1|_|_|_|_|_|_|_|6637851
amiodarone|Chemical|0|[10, 11]|2|-1|_|_|_|_|_|_|_|6637851
amiodarone|Chemical|1|[0, 1]|2|-1|_|_|_|_|_|_|_|6637851
calcium chloride|Chemical|0|[2, 4]|500|-1|_|_|_|_|_|_|_|8800187
4-aminopyridine|Chemical|0|[5, 8]|1|-1|_|_|_|_|_|_|_|8800187
desipramine|Chemical|0|[10, 11]|2|-1|_|_|_|_|_|_|_|8800187
cacl2|Chemical|5|[0, 1]|500|-1|_|_|_|_|_|_|_|8800187
cacl2|Chemical|7|[6, 7]|500|-1|_|_|_|_|_|_|_|8800187
cacl2|Chemical|10|[0, 1]|500|-1|_|_|_|_|_|_|_|8800187
cacl2|Chemical|11|[23, 24]|500|-1|_|_|_|_|_|_|_|8800187
cacl2|Chemical|12|[5, 6]|500|-1|_|_|_|_|_|_|_|8800187
cacl2|Chemical|13|[0, 1]|500|-1|_|_|_|_|_|_|_|8800187
nahco3|Chemical|7|[8, 9]|16|-1|_|_|_|_|_|_|_|8800187
nahco3|Chemical|9|[2, 3]|16|-1|_|_|_|_|_|_|_|8800187
overdose|Disease|1|[12, 13]|3|H|_|_|_|_|_|_|_|8800187
overdose|Disease|4|[19, 20]|3|H|_|_|_|_|_|_|_|8800187
hypotension|Disease|1|[2, 3]|4|-1|_|_|_|_|_|_|_|8800187
hypotension|Disease|1|[2, 3]|4|-1|_|_|_|_|_|_|_|8800187
hypotension|Disease|3|[15, 16]|4|-1|_|_|_|_|_|_|_|8800187
hypotension|Disease|6|[10, 11]|4|-1|_|_|_|_|_|_|_|8800187
hypotension|Disease|9|[9, 10]|4|-1|_|_|_|_|_|_|_|8800187
hypotension|Disease|12|[17, 18]|4|-1|_|_|_|_|_|_|_|8800187
hypotension|Disease|14|[19, 20]|4|-1|_|_|_|_|_|_|_|8800187
bradycardia|Disease|6|[16, 17]|13|-1|_|_|_|_|_|_|_|8800187
qrs prolongation|Disease|6|[12, 14]|14|-1|_|_|_|_|_|_|_|8800187
ventricular arrhythmias|Disease|11|[3, 5]|20|-1|_|_|_|_|_|_|_|8800187
seizures|Disease|11|[13, 14]|502|-1|_|_|_|_|_|_|_|8800187
central nervous system toxicity|Disease|13|[8, 12]|502|-1|_|_|_|_|_|_|_|8800187
calcium influx|Physiology|2|[7, 9]|6|-1|_|_|_|_|_|_|_|8800187
hypotension|Physiology|3|[15, 16]|8|-1|_|_|_|_|_|_|_|8800187
blood pressure|Physiology|4|[13, 15]|10|-1|_|_|_|_|_|_|_|8800187
neuroblastoma|Disease|0|[13, 14]|0|H|_|_|_|_|_|_|_|7707116
emesis|Disease|7|[52, 53]|9|-1|_|_|_|_|_|_|_|7707116
rash|Disease|7|[54, 55]|10|-1|_|_|_|_|_|_|_|7707116
rash|Disease|7|[40, 41]|10|-1|_|_|_|_|_|_|_|7707116
thrombocytopenia|Disease|7|[50, 51]|12|-1|_|_|_|_|_|_|_|7707116
hypercalcemia|Disease|7|[33, 34]|13|-1|_|_|_|_|_|_|_|7707116
anemia|Disease|7|[48, 49]|14|-1|_|_|_|_|_|_|_|7707116
metastases|Disease|9|[7, 8]|17|-1|_|_|_|_|_|_|_|7707116
13-cis-retinoic acid|Chemical|0|[4, 10]|501|-1|_|_|_|_|_|_|_|7707116
13-cis-retinoic acid (cis-ra)|Chemical|1|[8, 19]|501|-1|_|_|_|_|_|_|_|7707116
cis-ra|Chemical|2|[1, 4]|501|-1|_|_|_|_|_|_|_|7707116
cis-ra|Chemical|3|[22, 25]|501|-1|_|_|_|_|_|_|_|7707116
cis-ra|Chemical|4|[21, 24]|501|-1|_|_|_|_|_|_|_|7707116
cis-ra|Chemical|7|[5, 8]|501|-1|_|_|_|_|_|_|_|7707116
cis-ra|Chemical|8|[4, 7]|501|-1|_|_|_|_|_|_|_|7707116
cis-ra|Chemical|11|[19, 22]|501|-1|_|_|_|_|_|_|_|7707116
cis-ra|Chemical|12|[11, 14]|501|-1|_|_|_|_|_|_|_|7707116
cis-ra|Chemical|13|[5, 8]|501|-1|_|_|_|_|_|_|_|7707116
bone marrow transplantation|Treat|0|[15, 18]|2|-1|_|_|_|_|_|_|_|7707116
cytotoxic therapy|Treat|2|[20, 22]|5|-1|_|_|_|_|_|_|_|7707116
bone marrow transplantation (bmt)|Treat|3|[35, 41]|7|-1|_|_|_|_|_|_|_|7707116
calcium chloride|Chemical|0|[2, 4]|500|-1|_|_|_|_|_|_|_|6892185
calcium chloride|Chemical|5|[0, 2]|500|-1|_|_|_|_|_|_|_|6892185
carbachol|Chemical|0|[10, 11]|1|-1|_|_|_|_|_|_|_|6892185
carbachol|Chemical|5|[9, 10]|1|-1|_|_|_|_|_|_|_|6892185
eserine|Chemical|0|[12, 13]|2|-1|_|_|_|_|_|_|_|6892185
eserine|Chemical|5|[11, 12]|2|-1|_|_|_|_|_|_|_|6892185
calcium ions|Chemical|6|[7, 9]|500|-1|_|_|_|_|_|_|_|6892185
clonic-tonic convulsions|Disease|1|[47, 51]|3|-1|_|_|_|_|_|_|_|6892185
clonic-tonic convulsions|Disease|3|[9, 13]|3|-1|_|_|_|_|_|_|_|6892185
clonic-tonic convulsions|Disease|4|[24, 28]|3|-1|_|_|_|_|_|_|_|6892185
mydriasis|Disease|1|[43, 44]|4|-1|_|_|_|_|_|_|_|6892185
mydriasis|Disease|3|[5, 6]|4|-1|_|_|_|_|_|_|_|6892185
mydriasis|Disease|4|[20, 21]|4|-1|_|_|_|_|_|_|_|6892185
tremor|Disease|1|[45, 46]|5|-1|_|_|_|_|_|_|_|6892185
tremor|Disease|3|[7, 8]|5|-1|_|_|_|_|_|_|_|6892185
tremor|Disease|4|[22, 23]|5|-1|_|_|_|_|_|_|_|6892185
mydriasis|Physiology|1|[43, 44]|6|-1|_|_|_|_|_|_|_|6892185
arthritis|Disease|0|[11, 12]|0|H|_|_|_|_|_|_|_|6216862
arthritis|Disease|1|[26, 27]|0|H|_|_|_|_|_|_|_|6216862
arthritis|Disease|3|[30, 31]|0|H|_|_|_|_|_|_|_|6216862
rheumatoid arthritis|Disease|0|[10, 12]|1|-1|_|_|_|_|_|_|_|6216862
rheumatoid arthritis|Disease|1|[25, 27]|1|-1|_|_|_|_|_|_|_|6216862
proteinuria|Disease|1|[3, 4]|4|-1|_|_|_|_|_|_|_|6216862
skin rashes|Disease|1|[0, 2]|6|-1|_|_|_|_|_|_|_|6216862
systemic lupus erythematosus|Disease|1|[5, 8]|7|-1|_|_|_|_|_|_|_|6216862
polymyositis|Disease|1|[9, 10]|8|-1|_|_|_|_|_|_|_|6216862
myasthenia gravis|Disease|1|[11, 13]|9|-1|_|_|_|_|_|_|_|6216862
wilson's disease|Disease|3|[20, 24]|13|-1|_|_|_|_|_|_|_|6216862
penicillamine|Chemical|0|[4, 5]|2|-1|_|_|_|_|_|_|_|6216862
penicillamine|Chemical|1|[20, 21]|2|-1|_|_|_|_|_|_|_|6216862
therapy|Treat|0|[5, 6]|3|-1|_|_|_|_|_|_|_|6216862
cardiac arrhythmias|Disease|0|[3, 5]|0|H|_|_|_|_|_|_|_|2004
ventricular tachycardia|Disease|2|[20, 22]|500|-1|_|_|_|_|_|_|_|2004
supraventricular tachycardia|Disease|3|[0, 2]|4|-1|_|_|_|_|_|_|_|2004
left bundle branch block|Disease|4|[11, 15]|6|-1|_|_|_|_|_|_|_|2004
ventricular arrhythmias|Disease|6|[1, 3]|500|-1|_|_|_|_|_|_|_|2004
thioridazine|Chemical|2|[10, 11]|502|-1|_|_|_|_|_|_|_|2004
mellaril (thioridazine)|Chemical|2|[8, 12]|502|-1|_|_|_|_|_|_|_|2004
thorazine (chlorpromazine)|Chemical|3|[7, 11]|5|-1|_|_|_|_|_|_|_|2004
nortriptyline|Chemical|4|[2, 3]|7|-1|_|_|_|_|_|_|_|2004
amitriptyline|Chemical|4|[7, 8]|8|-1|_|_|_|_|_|_|_|2004
lidocaine|Chemical|6|[8, 9]|10|-1|_|_|_|_|_|_|_|2004
propranolol|Chemical|6|[27, 28]|11|-1|_|_|_|_|_|_|_|2004
intravenous administration|Treat|6|[24, 26]|12|-1|_|_|_|_|_|_|_|2004
intravenous administration|Treat|6|[5, 7]|12|-1|_|_|_|_|_|_|_|2004
direct current electric shock|Treat|6|[11, 15]|14|-1|_|_|_|_|_|_|_|2004
ventricular pacing|Treat|6|[30, 32]|15|-1|_|_|_|_|_|_|_|2004
ventricular pacing|Treat|6|[16, 18]|15|-1|_|_|_|_|_|_|_|2004
baclofen|Chemical|0|[5, 6]|500|-1|_|_|_|_|_|_|_|6118280
baclofen|Chemical|6|[5, 6]|500|-1|_|_|_|_|_|_|_|6118280
baclofen|Chemical|8|[16, 17]|500|-1|_|_|_|_|_|_|_|6118280
serotonergic drugs|Chemical|0|[0, 2]|2|H|_|_|_|_|_|_|_|6118280
muscimol|Chemical|0|[7, 8]|3|-1|_|_|_|_|_|_|_|6118280
5-hydroxytryptophan|Chemical|2|[47, 50]|501|-1|_|_|_|_|_|_|_|6118280
serotonin|Chemical|2|[41, 42]|501|H|_|_|_|_|_|_|_|6118280
l-dopa|Chemical|3|[6, 9]|6|-1|_|_|_|_|_|_|_|6118280
mk-212|Chemical|4|[14, 17]|7|-1|_|_|_|_|_|_|_|6118280
mk-212|Chemical|8|[8, 11]|7|-1|_|_|_|_|_|_|_|6118280
diazepam|Chemical|5|[26, 27]|8|-1|_|_|_|_|_|_|_|6118280
clonazepam|Chemical|5|[4, 5]|9|-1|_|_|_|_|_|_|_|6118280
(-)-baclofen|Chemical|6|[1, 6]|500|-1|_|_|_|_|_|_|_|6118280
(+)|Chemical|6|[24, 27]|500|-1|_|_|_|_|_|_|_|6118280
5-htp|Chemical|7|[4, 7]|501|-1|_|_|_|_|_|_|_|6118280
5-htp|Chemical|7|[4, 7]|501|-1|_|_|_|_|_|_|_|6118280
myoclonic jerks|Disease|0|[10, 12]|503|-1|_|_|_|_|_|_|_|6118280
myoclonus|Disease|7|[21, 22]|503|-1|_|_|_|_|_|_|_|6118280
myoclonus|Disease|7|[27, 28]|503|-1|_|_|_|_|_|_|_|6118280
hyperglycemic acidotic coma|Disease|0|[0, 3]|500|H|_|_|_|_|_|_|_|3703509
kearns-sayre syndrome|Disease|0|[6, 10]|1|-1|_|_|_|_|_|_|_|3703509
kearns-sayre syndrome|Disease|1|[16, 20]|1|-1|_|_|_|_|_|_|_|3703509
kearns-sayre syndrome|Disease|6|[17, 21]|1|-1|_|_|_|_|_|_|_|3703509
polyuria|Disease|2|[20, 21]|3|-1|_|_|_|_|_|_|_|3703509
somnolence|Disease|2|[13, 14]|5|-1|_|_|_|_|_|_|_|3703509
polydipsia|Disease|2|[15, 16]|6|H|_|_|_|_|_|_|_|3703509
polyphagia|Disease|2|[17, 18]|7|-1|_|_|_|_|_|_|_|3703509
hypotension|Disease|3|[10, 11]|8|-1|_|_|_|_|_|_|_|3703509
coma|Disease|3|[8, 9]|9|H|_|_|_|_|_|_|_|3703509
hyperglycemia|Disease|3|[13, 14]|500|H|_|_|_|_|_|_|_|3703509
lactic acidosis|Disease|4|[1, 3]|11|H|_|_|_|_|_|_|_|3703509
ketosis|Disease|4|[8, 9]|12|-1|_|_|_|_|_|_|_|3703509
resuscitation|Disease|5|[13, 14]|13|-1|_|_|_|_|_|_|_|3703509
prednisone|Chemical|2|[5, 6]|4|-1|_|_|_|_|_|_|_|3703509
alzheimer's disease|Disease|0|[18, 22]|0|H|_|_|_|_|_|_|_|20683499
alzheimer's disease|Disease|2|[11, 15]|0|H|_|_|_|_|_|_|_|20683499
alzheimer's disease|Disease|4|[1, 5]|0|H|_|_|_|_|_|_|_|20683499
alzheimer's disease|Disease|10|[40, 44]|0|H|_|_|_|_|_|_|_|20683499
stz|Disease|3|[39, 40]|500|-1|_|_|_|_|_|_|_|20683499
stz|Disease|3|[45, 46]|500|-1|_|_|_|_|_|_|_|20683499
stz|Disease|5|[1, 2]|500|-1|_|_|_|_|_|_|_|20683499
stz|Disease|8|[35, 36]|500|-1|_|_|_|_|_|_|_|20683499
stz|Disease|8|[16, 17]|500|-1|_|_|_|_|_|_|_|20683499
learning and memory impairment|Disease|9|[11, 15]|500|-1|_|_|_|_|_|_|_|20683499
stz-injected|Disease|9|[17, 20]|500|-1|_|_|_|_|_|_|_|20683499
cognitive deficits|Disease|10|[20, 22]|26|H|_|_|_|_|_|_|_|20683499
crocin|Chemical|0|[10, 11]|502|-1|_|_|_|_|_|_|_|20683499
carotenoids|Chemical|1|[8, 9]|502|-1|_|_|_|_|_|_|_|20683499
crocins|Chemical|1|[10, 11]|502|-1|_|_|_|_|_|_|_|20683499
stz|Chemical|2|[23, 24]|503|-1|_|_|_|_|_|_|_|20683499
stz|Chemical|3|[39, 40]|503|-1|_|_|_|_|_|_|_|20683499
stz|Chemical|3|[45, 46]|503|-1|_|_|_|_|_|_|_|20683499
stz|Chemical|3|[39, 40]|503|-1|_|_|_|_|_|_|_|20683499
stz|Chemical|3|[45, 46]|503|-1|_|_|_|_|_|_|_|20683499
stz|Chemical|4|[11, 12]|503|-1|_|_|_|_|_|_|_|20683499
stz|Chemical|4|[31, 32]|503|-1|_|_|_|_|_|_|_|20683499
stz|Chemical|5|[1, 2]|503|-1|_|_|_|_|_|_|_|20683499
stz|Chemical|8|[35, 36]|503|-1|_|_|_|_|_|_|_|20683499
stz|Chemical|8|[16, 17]|503|-1|_|_|_|_|_|_|_|20683499
stz|Chemical|9|[17, 18]|503|-1|_|_|_|_|_|_|_|20683499
stz|Chemical|10|[24, 25]|503|-1|_|_|_|_|_|_|_|20683499
streptozocin (stz)|Chemical|2|[21, 25]|503|-1|_|_|_|_|_|_|_|20683499
learning and memory processes|Physiology|1|[25, 29]|4|-1|_|_|_|_|_|_|_|20683499
dermatitis|Disease|0|[1, 2]|500|H|_|_|_|_|_|_|_|20466178
dermatitis|Disease|1|[10, 11]|500|H|_|_|_|_|_|_|_|20466178
dermatitis|Disease|1|[25, 26]|500|H|_|_|_|_|_|_|_|20466178
dermatitis|Disease|3|[19, 20]|500|H|_|_|_|_|_|_|_|20466178
eruptions|Disease|1|[11, 12]|500|H|_|_|_|_|_|_|_|20466178
telangiectasia|Disease|2|[4, 5]|6|-1|_|_|_|_|_|_|_|20466178
tacrolimus|Chemical|0|[5, 6]|1|-1|_|_|_|_|_|_|_|20466178
pimecrolimus|Chemical|3|[9, 10]|8|-1|_|_|_|_|_|_|_|20466178
topical tacrolimus treatment|Treat|0|[4, 7]|2|-1|_|_|_|_|_|_|_|20466178
blood-brain barrier (bbb)|Physiology|1|[37, 44]|0|-1|_|_|_|_|_|_|_|19944736
seizures|Disease|3|[12, 13]|1|-1|_|_|_|_|_|_|_|19944736
hippocampal damage|Disease|3|[15, 17]|500|-1|_|_|_|_|_|_|_|19944736
damage of neuronal cells|Disease|6|[9, 13]|500|-1|_|_|_|_|_|_|_|19944736
epilepsy|Disease|8|[27, 28]|8|-1|_|_|_|_|_|_|_|19944736
tacrine|Chemical|3|[0, 1]|3|-1|_|_|_|_|_|_|_|19944736
licl|Chemical|3|[4, 5]|4|-1|_|_|_|_|_|_|_|19944736
lithium|Chemical|8|[24, 25]|9|H|_|_|_|_|_|_|_|19944736
licl-pre-treated|Treat|4|[45, 50]|5|-1|_|_|_|_|_|_|_|19944736
nanoparticles|Treat|5|[8, 9]|6|-1|_|_|_|_|_|_|_|19944736
pilocarpine|Chemical|0|[8, 9]|0|-1|_|_|_|_|_|_|_|19721134
pilocarpine|Chemical|1|[9, 10]|0|-1|_|_|_|_|_|_|_|19721134
pilocarpine|Chemical|3|[5, 6]|0|-1|_|_|_|_|_|_|_|19721134
pilocarpine|Chemical|4|[23, 24]|0|-1|_|_|_|_|_|_|_|19721134
pilocarpine|Chemical|5|[34, 35]|0|-1|_|_|_|_|_|_|_|19721134
pilocarpine|Chemical|6|[4, 5]|0|-1|_|_|_|_|_|_|_|19721134
aconitine|Chemical|1|[19, 20]|3|-1|_|_|_|_|_|_|_|19721134
ouabain|Chemical|1|[24, 25]|4|-1|_|_|_|_|_|_|_|19721134
4-diphenylacetoxy-n-methylpiperidine-methiodide|Chemical|5|[18, 27]|500|-1|_|_|_|_|_|_|_|19721134
4-damp|Chemical|5|[14, 17]|500|-1|_|_|_|_|_|_|_|19721134
arrhythmia|Disease|1|[29, 30]|502|-1|_|_|_|_|_|_|_|19721134
ventricular tachycardia|Disease|3|[17, 19]|502|-1|_|_|_|_|_|_|_|19721134
ventricular tachycardia and fibrillation|Disease|3|[17, 21]|502|-1|_|_|_|_|_|_|_|19721134
arrhythmias|Disease|3|[10, 11]|502|-1|_|_|_|_|_|_|_|19721134
intracellular free-calcium concentrations|Physiology|2|[6, 11]|5|-1|_|_|_|_|_|_|_|19721134
[ca(2+)](i) overload|Physiology|4|[0, 11]|11|-1|_|_|_|_|_|_|_|19721134
ca(2+) handling|Physiology|6|[40, 46]|17|-1|_|_|_|_|_|_|_|19721134
m(3)-muscarinic acetylcholine receptor (machr)|Gene|5|[2, 13]|15|-1|_|_|_|_|_|_|_|19721134
optic and peripheral neuropathy|Disease|0|[4, 8]|0|H|_|_|_|_|_|_|_|17786501
optic and peripheral neuropathy|Disease|1|[7, 11]|0|H|_|_|_|_|_|_|_|17786501
intermittent headaches|Disease|3|[19, 21]|4|-1|_|_|_|_|_|_|_|17786501
paraesthesia|Disease|4|[4, 5]|5|-1|_|_|_|_|_|_|_|17786501
scotomata|Disease|7|[8, 9]|7|-1|_|_|_|_|_|_|_|17786501
alcohol dependence|Disease|8|[6, 8]|8|-1|_|_|_|_|_|_|_|17786501
disulfiram|Chemical|0|[0, 1]|1|-1|_|_|_|_|_|_|_|17786501
disulfiram|Chemical|9|[0, 1]|1|-1|_|_|_|_|_|_|_|17786501
alcohol|Chemical|1|[17, 18]|3|-1|_|_|_|_|_|_|_|17786501
vision|Physiology|5|[1, 2]|6|-1|_|_|_|_|_|_|_|17786501
hepatitis b virus-related cirrhosis|Disease|0|[8, 14]|500|-1|_|_|_|_|_|_|_|16960342
hepatitis b virus (hbv) infection|Disease|1|[0, 7]|500|H|_|_|_|_|_|_|_|16960342
hepatitis b virus (hbv) infection|Disease|1|[0, 7]|500|H|_|_|_|_|_|_|_|16960342
liver cirrhosis|Disease|1|[10, 12]|5|H|_|_|_|_|_|_|_|16960342
hepatocellular carcinoma|Disease|1|[13, 15]|6|-1|_|_|_|_|_|_|_|16960342
hbv|Disease|7|[8, 9]|500|H|_|_|_|_|_|_|_|16960342
hbv|Disease|7|[14, 15]|500|H|_|_|_|_|_|_|_|16960342
hepatitis b|Disease|9|[3, 5]|500|H|_|_|_|_|_|_|_|16960342
lamivudine|Chemical|0|[17, 18]|1|-1|_|_|_|_|_|_|_|16960342
antiviral|Chemical|8|[9, 10]|11|H|_|_|_|_|_|_|_|16960342
hepatitis b surface antigen and e antigen|Chemical|9|[3, 10]|12|-1|_|_|_|_|_|_|_|16960342
lamivudine monotherapy|Treat|0|[17, 19]|2|-1|_|_|_|_|_|_|_|16960342
antiviral therapy|Treat|3|[20, 22]|7|-1|_|_|_|_|_|_|_|16960342
administration of lamivudine|Treat|6|[3, 6]|8|-1|_|_|_|_|_|_|_|16960342
melatonin|Chemical|0|[3, 4]|0|-1|_|_|_|_|_|_|_|11226639
melatonin|Chemical|3|[0, 1]|0|-1|_|_|_|_|_|_|_|11226639
melatonin|Chemical|6|[0, 1]|0|-1|_|_|_|_|_|_|_|11226639
sodium thiopenthal|Chemical|2|[0, 2]|2|-1|_|_|_|_|_|_|_|11226639
ketamine|Chemical|6|[17, 18]|5|-1|_|_|_|_|_|_|_|11226639
ketamine|Chemical|6|[17, 18]|5|-1|_|_|_|_|_|_|_|11226639
diazepam|Chemical|6|[20, 21]|6|-1|_|_|_|_|_|_|_|11226639
diazepam|Chemical|6|[20, 21]|6|-1|_|_|_|_|_|_|_|11226639
circadian sleep/wake cycle|Physiology|1|[3, 8]|1|-1|_|_|_|_|_|_|_|11226639
narcosis|Disease|5|[30, 31]|4|-1|_|_|_|_|_|_|_|11226639
amnesia|Disease|0|[11, 12]|0|-1|_|_|_|_|_|_|_|9228650
amnesia|Disease|1|[12, 13]|0|-1|_|_|_|_|_|_|_|9228650
amnesia|Disease|6|[18, 19]|0|-1|_|_|_|_|_|_|_|9228650
amnesia|Disease|8|[29, 30]|0|-1|_|_|_|_|_|_|_|9228650
alzheimer's disease|Disease|9|[16, 20]|25|-1|_|_|_|_|_|_|_|9228650
scopolamine|Chemical|0|[8, 9]|1|-1|_|_|_|_|_|_|_|9228650
scopolamine|Chemical|1|[9, 10]|1|-1|_|_|_|_|_|_|_|9228650
scopolamine|Chemical|6|[21, 22]|1|-1|_|_|_|_|_|_|_|9228650
scopolamine|Chemical|8|[26, 27]|1|-1|_|_|_|_|_|_|_|9228650
nik-247|Chemical|0|[2, 5]|2|-1|_|_|_|_|_|_|_|9228650
nik-247|Chemical|1|[3, 6]|2|-1|_|_|_|_|_|_|_|9228650
nik-247|Chemical|2|[0, 3]|2|-1|_|_|_|_|_|_|_|9228650
nik-247|Chemical|3|[3, 6]|2|-1|_|_|_|_|_|_|_|9228650
nik-247|Chemical|5|[6, 9]|2|-1|_|_|_|_|_|_|_|9228650
nik-247|Chemical|8|[4, 7]|2|-1|_|_|_|_|_|_|_|9228650
nik-247|Chemical|9|[4, 7]|2|-1|_|_|_|_|_|_|_|9228650
e-2020|Chemical|1|[31, 34]|3|-1|_|_|_|_|_|_|_|9228650
e-2020|Chemical|1|[31, 34]|3|-1|_|_|_|_|_|_|_|9228650
e-2020|Chemical|2|[6, 9]|3|-1|_|_|_|_|_|_|_|9228650
e-2020|Chemical|2|[6, 9]|3|-1|_|_|_|_|_|_|_|9228650
e-2020|Chemical|3|[11, 14]|3|-1|_|_|_|_|_|_|_|9228650
e-2020|Chemical|3|[11, 14]|3|-1|_|_|_|_|_|_|_|9228650
tacrine|Chemical|1|[29, 30]|7|-1|_|_|_|_|_|_|_|9228650
acetylcholinesterase (ache)|Chemical|2|[12, 16]|12|-1|_|_|_|_|_|_|_|9228650
butyrylcholinestrase|Chemical|3|[17, 18]|16|-1|_|_|_|_|_|_|_|9228650
buche|Chemical|3|[19, 20]|17|-1|_|_|_|_|_|_|_|9228650
spontaneous movement|Physiology|7|[18, 20]|21|-1|_|_|_|_|_|_|_|9228650
hallucinations|Disease|0|[2, 3]|0|-1|_|_|_|_|_|_|_|8766220
hallucinations|Disease|0|[2, 3]|0|-1|_|_|_|_|_|_|_|8766220
hallucinations|Disease|3|[12, 13]|0|-1|_|_|_|_|_|_|_|8766220
cancer pain|Disease|1|[17, 19]|3|-1|_|_|_|_|_|_|_|8766220
chronic non malignant pain|Disease|1|[20, 24]|500|H|_|_|_|_|_|_|_|8766220
tetraparetic|Disease|2|[13, 14]|6|-1|_|_|_|_|_|_|_|8766220
chronic pain|Disease|2|[16, 18]|500|H|_|_|_|_|_|_|_|8766220
tramadol|Chemical|0|[9, 10]|2|-1|_|_|_|_|_|_|_|8766220
tramadol|Chemical|1|[0, 1]|2|-1|_|_|_|_|_|_|_|8766220
paroxetine|Chemical|2|[7, 8]|8|-1|_|_|_|_|_|_|_|8766220
dosulepine hydrochloride|Chemical|2|[9, 11]|9|-1|_|_|_|_|_|_|_|8766220
arthritis|Disease|0|[4, 5]|500|-1|_|_|_|_|_|_|_|8441146
arthritis|Disease|1|[14, 15]|500|-1|_|_|_|_|_|_|_|8441146
rheumatoid arthritis|Disease|0|[3, 5]|500|-1|_|_|_|_|_|_|_|8441146
aplastic anemia|Disease|2|[6, 8]|6|-1|_|_|_|_|_|_|_|8441146
ra|Disease|3|[26, 27]|500|-1|_|_|_|_|_|_|_|8441146
ra|Disease|4|[6, 7]|500|-1|_|_|_|_|_|_|_|8441146
synovitis|Disease|5|[20, 21]|500|-1|_|_|_|_|_|_|_|8441146
bone marrow transplantation|Treat|0|[6, 9]|2|-1|_|_|_|_|_|_|_|8441146
transplants|Treat|3|[8, 9]|9|-1|_|_|_|_|_|_|_|8441146
bmt|Treat|4|[8, 9]|12|-1|_|_|_|_|_|_|_|8441146
bmt|Treat|5|[9, 10]|12|-1|_|_|_|_|_|_|_|8441146
gold|Chemical|2|[12, 13]|4|-1|_|_|_|_|_|_|_|8441146
d-penicillamine|Chemical|2|[17, 20]|5|-1|_|_|_|_|_|_|_|8441146
d-penicillamine|Chemical|2|[17, 20]|5|-1|_|_|_|_|_|_|_|8441146
immunosuppressive therapy|Immune|3|[19, 21]|10|-1|_|_|_|_|_|_|_|8441146
acute experimental models of renal damage|Disease|1|[0, 6]|500|-1|_|_|_|_|_|_|_|3653576
renal damage|Disease|1|[4, 6]|500|H|_|_|_|_|_|_|_|3653576
nephrotoxicity|Disease|2|[4, 5]|5|H|_|_|_|_|_|_|_|3653576
excretion of proteins|Disease|5|[15, 18]|9|-1|_|_|_|_|_|_|_|3653576
hexachloro-1:3-butadiene (hcbd)|Chemical|1|[24, 34]|502|-1|_|_|_|_|_|_|_|3653576
puromycin aminonucleoside (pan)|Chemical|1|[35, 40]|503|-1|_|_|_|_|_|_|_|3653576
2-bromoethylamine (bea)|Chemical|1|[42, 48]|504|-1|_|_|_|_|_|_|_|3653576
hcbd|Chemical|3|[4, 5]|502|-1|_|_|_|_|_|_|_|3653576
hcbd|Chemical|6|[5, 6]|502|-1|_|_|_|_|_|_|_|3653576
bea|Chemical|3|[6, 7]|504|-1|_|_|_|_|_|_|_|3653576
bea|Chemical|6|[11, 12]|504|-1|_|_|_|_|_|_|_|3653576
pan|Chemical|3|[18, 19]|503|-1|_|_|_|_|_|_|_|3653576
magnesium sulfate|Chemical|0|[3, 5]|0|-1|_|_|_|_|_|_|_|2750819
nifedipine|Chemical|0|[6, 7]|1|-1|_|_|_|_|_|_|_|2750819
neuromuscular blockade|Disease|1|[8, 10]|2|-1|_|_|_|_|_|_|_|2750819
ifosfamide|Chemical|0|[0, 1]|0|-1|_|_|_|_|_|_|_|1899352
mesna|Chemical|0|[4, 5]|1|-1|_|_|_|_|_|_|_|1899352
mesna|Chemical|2|[31, 32]|1|-1|_|_|_|_|_|_|_|1899352
mesna|Chemical|7|[22, 23]|1|-1|_|_|_|_|_|_|_|1899352
mesna|Chemical|8|[11, 12]|1|-1|_|_|_|_|_|_|_|1899352
continuous infusion|Treat|0|[1, 3]|2|-1|_|_|_|_|_|_|_|1899352
hematuria|Disease|3|[47, 48]|4|-1|_|_|_|_|_|_|_|1899352
hematuria|Disease|3|[27, 28]|4|-1|_|_|_|_|_|_|_|1899352
nausea|Disease|4|[19, 20]|6|-1|_|_|_|_|_|_|_|1899352
confusion|Disease|4|[14, 15]|7|-1|_|_|_|_|_|_|_|1899352
leukopenia|Disease|4|[27, 28]|8|-1|_|_|_|_|_|_|_|1899352
myocardial infarction|Disease|0|[0, 2]|500|-1|_|_|_|_|_|_|_|18161408
thromboembolism|Disease|3|[0, 1]|501|H|_|_|_|_|_|_|_|18161408
coronary thrombosis|Disease|4|[1, 3]|5|H|_|_|_|_|_|_|_|18161408
mi|Disease|4|[23, 24]|500|-1|_|_|_|_|_|_|_|18161408
thrombosis|Disease|4|[2, 3]|501|H|_|_|_|_|_|_|_|18161408
thrombosis|Disease|11|[0, 1]|501|H|_|_|_|_|_|_|_|18161408
chest pain|Disease|5|[25, 27]|8|H|_|_|_|_|_|_|_|18161408
lateral and anterior wall myocardial infarction|Disease|6|[4, 10]|500|-1|_|_|_|_|_|_|_|18161408
radiation injury|Disease|8|[13, 15]|10|-1|_|_|_|_|_|_|_|18161408
life-threatening complication|Disease|12|[2, 6]|500|H|_|_|_|_|_|_|_|18161408
clomiphene citrate|Chemical|0|[6, 8]|1|-1|_|_|_|_|_|_|_|18161408
clomiphene citrate|Chemical|1|[2, 4]|1|-1|_|_|_|_|_|_|_|18161408
ovulation induction|Treat|0|[9, 11]|2|-1|_|_|_|_|_|_|_|18161408
cholangitis|Disease|0|[2, 3]|500|-1|_|_|_|_|_|_|_|17574447
liver disease|Disease|1|[34, 36]|501|H|_|_|_|_|_|_|_|17574447
epilepsy|Disease|2|[12, 13]|4|-1|_|_|_|_|_|_|_|17574447
cardiac arrest|Disease|2|[24, 26]|5|-1|_|_|_|_|_|_|_|17574447
bronchopneumonia|Disease|2|[31, 32]|6|-1|_|_|_|_|_|_|_|17574447
necrosis|Disease|3|[27, 28]|8|H|_|_|_|_|_|_|_|17574447
inflammatory reactions of internal and external hepatic biliary ducts|Disease|4|[0, 9]|500|H|_|_|_|_|_|_|_|17574447
chronic hepatic enzyme dysfunction|Disease|6|[19, 23]|501|H|_|_|_|_|_|_|_|17574447
phenobarbital|Chemical|0|[8, 9]|503|-1|_|_|_|_|_|_|_|17574447
phenobarbital|Chemical|1|[0, 1]|503|-1|_|_|_|_|_|_|_|17574447
pb|Chemical|2|[15, 16]|503|-1|_|_|_|_|_|_|_|17574447
ethambutol|Chemical|0|[0, 1]|0|-1|_|_|_|_|_|_|_|16710500
ethambutol|Chemical|1|[2, 3]|0|-1|_|_|_|_|_|_|_|16710500
ethambutol|Chemical|10|[2, 3]|0|-1|_|_|_|_|_|_|_|16710500
tuberculosis|Disease|1|[9, 10]|1|-1|_|_|_|_|_|_|_|16710500
visual field loss|Disease|5|[1, 4]|501|-1|_|_|_|_|_|_|_|16710500
permanent loss of visual function|Disease|9|[7, 12]|4|H|_|_|_|_|_|_|_|16710500
visual loss|Disease|10|[8, 10]|501|H|_|_|_|_|_|_|_|16710500
paracetamol|Chemical|0|[4, 5]|0|-1|_|_|_|_|_|_|_|11694026
paracetamol|Chemical|1|[8, 9]|0|-1|_|_|_|_|_|_|_|11694026
paracetamol|Chemical|2|[11, 12]|0|-1|_|_|_|_|_|_|_|11694026
paracetamol|Chemical|3|[17, 18]|0|-1|_|_|_|_|_|_|_|11694026
paracetamol|Chemical|4|[12, 13]|0|-1|_|_|_|_|_|_|_|11694026
paracetamol|Chemical|5|[17, 18]|0|-1|_|_|_|_|_|_|_|11694026
paracetamol|Chemical|6|[27, 28]|0|-1|_|_|_|_|_|_|_|11694026
paracetamol|Chemical|8|[12, 13]|0|-1|_|_|_|_|_|_|_|11694026
nimesulide|Chemical|0|[2, 3]|2|-1|_|_|_|_|_|_|_|11694026
nsaid|Chemical|7|[23, 24]|11|H|_|_|_|_|_|_|_|11694026
nsaid|Chemical|9|[29, 30]|11|H|_|_|_|_|_|_|_|11694026
angioedema|Disease|0|[13, 14]|1|-1|_|_|_|_|_|_|_|11694026
cutaneous|Disease|1|[12, 13]|4|-1|_|_|_|_|_|_|_|11694026
nonsteroidal anti-inflammatory drugs (nsaids)|Disease|1|[20, 28]|5|H|_|_|_|_|_|_|_|11694026
atrial fibrillation|Disease|0|[4, 6]|500|-1|_|_|_|_|_|_|_|11282081
atrial fibrillation|Disease|1|[13, 15]|500|-1|_|_|_|_|_|_|_|11282081
atrial tachycardia|Disease|1|[2, 4]|3|-1|_|_|_|_|_|_|_|11282081
atrial tachycardia|Disease|1|[2, 4]|3|-1|_|_|_|_|_|_|_|11282081
af|Disease|2|[24, 25]|500|-1|_|_|_|_|_|_|_|11282081
af|Disease|2|[19, 20]|500|-1|_|_|_|_|_|_|_|11282081
af|Disease|3|[8, 9]|500|-1|_|_|_|_|_|_|_|11282081
af|Disease|5|[12, 13]|500|-1|_|_|_|_|_|_|_|11282081
af|Disease|6|[4, 5]|500|-1|_|_|_|_|_|_|_|11282081
af|Disease|6|[14, 15]|500|-1|_|_|_|_|_|_|_|11282081
af|Disease|8|[71, 72]|500|-1|_|_|_|_|_|_|_|11282081
af|Disease|10|[11, 12]|500|-1|_|_|_|_|_|_|_|11282081
af|Disease|12|[6, 7]|500|-1|_|_|_|_|_|_|_|11282081
af|Disease|13|[4, 5]|500|-1|_|_|_|_|_|_|_|11282081
verapamil|Chemical|0|[2, 3]|1|-1|_|_|_|_|_|_|_|11282081
verapamil|Chemical|6|[2, 3]|1|-1|_|_|_|_|_|_|_|11282081
verapamil|Chemical|9|[22, 23]|1|-1|_|_|_|_|_|_|_|11282081
verapamil|Chemical|13|[2, 3]|1|-1|_|_|_|_|_|_|_|11282081
ca(2+)|Chemical|1|[23, 28]|6|H|_|_|_|_|_|_|_|11282081
ca(2+)|Chemical|2|[28, 33]|6|H|_|_|_|_|_|_|_|11282081
ca(2+)|Chemical|3|[11, 16]|6|H|_|_|_|_|_|_|_|11282081
chloralose|Chemical|3|[25, 26]|10|-1|_|_|_|_|_|_|_|11282081
diltiazem|Chemical|4|[0, 1]|14|-1|_|_|_|_|_|_|_|11282081
diltiazem|Chemical|9|[0, 1]|14|-1|_|_|_|_|_|_|_|11282081
atropine|Chemical|4|[11, 12]|15|-1|_|_|_|_|_|_|_|11282081
nadolol|Chemical|4|[13, 14]|16|-1|_|_|_|_|_|_|_|11282081
electrophysiological determinants|Physiology|0|[8, 10]|2|-1|_|_|_|_|_|_|_|11282081
ca(2+) channel|Physiology|3|[11, 17]|13|-1|_|_|_|_|_|_|_|11282081
electrophysiological mechanisms|Physiology|7|[1, 3]|21|-1|_|_|_|_|_|_|_|11282081
erp|Physiology|9|[4, 5]|25|-1|_|_|_|_|_|_|_|11282081
af cycle length|Physiology|9|[6, 9]|26|-1|_|_|_|_|_|_|_|11282081
af duration|Physiology|9|[10, 12]|27|-1|_|_|_|_|_|_|_|11282081
hypotension|Disease|0|[0, 1]|0|H|_|_|_|_|_|_|_|10074612
hypotension|Disease|1|[5, 6]|0|H|_|_|_|_|_|_|_|10074612
bradycardia|Disease|0|[2, 3]|1|H|_|_|_|_|_|_|_|10074612
bradycardia|Disease|1|[7, 8]|1|H|_|_|_|_|_|_|_|10074612
asystole|Disease|0|[5, 6]|2|-1|_|_|_|_|_|_|_|10074612
progressive renal failure|Disease|3|[14, 17]|6|H|_|_|_|_|_|_|_|10074612
pulmonary-renal syndrome|Disease|3|[6, 10]|7|H|_|_|_|_|_|_|_|10074612
hemoptysis|Disease|3|[11, 12]|8|-1|_|_|_|_|_|_|_|10074612
hypoxemia|Disease|3|[19, 20]|9|H|_|_|_|_|_|_|_|10074612
ventricular arrhythmia|Disease|5|[7, 9]|11|-1|_|_|_|_|_|_|_|10074612
ventricular arrhythmia|Disease|8|[20, 22]|11|-1|_|_|_|_|_|_|_|10074612
sudden death|Disease|6|[8, 10]|12|H|_|_|_|_|_|_|_|10074612
methylprednisolone|Chemical|0|[11, 12]|3|-1|_|_|_|_|_|_|_|10074612
advanced cardiopulmonary resuscitation|Treat|4|[2, 5]|10|-1|_|_|_|_|_|_|_|10074612
myelodysplasia|Disease|0|[10, 11]|500|H|_|_|_|_|_|_|_|9209318
macrocytic anemia|Disease|1|[4, 6]|2|-1|_|_|_|_|_|_|_|9209318
aids|Disease|1|[7, 8]|3|H|_|_|_|_|_|_|_|9209318
azt|Disease|2|[13, 14]|500|-1|_|_|_|_|_|_|_|9209318
azt|Disease|3|[46, 47]|500|-1|_|_|_|_|_|_|_|9209318
azt|Disease|3|[7, 8]|500|-1|_|_|_|_|_|_|_|9209318
thrombocytopenia|Disease|5|[9, 10]|13|-1|_|_|_|_|_|_|_|9209318
mds|Disease|5|[17, 18]|500|H|_|_|_|_|_|_|_|9209318
myelodysplastic syndrome|Disease|5|[14, 16]|500|H|_|_|_|_|_|_|_|9209318
hypocellular marrow|Disease|7|[41, 43]|16|-1|_|_|_|_|_|_|_|9209318
hypocellular marrow|Disease|7|[54, 56]|16|-1|_|_|_|_|_|_|_|9209318
dysmyelopoiesis|Disease|7|[38, 39]|18|-1|_|_|_|_|_|_|_|9209318
hemosiderosis|Disease|7|[51, 52]|19|-1|_|_|_|_|_|_|_|9209318
dyserythropoiesis|Disease|7|[49, 50]|20|-1|_|_|_|_|_|_|_|9209318
azidothymidine (azt)|Chemical|0|[5, 9]|502|-1|_|_|_|_|_|_|_|9209318
azt|Chemical|1|[0, 1]|502|-1|_|_|_|_|_|_|_|9209318
azt|Chemical|1|[12, 13]|502|-1|_|_|_|_|_|_|_|9209318
azt|Chemical|2|[13, 14]|502|-1|_|_|_|_|_|_|_|9209318
azt|Chemical|3|[46, 47]|502|-1|_|_|_|_|_|_|_|9209318
azt|Chemical|3|[7, 8]|502|-1|_|_|_|_|_|_|_|9209318
azt|Chemical|8|[2, 3]|502|-1|_|_|_|_|_|_|_|9209318
0.75 mg|Chemical|4|[8, 12]|502|-1|_|_|_|_|_|_|_|9209318
hepatotoxicity|Disease|0|[10, 11]|500|-1|_|_|_|_|_|_|_|8742498
hepatitis|Disease|1|[44, 45]|500|-1|_|_|_|_|_|_|_|8742498
liver injuries|Disease|3|[0, 2]|500|-1|_|_|_|_|_|_|_|8742498
liver damage|Disease|5|[34, 36]|500|-1|_|_|_|_|_|_|_|8742498
hepatic damage|Disease|8|[21, 23]|500|-1|_|_|_|_|_|_|_|8742498
nad|Chemical|0|[5, 6]|1|H|_|_|_|_|_|_|_|8742498
nad|Chemical|2|[13, 14]|1|H|_|_|_|_|_|_|_|8742498
nad|Chemical|7|[38, 39]|1|H|_|_|_|_|_|_|_|8742498
acetaminophen|Chemical|0|[9, 10]|2|-1|_|_|_|_|_|_|_|8742498
poly(adp-ribose)|Chemical|1|[16, 22]|3|H|_|_|_|_|_|_|_|8742498
poly(adp-ribose)|Chemical|1|[16, 22]|3|H|_|_|_|_|_|_|_|8742498
nicotinic acid amide|Chemical|1|[8, 11]|502|-1|_|_|_|_|_|_|_|8742498
ethanol|Chemical|2|[35, 36]|8|H|_|_|_|_|_|_|_|8742498
oxaloacetate|Chemical|3|[10, 11]|9|-1|_|_|_|_|_|_|_|8742498
pyruvate|Chemical|3|[18, 19]|10|H|_|_|_|_|_|_|_|8742498
glutamate-oxaloacetate transaminase (got)|Chemical|3|[8, 15]|12|-1|_|_|_|_|_|_|_|8742498
glutamate-pyruvate transaminase (gpt)|Chemical|3|[16, 23]|13|-1|_|_|_|_|_|_|_|8742498
nicotinic acid amide (naa)|Chemical|4|[30, 36]|502|-1|_|_|_|_|_|_|_|8742498
aap|Chemical|4|[1, 2]|15|-1|_|_|_|_|_|_|_|8742498
aap|Chemical|5|[17, 18]|15|-1|_|_|_|_|_|_|_|8742498
naa|Chemical|6|[10, 11]|502|-1|_|_|_|_|_|_|_|8742498
naa|Chemical|7|[27, 28]|502|-1|_|_|_|_|_|_|_|8742498
ethanol/aap|Chemical|6|[14, 17]|19|-1|_|_|_|_|_|_|_|8742498
ventricular arrhythmias|Disease|0|[7, 9]|500|-1|_|_|_|_|_|_|_|2435991
ventricular arrhythmias|Disease|1|[16, 18]|500|-1|_|_|_|_|_|_|_|2435991
arrhythmias|Disease|0|[8, 9]|500|-1|_|_|_|_|_|_|_|2435991
arrhythmia|Disease|3|[6, 7]|500|-1|_|_|_|_|_|_|_|2435991
hypotensive|Disease|5|[5, 6]|8|-1|_|_|_|_|_|_|_|2435991
depressive|Disease|5|[9, 10]|9|-1|_|_|_|_|_|_|_|2435991
cibenzoline|Chemical|0|[4, 5]|2|-1|_|_|_|_|_|_|_|2435991
adrenaline|Chemical|1|[12, 13]|4|-1|_|_|_|_|_|_|_|2435991
mexiletine|Chemical|4|[8, 9]|6|-1|_|_|_|_|_|_|_|2435991
tocainide|Chemical|4|[10, 11]|7|-1|_|_|_|_|_|_|_|2435991
glomerular disease|Disease|0|[5, 7]|500|H|_|_|_|_|_|_|_|950631
proteinuria|Disease|1|[7, 8]|3|H|_|_|_|_|_|_|_|950631
arthritis|Disease|1|[4, 5]|501|H|_|_|_|_|_|_|_|950631
rheumatoid arthritis|Disease|1|[3, 5]|501|H|_|_|_|_|_|_|_|950631
mesangial cell hyperactivity|Disease|3|[22, 25]|9|-1|_|_|_|_|_|_|_|950631
fusion of epithelial cell foot processes|Disease|3|[12, 18]|10|-1|_|_|_|_|_|_|_|950631
glomerulonephritis|Disease|5|[9, 10]|500|H|_|_|_|_|_|_|_|950631
penicillamine|Chemical|0|[2, 3]|503|-1|_|_|_|_|_|_|_|950631
d-penicillamine|Chemical|1|[16, 19]|503|-1|_|_|_|_|_|_|_|950631
d-penicillamine|Chemical|1|[16, 19]|503|-1|_|_|_|_|_|_|_|950631
immunopathology|Immune|0|[0, 1]|2|-1|_|_|_|_|_|_|_|950631
classical pathway|Immune|6|[10, 12]|12|-1|_|_|_|_|_|_|_|950631
treatment with d-penicillamine|Treat|1|[14, 19]|8|-1|_|_|_|_|_|_|_|950631
ventricular fibrillation|Disease|0|[0, 2]|0|-1|_|_|_|_|_|_|_|663266
ventricular fibrillation|Disease|3|[0, 2]|0|-1|_|_|_|_|_|_|_|663266
renografin|Chemical|1|[3, 4]|1|H|_|_|_|_|_|_|_|663266
renografin|Chemical|3|[7, 8]|1|H|_|_|_|_|_|_|_|663266
hypaque|Chemical|1|[10, 11]|501|-1|_|_|_|_|_|_|_|663266
sodium citrate|Chemical|2|[19, 21]|3|-1|_|_|_|_|_|_|_|663266
sodium citrate|Chemical|2|[5, 7]|3|-1|_|_|_|_|_|_|_|663266
disodium edetate|Chemical|2|[15, 17]|501|-1|_|_|_|_|_|_|_|663266
disodium edetate|Chemical|2|[8, 10]|501|-1|_|_|_|_|_|_|_|663266
calcium disodium edetate|Chemical|2|[14, 17]|501|-1|_|_|_|_|_|_|_|663266
warfarin|Chemical|0|[12, 13]|0|-1|_|_|_|_|_|_|_|19319147
warfarin|Chemical|1|[0, 1]|0|-1|_|_|_|_|_|_|_|19319147
warfarin|Chemical|1|[0, 1]|0|-1|_|_|_|_|_|_|_|19319147
warfarin|Chemical|4|[8, 9]|0|-1|_|_|_|_|_|_|_|19319147
pcc|Chemical|7|[12, 13]|12|-1|_|_|_|_|_|_|_|19319147
pcc|Chemical|10|[8, 9]|12|-1|_|_|_|_|_|_|_|19319147
intracerebral hemorrhage|Disease|0|[15, 17]|501|-1|_|_|_|_|_|_|_|19319147
stroke|Disease|1|[15, 16]|501|-1|_|_|_|_|_|_|_|19319147
ich|Disease|1|[8, 9]|501|-1|_|_|_|_|_|_|_|19319147
ich|Disease|2|[11, 12]|501|-1|_|_|_|_|_|_|_|19319147
ich|Disease|13|[15, 16]|501|-1|_|_|_|_|_|_|_|19319147
ich|Disease|14|[17, 18]|501|-1|_|_|_|_|_|_|_|19319147
w-ich|Disease|2|[9, 12]|501|-1|_|_|_|_|_|_|_|19319147
w-ich|Disease|13|[13, 16]|501|-1|_|_|_|_|_|_|_|19319147
w-ich|Disease|14|[15, 18]|501|-1|_|_|_|_|_|_|_|19319147
hemorrhage|Disease|6|[11, 12]|501|-1|_|_|_|_|_|_|_|19319147
pcc|Treat|3|[19, 20]|8|-1|_|_|_|_|_|_|_|19319147
pcc|Treat|13|[5, 6]|8|-1|_|_|_|_|_|_|_|19319147
saline i.v.|Treat|7|[20, 25]|13|-1|_|_|_|_|_|_|_|19319147
pcc-treated|Treat|10|[8, 11]|16|-1|_|_|_|_|_|_|_|19319147
international normalized ratio|Physiology|4|[32, 35]|10|-1|_|_|_|_|_|_|_|19319147
blood volume|Physiology|9|[9, 11]|14|-1|_|_|_|_|_|_|_|19319147
alcohol|Chemical|0|[2, 3]|0|-1|_|_|_|_|_|_|_|16634859
amphetamine|Chemical|12|[0, 1]|4|-1|_|_|_|_|_|_|_|16634859
brief alcohol intervention|Treat|4|[21, 24]|1|-1|_|_|_|_|_|_|_|16634859
abstinence|Treat|14|[22, 23]|7|-1|_|_|_|_|_|_|_|16634859
gestational age|Physiology|8|[18, 20]|2|-1|_|_|_|_|_|_|_|16634859
cranial to body growth ratios|Physiology|12|[6, 11]|5|-1|_|_|_|_|_|_|_|16634859
decreased cranial to body growth|Disease|11|[17, 22]|501|-1|_|_|_|_|_|_|_|16634859
fetal alcohol effects|Disease|14|[33, 36]|501|-1|_|_|_|_|_|_|_|16634859
overactive bladder|Disease|0|[11, 13]|500|-1|_|_|_|_|_|_|_|16471092
overactive bladder (oab)|Disease|1|[16, 21]|500|-1|_|_|_|_|_|_|_|16471092
oab|Disease|2|[16, 17]|500|H|_|_|_|_|_|_|_|16471092
oab|Disease|11|[18, 19]|500|H|_|_|_|_|_|_|_|16471092
nocturia|Disease|7|[3, 4]|9|-1|_|_|_|_|_|_|_|16471092
dry mouth|Disease|9|[17, 19]|10|-1|_|_|_|_|_|_|_|16471092
tolterodine|Chemical|0|[14, 15]|1|-1|_|_|_|_|_|_|_|16471092
tolterodine|Chemical|3|[0, 1]|1|-1|_|_|_|_|_|_|_|16471092
tolterodine|Chemical|11|[2, 3]|1|-1|_|_|_|_|_|_|_|16471092
quality of life|Physiology|0|[3, 6]|2|-1|_|_|_|_|_|_|_|16471092
micturition|Physiology|4|[7, 8]|8|-1|_|_|_|_|_|_|_|16471092
physical functioning|Physiology|10|[11, 13]|11|-1|_|_|_|_|_|_|_|16471092
tolterodine treatment|Treat|1|[22, 24]|4|-1|_|_|_|_|_|_|_|16471092
treatment|Treat|4|[3, 4]|7|-1|_|_|_|_|_|_|_|16471092
cocaine|Chemical|0|[6, 7]|0|-1|_|_|_|_|_|_|_|16174948
cocaine|Chemical|1|[2, 3]|0|-1|_|_|_|_|_|_|_|16174948
cocaine|Chemical|2|[10, 11]|0|-1|_|_|_|_|_|_|_|16174948
cocaine|Chemical|3|[12, 13]|0|-1|_|_|_|_|_|_|_|16174948
cocaine|Chemical|3|[25, 26]|0|-1|_|_|_|_|_|_|_|16174948
cocaine|Chemical|4|[16, 17]|0|-1|_|_|_|_|_|_|_|16174948
cocaine|Chemical|7|[6, 7]|0|-1|_|_|_|_|_|_|_|16174948
cocaine|Chemical|11|[33, 34]|0|-1|_|_|_|_|_|_|_|16174948
subarachnoid hemorrhage|Disease|0|[9, 11]|501|H|_|_|_|_|_|_|_|16174948
neurovascular complications|Disease|1|[8, 10]|3|H|_|_|_|_|_|_|_|16174948
vasculitis|Disease|1|[15, 16]|5|-1|_|_|_|_|_|_|_|16174948
sah|Disease|3|[18, 19]|501|H|_|_|_|_|_|_|_|16174948
sah|Disease|4|[6, 7]|501|H|_|_|_|_|_|_|_|16174948
sah|Disease|4|[6, 7]|501|H|_|_|_|_|_|_|_|16174948
sah|Disease|5|[17, 18]|501|H|_|_|_|_|_|_|_|16174948
sah|Disease|5|[17, 18]|501|H|_|_|_|_|_|_|_|16174948
sah|Disease|11|[30, 31]|501|H|_|_|_|_|_|_|_|16174948
subarachnoid hemorrhage (sah)|Disease|3|[15, 20]|501|H|_|_|_|_|_|_|_|16174948
arterial diameter measurements|Disease|5|[1, 4]|17|-1|_|_|_|_|_|_|_|16174948
aneurysmal|Disease|11|[29, 30]|20|-1|_|_|_|_|_|_|_|16174948
cerebral vasoconstriction|Physiology|0|[3, 5]|2|-1|_|_|_|_|_|_|_|16174948
arterial vasoconstriction|Physiology|1|[12, 14]|6|-1|_|_|_|_|_|_|_|16174948
gastric lymphoma|Disease|0|[12, 14]|0|-1|_|_|_|_|_|_|_|15042318
gastric lymphoma|Disease|1|[11, 13]|0|-1|_|_|_|_|_|_|_|15042318
atrial fibrillation|Disease|0|[0, 2]|1|-1|_|_|_|_|_|_|_|15042318
myotonic dystrophy (steinert's disease)|Disease|0|[18, 26]|500|-1|_|_|_|_|_|_|_|15042318
muscular dystrophy|Disease|1|[23, 25]|500|-1|_|_|_|_|_|_|_|15042318
myotonic dystrophy|Disease|1|[14, 16]|500|-1|_|_|_|_|_|_|_|15042318
cardiac arrhythmias|Disease|2|[4, 6]|501|H|_|_|_|_|_|_|_|15042318
arrhythmia|Disease|3|[18, 19]|501|H|_|_|_|_|_|_|_|15042318
chemotherapy|Treat|0|[3, 4]|3|-1|_|_|_|_|_|_|_|15042318
doxorubicin|Chemical|1|[34, 35]|6|-1|_|_|_|_|_|_|_|15042318
renal cell carcinoma|Disease|0|[9, 12]|500|H|_|_|_|_|_|_|_|12448656
renal cell cancer|Disease|1|[15, 18]|500|H|_|_|_|_|_|_|_|12448656
metastases|Disease|6|[23, 24]|501|-1|_|_|_|_|_|_|_|12448656
pulmonary metastases|Disease|6|[22, 24]|501|-1|_|_|_|_|_|_|_|12448656
somnolence|Disease|7|[0, 1]|6|-1|_|_|_|_|_|_|_|12448656
constipation|Disease|7|[2, 3]|7|-1|_|_|_|_|_|_|_|12448656
thalidomide|Chemical|0|[5, 6]|1|-1|_|_|_|_|_|_|_|12448656
vascular endothelial growth factor (vegf)165|Chemical|1|[27, 35]|3|-1|_|_|_|_|_|_|_|12448656
mglur1|Gene|1|[16, 17]|0|-1|_|_|_|_|_|_|_|12231232
parkinsonian|Disease|2|[9, 10]|500|-1|_|_|_|_|_|_|_|12231232
parkinsonian|Disease|6|[23, 24]|500|-1|_|_|_|_|_|_|_|12231232
muscle rigidity|Disease|2|[12, 14]|500|-1|_|_|_|_|_|_|_|12231232
muscle rigidity|Disease|4|[20, 22]|500|-1|_|_|_|_|_|_|_|12231232
muscle rigidity|Disease|6|[24, 26]|500|-1|_|_|_|_|_|_|_|12231232
parkinsonian muscle rigidity|Disease|6|[23, 26]|500|-1|_|_|_|_|_|_|_|12231232
haloperidol|Chemical|2|[0, 1]|2|-1|_|_|_|_|_|_|_|12231232
haloperidol|Chemical|2|[0, 1]|2|-1|_|_|_|_|_|_|_|12231232
haloperidol|Chemical|3|[86, 87]|2|-1|_|_|_|_|_|_|_|12231232
haloperidol|Chemical|4|[17, 18]|2|-1|_|_|_|_|_|_|_|12231232
2r,4r-apdc|Chemical|3|[54, 59]|502|-1|_|_|_|_|_|_|_|12231232
2r,4r-apdc|Chemical|5|[3, 8]|502|-1|_|_|_|_|_|_|_|12231232
2r,4r-apdc|Chemical|5|[3, 8]|502|-1|_|_|_|_|_|_|_|12231232
(rs)-1-aminoindan-1,5-dicarboxylic acid|Chemical|3|[0, 14]|7|-1|_|_|_|_|_|_|_|12231232
(2r,4r)-4-aminopyrrolidine-2,4-dicarboxylate|Chemical|3|[38, 53]|502|-1|_|_|_|_|_|_|_|12231232
aida|Chemical|4|[0, 1]|11|-1|_|_|_|_|_|_|_|12231232
isoflurane|Chemical|0|[6, 7]|0|-1|_|_|_|_|_|_|_|11847945
isoflurane|Chemical|8|[2, 3]|0|-1|_|_|_|_|_|_|_|11847945
dipyrone|Chemical|4|[7, 8]|3|-1|_|_|_|_|_|_|_|11847945
halothane|Chemical|7|[11, 12]|4|-1|_|_|_|_|_|_|_|11847945
cholestatic hepatitis|Disease|1|[8, 10]|1|-1|_|_|_|_|_|_|_|11847945
hepatitis|Disease|3|[13, 14]|2|H|_|_|_|_|_|_|_|11847945
headache|Disease|0|[11, 12]|500|-1|_|_|_|_|_|_|_|11284996
headache|Disease|0|[19, 20]|500|-1|_|_|_|_|_|_|_|11284996
headache|Disease|1|[11, 12]|500|-1|_|_|_|_|_|_|_|11284996
headache|Disease|2|[13, 14]|500|-1|_|_|_|_|_|_|_|11284996
headache|Disease|2|[32, 33]|500|-1|_|_|_|_|_|_|_|11284996
headache|Disease|3|[23, 24]|500|-1|_|_|_|_|_|_|_|11284996
headache|Disease|5|[8, 9]|500|-1|_|_|_|_|_|_|_|11284996
headache|Disease|5|[20, 21]|500|-1|_|_|_|_|_|_|_|11284996
headache|Disease|9|[9, 10]|500|-1|_|_|_|_|_|_|_|11284996
primary headaches|Disease|1|[13, 15]|500|-1|_|_|_|_|_|_|_|11284996
nitric oxide|Chemical|0|[7, 9]|502|-1|_|_|_|_|_|_|_|11284996
nitric oxide (no)|Chemical|1|[5, 10]|502|-1|_|_|_|_|_|_|_|11284996
glyceryl trinitrate (gtn)|Chemical|2|[19, 24]|502|-1|_|_|_|_|_|_|_|11284996
no|Chemical|2|[17, 18]|502|-1|_|_|_|_|_|_|_|11284996
no|Chemical|9|[5, 6]|502|-1|_|_|_|_|_|_|_|11284996
gtn|Chemical|3|[15, 16]|502|-1|_|_|_|_|_|_|_|11284996
gtn|Chemical|5|[11, 12]|502|-1|_|_|_|_|_|_|_|11284996
gtn|Chemical|6|[15, 16]|502|-1|_|_|_|_|_|_|_|11284996
calcitonin gene-related peptide (cgrp)|Gene|1|[21, 29]|6|-1|_|_|_|_|_|_|_|11284996
plasma levels of cgrp|Physiology|2|[8, 12]|11|-1|_|_|_|_|_|_|_|11284996
blood|Physiology|4|[0, 1]|14|-1|_|_|_|_|_|_|_|11284996
gtn|Treat|8|[16, 17]|19|-1|_|_|_|_|_|_|_|11284996
myocardial ischemia|Disease|0|[0, 2]|0|H|_|_|_|_|_|_|_|11078231
myocardial ischemia|Disease|0|[0, 2]|0|H|_|_|_|_|_|_|_|11078231
myocardial ischemia|Disease|1|[14, 16]|0|H|_|_|_|_|_|_|_|11078231
myocardial ischemia|Disease|3|[10, 12]|0|H|_|_|_|_|_|_|_|11078231
coronary artery stenosis|Disease|2|[28, 31]|4|-1|_|_|_|_|_|_|_|11078231
coronary spasm|Disease|3|[14, 16]|500|-1|_|_|_|_|_|_|_|11078231
coronary spasm|Disease|6|[0, 2]|500|-1|_|_|_|_|_|_|_|11078231
coronary spasm|Disease|10|[7, 9]|500|-1|_|_|_|_|_|_|_|11078231
coronary spasm|Disease|11|[18, 20]|500|-1|_|_|_|_|_|_|_|11078231
coronary spastic angina|Disease|4|[7, 10]|500|-1|_|_|_|_|_|_|_|11078231
anginal|Disease|5|[3, 4]|500|H|_|_|_|_|_|_|_|11078231
variant angina|Disease|5|[14, 16]|500|-1|_|_|_|_|_|_|_|11078231
chest pain|Disease|9|[9, 11]|500|-1|_|_|_|_|_|_|_|11078231
chest pain|Disease|9|[16, 18]|500|-1|_|_|_|_|_|_|_|11078231
dobutamine|Chemical|0|[8, 9]|2|-1|_|_|_|_|_|_|_|11078231
hypertension|Disease|0|[11, 12]|0|-1|_|_|_|_|_|_|_|10523326
nitric oxide|Chemical|0|[0, 2]|501|-1|_|_|_|_|_|_|_|10523326
nitrotyrosine|Chemical|1|[26, 27]|2|-1|_|_|_|_|_|_|_|10523326
no|Chemical|1|[15, 16]|501|-1|_|_|_|_|_|_|_|10523326
no|Chemical|1|[23, 24]|501|-1|_|_|_|_|_|_|_|10523326
no|Chemical|10|[11, 12]|501|-1|_|_|_|_|_|_|_|10523326
lead acetate|Chemical|3|[16, 18]|5|-1|_|_|_|_|_|_|_|10523326
vitamin e|Chemical|3|[54, 56]|6|-1|_|_|_|_|_|_|_|10523326
vitamin e|Chemical|3|[36, 38]|6|-1|_|_|_|_|_|_|_|10523326
vitamin e|Chemical|6|[0, 2]|6|-1|_|_|_|_|_|_|_|10523326
malondialdehyde (mda)|Chemical|4|[9, 13]|502|-1|_|_|_|_|_|_|_|10523326
mda|Chemical|6|[8, 9]|502|-1|_|_|_|_|_|_|_|10523326
mda|Chemical|7|[12, 13]|502|-1|_|_|_|_|_|_|_|10523326
lead|Chemical|8|[11, 12]|16|H|_|_|_|_|_|_|_|10523326
blood pressure|Physiology|4|[1, 3]|8|-1|_|_|_|_|_|_|_|10523326
shear stress|Physiology|10|[28, 30]|20|-1|_|_|_|_|_|_|_|10523326
lead-treated|Treat|5|[1, 4]|10|-1|_|_|_|_|_|_|_|10523326
enos|Gene|6|[26, 27]|13|-1|_|_|_|_|_|_|_|10523326
enos|Gene|9|[20, 21]|13|-1|_|_|_|_|_|_|_|10523326
inos|Gene|6|[28, 29]|14|-1|_|_|_|_|_|_|_|10523326
inos|Gene|9|[22, 23]|14|-1|_|_|_|_|_|_|_|10523326
fenfluramine|Chemical|0|[8, 9]|0|-1|_|_|_|_|_|_|_|9867728
phentermine|Chemical|8|[24, 25]|2|-1|_|_|_|_|_|_|_|9867728
aortic regurgitation|Disease|7|[42, 44]|1|-1|_|_|_|_|_|_|_|9867728
aortic insufficiency|Disease|10|[6, 8]|3|-1|_|_|_|_|_|_|_|9867728
carboplatin|Chemical|0|[0, 1]|500|-1|_|_|_|_|_|_|_|9636837
cisplatin|Chemical|1|[14, 15]|1|H|_|_|_|_|_|_|_|9636837
cbdca|Chemical|2|[5, 6]|500|-1|_|_|_|_|_|_|_|9636837
cbdca|Chemical|3|[8, 9]|500|-1|_|_|_|_|_|_|_|9636837
cbdca|Chemical|6|[2, 3]|500|-1|_|_|_|_|_|_|_|9636837
cbdca|Chemical|9|[16, 17]|500|-1|_|_|_|_|_|_|_|9636837
cbdca|Chemical|10|[2, 3]|500|-1|_|_|_|_|_|_|_|9636837
cbdca|Chemical|11|[17, 18]|500|-1|_|_|_|_|_|_|_|9636837
cddp|Chemical|8|[23, 24]|11|-1|_|_|_|_|_|_|_|9636837
cddp|Chemical|10|[25, 26]|11|-1|_|_|_|_|_|_|_|9636837
peripheral nervous system damage|Disease|2|[29, 33]|2|-1|_|_|_|_|_|_|_|9636837
neurotoxicity|Disease|5|[0, 1]|502|-1|_|_|_|_|_|_|_|9636837
neurotoxicity|Disease|5|[0, 1]|502|-1|_|_|_|_|_|_|_|9636837
neurotoxicity|Disease|6|[9, 10]|502|-1|_|_|_|_|_|_|_|9636837
neurotoxicity|Disease|10|[31, 32]|502|-1|_|_|_|_|_|_|_|9636837
peripheral neurotoxicity|Disease|6|[8, 10]|502|-1|_|_|_|_|_|_|_|9636837
nerve conduction velocity|Physiology|5|[14, 17]|7|-1|_|_|_|_|_|_|_|9636837
endometrial carcinoma|Disease|0|[3, 5]|500|-1|_|_|_|_|_|_|_|9579567
endometrial cancer|Disease|2|[6, 8]|500|-1|_|_|_|_|_|_|_|9579567
endometrial cancers|Disease|11|[0, 2]|500|-1|_|_|_|_|_|_|_|9579567
tamoxifen|Chemical|1|[1, 2]|1|-1|_|_|_|_|_|_|_|9579567
treatment|Treat|1|[8, 9]|2|-1|_|_|_|_|_|_|_|9579567
pelvic radiotherapy|Treat|7|[36, 38]|4|-1|_|_|_|_|_|_|_|9579567
tamoxifen|Treat|8|[8, 9]|5|-1|_|_|_|_|_|_|_|9579567
breast cancer prevention|Treat|9|[19, 22]|6|-1|_|_|_|_|_|_|_|9579567
radiotherapy|Treat|10|[1, 2]|7|-1|_|_|_|_|_|_|_|9579567
preventive treatment|Treat|13|[15, 17]|9|-1|_|_|_|_|_|_|_|9579567
granulosa cell tumor of the ovary|Disease|0|[0, 6]|500|-1|_|_|_|_|_|_|_|9205462
breast carcinoma|Disease|3|[21, 23]|2|-1|_|_|_|_|_|_|_|9205462
liver dysfunction|Disease|6|[7, 9]|3|-1|_|_|_|_|_|_|_|9205462
granulosa cell tumors|Disease|6|[15, 18]|500|-1|_|_|_|_|_|_|_|9205462
tamoxifen|Chemical|0|[9, 10]|1|-1|_|_|_|_|_|_|_|9205462
adenomyosis|Disease|0|[4, 5]|0|-1|_|_|_|_|_|_|_|9098464
adenomyosis|Disease|0|[22, 23]|0|-1|_|_|_|_|_|_|_|9098464
hyperprolactinemia|Disease|1|[19, 20]|4|-1|_|_|_|_|_|_|_|9098464
fluoxetine hydrochloride|Chemical|0|[12, 14]|501|-1|_|_|_|_|_|_|_|9098464
serotonin|Chemical|0|[17, 18]|3|H|_|_|_|_|_|_|_|9098464
fluoxetine|Chemical|1|[11, 12]|501|-1|_|_|_|_|_|_|_|9098464
prolactin levels|Physiology|6|[5, 7]|6|-1|_|_|_|_|_|_|_|9098464
hypotension|Disease|0|[3, 4]|0|H|_|_|_|_|_|_|_|8424298
hypotension|Disease|1|[4, 5]|0|H|_|_|_|_|_|_|_|8424298
hypotension|Disease|2|[13, 14]|0|H|_|_|_|_|_|_|_|8424298
hypotension|Disease|3|[3, 4]|0|H|_|_|_|_|_|_|_|8424298
hypotension|Disease|4|[24, 25]|0|H|_|_|_|_|_|_|_|8424298
hypotension|Disease|4|[45, 46]|0|H|_|_|_|_|_|_|_|8424298
hypotension|Disease|8|[4, 5]|0|H|_|_|_|_|_|_|_|8424298
hypotensive|Disease|2|[20, 21]|5|-1|_|_|_|_|_|_|_|8424298
hypotensive|Disease|4|[48, 49]|5|-1|_|_|_|_|_|_|_|8424298
anxiety|Disease|5|[41, 42]|10|-1|_|_|_|_|_|_|_|8424298
depression|Disease|5|[47, 48]|11|-1|_|_|_|_|_|_|_|8424298
labetalol|Chemical|0|[6, 7]|1|-1|_|_|_|_|_|_|_|8424298
isoflurane|Chemical|0|[8, 9]|2|-1|_|_|_|_|_|_|_|8424298
bupivacaine|Chemical|2|[0, 1]|0|-1|_|_|_|_|_|_|_|7880714
bupivacaine|Chemical|2|[20, 21]|0|-1|_|_|_|_|_|_|_|7880714
adrenaline|Chemical|2|[5, 6]|2|-1|_|_|_|_|_|_|_|7880714
hearing impairment|Disease|4|[3, 5]|501|-1|_|_|_|_|_|_|_|7880714
auditory dysfunction|Disease|8|[4, 6]|501|-1|_|_|_|_|_|_|_|7880714
midazolam|Chemical|0|[0, 1]|0|-1|_|_|_|_|_|_|_|7102237
thiopentone|Chemical|0|[3, 4]|1|-1|_|_|_|_|_|_|_|7102237
scopolamine|Chemical|1|[4, 5]|2|-1|_|_|_|_|_|_|_|7102237
morphine|Chemical|1|[6, 7]|3|-1|_|_|_|_|_|_|_|7102237
nitrazepam|Chemical|1|[11, 12]|4|-1|_|_|_|_|_|_|_|7102237
apnoea|Disease|2|[16, 17]|5|-1|_|_|_|_|_|_|_|7102237
induction in combination anaesthesia|Treat|4|[7, 11]|6|-1|_|_|_|_|_|_|_|7102237
cardiotoxic|Disease|0|[0, 1]|0|H|_|_|_|_|_|_|_|6769133
congestive heart failure|Disease|2|[6, 9]|2|-1|_|_|_|_|_|_|_|6769133
cardiomyopathy|Disease|3|[13, 14]|3|-1|_|_|_|_|_|_|_|6769133
myeloblastic leukemia|Disease|4|[7, 9]|4|-1|_|_|_|_|_|_|_|6769133
adriamycin|Chemical|0|[6, 7]|1|-1|_|_|_|_|_|_|_|6769133
prolonged treatment with this drug|Treat|5|[24, 29]|5|-1|_|_|_|_|_|_|_|6769133
doxorubicin|Chemical|0|[0, 1]|0|-1|_|_|_|_|_|_|_|6292680
doxorubicin|Chemical|0|[0, 1]|0|-1|_|_|_|_|_|_|_|6292680
doxorubicin|Chemical|1|[23, 24]|0|-1|_|_|_|_|_|_|_|6292680
doxorubicin|Chemical|2|[30, 31]|0|-1|_|_|_|_|_|_|_|6292680
doxorubicin|Chemical|3|[4, 5]|0|-1|_|_|_|_|_|_|_|6292680
wilms tumor|Disease|0|[8, 10]|2|-1|_|_|_|_|_|_|_|6292680
wilms tumor|Disease|1|[3, 5]|2|-1|_|_|_|_|_|_|_|6292680
wilms tumor|Disease|3|[12, 14]|2|-1|_|_|_|_|_|_|_|6292680
cardiomyopathy|Disease|2|[1, 2]|6|-1|_|_|_|_|_|_|_|6292680
irradiation|Treat|2|[32, 33]|7|-1|_|_|_|_|_|_|_|6292680
postoperative irradiation|Treat|3|[20, 22]|10|-1|_|_|_|_|_|_|_|6292680
fat|Chemical|0|[6, 7]|0|-1|_|_|_|_|_|_|_|3969369
fat|Chemical|3|[25, 26]|0|-1|_|_|_|_|_|_|_|3969369
testosterone|Chemical|0|[3, 4]|1|-1|_|_|_|_|_|_|_|3969369
prostate adenocarcinomas|Disease|1|[21, 23]|501|-1|_|_|_|_|_|_|_|3969369
prostate cancer|Disease|2|[17, 19]|501|-1|_|_|_|_|_|_|_|3969369
prostatitis|Disease|5|[14, 15]|6|-1|_|_|_|_|_|_|_|3969369
implanted|Treat|2|[4, 5]|4|-1|_|_|_|_|_|_|_|3969369
genetic susceptibility|Gene|6|[4, 6]|7|-1|_|_|_|_|_|_|_|3969369
mitomycin c|Chemical|0|[0, 2]|0|-1|_|_|_|_|_|_|_|3108839
mitomycin c|Chemical|1|[0, 2]|0|-1|_|_|_|_|_|_|_|3108839
mitomycin c|Chemical|2|[14, 16]|0|-1|_|_|_|_|_|_|_|3108839
mitomycin c|Chemical|3|[13, 15]|0|-1|_|_|_|_|_|_|_|3108839
mitomycin c|Chemical|5|[7, 9]|0|-1|_|_|_|_|_|_|_|3108839
mitomycin c|Chemical|6|[28, 30]|0|-1|_|_|_|_|_|_|_|3108839
hemolytic uremic syndrome|Disease|1|[3, 6]|501|H|_|_|_|_|_|_|_|3108839
progressive renal failure|Disease|2|[9, 12]|501|H|_|_|_|_|_|_|_|3108839
hemolytic anemia|Disease|2|[4, 6]|501|H|_|_|_|_|_|_|_|3108839
thrombocytopenia|Disease|2|[7, 8]|5|-1|_|_|_|_|_|_|_|3108839
thrombocytopenia|Disease|6|[23, 24]|5|-1|_|_|_|_|_|_|_|3108839
edema|Disease|3|[27, 28]|7|H|_|_|_|_|_|_|_|3108839
edema|Disease|6|[34, 35]|7|H|_|_|_|_|_|_|_|3108839
hus|Disease|4|[9, 10]|501|H|_|_|_|_|_|_|_|3108839
arteriolar fibrin thrombi|Disease|4|[12, 15]|10|H|_|_|_|_|_|_|_|3108839
mesangiolysis|Disease|4|[31, 32]|11|-1|_|_|_|_|_|_|_|3108839
gastric adenocarcinoma|Disease|6|[16, 18]|15|-1|_|_|_|_|_|_|_|3108839
fluorouracil|Chemical|0|[5, 6]|500|-1|_|_|_|_|_|_|_|2466960
fluorouracil (5-fu)|Chemical|1|[11, 17]|500|-1|_|_|_|_|_|_|_|2466960
5-fu|Chemical|2|[11, 14]|500|-1|_|_|_|_|_|_|_|2466960
5-fu|Chemical|3|[11, 14]|500|-1|_|_|_|_|_|_|_|2466960
5-fu|Chemical|3|[24, 27]|500|-1|_|_|_|_|_|_|_|2466960
5-fu|Chemical|4|[12, 15]|500|-1|_|_|_|_|_|_|_|2466960
5-fu|Chemical|5|[40, 43]|500|-1|_|_|_|_|_|_|_|2466960
5-fu|Chemical|5|[30, 33]|500|-1|_|_|_|_|_|_|_|2466960
5-fu|Chemical|6|[36, 39]|500|-1|_|_|_|_|_|_|_|2466960
5-fu|Chemical|6|[88, 91]|500|-1|_|_|_|_|_|_|_|2466960
5-fu|Chemical|6|[69, 72]|500|-1|_|_|_|_|_|_|_|2466960
5-fu|Chemical|6|[21, 24]|500|-1|_|_|_|_|_|_|_|2466960
5-fu|Chemical|9|[3, 6]|500|-1|_|_|_|_|_|_|_|2466960
solid tumors|Disease|2|[18, 20]|2|-1|_|_|_|_|_|_|_|2466960
anginal|Disease|4|[0, 1]|502|-1|_|_|_|_|_|_|_|2466960
angina|Disease|4|[9, 10]|502|-1|_|_|_|_|_|_|_|2466960
sudden death|Disease|8|[5, 7]|17|-1|_|_|_|_|_|_|_|2466960
infusion|Treat|2|[14, 15]|4|-1|_|_|_|_|_|_|_|2466960
chemotherapy|Treat|8|[17, 18]|18|-1|_|_|_|_|_|_|_|2466960
ecg|Physiology|6|[51, 52]|16|-1|_|_|_|_|_|_|_|2466960
anuria|Disease|0|[1, 2]|0|-1|_|_|_|_|_|_|_|2320800
anuria|Disease|1|[24, 25]|0|-1|_|_|_|_|_|_|_|2320800
anuria|Disease|3|[24, 25]|0|-1|_|_|_|_|_|_|_|2320800
anuria|Disease|6|[6, 7]|0|-1|_|_|_|_|_|_|_|2320800
impaired renal function|Disease|0|[14, 17]|2|H|_|_|_|_|_|_|_|2320800
postrenal failure|Disease|2|[0, 2]|5|-1|_|_|_|_|_|_|_|2320800
hypotension|Disease|3|[13, 14]|6|-1|_|_|_|_|_|_|_|2320800
hypotension|Disease|6|[30, 31]|6|-1|_|_|_|_|_|_|_|2320800
tubulopathies|Disease|5|[8, 9]|10|-1|_|_|_|_|_|_|_|2320800
nephrotoxic|Disease|7|[10, 11]|15|H|_|_|_|_|_|_|_|2320800
ifosfamide|Chemical|0|[5, 6]|1|-1|_|_|_|_|_|_|_|2320800
ifosfamide|Chemical|5|[0, 1]|1|-1|_|_|_|_|_|_|_|2320800
cisplatin|Chemical|1|[15, 16]|4|-1|_|_|_|_|_|_|_|2320800
hypotension|Physiology|3|[13, 14]|8|-1|_|_|_|_|_|_|_|2320800
hemodynamic parameters|Physiology|4|[5, 7]|9|-1|_|_|_|_|_|_|_|2320800
kidney perfusion|Physiology|6|[25, 27]|14|-1|_|_|_|_|_|_|_|2320800
chemotherapy|Treat|7|[11, 12]|16|-1|_|_|_|_|_|_|_|2320800
vein thrombosis|Disease|0|[1, 3]|0|-1|_|_|_|_|_|_|_|2220369
vein thrombosis|Disease|1|[15, 17]|0|-1|_|_|_|_|_|_|_|2220369
glaucoma|Disease|1|[33, 34]|3|-1|_|_|_|_|_|_|_|2220369
dipivalyl epinephrine|Chemical|0|[5, 7]|1|-1|_|_|_|_|_|_|_|2220369
hypokalemia|Disease|0|[5, 6]|0|-1|_|_|_|_|_|_|_|326460
bendrofluazide|Chemical|0|[2, 3]|1|-1|_|_|_|_|_|_|_|326460
bendrofluazide|Chemical|2|[13, 14]|1|-1|_|_|_|_|_|_|_|326460
timolol|Chemical|0|[7, 8]|2|-1|_|_|_|_|_|_|_|326460
timolol|Chemical|2|[0, 1]|2|-1|_|_|_|_|_|_|_|326460
plasma aldosterone|Physiology|2|[6, 8]|5|-1|_|_|_|_|_|_|_|326460
urine potassium excretion|Physiology|2|[9, 12]|6|-1|_|_|_|_|_|_|_|326460
urine sodium/potassium ratio|Physiology|2|[17, 22]|7|-1|_|_|_|_|_|_|_|326460
risperidone|Chemical|0|[9, 10]|0|-1|_|_|_|_|_|_|_|20331935
risperidone|Chemical|6|[17, 18]|0|-1|_|_|_|_|_|_|_|20331935
selective serotonin reuptake inhibitors|Chemical|0|[11, 15]|1|-1|_|_|_|_|_|_|_|20331935
testosterone|Chemical|7|[1, 2]|7|-1|_|_|_|_|_|_|_|20331935
serotonin|Chemical|10|[11, 12]|11|H|_|_|_|_|_|_|_|20331935
bone mineral density|Physiology|0|[16, 19]|2|-1|_|_|_|_|_|_|_|20331935
bone mineral density (bmd)|Physiology|1|[20, 26]|4|-1|_|_|_|_|_|_|_|20331935
bone mineral content|Physiology|8|[3, 6]|8|-1|_|_|_|_|_|_|_|20331935
bmd|Physiology|8|[7, 8]|9|-1|_|_|_|_|_|_|_|20331935
bmd|Physiology|10|[23, 24]|9|-1|_|_|_|_|_|_|_|20331935
bmd|Physiology|10|[34, 35]|9|-1|_|_|_|_|_|_|_|20331935
bmd|Physiology|13|[18, 19]|9|-1|_|_|_|_|_|_|_|20331935
bmi|Physiology|9|[11, 12]|10|-1|_|_|_|_|_|_|_|20331935
hyperprolactinemia|Disease|1|[17, 18]|3|-1|_|_|_|_|_|_|_|20331935
hyperprolactinemia|Disease|6|[2, 3]|3|-1|_|_|_|_|_|_|_|20331935
fractures|Disease|12|[3, 4]|501|-1|_|_|_|_|_|_|_|20331935
fracture|Disease|14|[20, 21]|501|-1|_|_|_|_|_|_|_|20331935
treatment with selective serotonin reuptake inhibitors (ssris)|Treat|10|[8, 17]|12|-1|_|_|_|_|_|_|_|20331935
seizures|Disease|0|[0, 1]|0|-1|_|_|_|_|_|_|_|19707748
levofloxacin|Chemical|0|[3, 4]|1|-1|_|_|_|_|_|_|_|19707748
cytochrome p450 (cyp) 1a2|Chemical|1|[32, 38]|2|-1|_|_|_|_|_|_|_|19707748
cyp1a2|Gene|7|[22, 23]|3|-1|_|_|_|_|_|_|_|19707748
polyuria|Disease|0|[11, 12]|0|-1|_|_|_|_|_|_|_|19692487
polyuria|Disease|1|[13, 14]|0|-1|_|_|_|_|_|_|_|19692487
polyuria|Disease|3|[10, 11]|0|-1|_|_|_|_|_|_|_|19692487
polyuria|Disease|4|[36, 37]|0|-1|_|_|_|_|_|_|_|19692487
polyuria|Disease|6|[17, 18]|0|-1|_|_|_|_|_|_|_|19692487
polyuria|Disease|12|[16, 17]|0|-1|_|_|_|_|_|_|_|19692487
lithium|Chemical|0|[8, 9]|1|H|_|_|_|_|_|_|_|19692487
licl|Chemical|4|[6, 7]|7|-1|_|_|_|_|_|_|_|19692487
pge(2)|Chemical|5|[14, 18]|8|-1|_|_|_|_|_|_|_|19692487
pge(2)|Chemical|5|[14, 18]|8|-1|_|_|_|_|_|_|_|19692487
pge(2)|Chemical|6|[32, 36]|8|-1|_|_|_|_|_|_|_|19692487
pge(2)|Chemical|6|[32, 36]|8|-1|_|_|_|_|_|_|_|19692487
pge(2)|Chemical|12|[8, 12]|8|-1|_|_|_|_|_|_|_|19692487
pge(2)|Chemical|12|[8, 12]|8|-1|_|_|_|_|_|_|_|19692487
mpges-1|Gene|0|[2, 5]|2|-1|_|_|_|_|_|_|_|19692487
mpges-1|Gene|3|[22, 25]|2|-1|_|_|_|_|_|_|_|19692487
mpges-1|Gene|12|[3, 6]|2|-1|_|_|_|_|_|_|_|19692487
aqp2|Gene|7|[22, 23]|13|-1|_|_|_|_|_|_|_|19692487
aqp2|Gene|9|[9, 10]|13|-1|_|_|_|_|_|_|_|19692487
aqp2|Gene|12|[21, 22]|13|-1|_|_|_|_|_|_|_|19692487
-/-|Gene|8|[7, 10]|14|-1|_|_|_|_|_|_|_|19692487
nkcc2|Gene|10|[15, 16]|16|-1|_|_|_|_|_|_|_|19692487
nkcc2|Gene|11|[8, 9]|16|-1|_|_|_|_|_|_|_|19692487
nkcc2|Gene|12|[23, 24]|16|-1|_|_|_|_|_|_|_|19692487
chondroitin sulfate|Chemical|0|[13, 15]|500|-1|_|_|_|_|_|_|_|19289093
gag derivatives|Chemical|6|[15, 17]|500|-1|_|_|_|_|_|_|_|19289093
hypotensive|Disease|2|[28, 29]|502|-1|_|_|_|_|_|_|_|19289093
hypotension|Disease|3|[20, 21]|502|-1|_|_|_|_|_|_|_|19289093
doxorubicin|Chemical|0|[0, 1]|500|-1|_|_|_|_|_|_|_|18627295
doxorubicin|Chemical|1|[5, 6]|500|-1|_|_|_|_|_|_|_|18627295
dox|Chemical|2|[42, 43]|500|-1|_|_|_|_|_|_|_|18627295
dox|Chemical|2|[17, 18]|500|-1|_|_|_|_|_|_|_|18627295
dox|Chemical|6|[1, 2]|500|-1|_|_|_|_|_|_|_|18627295
dox|Chemical|6|[16, 17]|500|-1|_|_|_|_|_|_|_|18627295
dox|Chemical|7|[8, 9]|500|-1|_|_|_|_|_|_|_|18627295
mrna|Chemical|5|[2, 3]|15|-1|_|_|_|_|_|_|_|18627295
cardiomyopathy|Disease|0|[1, 2]|1|-1|_|_|_|_|_|_|_|18627295
cardiotoxic|Disease|1|[13, 14]|3|-1|_|_|_|_|_|_|_|18627295
cardiac dysfunction|Disease|3|[4, 6]|10|H|_|_|_|_|_|_|_|18627295
kinin b1 receptor|Gene|0|[14, 17]|2|-1|_|_|_|_|_|_|_|18627295
b1r|Gene|2|[11, 12]|7|-1|_|_|_|_|_|_|_|18627295
b1r|Gene|2|[26, 27]|7|-1|_|_|_|_|_|_|_|18627295
b1r|Gene|2|[22, 23]|7|-1|_|_|_|_|_|_|_|18627295
b1r|Gene|7|[4, 5]|7|-1|_|_|_|_|_|_|_|18627295
akt|Gene|4|[9, 10]|12|-1|_|_|_|_|_|_|_|18627295
bax|Gene|4|[16, 17]|13|-1|_|_|_|_|_|_|_|18627295
bcl2|Gene|4|[18, 19]|14|-1|_|_|_|_|_|_|_|18627295
bcl-2|Gene|6|[29, 32]|19|-1|_|_|_|_|_|_|_|18627295
pressure-volume loops|Physiology|3|[8, 12]|11|-1|_|_|_|_|_|_|_|18627295
interleukin 6|Immune|5|[8, 10]|16|-1|_|_|_|_|_|_|_|18627295
arthritis|Disease|0|[6, 7]|0|-1|_|_|_|_|_|_|_|18405372
hepatotoxicity|Disease|0|[0, 1]|1|-1|_|_|_|_|_|_|_|18405372
liver failure|Disease|2|[28, 30]|500|-1|_|_|_|_|_|_|_|18405372
hepatic failure|Disease|8|[7, 9]|500|-1|_|_|_|_|_|_|_|18405372
rash|Disease|10|[5, 6]|501|-1|_|_|_|_|_|_|_|18405372
interstitial nephritis|Disease|10|[11, 13]|7|-1|_|_|_|_|_|_|_|18405372
skin rash|Disease|10|[4, 6]|501|-1|_|_|_|_|_|_|_|18405372
sulfasalazine|Chemical|0|[3, 4]|2|-1|_|_|_|_|_|_|_|18405372
liver transplant|Treat|8|[14, 16]|5|-1|_|_|_|_|_|_|_|18405372
nephrotoxicity|Disease|0|[4, 5]|0|-1|_|_|_|_|_|_|_|18356633
nephrotoxicity|Disease|3|[5, 6]|0|-1|_|_|_|_|_|_|_|18356633
nephrotoxicity|Disease|5|[3, 4]|0|-1|_|_|_|_|_|_|_|18356633
nephrotoxicity|Disease|6|[3, 4]|0|-1|_|_|_|_|_|_|_|18356633
nephrotoxicity|Disease|8|[3, 4]|0|-1|_|_|_|_|_|_|_|18356633
febrile neutropenia|Disease|1|[15, 17]|2|-1|_|_|_|_|_|_|_|18356633
oncology|Disease|2|[32, 33]|5|H|_|_|_|_|_|_|_|18356633
hematologic/oncologic disorder|Disease|4|[8, 12]|7|H|_|_|_|_|_|_|_|18356633
amikacin|Chemical|0|[3, 4]|1|-1|_|_|_|_|_|_|_|18356633
amikacin|Chemical|1|[0, 1]|1|-1|_|_|_|_|_|_|_|18356633
empirical double gram-negative treatment|Treat|1|[8, 14]|4|-1|_|_|_|_|_|_|_|18356633
treatment with an aminoglycoside|Treat|4|[14, 18]|8|-1|_|_|_|_|_|_|_|18356633
serotonin|Chemical|0|[3, 4]|0|-1|_|_|_|_|_|_|_|16574713
mdma|Chemical|1|[7, 8]|2|-1|_|_|_|_|_|_|_|16574713
mdma|Chemical|1|[40, 41]|2|-1|_|_|_|_|_|_|_|16574713
mdma|Chemical|2|[51, 52]|2|-1|_|_|_|_|_|_|_|16574713
mdma|Chemical|3|[14, 15]|2|-1|_|_|_|_|_|_|_|16574713
mdma|Chemical|3|[31, 32]|2|-1|_|_|_|_|_|_|_|16574713
mdma|Chemical|5|[2, 3]|2|-1|_|_|_|_|_|_|_|16574713
mdma|Chemical|5|[24, 25]|2|-1|_|_|_|_|_|_|_|16574713
mdma|Chemical|5|[12, 13]|2|-1|_|_|_|_|_|_|_|16574713
mdma|Chemical|8|[4, 5]|2|-1|_|_|_|_|_|_|_|16574713
mdma|Chemical|9|[12, 13]|2|-1|_|_|_|_|_|_|_|16574713
mdma|Chemical|11|[4, 5]|2|-1|_|_|_|_|_|_|_|16574713
mdma|Chemical|11|[25, 26]|2|-1|_|_|_|_|_|_|_|16574713
mdma|Chemical|12|[12, 13]|2|-1|_|_|_|_|_|_|_|16574713
serotonin transporter promoter gene|Gene|0|[3, 7]|1|-1|_|_|_|_|_|_|_|16574713
5-httlpr|Gene|2|[42, 45]|4|-1|_|_|_|_|_|_|_|16574713
5-httlpr|Gene|3|[37, 40]|4|-1|_|_|_|_|_|_|_|16574713
5-httlpr|Gene|6|[9, 12]|4|-1|_|_|_|_|_|_|_|16574713
5-httlpr|Gene|10|[4, 7]|4|-1|_|_|_|_|_|_|_|16574713
5-httlpr|Gene|12|[3, 6]|4|-1|_|_|_|_|_|_|_|16574713
memory function|Physiology|7|[8, 10]|13|-1|_|_|_|_|_|_|_|16574713
memory impairment|Disease|9|[6, 8]|501|-1|_|_|_|_|_|_|_|16574713
memory impairments|Disease|11|[32, 34]|501|-1|_|_|_|_|_|_|_|16574713
haloperidol|Chemical|0|[16, 17]|500|-1|_|_|_|_|_|_|_|15638391
haloperidol|Chemical|1|[15, 16]|500|-1|_|_|_|_|_|_|_|15638391
haloperidol (hal)|Chemical|1|[15, 19]|500|-1|_|_|_|_|_|_|_|15638391
testosterone|Chemical|3|[8, 9]|500|-1|_|_|_|_|_|_|_|15638391
anti-proliferating cell nuclear antigen (pcna)|Chemical|5|[3, 12]|500|-1|_|_|_|_|_|_|_|15638391
t|Chemical|6|[20, 21]|500|-1|_|_|_|_|_|_|_|15638391
pcna|Chemical|7|[18, 19]|500|-1|_|_|_|_|_|_|_|15638391
hyperprolactinemia|Disease|0|[13, 14]|1|-1|_|_|_|_|_|_|_|15638391
hyperplasia|Disease|7|[9, 10]|7|-1|_|_|_|_|_|_|_|15638391
cardiovascular disease|Disease|0|[5, 7]|0|H|_|_|_|_|_|_|_|15531665
diabetes|Disease|0|[11, 12]|2|-1|_|_|_|_|_|_|_|15531665
stroke|Disease|4|[32, 33]|5|-1|_|_|_|_|_|_|_|15531665
stroke|Disease|6|[39, 40]|5|-1|_|_|_|_|_|_|_|15531665
vitamin c|Chemical|0|[2, 4]|1|-1|_|_|_|_|_|_|_|15531665
vitamin c|Chemical|1|[2, 4]|1|-1|_|_|_|_|_|_|_|15531665
vitamin c|Chemical|2|[11, 13]|1|-1|_|_|_|_|_|_|_|15531665
vitamin c|Chemical|5|[103, 105]|1|-1|_|_|_|_|_|_|_|15531665
vitamin c|Chemical|7|[4, 6]|1|-1|_|_|_|_|_|_|_|15531665
vitamin c|Chemical|7|[12, 14]|1|-1|_|_|_|_|_|_|_|15531665
vitamin c|Chemical|8|[0, 2]|1|-1|_|_|_|_|_|_|_|15531665
vitamin c|Chemical|9|[4, 6]|1|-1|_|_|_|_|_|_|_|15531665
vitamin e|Chemical|5|[52, 54]|7|-1|_|_|_|_|_|_|_|15531665
beta-carotene|Chemical|5|[56, 59]|8|-1|_|_|_|_|_|_|_|15531665
venous thromboembolism|Disease|0|[5, 7]|0|-1|_|_|_|_|_|_|_|12851669
vte|Disease|2|[38, 39]|2|-1|_|_|_|_|_|_|_|12851669
vte|Disease|5|[17, 18]|2|-1|_|_|_|_|_|_|_|12851669
vte|Disease|8|[5, 6]|2|-1|_|_|_|_|_|_|_|12851669
vte|Disease|9|[9, 10]|2|-1|_|_|_|_|_|_|_|12851669
ethinylestradiol|Chemical|0|[14, 15]|1|-1|_|_|_|_|_|_|_|12851669
cocs|Chemical|5|[20, 21]|4|H|_|_|_|_|_|_|_|12851669
cocs|Chemical|8|[57, 58]|4|H|_|_|_|_|_|_|_|12851669
cocs|Chemical|8|[30, 31]|4|H|_|_|_|_|_|_|_|12851669
cocs|Chemical|9|[14, 15]|4|H|_|_|_|_|_|_|_|12851669
levonorgestrel|Chemical|6|[7, 8]|5|-1|_|_|_|_|_|_|_|12851669
neurotoxicity|Disease|0|[17, 18]|0|H|_|_|_|_|_|_|_|12842176
convulsions|Disease|6|[35, 36]|11|-1|_|_|_|_|_|_|_|12842176
convulsions|Disease|6|[69, 70]|11|-1|_|_|_|_|_|_|_|12842176
lindane|Chemical|0|[2, 3]|1|-1|_|_|_|_|_|_|_|12842176
lindane|Chemical|0|[15, 16]|1|-1|_|_|_|_|_|_|_|12842176
ndma|Chemical|1|[66, 67]|501|-1|_|_|_|_|_|_|_|12842176
ndma|Chemical|5|[29, 30]|501|-1|_|_|_|_|_|_|_|12842176
7-ethoxyresorufin-o-deethylase (erod)|Chemical|1|[39, 49]|4|-1|_|_|_|_|_|_|_|12842176
7-pentoxyresorufin-o-dealkylase (prod)|Chemical|1|[50, 60]|5|-1|_|_|_|_|_|_|_|12842176
n-nitrosodimethylamine demethylase (ndma-d)|Chemical|1|[61, 70]|501|-1|_|_|_|_|_|_|_|12842176
p450 1a1/1a2|Chemical|4|[22, 26]|7|H|_|_|_|_|_|_|_|12842176
mc|Chemical|6|[13, 14]|502|H|_|_|_|_|_|_|_|12842176
3-methylcholanthrene (mc)|Chemical|6|[9, 15]|502|H|_|_|_|_|_|_|_|12842176
phenobarbital (pb)|Chemical|6|[39, 43]|14|-1|_|_|_|_|_|_|_|12842176
ethanol|Chemical|6|[52, 53]|15|-1|_|_|_|_|_|_|_|12842176
cobalt chloride|Chemical|7|[13, 15]|16|-1|_|_|_|_|_|_|_|12842176
p450 2b1/2b2|Gene|5|[41, 45]|9|-1|_|_|_|_|_|_|_|12842176
seizure|Disease|0|[0, 1]|500|-1|_|_|_|_|_|_|_|12745515
seizures|Disease|4|[8, 9]|500|-1|_|_|_|_|_|_|_|12745515
bupropion|Chemical|0|[9, 10]|1|-1|_|_|_|_|_|_|_|12745515
angiography|Treat|0|[8, 9]|0|-1|_|_|_|_|_|_|_|12571256
nephropathy|Disease|1|[11, 12]|1|-1|_|_|_|_|_|_|_|12571256
nephropathy|Disease|11|[2, 3]|1|-1|_|_|_|_|_|_|_|12571256
nephrotoxic|Disease|2|[8, 9]|2|-1|_|_|_|_|_|_|_|12571256
diabetes|Disease|4|[6, 7]|5|-1|_|_|_|_|_|_|_|12571256
iodixanol|Chemical|3|[31, 32]|3|-1|_|_|_|_|_|_|_|12571256
iohexol|Chemical|3|[47, 48]|4|-1|_|_|_|_|_|_|_|12571256
capsaicin|Chemical|0|[5, 6]|0|-1|_|_|_|_|_|_|_|9514561
capsaicin|Chemical|4|[4, 5]|0|-1|_|_|_|_|_|_|_|9514561
headache|Disease|1|[35, 36]|1|H|_|_|_|_|_|_|_|9514561
headache|Disease|1|[28, 29]|1|H|_|_|_|_|_|_|_|9514561
headache|Disease|7|[37, 38]|1|H|_|_|_|_|_|_|_|9514561
headache|Disease|7|[43, 44]|1|H|_|_|_|_|_|_|_|9514561
migraine without aura|Disease|1|[15, 18]|501|H|_|_|_|_|_|_|_|9514561
migraine|Disease|2|[12, 13]|501|-1|_|_|_|_|_|_|_|9514561
migraine|Disease|2|[21, 22]|501|-1|_|_|_|_|_|_|_|9514561
painful|Disease|4|[16, 17]|6|H|_|_|_|_|_|_|_|9514561
pain|Disease|6|[27, 28]|9|H|_|_|_|_|_|_|_|9514561
pain|Disease|6|[22, 23]|9|H|_|_|_|_|_|_|_|9514561
cluster headache|Disease|7|[42, 44]|13|-1|_|_|_|_|_|_|_|9514561
regional cerebral blood flow (rcbf)|Physiology|5|[2, 9]|8|-1|_|_|_|_|_|_|_|9514561
neuroleptic malignant syndrome|Disease|0|[0, 3]|0|-1|_|_|_|_|_|_|_|9165568
neuroleptic malignant syndrome|Disease|1|[0, 3]|0|-1|_|_|_|_|_|_|_|9165568
extrapyramidal symptoms|Disease|3|[11, 13]|6|-1|_|_|_|_|_|_|_|9165568
risperidone|Chemical|0|[4, 5]|1|-1|_|_|_|_|_|_|_|9165568
risperidone|Chemical|2|[0, 1]|1|-1|_|_|_|_|_|_|_|9165568
dopamine|Chemical|1|[10, 11]|3|H|_|_|_|_|_|_|_|9165568
serotonin|Chemical|2|[9, 10]|5|-1|_|_|_|_|_|_|_|9165568
dantrolene|Chemical|6|[10, 11]|7|-1|_|_|_|_|_|_|_|9165568
bromocriptine|Chemical|6|[12, 13]|8|-1|_|_|_|_|_|_|_|9165568
nephrotic syndrome|Disease|0|[10, 12]|500|H|_|_|_|_|_|_|_|9154656
nephrotic syndrome (ns)|Disease|1|[17, 22]|500|H|_|_|_|_|_|_|_|9154656
nephrotic|Disease|2|[44, 45]|500|-1|_|_|_|_|_|_|_|9154656
pan|Disease|5|[36, 37]|11|-1|_|_|_|_|_|_|_|9154656
angiotensinogen|Gene|0|[3, 4]|1|-1|_|_|_|_|_|_|_|9154656
mrna|Gene|2|[8, 9]|6|-1|_|_|_|_|_|_|_|9154656
mrna|Gene|5|[4, 5]|6|-1|_|_|_|_|_|_|_|9154656
ao|Gene|4|[12, 13]|9|-1|_|_|_|_|_|_|_|9154656
ao|Gene|4|[29, 30]|9|-1|_|_|_|_|_|_|_|9154656
ao mrna|Gene|6|[8, 10]|15|-1|_|_|_|_|_|_|_|9154656
mrna|Chemical|2|[8, 9]|502|-1|_|_|_|_|_|_|_|9154656
angiotensinogen|Chemical|2|[12, 13]|502|-1|_|_|_|_|_|_|_|9154656
puromycin amino-nucleoside (pan)|Chemical|3|[8, 15]|503|-1|_|_|_|_|_|_|_|9154656
pan|Chemical|4|[19, 20]|503|H|_|_|_|_|_|_|_|9154656
pan|Chemical|6|[22, 23]|503|H|_|_|_|_|_|_|_|9154656
ao mrna|Chemical|5|[3, 5]|502|-1|_|_|_|_|_|_|_|9154656
bladder cancer|Disease|0|[2, 4]|500|-1|_|_|_|_|_|_|_|8911359
urothelial cancer|Disease|1|[15, 17]|500|-1|_|_|_|_|_|_|_|8911359
cyclophosphamide associated bladder tumor|Disease|7|[2, 6]|500|-1|_|_|_|_|_|_|_|8911359
bladder tumors|Disease|8|[14, 16]|500|-1|_|_|_|_|_|_|_|8911359
cyclophosphamide|Chemical|0|[0, 1]|1|-1|_|_|_|_|_|_|_|8911359
cyclophosphamide|Chemical|7|[2, 3]|1|-1|_|_|_|_|_|_|_|8911359
endoscopic resection|Treat|4|[7, 9]|3|-1|_|_|_|_|_|_|_|8911359
cystectomy|Treat|5|[7, 8]|4|-1|_|_|_|_|_|_|_|8911359
partial cystectomy|Treat|6|[7, 9]|5|-1|_|_|_|_|_|_|_|8911359
back pain|Disease|0|[2, 4]|500|-1|_|_|_|_|_|_|_|8686832
pain|Disease|2|[5, 6]|500|-1|_|_|_|_|_|_|_|8686832
recovery from anaesthesia|Disease|2|[14, 17]|3|H|_|_|_|_|_|_|_|8686832
leg and/or back pain|Disease|5|[0, 6]|500|-1|_|_|_|_|_|_|_|8686832
lignocaine|Chemical|0|[10, 11]|1|-1|_|_|_|_|_|_|_|8686832
alcohol|Chemical|4|[25, 26]|4|-1|_|_|_|_|_|_|_|8686832
hypertension|Disease|0|[11, 12]|500|-1|_|_|_|_|_|_|_|8607407
hypertensive|Disease|1|[9, 10]|500|-1|_|_|_|_|_|_|_|8607407
hypertensive|Disease|3|[1, 2]|500|-1|_|_|_|_|_|_|_|8607407
hypertensive|Disease|9|[19, 20]|500|-1|_|_|_|_|_|_|_|8607407
hypertensive|Disease|10|[4, 5]|500|-1|_|_|_|_|_|_|_|8607407
hypertensives|Disease|10|[34, 35]|500|-1|_|_|_|_|_|_|_|8607407
caffeine|Chemical|0|[5, 6]|1|-1|_|_|_|_|_|_|_|8607407
blood pressure|Physiology|0|[1, 3]|2|-1|_|_|_|_|_|_|_|8607407
diastolic bp|Physiology|6|[5, 7]|5|-1|_|_|_|_|_|_|_|8607407
systemic vascular resistance|Physiology|6|[51, 54]|6|-1|_|_|_|_|_|_|_|8607407
resistance states|Physiology|11|[10, 12]|11|-1|_|_|_|_|_|_|_|8607407
treatment|Treat|11|[32, 33]|10|-1|_|_|_|_|_|_|_|8607407
neurotoxicity|Disease|0|[5, 6]|0|H|_|_|_|_|_|_|_|8111719
neurotoxicity|Disease|1|[8, 9]|0|H|_|_|_|_|_|_|_|8111719
neurotoxicity|Disease|7|[11, 12]|0|H|_|_|_|_|_|_|_|8111719
neurotoxicity|Disease|9|[19, 20]|0|H|_|_|_|_|_|_|_|8111719
hallucinations|Disease|0|[0, 1]|500|-1|_|_|_|_|_|_|_|8111719
hallucinations|Disease|0|[0, 1]|500|-1|_|_|_|_|_|_|_|8111719
hallucinations|Disease|1|[2, 3]|500|-1|_|_|_|_|_|_|_|8111719
hallucinations|Disease|2|[6, 7]|500|-1|_|_|_|_|_|_|_|8111719
hallucinations|Disease|3|[11, 12]|500|-1|_|_|_|_|_|_|_|8111719
hallucinations|Disease|5|[2, 3]|500|-1|_|_|_|_|_|_|_|8111719
hallucinations|Disease|5|[2, 3]|500|-1|_|_|_|_|_|_|_|8111719
hallucinations|Disease|6|[3, 4]|500|-1|_|_|_|_|_|_|_|8111719
hallucinations|Disease|7|[2, 3]|500|-1|_|_|_|_|_|_|_|8111719
hallucinations|Disease|9|[10, 11]|500|-1|_|_|_|_|_|_|_|8111719
hallucinatory experiences|Disease|10|[5, 7]|500|-1|_|_|_|_|_|_|_|8111719
disturbed patients|Disease|12|[4, 6]|18|H|_|_|_|_|_|_|_|8111719
ifosfamide|Chemical|0|[2, 3]|3|-1|_|_|_|_|_|_|_|8111719
haloperidol|Chemical|13|[15, 16]|19|-1|_|_|_|_|_|_|_|8111719
bone marrow transplant procedure|Treat|4|[12, 16]|8|-1|_|_|_|_|_|_|_|8111719
infusion-time|Physiology|8|[6, 9]|14|-1|_|_|_|_|_|_|_|8111719
optic neuropathy|Disease|0|[3, 5]|0|-1|_|_|_|_|_|_|_|7059267
adult-onset diabetes|Disease|1|[8, 12]|2|-1|_|_|_|_|_|_|_|7059267
diabetics|Disease|2|[4, 5]|3|H|_|_|_|_|_|_|_|7059267
diabetics|Disease|3|[20, 21]|3|H|_|_|_|_|_|_|_|7059267
visual loss|Disease|3|[17, 19]|5|H|_|_|_|_|_|_|_|7059267
chlorpropamide|Chemical|0|[0, 1]|1|-1|_|_|_|_|_|_|_|7059267
levodopa|Chemical|0|[0, 1]|0|-1|_|_|_|_|_|_|_|6381653
levodopa|Chemical|1|[0, 1]|0|-1|_|_|_|_|_|_|_|6381653
levodopa|Chemical|1|[0, 1]|0|-1|_|_|_|_|_|_|_|6381653
levodopa|Chemical|2|[2, 3]|0|-1|_|_|_|_|_|_|_|6381653
dyskinesia|Disease|0|[3, 4]|1|H|_|_|_|_|_|_|_|6381653
dystonic|Disease|1|[19, 20]|3|-1|_|_|_|_|_|_|_|6381653
parkinsonism|Disease|1|[11, 12]|5|H|_|_|_|_|_|_|_|6381653
parkinsonism|Disease|2|[16, 17]|5|H|_|_|_|_|_|_|_|6381653
thalamic lesions|Disease|2|[7, 9]|8|-1|_|_|_|_|_|_|_|6381653
thalamotomy|Treat|0|[5, 6]|2|-1|_|_|_|_|_|_|_|6381653
stereotaxic surgery|Treat|1|[28, 30]|7|-1|_|_|_|_|_|_|_|6381653
thalamic lesions|Treat|2|[7, 9]|11|-1|_|_|_|_|_|_|_|6381653
nephrotoxicity|Disease|0|[3, 4]|0|H|_|_|_|_|_|_|_|3950060
nephrotoxicity|Disease|1|[13, 14]|0|H|_|_|_|_|_|_|_|3950060
nephrotoxicity|Disease|5|[23, 24]|0|H|_|_|_|_|_|_|_|3950060
nephrotoxic|Disease|7|[16, 17]|5|-1|_|_|_|_|_|_|_|3950060
amikacin|Chemical|0|[10, 11]|1|-1|_|_|_|_|_|_|_|3950060
therapy|Treat|6|[12, 13]|4|-1|_|_|_|_|_|_|_|3950060
cardiac transplantation|Disease|0|[0, 2]|0|-1|_|_|_|_|_|_|_|3311455
nephrotoxicity|Disease|5|[9, 10]|10|-1|_|_|_|_|_|_|_|3311455
nephrotoxicity|Disease|7|[12, 13]|10|-1|_|_|_|_|_|_|_|3311455
cardiac transplantation|Treat|0|[0, 2]|1|-1|_|_|_|_|_|_|_|3311455
loading dose|Treat|2|[12, 14]|4|-1|_|_|_|_|_|_|_|3311455
immunosuppressive regimen|Treat|7|[19, 21]|12|-1|_|_|_|_|_|_|_|3311455
immunosuppressive|Immune|0|[10, 11]|2|-1|_|_|_|_|_|_|_|3311455
cyclosporine|Chemical|2|[4, 5]|3|-1|_|_|_|_|_|_|_|3311455
azathioprine|Chemical|3|[19, 20]|6|-1|_|_|_|_|_|_|_|3311455
blood urea nitrogen|Chemical|4|[12, 15]|501|-1|_|_|_|_|_|_|_|3311455
urea nitrogen|Chemical|4|[13, 15]|501|-1|_|_|_|_|_|_|_|3311455
creatinine levels|Chemical|4|[17, 19]|9|-1|_|_|_|_|_|_|_|3311455
whole blood level|Physiology|2|[30, 33]|5|-1|_|_|_|_|_|_|_|3311455
cholestasis|Disease|0|[1, 2]|0|-1|_|_|_|_|_|_|_|2051906
liver disease|Disease|1|[16, 18]|2|H|_|_|_|_|_|_|_|2051906
polymyositis|Disease|1|[10, 11]|3|-1|_|_|_|_|_|_|_|2051906
azathioprine|Chemical|0|[7, 8]|1|-1|_|_|_|_|_|_|_|2051906
azathioprine|Chemical|3|[0, 1]|1|-1|_|_|_|_|_|_|_|2051906
withdrawal|Treat|3|[1, 2]|5|-1|_|_|_|_|_|_|_|2051906
hypotension|Disease|0|[9, 10]|0|-1|_|_|_|_|_|_|_|2021202
hypotension|Disease|1|[6, 7]|0|-1|_|_|_|_|_|_|_|2021202
hypotension|Disease|4|[0, 1]|0|-1|_|_|_|_|_|_|_|2021202
hypotension|Disease|4|[0, 1]|0|-1|_|_|_|_|_|_|_|2021202
hypotension|Disease|5|[14, 15]|0|-1|_|_|_|_|_|_|_|2021202
hypotension|Disease|7|[9, 10]|0|-1|_|_|_|_|_|_|_|2021202
hypotension|Disease|8|[12, 13]|0|-1|_|_|_|_|_|_|_|2021202
isoflurane|Chemical|0|[6, 7]|1|-1|_|_|_|_|_|_|_|2021202
pah|Chemical|2|[23, 24]|501|-1|_|_|_|_|_|_|_|2021202
para-aminohippurate (pah)|Chemical|2|[19, 25]|501|-1|_|_|_|_|_|_|_|2021202
fentanyl|Chemical|3|[4, 5]|9|-1|_|_|_|_|_|_|_|2021202
nitrous oxide|Chemical|3|[6, 8]|10|-1|_|_|_|_|_|_|_|2021202
oxygen|Chemical|3|[9, 10]|11|-1|_|_|_|_|_|_|_|2021202
renal blood flow|Physiology|1|[11, 14]|3|-1|_|_|_|_|_|_|_|2021202
glomerular function|Physiology|1|[8, 10]|4|-1|_|_|_|_|_|_|_|2021202
glomerular filtration rate (gfr)|Physiology|2|[0, 6]|7|-1|_|_|_|_|_|_|_|2021202
effective renal plasma flow (erpf)|Physiology|2|[7, 14]|8|-1|_|_|_|_|_|_|_|2021202
mean arterial pressure|Physiology|4|[23, 26]|14|-1|_|_|_|_|_|_|_|2021202
erpf|Physiology|6|[2, 3]|16|-1|_|_|_|_|_|_|_|2021202
gfr|Physiology|6|[9, 10]|17|-1|_|_|_|_|_|_|_|2021202
renal vascular resistance|Physiology|7|[0, 3]|19|-1|_|_|_|_|_|_|_|2021202
hypotension|Physiology|7|[9, 10]|20|-1|_|_|_|_|_|_|_|2021202
renal function|Physiology|8|[15, 17]|22|-1|_|_|_|_|_|_|_|2021202
hemodynamics|Physiology|8|[18, 19]|23|-1|_|_|_|_|_|_|_|2021202
normotension|Physiology|8|[24, 25]|24|-1|_|_|_|_|_|_|_|2021202
metoprolol|Chemical|0|[12, 13]|500|H|_|_|_|_|_|_|_|1848636
debrisoquine|Chemical|0|[0, 1]|1|-1|_|_|_|_|_|_|_|1848636
terbutaline|Chemical|4|[10, 11]|6|-1|_|_|_|_|_|_|_|1848636
racemic metoprolol|Chemical|5|[8, 10]|500|H|_|_|_|_|_|_|_|1848636
alpha-hydroxymetoprolol|Chemical|8|[24, 27]|9|-1|_|_|_|_|_|_|_|1848636
beta-2 receptor pharmacodynamics|Physiology|0|[6, 11]|2|-1|_|_|_|_|_|_|_|1848636
beta-1 adrenoceptor antagonistic potency|Physiology|2|[25, 31]|4|-1|_|_|_|_|_|_|_|1848636
beta-2 adrenoceptor antagonism|Physiology|3|[9, 14]|5|-1|_|_|_|_|_|_|_|1848636
debrisoquine/sparteine|Gene|1|[15, 18]|3|-1|_|_|_|_|_|_|_|1848636
hypokalemia|Disease|4|[13, 14]|7|-1|_|_|_|_|_|_|_|1848636
hemolytic anemia|Disease|0|[4, 6]|500|-1|_|_|_|_|_|_|_|1445986
hemolytic anemia|Disease|1|[1, 3]|500|-1|_|_|_|_|_|_|_|1445986
hemolytic anemia|Disease|5|[20, 22]|500|-1|_|_|_|_|_|_|_|1445986
anemia|Disease|2|[6, 7]|3|H|_|_|_|_|_|_|_|1445986
hemolytic reactions|Disease|6|[9, 11]|500|-1|_|_|_|_|_|_|_|1445986
cefotetan|Chemical|0|[0, 1]|1|-1|_|_|_|_|_|_|_|1445986
cefotetan|Chemical|3|[0, 1]|1|-1|_|_|_|_|_|_|_|1445986
antibodies|Immune|3|[3, 4]|5|-1|_|_|_|_|_|_|_|1445986
autoantibodies|Immune|4|[23, 24]|6|-1|_|_|_|_|_|_|_|1445986
extravascular hemolysis|Physiology|5|[11, 13]|8|-1|_|_|_|_|_|_|_|1445986
acute renal failure|Disease|0|[0, 3]|0|H|_|_|_|_|_|_|_|982002
anuria|Disease|3|[5, 6]|2|-1|_|_|_|_|_|_|_|982002
renal lesions|Disease|10|[6, 8]|6|-1|_|_|_|_|_|_|_|982002
rifampicin|Chemical|0|[8, 9]|1|-1|_|_|_|_|_|_|_|982002
131i-hippuran|Chemical|9|[6, 9]|5|-1|_|_|_|_|_|_|_|982002
hemodialysis|Treat|3|[21, 22]|3|-1|_|_|_|_|_|_|_|982002
renal function|Physiology|8|[0, 2]|4|-1|_|_|_|_|_|_|_|982002
an immunological mechanism|Immune|10|[15, 18]|7|-1|_|_|_|_|_|_|_|982002
type b hepatitis|Disease|0|[0, 3]|500|-1|_|_|_|_|_|_|_|343678
type b hepatitis|Disease|7|[6, 9]|500|-1|_|_|_|_|_|_|_|343678
hepatitis b|Disease|1|[40, 42]|500|-1|_|_|_|_|_|_|_|343678
hepatitis b|Disease|1|[0, 2]|500|-1|_|_|_|_|_|_|_|343678
hepatitis b|Disease|6|[0, 2]|500|-1|_|_|_|_|_|_|_|343678
hepatitis|Disease|2|[1, 2]|500|-1|_|_|_|_|_|_|_|343678
hepatitis b immune globulin|Treat|0|[11, 15]|1|-1|_|_|_|_|_|_|_|343678
hbsag|Chemical|1|[45, 46]|2|H|_|_|_|_|_|_|_|343678
hbsag|Chemical|1|[45, 46]|2|H|_|_|_|_|_|_|_|343678
hbsag|Chemical|5|[14, 15]|2|H|_|_|_|_|_|_|_|343678
hbsag|Chemical|5|[14, 15]|2|H|_|_|_|_|_|_|_|343678
hbeag|Chemical|4|[17, 18]|8|-1|_|_|_|_|_|_|_|343678
hbeag|Chemical|5|[3, 4]|8|-1|_|_|_|_|_|_|_|343678
hbeag|Chemical|5|[3, 4]|8|-1|_|_|_|_|_|_|_|343678
dna polymerase|Chemical|4|[6, 8]|502|-1|_|_|_|_|_|_|_|343678
dnap|Chemical|5|[1, 2]|502|-1|_|_|_|_|_|_|_|343678
anti-hbs|Immune|2|[28, 31]|7|-1|_|_|_|_|_|_|_|343678
anti-hbe|Immune|4|[19, 22]|10|-1|_|_|_|_|_|_|_|343678
hbeag|Immune|4|[17, 18]|11|-1|_|_|_|_|_|_|_|343678
hepatitis b immune globulin|Immune|6|[0, 4]|18|-1|_|_|_|_|_|_|_|343678
serotonin syndrome|Disease|0|[0, 2]|0|H|_|_|_|_|_|_|_|8888541
confusion|Disease|1|[22, 23]|3|-1|_|_|_|_|_|_|_|8888541
muscle rigidity|Disease|1|[17, 19]|4|H|_|_|_|_|_|_|_|8888541
muscle rigidity|Disease|10|[4, 6]|4|H|_|_|_|_|_|_|_|8888541
muscle rigidity|Disease|11|[16, 18]|4|H|_|_|_|_|_|_|_|8888541
hyperthermia|Disease|1|[26, 27]|5|-1|_|_|_|_|_|_|_|8888541
depression|Disease|4|[26, 27]|8|H|_|_|_|_|_|_|_|8888541
tremors|Disease|6|[13, 14]|500|H|_|_|_|_|_|_|_|8888541
jerking movements of his extremities|Disease|6|[7, 12]|500|-1|_|_|_|_|_|_|_|8888541
rigidity|Disease|6|[15, 16]|11|H|_|_|_|_|_|_|_|8888541
myoclonic jerks|Disease|7|[19, 21]|500|-1|_|_|_|_|_|_|_|8888541
salivation|Disease|7|[24, 25]|13|-1|_|_|_|_|_|_|_|8888541
hypoventilation|Disease|11|[9, 10]|17|H|_|_|_|_|_|_|_|8888541
thrombocytopenia|Disease|12|[9, 10]|18|-1|_|_|_|_|_|_|_|8888541
rhabdomyolysis|Disease|13|[25, 26]|19|-1|_|_|_|_|_|_|_|8888541
venlafaxine|Chemical|0|[3, 4]|1|-1|_|_|_|_|_|_|_|8888541
tranylcypromine|Chemical|0|[5, 6]|2|-1|_|_|_|_|_|_|_|8888541
serotonin|Chemical|1|[10, 11]|6|-1|_|_|_|_|_|_|_|8888541
serotonin|Chemical|1|[3, 4]|6|-1|_|_|_|_|_|_|_|8888541
diazepam|Chemical|9|[33, 34]|14|-1|_|_|_|_|_|_|_|8888541
l-dopa|Chemical|0|[5, 8]|500|-1|_|_|_|_|_|_|_|8106150
l-dopa|Chemical|0|[5, 8]|500|-1|_|_|_|_|_|_|_|8106150
l-dopa|Chemical|2|[6, 9]|500|-1|_|_|_|_|_|_|_|8106150
l-dopa|Chemical|2|[6, 9]|500|-1|_|_|_|_|_|_|_|8106150
l-dopa|Chemical|4|[17, 20]|500|-1|_|_|_|_|_|_|_|8106150
l-dopa|Chemical|4|[17, 20]|500|-1|_|_|_|_|_|_|_|8106150
mptp|Chemical|0|[12, 13]|3|-1|_|_|_|_|_|_|_|8106150
mptp|Chemical|1|[11, 12]|3|-1|_|_|_|_|_|_|_|8106150
benserazide|Chemical|2|[10, 11]|7|-1|_|_|_|_|_|_|_|8106150
l-dopa/benserazide|Chemical|2|[6, 11]|500|-1|_|_|_|_|_|_|_|8106150
dopamine|Chemical|4|[10, 11]|13|H|_|_|_|_|_|_|_|8106150
clonidine|Chemical|5|[4, 5]|15|-1|_|_|_|_|_|_|_|8106150
methysergide|Chemical|5|[8, 9]|16|-1|_|_|_|_|_|_|_|8106150
propranolol|Chemical|5|[14, 15]|17|-1|_|_|_|_|_|_|_|8106150
yohimbine|Chemical|6|[2, 3]|18|-1|_|_|_|_|_|_|_|8106150
meperidine|Chemical|6|[4, 5]|19|-1|_|_|_|_|_|_|_|8106150
baclofen|Chemical|7|[0, 1]|21|-1|_|_|_|_|_|_|_|8106150
baclofen|Chemical|7|[0, 1]|21|-1|_|_|_|_|_|_|_|8106150
atropine|Chemical|8|[0, 1]|24|-1|_|_|_|_|_|_|_|8106150
dyskinesias|Disease|0|[10, 11]|502|H|_|_|_|_|_|_|_|8106150
parkinsonian|Disease|1|[7, 8]|4|H|_|_|_|_|_|_|_|8106150
parkinsonian|Disease|5|[34, 35]|4|H|_|_|_|_|_|_|_|8106150
dyskinesia|Disease|3|[12, 13]|502|H|_|_|_|_|_|_|_|8106150
dystonic|Disease|7|[10, 11]|20|-1|_|_|_|_|_|_|_|8106150
dystonic|Disease|8|[3, 4]|20|-1|_|_|_|_|_|_|_|8106150
chorea|Disease|8|[6, 7]|25|-1|_|_|_|_|_|_|_|8106150
ccnu|Chemical|0|[0, 1]|500|-1|_|_|_|_|_|_|_|21418164
ccnu|Chemical|2|[12, 13]|500|-1|_|_|_|_|_|_|_|21418164
ccnu|Chemical|3|[8, 9]|500|-1|_|_|_|_|_|_|_|21418164
ccnu|Chemical|4|[0, 1]|500|-1|_|_|_|_|_|_|_|21418164
ccnu|Chemical|9|[2, 3]|500|-1|_|_|_|_|_|_|_|21418164
lomustine|Chemical|0|[2, 3]|500|-1|_|_|_|_|_|_|_|21418164
1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (ccnu)|Chemical|1|[21, 39]|500|-1|_|_|_|_|_|_|_|21418164
haematological, renal, hepatic and gastrointestinal toxicities|Disease|1|[7, 15]|2|H|_|_|_|_|_|_|_|21418164
lymphoma|Disease|4|[9, 10]|7|H|_|_|_|_|_|_|_|21418164
lymphoma|Disease|4|[22, 23]|7|H|_|_|_|_|_|_|_|21418164
mast cell tumour|Disease|4|[11, 14]|9|-1|_|_|_|_|_|_|_|21418164
brain tumour|Disease|4|[15, 17]|10|-1|_|_|_|_|_|_|_|21418164
histiocytic tumours|Disease|4|[18, 20]|11|H|_|_|_|_|_|_|_|21418164
epitheliotropic lymphoma|Disease|4|[21, 23]|12|-1|_|_|_|_|_|_|_|21418164
thrombocytopenia|Disease|5|[21, 22]|14|-1|_|_|_|_|_|_|_|21418164
neutropenia|Disease|5|[9, 10]|15|-1|_|_|_|_|_|_|_|21418164
anaemia|Disease|5|[15, 16]|16|-1|_|_|_|_|_|_|_|21418164
vomiting|Disease|6|[18, 19]|17|-1|_|_|_|_|_|_|_|21418164
gastrointestinal toxicosis|Disease|6|[0, 2]|18|H|_|_|_|_|_|_|_|21418164
renal toxicity|Disease|7|[1, 3]|19|-1|_|_|_|_|_|_|_|21418164
elevated alanine transaminase (alt) concentration|Disease|7|[4, 11]|20|-1|_|_|_|_|_|_|_|21418164
hepatic failure|Disease|8|[3, 5]|21|-1|_|_|_|_|_|_|_|21418164
treated with ccnu|Treat|2|[10, 13]|5|-1|_|_|_|_|_|_|_|21418164
pilocarpine|Chemical|0|[4, 5]|0|-1|_|_|_|_|_|_|_|9121607
pilocarpine|Chemical|1|[46, 47]|0|-1|_|_|_|_|_|_|_|9121607
pilocarpine|Chemical|2|[30, 31]|0|-1|_|_|_|_|_|_|_|9121607
pilocarpine|Chemical|4|[15, 16]|0|-1|_|_|_|_|_|_|_|9121607
pilocarpine|Chemical|8|[11, 12]|0|-1|_|_|_|_|_|_|_|9121607
kainic acid|Chemical|0|[7, 9]|2|-1|_|_|_|_|_|_|_|9121607
neuroactive steroids|Chemical|0|[0, 2]|500|-1|_|_|_|_|_|_|_|9121607
progesterone|Chemical|1|[5, 6]|500|-1|_|_|_|_|_|_|_|9121607
deoxycorticosterone|Chemical|1|[18, 19]|500|-1|_|_|_|_|_|_|_|9121607
n-methyl-d-aspartate (nmda)|Chemical|1|[53, 63]|8|-1|_|_|_|_|_|_|_|9121607
clonazepam|Chemical|4|[11, 12]|11|-1|_|_|_|_|_|_|_|9121607
clonazepam|Chemical|4|[48, 49]|11|-1|_|_|_|_|_|_|_|9121607
steroid|Chemical|6|[8, 9]|500|-1|_|_|_|_|_|_|_|9121607
status epilepticus|Disease|0|[14, 16]|1|-1|_|_|_|_|_|_|_|9121607
seizures|Disease|1|[65, 66]|502|-1|_|_|_|_|_|_|_|9121607
limbic seizures|Disease|5|[28, 30]|502|-1|_|_|_|_|_|_|_|9121607
hiv-1 infection|Disease|0|[21, 25]|0|-1|_|_|_|_|_|_|_|7905523
immunodeficiency|Disease|5|[33, 34]|7|H|_|_|_|_|_|_|_|7905523
diarrhea|Disease|9|[0, 1]|10|-1|_|_|_|_|_|_|_|7905523
flatulence|Disease|9|[2, 3]|11|-1|_|_|_|_|_|_|_|7905523
abdominal pain|Disease|9|[4, 6]|12|-1|_|_|_|_|_|_|_|7905523
weight loss|Disease|9|[8, 10]|13|-1|_|_|_|_|_|_|_|7905523
n-butyl-deoxynojirimycin (sc-48334)|Chemical|0|[6, 16]|501|-1|_|_|_|_|_|_|_|7905523
zidovudine|Chemical|0|[17, 18]|2|-1|_|_|_|_|_|_|_|7905523
n-butyl-deoxynojirimycin|Chemical|1|[21, 26]|501|-1|_|_|_|_|_|_|_|7905523
sc-48334|Chemical|1|[27, 30]|501|-1|_|_|_|_|_|_|_|7905523
sc-48334|Chemical|2|[21, 24]|501|-1|_|_|_|_|_|_|_|7905523
sc-48334|Chemical|5|[2, 5]|501|-1|_|_|_|_|_|_|_|7905523
combination therapy|Treat|1|[18, 20]|5|-1|_|_|_|_|_|_|_|7905523
cd4 cells|Physiology|7|[11, 13]|9|-1|_|_|_|_|_|_|_|7905523
n10-propargyl-5,8-dideazafolic acid|Chemical|0|[10, 20]|500|-1|_|_|_|_|_|_|_|3431591
n10-propargyl-5,8-dideazafolic acid|Chemical|1|[3, 13]|500|-1|_|_|_|_|_|_|_|3431591
cb 3717|Chemical|0|[21, 23]|500|-1|_|_|_|_|_|_|_|3431591
cb 3717|Chemical|1|[0, 2]|500|-1|_|_|_|_|_|_|_|3431591
cb 3717|Chemical|2|[10, 12]|500|-1|_|_|_|_|_|_|_|3431591
cb 3717|Chemical|3|[15, 17]|500|-1|_|_|_|_|_|_|_|3431591
cb 3717|Chemical|3|[28, 30]|500|-1|_|_|_|_|_|_|_|3431591
cb 3717|Chemical|4|[7, 9]|500|-1|_|_|_|_|_|_|_|3431591
cb 3717|Chemical|4|[35, 37]|500|-1|_|_|_|_|_|_|_|3431591
cb 3717|Chemical|4|[52, 54]|500|-1|_|_|_|_|_|_|_|3431591
cb 3717|Chemical|5|[5, 7]|500|-1|_|_|_|_|_|_|_|3431591
cb 3717|Chemical|7|[23, 25]|500|-1|_|_|_|_|_|_|_|3431591
cb 3717|Chemical|8|[12, 14]|500|-1|_|_|_|_|_|_|_|3431591
cb 3717|Chemical|12|[10, 12]|500|-1|_|_|_|_|_|_|_|3431591
[3h]cb 3717|Chemical|3|[12, 17]|500|-1|_|_|_|_|_|_|_|3431591
cb 3717 di-|Chemical|4|[7, 11]|500|-1|_|_|_|_|_|_|_|3431591
ts|Gene|1|[24, 25]|4|-1|_|_|_|_|_|_|_|3431591
ovarian cancer|Disease|5|[16, 18]|13|-1|_|_|_|_|_|_|_|3431591
hepatoma|Disease|5|[19, 20]|14|-1|_|_|_|_|_|_|_|3431591
mesothelioma|Disease|5|[22, 23]|15|-1|_|_|_|_|_|_|_|3431591
nephrotoxicity|Disease|6|[10, 11]|502|-1|_|_|_|_|_|_|_|3431591
nephrotoxicity|Disease|9|[14, 15]|502|-1|_|_|_|_|_|_|_|3431591
hepatotoxicity|Disease|6|[2, 3]|18|-1|_|_|_|_|_|_|_|3431591
malaise|Disease|6|[4, 5]|19|-1|_|_|_|_|_|_|_|3431591
renal toxicity|Disease|9|[24, 26]|502|-1|_|_|_|_|_|_|_|3431591
alkaline diuresis|Treat|8|[16, 18]|22|-1|_|_|_|_|_|_|_|3431591
urinary excretion|Physiology|12|[15, 17]|26|-1|_|_|_|_|_|_|_|3431591
plasma levels|Physiology|12|[12, 14]|27|-1|_|_|_|_|_|_|_|3431591
parkinsonism|Disease|0|[7, 8]|500|-1|_|_|_|_|_|_|_|33969
schizophrenic|Disease|1|[23, 24]|3|-1|_|_|_|_|_|_|_|33969
parkinsonian|Disease|2|[11, 12]|500|-1|_|_|_|_|_|_|_|33969
parkinsonian|Disease|4|[18, 19]|500|-1|_|_|_|_|_|_|_|33969
parkinsonian symptoms|Disease|2|[11, 13]|500|-1|_|_|_|_|_|_|_|33969
tardive dyskinesia|Disease|3|[10, 12]|9|-1|_|_|_|_|_|_|_|33969
anxiety|Disease|3|[23, 24]|10|-1|_|_|_|_|_|_|_|33969
depression|Disease|3|[25, 26]|11|-1|_|_|_|_|_|_|_|33969
ethopropazine|Chemical|0|[0, 1]|1|-1|_|_|_|_|_|_|_|33969
ethopropazine|Chemical|2|[0, 1]|1|-1|_|_|_|_|_|_|_|33969
benztropine|Chemical|0|[2, 3]|2|-1|_|_|_|_|_|_|_|33969
fluphenazine enanthate|Chemical|1|[19, 21]|4|-1|_|_|_|_|_|_|_|33969
procyclidine|Chemical|2|[18, 19]|8|H|_|_|_|_|_|_|_|33969
procyclindine|Chemical|3|[17, 18]|12|-1|_|_|_|_|_|_|_|33969
treatment|Treat|4|[13, 14]|14|-1|_|_|_|_|_|_|_|33969
neurotoxicity|Disease|0|[11, 12]|500|-1|_|_|_|_|_|_|_|16844102
neurotoxicity|Disease|1|[7, 8]|500|-1|_|_|_|_|_|_|_|16844102
neurotoxicity|Disease|2|[37, 38]|500|-1|_|_|_|_|_|_|_|16844102
hyperthermia|Disease|6|[10, 11]|17|-1|_|_|_|_|_|_|_|16844102
neuronal damage|Disease|9|[13, 15]|500|-1|_|_|_|_|_|_|_|16844102
alpha-tocopherol|Chemical|0|[2, 5]|502|-1|_|_|_|_|_|_|_|16844102
deferoxamine|Chemical|0|[6, 7]|503|-1|_|_|_|_|_|_|_|16844102
methamphetamine|Chemical|0|[8, 9]|504|-1|_|_|_|_|_|_|_|16844102
ma|Chemical|3|[5, 6]|504|-1|_|_|_|_|_|_|_|16844102
ma|Chemical|4|[36, 37]|504|-1|_|_|_|_|_|_|_|16844102
ma|Chemical|4|[22, 23]|504|-1|_|_|_|_|_|_|_|16844102
ma|Chemical|5|[15, 16]|504|-1|_|_|_|_|_|_|_|16844102
ma|Chemical|6|[7, 8]|504|-1|_|_|_|_|_|_|_|16844102
alpha-tc|Chemical|4|[4, 7]|502|-1|_|_|_|_|_|_|_|16844102
alpha-tc|Chemical|5|[23, 26]|502|-1|_|_|_|_|_|_|_|16844102
alpha-tc|Chemical|6|[0, 3]|502|-1|_|_|_|_|_|_|_|16844102
alpha-tc|Chemical|8|[6, 9]|502|-1|_|_|_|_|_|_|_|16844102
alpha-tc|Chemical|9|[3, 6]|502|-1|_|_|_|_|_|_|_|16844102
dfo|Chemical|4|[25, 26]|503|-1|_|_|_|_|_|_|_|16844102
dfo|Chemical|5|[27, 28]|503|-1|_|_|_|_|_|_|_|16844102
dfo|Chemical|6|[4, 5]|503|-1|_|_|_|_|_|_|_|16844102
dfo|Chemical|8|[10, 11]|503|-1|_|_|_|_|_|_|_|16844102
dfo|Chemical|9|[7, 8]|503|-1|_|_|_|_|_|_|_|16844102
dopamine|Chemical|5|[3, 4]|12|-1|_|_|_|_|_|_|_|16844102
serotonin|Chemical|5|[8, 9]|13|-1|_|_|_|_|_|_|_|16844102
reduced glutathione|Chemical|7|[9, 11]|505|-1|_|_|_|_|_|_|_|16844102
glutathione|Chemical|7|[10, 11]|505|-1|_|_|_|_|_|_|_|16844102
injections|Treat|3|[17, 18]|7|-1|_|_|_|_|_|_|_|16844102
hemorrhagic cystitis|Disease|0|[12, 14]|500|-1|_|_|_|_|_|_|_|14633084
hemorrhagic cystitis|Disease|1|[2, 4]|500|-1|_|_|_|_|_|_|_|14633084
hemorrhagic cystitis|Disease|1|[2, 4]|500|-1|_|_|_|_|_|_|_|14633084
hc|Disease|2|[23, 24]|500|-1|_|_|_|_|_|_|_|14633084
hc|Disease|9|[14, 15]|500|-1|_|_|_|_|_|_|_|14633084
hc|Disease|10|[23, 24]|500|-1|_|_|_|_|_|_|_|14633084
cystitis|Disease|5|[0, 1]|500|-1|_|_|_|_|_|_|_|14633084
dexamethasone|Chemical|0|[2, 3]|1|-1|_|_|_|_|_|_|_|14633084
mesna|Chemical|0|[4, 5]|2|-1|_|_|_|_|_|_|_|14633084
ifosfamide|Chemical|0|[9, 10]|3|H|_|_|_|_|_|_|_|14633084
ifs|Chemical|3|[45, 46]|7|-1|_|_|_|_|_|_|_|14633084
reserpine|Chemical|0|[7, 8]|0|-1|_|_|_|_|_|_|_|11999899
reserpine|Chemical|1|[34, 35]|0|-1|_|_|_|_|_|_|_|11999899
reserpine|Chemical|3|[0, 1]|0|-1|_|_|_|_|_|_|_|11999899
reserpine|Chemical|4|[0, 1]|0|-1|_|_|_|_|_|_|_|11999899
reserpine|Chemical|4|[0, 1]|0|-1|_|_|_|_|_|_|_|11999899
reserpine|Chemical|5|[32, 33]|0|-1|_|_|_|_|_|_|_|11999899
reserpine|Chemical|6|[13, 14]|0|-1|_|_|_|_|_|_|_|11999899
reserpine|Chemical|7|[0, 1]|0|-1|_|_|_|_|_|_|_|11999899
reserpine|Chemical|7|[0, 1]|0|-1|_|_|_|_|_|_|_|11999899
reserpine|Chemical|8|[5, 6]|0|-1|_|_|_|_|_|_|_|11999899
reserpine|Chemical|9|[19, 20]|0|-1|_|_|_|_|_|_|_|11999899
reserpine|Chemical|10|[2, 3]|0|-1|_|_|_|_|_|_|_|11999899
reserpine|Chemical|10|[56, 57]|0|-1|_|_|_|_|_|_|_|11999899
reserpine|Chemical|11|[4, 5]|0|-1|_|_|_|_|_|_|_|11999899
dizocilpine|Chemical|1|[3, 4]|2|-1|_|_|_|_|_|_|_|11999899
apomophine|Chemical|7|[17, 18]|15|-1|_|_|_|_|_|_|_|11999899
reserpine treatments|Treat|1|[34, 36]|3|-1|_|_|_|_|_|_|_|11999899
tardive dyskinesia|Disease|2|[18, 20]|4|-1|_|_|_|_|_|_|_|11999899
tremor|Disease|4|[3, 4]|7|H|_|_|_|_|_|_|_|11999899
tremor|Disease|6|[11, 12]|7|H|_|_|_|_|_|_|_|11999899
tremor|Disease|8|[9, 10]|7|H|_|_|_|_|_|_|_|11999899
tremor|Disease|9|[16, 17]|7|H|_|_|_|_|_|_|_|11999899
tremor|Disease|10|[30, 31]|7|H|_|_|_|_|_|_|_|11999899
tremor|Disease|12|[22, 23]|7|H|_|_|_|_|_|_|_|11999899
catalepsy|Disease|4|[5, 6]|9|-1|_|_|_|_|_|_|_|11999899
parkinsonian|Disease|11|[24, 25]|23|-1|_|_|_|_|_|_|_|11999899
spasm|Disease|0|[9, 10]|500|H|_|_|_|_|_|_|_|9431903
oddi dyskinesia|Disease|1|[30, 32]|501|H|_|_|_|_|_|_|_|9431903
oddi dyskinesia|Disease|7|[25, 27]|501|H|_|_|_|_|_|_|_|9431903
sphincter of oddi dyskinesia|Disease|1|[28, 32]|501|H|_|_|_|_|_|_|_|9431903
sphincter of oddi dyskinesia|Disease|7|[23, 27]|501|H|_|_|_|_|_|_|_|9431903
sphincter of oddi spasm|Disease|2|[2, 6]|501|-1|_|_|_|_|_|_|_|9431903
sphincter of oddi spasm|Disease|6|[19, 23]|501|-1|_|_|_|_|_|_|_|9431903
spasm at the level of the sphincter of oddi|Disease|4|[168, 177]|501|-1|_|_|_|_|_|_|_|9431903
glyceryl trinitrate|Chemical|0|[2, 4]|503|-1|_|_|_|_|_|_|_|9431903
prostigmine|Chemical|1|[12, 13]|4|-1|_|_|_|_|_|_|_|9431903
prostigmine|Chemical|4|[2, 3]|4|-1|_|_|_|_|_|_|_|9431903
morphine|Chemical|1|[14, 15]|5|-1|_|_|_|_|_|_|_|9431903
morphine|Chemical|4|[4, 5]|5|-1|_|_|_|_|_|_|_|9431903
nitrolingual|Chemical|3|[10, 11]|503|-1|_|_|_|_|_|_|_|9431903
steroid|Chemical|0|[3, 4]|500|H|_|_|_|_|_|_|_|8665051
steroid|Chemical|3|[56, 57]|500|H|_|_|_|_|_|_|_|8665051
steroid|Chemical|6|[10, 11]|500|H|_|_|_|_|_|_|_|8665051
steroid|Chemical|8|[8, 9]|500|H|_|_|_|_|_|_|_|8665051
steroid|Chemical|9|[0, 1]|500|H|_|_|_|_|_|_|_|8665051
steroid|Chemical|10|[18, 19]|500|H|_|_|_|_|_|_|_|8665051
steroid|Chemical|12|[50, 51]|500|H|_|_|_|_|_|_|_|8665051
corticosteroids|Chemical|1|[17, 18]|500|H|_|_|_|_|_|_|_|8665051
methylprednisolone|Chemical|3|[18, 19]|6|-1|_|_|_|_|_|_|_|8665051
triamcinolone|Chemical|3|[24, 25]|7|-1|_|_|_|_|_|_|_|8665051
myopathy|Disease|1|[7, 8]|502|H|_|_|_|_|_|_|_|8665051
myopathy|Disease|2|[4, 5]|502|H|_|_|_|_|_|_|_|8665051
reduction of food intake|Disease|3|[50, 54]|4|H|_|_|_|_|_|_|_|8665051
loss in body weight|Disease|4|[6, 10]|9|H|_|_|_|_|_|_|_|8665051
tetanic|Disease|8|[22, 23]|13|-1|_|_|_|_|_|_|_|8665051
atrophy|Disease|10|[15, 16]|503|-1|_|_|_|_|_|_|_|8665051
atrophy|Disease|10|[25, 26]|503|-1|_|_|_|_|_|_|_|8665051
atrophy|Disease|11|[27, 28]|503|-1|_|_|_|_|_|_|_|8665051
atrophy|Disease|12|[60, 61]|503|-1|_|_|_|_|_|_|_|8665051
atrophy|Disease|12|[34, 35]|503|-1|_|_|_|_|_|_|_|8665051
type iia atrophy|Disease|10|[23, 26]|503|-1|_|_|_|_|_|_|_|8665051
muscle atrophy|Disease|11|[26, 28]|503|-1|_|_|_|_|_|_|_|8665051
injection of saline|Treat|3|[11, 14]|8|-1|_|_|_|_|_|_|_|8665051
steroid treatment|Treat|6|[10, 12]|12|-1|_|_|_|_|_|_|_|8665051
short-term treatment with massive doses of steroids|Treat|12|[6, 15]|26|-1|_|_|_|_|_|_|_|8665051
contractility|Physiology|5|[7, 8]|10|-1|_|_|_|_|_|_|_|8665051
tension|Physiology|8|[15, 16]|15|-1|_|_|_|_|_|_|_|8665051
heart block|Disease|0|[5, 7]|0|-1|_|_|_|_|_|_|_|7785794
hypotension|Disease|1|[16, 17]|3|H|_|_|_|_|_|_|_|7785794
hypotension|Disease|3|[13, 14]|3|H|_|_|_|_|_|_|_|7785794
hypotensive|Disease|2|[5, 6]|5|-1|_|_|_|_|_|_|_|7785794
verapamil sr|Chemical|0|[8, 10]|1|-1|_|_|_|_|_|_|_|7785794
metoprolol|Chemical|0|[11, 12]|2|-1|_|_|_|_|_|_|_|7785794
verapamil|Chemical|1|[27, 28]|4|H|_|_|_|_|_|_|_|7785794
atropine|Chemical|2|[17, 18]|6|-1|_|_|_|_|_|_|_|7785794
dopamine|Chemical|2|[28, 29]|7|-1|_|_|_|_|_|_|_|7785794
dobutamine|Chemical|2|[30, 31]|8|-1|_|_|_|_|_|_|_|7785794
calcium chloride|Chemical|3|[8, 10]|10|-1|_|_|_|_|_|_|_|7785794
antipurine|Chemical|0|[7, 8]|500|H|_|_|_|_|_|_|_|8958188
lometrexol|Chemical|1|[0, 1]|500|-1|_|_|_|_|_|_|_|8958188
glycinamide ribonucleotide formyltransferase (garft)|Chemical|1|[6, 12]|2|H|_|_|_|_|_|_|_|8958188
methotrexate|Chemical|2|[22, 23]|4|-1|_|_|_|_|_|_|_|8958188
folic acid|Chemical|4|[15, 17]|5|-1|_|_|_|_|_|_|_|8958188
class of compounds|Chemical|10|[9, 12]|500|H|_|_|_|_|_|_|_|8958188
tumours|Disease|2|[13, 14]|3|H|_|_|_|_|_|_|_|8958188
thrombocytopenia|Disease|6|[0, 1]|6|-1|_|_|_|_|_|_|_|8958188
thrombocytopenia|Disease|6|[0, 1]|6|-1|_|_|_|_|_|_|_|8958188
mucositis|Disease|6|[2, 3]|8|-1|_|_|_|_|_|_|_|8958188
plasma|Physiology|7|[12, 13]|9|-1|_|_|_|_|_|_|_|8958188
mu-opiate receptor|Chemical|0|[3, 7]|500|-1|_|_|_|_|_|_|_|2557556
trans-3,4-dichloro-n-methyl-n[2-(1-pyrrolidinyl) cyclohexyl]benzeneactemide|Chemical|1|[29, 53]|1|-1|_|_|_|_|_|_|_|2557556
trans-3,4-dichloro-n-methyl-n[2-(1-pyrrolidinyl) cyclohexyl]benzeneactemide|Chemical|1|[29, 53]|1|-1|_|_|_|_|_|_|_|2557556
[d-pen2.5]-enkephalin|Chemical|1|[57, 66]|2|-1|_|_|_|_|_|_|_|2557556
[d-pen2.5]-enkephalin|Chemical|1|[57, 66]|2|-1|_|_|_|_|_|_|_|2557556
[d-ser2]-[leu]enkephalin-thr|Chemical|1|[67, 79]|3|-1|_|_|_|_|_|_|_|2557556
[d-ser2]-[leu]enkephalin-thr|Chemical|1|[67, 79]|3|-1|_|_|_|_|_|_|_|2557556
morphine|Chemical|1|[6, 7]|500|-1|_|_|_|_|_|_|_|2557556
morphine|Chemical|4|[0, 1]|500|-1|_|_|_|_|_|_|_|2557556
tyr-d-ala-gly-nme-phe-gly-ol|Chemical|1|[8, 23]|500|-1|_|_|_|_|_|_|_|2557556
morphiceptin|Chemical|1|[24, 25]|500|-1|_|_|_|_|_|_|_|2557556
prostaglandin e2|Chemical|2|[22, 24]|10|-1|_|_|_|_|_|_|_|2557556
prostaglandin e2|Chemical|2|[22, 24]|10|-1|_|_|_|_|_|_|_|2557556
naloxone|Chemical|3|[15, 16]|12|-1|_|_|_|_|_|_|_|2557556
8-bromo cyclic adenosine monophosphate|Chemical|4|[11, 17]|13|-1|_|_|_|_|_|_|_|2557556
cyclic adenosine monophosphate|Chemical|5|[38, 41]|15|H|_|_|_|_|_|_|_|2557556
mu-opioid receptor|Gene|5|[24, 28]|16|-1|_|_|_|_|_|_|_|2557556
chronic hepatitis c|Disease|0|[17, 20]|0|H|_|_|_|_|_|_|_|15580403
chronic hepatitis c|Disease|0|[17, 20]|0|H|_|_|_|_|_|_|_|15580403
hepatitis c|Disease|0|[18, 20]|1|H|_|_|_|_|_|_|_|15580403
hemolytic anemia|Disease|1|[2, 4]|5|-1|_|_|_|_|_|_|_|15580403
hemolytic anemia|Disease|1|[2, 4]|5|-1|_|_|_|_|_|_|_|15580403
hemolytic anemia|Disease|2|[5, 7]|5|-1|_|_|_|_|_|_|_|15580403
hcv-genotype 1b|Disease|4|[10, 14]|9|-1|_|_|_|_|_|_|_|15580403
anemia|Disease|4|[37, 38]|10|H|_|_|_|_|_|_|_|15580403
anemia|Disease|4|[28, 29]|10|H|_|_|_|_|_|_|_|15580403
ribavirin|Chemical|0|[15, 16]|3|-1|_|_|_|_|_|_|_|15580403
ribavirin|Chemical|0|[3, 4]|3|-1|_|_|_|_|_|_|_|15580403
biological response|Chemical|9|[12, 14]|13|H|_|_|_|_|_|_|_|15580403
combination therapy|Treat|3|[20, 22]|8|-1|_|_|_|_|_|_|_|15580403
therapy|Treat|10|[17, 18]|14|-1|_|_|_|_|_|_|_|15580403
hemoglobin|Physiology|7|[23, 24]|12|-1|_|_|_|_|_|_|_|15580403
hemoglobin level|Physiology|10|[3, 5]|15|-1|_|_|_|_|_|_|_|15580403
nephrotic syndrome|Disease|0|[14, 16]|0|H|_|_|_|_|_|_|_|15075188
edema|Disease|1|[10, 11]|2|H|_|_|_|_|_|_|_|15075188
ascites|Disease|5|[19, 20]|6|-1|_|_|_|_|_|_|_|15075188
proteinuria|Disease|5|[8, 9]|7|H|_|_|_|_|_|_|_|15075188
hypoalbuminemia|Disease|5|[10, 11]|8|-1|_|_|_|_|_|_|_|15075188
pan|Disease|9|[23, 24]|12|-1|_|_|_|_|_|_|_|15075188
puromycin aminonucleoside|Chemical|0|[10, 12]|501|-1|_|_|_|_|_|_|_|15075188
pan|Chemical|5|[4, 5]|501|-1|_|_|_|_|_|_|_|15075188
beta-enac|Chemical|8|[18, 21]|10|-1|_|_|_|_|_|_|_|15075188
gamma-enac|Chemical|8|[23, 26]|11|-1|_|_|_|_|_|_|_|15075188
thiazide|Chemical|10|[45, 46]|15|-1|_|_|_|_|_|_|_|15075188
na(+)|Chemical|10|[23, 27]|16|H|_|_|_|_|_|_|_|15075188
na(+)|Chemical|10|[7, 11]|16|H|_|_|_|_|_|_|_|15075188
na(+)|Chemical|10|[48, 52]|16|H|_|_|_|_|_|_|_|15075188
cl(-)|Chemical|10|[53, 57]|19|H|_|_|_|_|_|_|_|15075188
k(+)|Chemical|10|[28, 32]|20|H|_|_|_|_|_|_|_|15075188
na-k-atpase|Chemical|11|[14, 19]|21|-1|_|_|_|_|_|_|_|15075188
sodium retention|'Physiology'|3|[17, 19]|3|-1|_|_|_|_|_|_|_|15075188
enac|'Gene'|3|[7, 8]|4|-1|_|_|_|_|_|_|_|15075188
iv|Treat|4|[17, 18]|5|-1|_|_|_|_|_|_|_|15075188
alpha-enac|Gene|9|[33, 36]|13|-1|_|_|_|_|_|_|_|15075188
alpha-enac|Gene|9|[8, 11]|13|-1|_|_|_|_|_|_|_|15075188
enac|Gene|12|[9, 10]|22|-1|_|_|_|_|_|_|_|15075188
excretion|Physiology|13|[26, 27]|23|-1|_|_|_|_|_|_|_|15075188
detrimental effect on memory and cognition|Disease|0|[11, 17]|0|-1|_|_|_|_|_|_|_|14745746
psychological morbidity|Disease|4|[14, 16]|9|-1|_|_|_|_|_|_|_|14745746
hormone therapy|Treat|0|[1, 3]|1|-1|_|_|_|_|_|_|_|14745746
randomised trial|Treat|2|[4, 6]|6|-1|_|_|_|_|_|_|_|14745746
hormone replacement therapy|Treat|3|[39, 42]|7|-1|_|_|_|_|_|_|_|14745746
length of treatment|Treat|4|[8, 11]|10|-1|_|_|_|_|_|_|_|14745746
hormonal therapy|Treat|5|[14, 16]|11|-1|_|_|_|_|_|_|_|14745746
memory and cognition|Physiology|0|[14, 17]|2|-1|_|_|_|_|_|_|_|14745746
cognition|Physiology|1|[11, 12]|3|-1|_|_|_|_|_|_|_|14745746
processing speed|Physiology|3|[12, 14]|8|-1|_|_|_|_|_|_|_|14745746
anastrozole|Chemical|2|[7, 8]|4|-1|_|_|_|_|_|_|_|14745746
tamoxifen|Chemical|2|[9, 10]|5|-1|_|_|_|_|_|_|_|14745746
oestrogen|Chemical|6|[9, 10]|12|H|_|_|_|_|_|_|_|14745746
nephropathy|Disease|0|[12, 13]|0|H|_|_|_|_|_|_|_|11208990
nephrotic syndrome|Disease|2|[17, 19]|3|H|_|_|_|_|_|_|_|11208990
mesangial proliferation|Disease|7|[16, 18]|11|-1|_|_|_|_|_|_|_|11208990
tubulointerstitial inflammation|Disease|7|[20, 22]|12|H|_|_|_|_|_|_|_|11208990
proteinuria|Disease|8|[7, 8]|14|H|_|_|_|_|_|_|_|11208990
nephrosis|Disease|15|[20, 21]|19|H|_|_|_|_|_|_|_|11208990
nitric oxide|Chemical|0|[2, 4]|501|-1|_|_|_|_|_|_|_|11208990
nitric oxide (no)|Chemical|1|[8, 13]|501|-1|_|_|_|_|_|_|_|11208990
no|Chemical|2|[6, 7]|501|-1|_|_|_|_|_|_|_|11208990
no|Chemical|3|[6, 7]|501|-1|_|_|_|_|_|_|_|11208990
no|Chemical|5|[33, 34]|501|-1|_|_|_|_|_|_|_|11208990
no|Chemical|15|[7, 8]|501|-1|_|_|_|_|_|_|_|11208990
adriamycin (adr)|Chemical|2|[25, 29]|502|-1|_|_|_|_|_|_|_|11208990
adr|Chemical|4|[7, 8]|502|-1|_|_|_|_|_|_|_|11208990
adr|Chemical|7|[11, 12]|502|-1|_|_|_|_|_|_|_|11208990
aminoguanidine|Chemical|5|[21, 22]|9|-1|_|_|_|_|_|_|_|11208990
phenylephrine|Chemical|10|[3, 4]|16|-1|_|_|_|_|_|_|_|11208990
vascular reactivity|Physiology|3|[24, 26]|7|-1|_|_|_|_|_|_|_|11208990
treatment|Treat|8|[12, 13]|15|-1|_|_|_|_|_|_|_|11208990
ag|Treat|14|[2, 3]|18|-1|_|_|_|_|_|_|_|11208990
apoptosis|Biological Process|11|[0, 1]|17|-1|_|_|_|_|_|_|_|11208990
catalepsy|Disease|0|[17, 18]|0|-1|_|_|_|_|_|_|_|9201797
akathisia|Disease|1|[14, 15]|2|-1|_|_|_|_|_|_|_|9201797
hyperlocomotion|Disease|6|[15, 16]|8|-1|_|_|_|_|_|_|_|9201797
carteolol hydrochloride|Chemical|0|[4, 6]|501|-1|_|_|_|_|_|_|_|9201797
haloperidol|Chemical|3|[14, 15]|3|-1|_|_|_|_|_|_|_|9201797
haloperidol|Chemical|4|[11, 12]|3|-1|_|_|_|_|_|_|_|9201797
haloperidol|Chemical|7|[8, 9]|3|-1|_|_|_|_|_|_|_|9201797
haloperidol|Chemical|10|[7, 8]|3|-1|_|_|_|_|_|_|_|9201797
carteolol|Chemical|3|[5, 6]|501|-1|_|_|_|_|_|_|_|9201797
carteolol|Chemical|6|[0, 1]|501|-1|_|_|_|_|_|_|_|9201797
propranolol|Chemical|3|[28, 29]|5|-1|_|_|_|_|_|_|_|9201797
biperiden|Chemical|3|[30, 31]|6|-1|_|_|_|_|_|_|_|9201797
dopamine|Chemical|6|[5, 6]|10|H|_|_|_|_|_|_|_|9201797
apomorphine|Chemical|7|[10, 11]|12|-1|_|_|_|_|_|_|_|9201797
5-hydroxytryptophan|Chemical|8|[27, 30]|13|-1|_|_|_|_|_|_|_|9201797
arthritis|Disease|0|[11, 12]|0|H|_|_|_|_|_|_|_|8267029
arthritis|Disease|1|[9, 10]|0|H|_|_|_|_|_|_|_|8267029
glomerulonephritis|Disease|0|[5, 6]|500|-1|_|_|_|_|_|_|_|8267029
glomerulonephritis|Disease|1|[13, 14]|500|-1|_|_|_|_|_|_|_|8267029
glomerulonephritis|Disease|2|[5, 6]|500|-1|_|_|_|_|_|_|_|8267029
rheumatoid arthritis|Disease|0|[10, 12]|2|-1|_|_|_|_|_|_|_|8267029
rpgn|Disease|1|[15, 16]|500|-1|_|_|_|_|_|_|_|8267029
rpgn|Disease|6|[4, 5]|500|-1|_|_|_|_|_|_|_|8267029
proteinuria|Disease|6|[28, 29]|13|-1|_|_|_|_|_|_|_|8267029
penicillamine|Chemical|0|[0, 1]|502|-1|_|_|_|_|_|_|_|8267029
d-penicillamine|Chemical|1|[21, 24]|502|-1|_|_|_|_|_|_|_|8267029
d-penicillamine|Chemical|1|[21, 24]|502|-1|_|_|_|_|_|_|_|8267029
d-penicillamine|Chemical|6|[9, 12]|502|-1|_|_|_|_|_|_|_|8267029
d-penicillamine|Chemical|6|[9, 12]|502|-1|_|_|_|_|_|_|_|8267029
d-penicillamine|Chemical|7|[4, 7]|502|-1|_|_|_|_|_|_|_|8267029
d-penicillamine|Chemical|7|[4, 7]|502|-1|_|_|_|_|_|_|_|8267029
antiplatelet agents|Chemical|4|[12, 14]|10|-1|_|_|_|_|_|_|_|8267029
steroid|Chemical|4|[5, 6]|11|-1|_|_|_|_|_|_|_|8267029
cyclophosphamide|Chemical|4|[10, 11]|12|-1|_|_|_|_|_|_|_|8267029
renal function|Physiology|6|[20, 22]|17|-1|_|_|_|_|_|_|_|8267029
vigorous treatment measures|Treat|7|[8, 11]|20|-1|_|_|_|_|_|_|_|8267029
zidovudine|Chemical|0|[8, 9]|500|-1|_|_|_|_|_|_|_|2528969
azidothymidine|Chemical|0|[19, 20]|500|-1|_|_|_|_|_|_|_|2528969
hiv disease|Disease|2|[32, 34]|2|-1|_|_|_|_|_|_|_|2528969
headache|Disease|6|[22, 23]|3|-1|_|_|_|_|_|_|_|2528969
nausea|Disease|6|[12, 13]|4|-1|_|_|_|_|_|_|_|2528969
fatigue|Disease|6|[17, 18]|5|-1|_|_|_|_|_|_|_|2528969
therapy|Treat|8|[9, 10]|6|-1|_|_|_|_|_|_|_|2528969
treatment|Treat|9|[11, 12]|8|-1|_|_|_|_|_|_|_|2528969
hemoglobin|Physiology|8|[3, 4]|7|-1|_|_|_|_|_|_|_|2528969
reticulocyte count|Physiology|11|[3, 5]|9|-1|_|_|_|_|_|_|_|2528969
bilateral optic neuropathy|Disease|0|[0, 3]|500|H|_|_|_|_|_|_|_|384871
bilateral optic neuropathy|Disease|0|[0, 3]|500|H|_|_|_|_|_|_|_|384871
kidney transplantation|Disease|1|[15, 17]|4|-1|_|_|_|_|_|_|_|384871
scotoma|Disease|2|[10, 11]|6|-1|_|_|_|_|_|_|_|384871
bilateral retrobulbar neuropathy|Disease|2|[1, 4]|500|H|_|_|_|_|_|_|_|384871
optic nerve toxicity|Disease|5|[3, 6]|500|H|_|_|_|_|_|_|_|384871
ethambutol|Chemical|0|[6, 7]|2|-1|_|_|_|_|_|_|_|384871
ethambutol|Chemical|3|[0, 1]|2|-1|_|_|_|_|_|_|_|384871
isoniazid|Chemical|0|[8, 9]|3|-1|_|_|_|_|_|_|_|384871
kidney transplantation|Treat|1|[15, 17]|5|-1|_|_|_|_|_|_|_|384871
visual acuity|Physiology|4|[12, 14]|9|-1|_|_|_|_|_|_|_|384871
blood coagulation|Disease|0|[22, 24]|0|H|_|_|_|_|_|_|_|133615
blood coagulation|Disease|0|[3, 5]|0|H|_|_|_|_|_|_|_|133615
blood coagulation|Disease|2|[7, 9]|0|H|_|_|_|_|_|_|_|133615
blood coagulation|Disease|4|[5, 7]|0|H|_|_|_|_|_|_|_|133615
thromboembolic|Disease|0|[8, 9]|3|H|_|_|_|_|_|_|_|133615
myocardial infarction|Disease|6|[6, 8]|11|-1|_|_|_|_|_|_|_|133615
retinopathy|Disease|7|[3, 4]|12|-1|_|_|_|_|_|_|_|133615
thrombophlebitis|Disease|7|[14, 15]|13|-1|_|_|_|_|_|_|_|133615
oral contraceptive|Chemical|0|[13, 15]|501|-1|_|_|_|_|_|_|_|133615
oral contraceptive|Chemical|11|[23, 25]|501|-1|_|_|_|_|_|_|_|133615
contraceptive|Chemical|8|[10, 11]|501|-1|_|_|_|_|_|_|_|133615
oral contraceptive therapy|Treat|0|[13, 16]|4|-1|_|_|_|_|_|_|_|133615
blood coagulation|Physiology|0|[22, 24]|5|-1|_|_|_|_|_|_|_|133615
blood coagulation|Physiology|0|[3, 5]|5|-1|_|_|_|_|_|_|_|133615
blood coagulation and fibrinolysin systems|Physiology|2|[7, 12]|8|-1|_|_|_|_|_|_|_|133615
blood coagulation profile|Physiology|4|[5, 8]|10|-1|_|_|_|_|_|_|_|133615
blood group|Physiology|9|[9, 11]|15|-1|_|_|_|_|_|_|_|133615
cerebral palsy|Disease|0|[6, 8]|0|-1|_|_|_|_|_|_|_|17263743
cardiac arrest|Disease|0|[0, 2]|3|-1|_|_|_|_|_|_|_|17263743
restlessness|Disease|2|[22, 23]|5|-1|_|_|_|_|_|_|_|17263743
anxiety|Disease|3|[28, 29]|8|-1|_|_|_|_|_|_|_|17263743
hypotension|Disease|4|[10, 11]|9|-1|_|_|_|_|_|_|_|17263743
bradycardia|Disease|4|[8, 9]|10|-1|_|_|_|_|_|_|_|17263743
sevoflurane|Chemical|0|[9, 10]|1|-1|_|_|_|_|_|_|_|17263743
clonidine|Chemical|0|[15, 16]|2|-1|_|_|_|_|_|_|_|17263743
baclofen|Chemical|2|[30, 31]|6|-1|_|_|_|_|_|_|_|17263743
blood pressure|Physiology|1|[15, 17]|4|-1|_|_|_|_|_|_|_|17263743
baclofen pump|Treat|2|[30, 32]|7|-1|_|_|_|_|_|_|_|17263743
induction of anesthesia|Treat|5|[15, 18]|11|-1|_|_|_|_|_|_|_|17263743
sm 21|Chemical|0|[10, 12]|500|-1|_|_|_|_|_|_|_|17241657
sm 21|Chemical|3|[35, 37]|500|-1|_|_|_|_|_|_|_|17241657
sm 21|Chemical|4|[13, 15]|500|-1|_|_|_|_|_|_|_|17241657
sm 21|Chemical|5|[18, 20]|500|-1|_|_|_|_|_|_|_|17241657
sm 21|Chemical|6|[10, 12]|500|-1|_|_|_|_|_|_|_|17241657
cocaine|Chemical|0|[26, 27]|1|-1|_|_|_|_|_|_|_|17241657
cocaine|Chemical|1|[21, 22]|1|-1|_|_|_|_|_|_|_|17241657
cocaine|Chemical|5|[22, 23]|1|-1|_|_|_|_|_|_|_|17241657
cocaine|Chemical|7|[20, 21]|1|-1|_|_|_|_|_|_|_|17241657
umb24|Chemical|0|[2, 3]|2|-1|_|_|_|_|_|_|_|17241657
umb24|Chemical|3|[8, 9]|2|-1|_|_|_|_|_|_|_|17241657
umb24|Chemical|4|[5, 6]|2|-1|_|_|_|_|_|_|_|17241657
umb24|Chemical|5|[10, 11]|2|-1|_|_|_|_|_|_|_|17241657
umb24|Chemical|6|[24, 25]|2|-1|_|_|_|_|_|_|_|17241657
sigma2 receptors|Chemical|2|[6, 8]|500|-1|_|_|_|_|_|_|_|17241657
(+/-)-sm 21|Chemical|6|[4, 12]|500|-1|_|_|_|_|_|_|_|17241657
convulsive|Disease|1|[11, 12]|502|-1|_|_|_|_|_|_|_|17241657
convulsions|Disease|5|[25, 26]|502|-1|_|_|_|_|_|_|_|17241657
sigma2|Gene|7|[6, 7]|18|-1|_|_|_|_|_|_|_|17241657
cholestatic jaundice|Disease|0|[3, 5]|500|-1|_|_|_|_|_|_|_|14982270
hyperthyroidism|Disease|2|[32, 33]|3|-1|_|_|_|_|_|_|_|14982270
pruritus|Disease|4|[16, 17]|5|-1|_|_|_|_|_|_|_|14982270
icterus|Disease|4|[14, 15]|501|H|_|_|_|_|_|_|_|14982270
hyperbilirubinemia|Disease|4|[19, 20]|501|H|_|_|_|_|_|_|_|14982270
cholestasis|Disease|5|[3, 4]|500|-1|_|_|_|_|_|_|_|14982270
methimazole|Chemical|0|[0, 1]|1|-1|_|_|_|_|_|_|_|14982270
methimazole|Chemical|1|[0, 1]|1|-1|_|_|_|_|_|_|_|14982270
methimazole|Chemical|5|[0, 1]|1|-1|_|_|_|_|_|_|_|14982270
propranolol|Chemical|2|[23, 24]|4|-1|_|_|_|_|_|_|_|14982270
propranolol|Chemical|5|[8, 9]|4|-1|_|_|_|_|_|_|_|14982270
therapy|Treat|7|[9, 10]|11|-1|_|_|_|_|_|_|_|14982270
hemolytic anemia|Disease|0|[8, 10]|0|-1|_|_|_|_|_|_|_|12911170
hemolytic anemia|Disease|1|[12, 14]|0|-1|_|_|_|_|_|_|_|12911170
hemolytic anemia|Disease|3|[16, 18]|0|-1|_|_|_|_|_|_|_|12911170
hemolytic anemia|Disease|4|[0, 2]|0|-1|_|_|_|_|_|_|_|12911170
hemolytic anemia|Disease|4|[0, 2]|0|-1|_|_|_|_|_|_|_|12911170
interstitial nephritis|Disease|0|[4, 6]|1|-1|_|_|_|_|_|_|_|12911170
interstitial nephritis|Disease|1|[9, 11]|1|-1|_|_|_|_|_|_|_|12911170
interstitial nephritis|Disease|3|[12, 14]|1|-1|_|_|_|_|_|_|_|12911170
interstitial nephritis|Disease|5|[3, 5]|1|-1|_|_|_|_|_|_|_|12911170
end-stage renal disease|Disease|5|[11, 16]|13|H|_|_|_|_|_|_|_|12911170
ciprofloxacin|Chemical|0|[0, 1]|2|-1|_|_|_|_|_|_|_|12911170
ciprofloxacin|Chemical|1|[0, 1]|2|-1|_|_|_|_|_|_|_|12911170
steroid|Chemical|4|[10, 11]|9|-1|_|_|_|_|_|_|_|12911170
steroid therapy|Treat|4|[10, 12]|11|-1|_|_|_|_|_|_|_|12911170
syndrome of inappropriate secretion of antidiuretic hormone|Disease|0|[6, 13]|500|-1|_|_|_|_|_|_|_|11195262
siadh|Disease|1|[33, 34]|500|-1|_|_|_|_|_|_|_|11195262
siadh|Disease|4|[5, 6]|500|-1|_|_|_|_|_|_|_|11195262
tonic-clonic convulsions|Disease|2|[10, 14]|4|-1|_|_|_|_|_|_|_|11195262
weakness of the central nervous system|Disease|4|[17, 23]|8|-1|_|_|_|_|_|_|_|11195262
sodium valproate|Chemical|0|[2, 4]|502|-1|_|_|_|_|_|_|_|11195262
sodium valproate (vpa)|Chemical|1|[15, 20]|502|-1|_|_|_|_|_|_|_|11195262
vpa|Chemical|2|[4, 5]|502|-1|_|_|_|_|_|_|_|11195262
vpa|Chemical|3|[2, 3]|502|-1|_|_|_|_|_|_|_|11195262
vpa|Chemical|4|[30, 31]|502|-1|_|_|_|_|_|_|_|11195262
zonisamide|Chemical|3|[4, 5]|6|-1|_|_|_|_|_|_|_|11195262
hypotension|Disease|0|[8, 9]|0|-1|_|_|_|_|_|_|_|10728962
hypotension|Disease|1|[23, 24]|0|-1|_|_|_|_|_|_|_|10728962
hypotension|Disease|2|[7, 8]|0|-1|_|_|_|_|_|_|_|10728962
heart failure|Disease|0|[11, 13]|3|-1|_|_|_|_|_|_|_|10728962
vasopressin|Chemical|0|[0, 1]|1|-1|_|_|_|_|_|_|_|10728962
vasopressin|Chemical|2|[16, 17]|1|-1|_|_|_|_|_|_|_|10728962
milrinone|Chemical|0|[5, 6]|2|-1|_|_|_|_|_|_|_|10728962
milrinone|Chemical|1|[7, 8]|2|-1|_|_|_|_|_|_|_|10728962
milrinone|Chemical|2|[11, 12]|2|-1|_|_|_|_|_|_|_|10728962
milrinone|Chemical|2|[26, 27]|2|-1|_|_|_|_|_|_|_|10728962
hypotension|Physiology|0|[8, 9]|4|-1|_|_|_|_|_|_|_|10728962
blood pressure|Physiology|2|[18, 20]|11|-1|_|_|_|_|_|_|_|10728962
halothane|Chemical|0|[12, 13]|0|-1|_|_|_|_|_|_|_|7647582
halothane|Chemical|1|[25, 26]|0|-1|_|_|_|_|_|_|_|7647582
halothane|Chemical|2|[0, 1]|0|-1|_|_|_|_|_|_|_|7647582
halothane|Chemical|3|[18, 19]|0|-1|_|_|_|_|_|_|_|7647582
halothane|Chemical|4|[18, 19]|0|-1|_|_|_|_|_|_|_|7647582
halothane|Chemical|5|[10, 11]|0|-1|_|_|_|_|_|_|_|7647582
halothane|Chemical|8|[32, 33]|0|-1|_|_|_|_|_|_|_|7647582
halothane|Chemical|8|[25, 26]|0|-1|_|_|_|_|_|_|_|7647582
enflurane|Chemical|1|[4, 5]|3|-1|_|_|_|_|_|_|_|7647582
enflurane|Chemical|6|[0, 1]|3|-1|_|_|_|_|_|_|_|7647582
isoflurane|Chemical|1|[6, 7]|4|-1|_|_|_|_|_|_|_|7647582
fluorinated liver adducts|Chemical|7|[8, 11]|12|H|_|_|_|_|_|_|_|7647582
hepatic injury|Disease|1|[16, 18]|501|-1|_|_|_|_|_|_|_|7647582
hypersensitivity|Disease|4|[15, 16]|501|-1|_|_|_|_|_|_|_|7647582
immune response|Immune|2|[7, 9]|6|-1|_|_|_|_|_|_|_|7647582
immunological response|Immune|9|[15, 17]|15|-1|_|_|_|_|_|_|_|7647582
paracetamol|Chemical|0|[2, 3]|0|-1|_|_|_|_|_|_|_|4090988
paracetamol|Chemical|1|[21, 22]|0|-1|_|_|_|_|_|_|_|4090988
paracetamol|Chemical|4|[11, 12]|0|-1|_|_|_|_|_|_|_|4090988
paracetamol|Chemical|6|[6, 7]|0|-1|_|_|_|_|_|_|_|4090988
paracetamol|Chemical|7|[12, 13]|0|-1|_|_|_|_|_|_|_|4090988
paracetamol|Chemical|8|[8, 9]|0|-1|_|_|_|_|_|_|_|4090988
liver tumours|Disease|0|[6, 8]|501|H|_|_|_|_|_|_|_|4090988
neoplastic nodules of the liver|Disease|2|[15, 20]|501|-1|_|_|_|_|_|_|_|4090988
foci of cellular alteration|Disease|3|[13, 17]|4|-1|_|_|_|_|_|_|_|4090988
bladder tumours|Disease|5|[5, 7]|501|-1|_|_|_|_|_|_|_|4090988
bladder calculi|Disease|6|[25, 27]|7|-1|_|_|_|_|_|_|_|4090988
hyperplasia|Disease|6|[11, 12]|9|-1|_|_|_|_|_|_|_|4090988
tumours|Disease|7|[4, 5]|501|H|_|_|_|_|_|_|_|4090988
hepatocarcinogens|Disease|8|[30, 31]|13|H|_|_|_|_|_|_|_|4090988
bupivacaine hydrochloride|Chemical|1|[13, 15]|500|-1|_|_|_|_|_|_|_|4038130
mepivacaine hydrochloride|Chemical|1|[19, 21]|501|-1|_|_|_|_|_|_|_|4038130
lidocaine hydrochloride|Chemical|1|[26, 28]|502|-1|_|_|_|_|_|_|_|4038130
epinephrine|Chemical|1|[34, 35]|3|-1|_|_|_|_|_|_|_|4038130
mepivacaine|Chemical|5|[19, 20]|501|-1|_|_|_|_|_|_|_|4038130
lidocaine|Chemical|5|[21, 22]|502|-1|_|_|_|_|_|_|_|4038130
anesthetic|Chemical|6|[24, 25]|502|H|_|_|_|_|_|_|_|4038130
muscle degeneration|Disease|4|[0, 2]|504|-1|_|_|_|_|_|_|_|4038130
muscle damage|Disease|5|[3, 5]|504|-1|_|_|_|_|_|_|_|4038130
diplopia|Disease|6|[12, 13]|8|-1|_|_|_|_|_|_|_|4038130
ophthalmic surgery|Treat|6|[18, 20]|10|-1|_|_|_|_|_|_|_|4038130
aryl-piperazine|Chemical|0|[8, 11]|0|H|_|_|_|_|_|_|_|2907585
aryl-piperazine|Chemical|2|[3, 6]|0|H|_|_|_|_|_|_|_|2907585
haloperidol|Chemical|1|[11, 12]|2|-1|_|_|_|_|_|_|_|2907585
haloperidol|Chemical|2|[22, 23]|2|-1|_|_|_|_|_|_|_|2907585
buspirone|Chemical|1|[5, 6]|500|-1|_|_|_|_|_|_|_|2907585
5-hydroxytryptaminergic agonists|Chemical|2|[11, 15]|500|H|_|_|_|_|_|_|_|2907585
catalepsy|Disease|0|[5, 6]|1|-1|_|_|_|_|_|_|_|2907585
bradycardia|Disease|0|[3, 4]|0|-1|_|_|_|_|_|_|_|2894433
bradycardia|Disease|3|[3, 4]|0|-1|_|_|_|_|_|_|_|2894433
bradycardia|Disease|4|[27, 28]|0|-1|_|_|_|_|_|_|_|2894433
bradycardia|Disease|5|[10, 11]|0|-1|_|_|_|_|_|_|_|2894433
bradycardia|Disease|6|[24, 25]|0|-1|_|_|_|_|_|_|_|2894433
diazepam|Chemical|0|[0, 1]|1|-1|_|_|_|_|_|_|_|2894433
diazepam|Chemical|0|[0, 1]|1|-1|_|_|_|_|_|_|_|2894433
diazepam|Chemical|1|[3, 4]|1|-1|_|_|_|_|_|_|_|2894433
diazepam|Chemical|2|[3, 4]|1|-1|_|_|_|_|_|_|_|2894433
diazepam|Chemical|4|[6, 7]|1|-1|_|_|_|_|_|_|_|2894433
diazepam|Chemical|5|[3, 4]|1|-1|_|_|_|_|_|_|_|2894433
diazepam|Chemical|6|[4, 5]|1|-1|_|_|_|_|_|_|_|2894433
adrenaline|Chemical|3|[12, 13]|10|-1|_|_|_|_|_|_|_|2894433
picrotoxin|Chemical|5|[22, 23]|16|-1|_|_|_|_|_|_|_|2894433
bradycardia|Physiology|0|[3, 4]|3|-1|_|_|_|_|_|_|_|2894433
cardiovascular function|Physiology|1|[5, 7]|5|-1|_|_|_|_|_|_|_|2894433
mean arterial pressure|Physiology|2|[22, 25]|7|-1|_|_|_|_|_|_|_|2894433
heart rate|Physiology|2|[27, 29]|8|-1|_|_|_|_|_|_|_|2894433
pressor effect|Physiology|4|[17, 19]|13|-1|_|_|_|_|_|_|_|2894433
arterial pressure|Physiology|6|[36, 38]|19|-1|_|_|_|_|_|_|_|2894433
cocaine|Chemical|0|[11, 12]|0|-1|_|_|_|_|_|_|_|2790457
cocaine|Chemical|2|[11, 12]|0|-1|_|_|_|_|_|_|_|2790457
cocaine|Chemical|3|[13, 14]|0|-1|_|_|_|_|_|_|_|2790457
cocaine|Chemical|4|[25, 26]|0|-1|_|_|_|_|_|_|_|2790457
cocaine|Chemical|5|[25, 26]|0|-1|_|_|_|_|_|_|_|2790457
cocaine|Chemical|8|[16, 17]|0|-1|_|_|_|_|_|_|_|2790457
carbamazepine|Chemical|0|[1, 2]|500|-1|_|_|_|_|_|_|_|2790457
lidocaine|Chemical|0|[13, 14]|3|-1|_|_|_|_|_|_|_|2790457
carbamazepine (cbz)|Chemical|1|[3, 7]|500|-1|_|_|_|_|_|_|_|2790457
cbz|Chemical|2|[2, 3]|500|-1|_|_|_|_|_|_|_|2790457
cbz|Chemical|3|[1, 2]|500|-1|_|_|_|_|_|_|_|2790457
cbz|Chemical|4|[1, 2]|500|-1|_|_|_|_|_|_|_|2790457
cbz|Chemical|5|[7, 8]|500|-1|_|_|_|_|_|_|_|2790457
cbz|Chemical|6|[4, 5]|500|-1|_|_|_|_|_|_|_|2790457
cbz|Chemical|7|[11, 12]|500|-1|_|_|_|_|_|_|_|2790457
cbz|Chemical|8|[5, 6]|500|-1|_|_|_|_|_|_|_|2790457
seizures|Disease|0|[8, 9]|1|-1|_|_|_|_|_|_|_|2790457
d-penicillamine|Chemical|0|[0, 3]|0|-1|_|_|_|_|_|_|_|2334179
d-penicillamine|Chemical|0|[0, 3]|0|-1|_|_|_|_|_|_|_|2334179
d-penicillamine|Chemical|3|[15, 18]|0|-1|_|_|_|_|_|_|_|2334179
d-penicillamine|Chemical|3|[15, 18]|0|-1|_|_|_|_|_|_|_|2334179
d-penicillamine|Chemical|7|[3, 6]|0|-1|_|_|_|_|_|_|_|2334179
d-penicillamine|Chemical|7|[3, 6]|0|-1|_|_|_|_|_|_|_|2334179
d-penicillamine|Chemical|8|[0, 3]|0|-1|_|_|_|_|_|_|_|2334179
d-penicillamine|Chemical|8|[0, 3]|0|-1|_|_|_|_|_|_|_|2334179
d-penicillamine|Chemical|9|[4, 7]|0|-1|_|_|_|_|_|_|_|2334179
d-penicillamine|Chemical|9|[4, 7]|0|-1|_|_|_|_|_|_|_|2334179
localized scleroderma|Disease|0|[7, 9]|501|-1|_|_|_|_|_|_|_|2334179
localized scleroderma|Disease|1|[0, 2]|501|-1|_|_|_|_|_|_|_|2334179
localized scleroderma|Disease|2|[8, 10]|501|-1|_|_|_|_|_|_|_|2334179
scleroderma|Disease|3|[10, 11]|501|-1|_|_|_|_|_|_|_|2334179
cutaneous lesions|Disease|5|[13, 15]|501|-1|_|_|_|_|_|_|_|2334179
contractures|Disease|6|[3, 4]|9|-1|_|_|_|_|_|_|_|2334179
proteinuria|Disease|8|[12, 13]|12|H|_|_|_|_|_|_|_|2334179
nephrotic syndrome|Disease|8|[4, 6]|14|-1|_|_|_|_|_|_|_|2334179
hypotension|Disease|0|[6, 7]|0|-1|_|_|_|_|_|_|_|1969772
hypotension|Disease|1|[7, 8]|0|-1|_|_|_|_|_|_|_|1969772
hypotension|Disease|4|[9, 10]|0|-1|_|_|_|_|_|_|_|1969772
hypotension|Disease|7|[11, 12]|0|-1|_|_|_|_|_|_|_|1969772
hypotension|Disease|7|[33, 34]|0|-1|_|_|_|_|_|_|_|1969772
hypotension|Disease|8|[24, 25]|0|-1|_|_|_|_|_|_|_|1969772
hypotension|Disease|9|[33, 34]|0|-1|_|_|_|_|_|_|_|1969772
fenoldopam|Chemical|0|[9, 10]|501|-1|_|_|_|_|_|_|_|1969772
fenoldopam|Chemical|9|[0, 1]|501|-1|_|_|_|_|_|_|_|1969772
dopamine-2|Chemical|2|[9, 12]|5|-1|_|_|_|_|_|_|_|1969772
fenoldopam mesylate|Chemical|3|[0, 2]|501|-1|_|_|_|_|_|_|_|1969772
nitroprusside|Chemical|5|[37, 38]|10|-1|_|_|_|_|_|_|_|1969772
nitroprusside|Chemical|6|[50, 51]|10|-1|_|_|_|_|_|_|_|1969772
nitroprusside|Chemical|7|[30, 31]|10|-1|_|_|_|_|_|_|_|1969772
nitroprusside|Chemical|8|[1, 2]|10|-1|_|_|_|_|_|_|_|1969772
halothane|Chemical|5|[42, 43]|11|-1|_|_|_|_|_|_|_|1969772
renal blood flow|Physiology|0|[2, 5]|2|-1|_|_|_|_|_|_|_|1969772
renal blood flow|Physiology|7|[0, 3]|2|-1|_|_|_|_|_|_|_|1969772
hypotension|Physiology|1|[7, 8]|4|-1|_|_|_|_|_|_|_|1969772
blood pressure|Physiology|3|[10, 12]|6|-1|_|_|_|_|_|_|_|1969772
blood flow|Physiology|4|[12, 14]|9|-1|_|_|_|_|_|_|_|1969772
ventricular arrhythmias|Disease|0|[9, 11]|500|-1|_|_|_|_|_|_|_|1700207
arrhythmias|Disease|0|[10, 11]|500|-1|_|_|_|_|_|_|_|1700207
ventricular arrhythmia|Disease|1|[19, 21]|500|-1|_|_|_|_|_|_|_|1700207
arrhythmia|Disease|1|[20, 21]|500|-1|_|_|_|_|_|_|_|1700207
digitalis arrhythmia|Disease|2|[0, 2]|500|-1|_|_|_|_|_|_|_|1700207
cibenzoline|Chemical|0|[6, 7]|502|-1|_|_|_|_|_|_|_|1700207
pentobarbital|Chemical|2|[26, 27]|5|-1|_|_|_|_|_|_|_|1700207
ouabain|Chemical|2|[24, 25]|7|-1|_|_|_|_|_|_|_|1700207
na channel blockers|Chemical|2|[7, 10]|8|H|_|_|_|_|_|_|_|1700207
halothane|Chemical|3|[17, 18]|9|-1|_|_|_|_|_|_|_|1700207
adrenaline|Chemical|3|[0, 1]|10|-1|_|_|_|_|_|_|_|1700207
adrenaline|Chemical|3|[14, 15]|10|-1|_|_|_|_|_|_|_|1700207
(+)-cibenzoline|Chemical|5|[6, 11]|502|-1|_|_|_|_|_|_|_|1700207
-cibenzoline|Chemical|6|[16, 18]|502|-1|_|_|_|_|_|_|_|1700207
na channels|Physiology|8|[29, 31]|14|-1|_|_|_|_|_|_|_|1700207
ca channels|Physiology|8|[38, 40]|15|-1|_|_|_|_|_|_|_|1700207
hibiscus rosa sinensis|Chemical|0|[2, 5]|500|-1|_|_|_|_|_|_|_|19761039
hibiscus rosa sinensis|Chemical|0|[2, 5]|500|-1|_|_|_|_|_|_|_|19761039
hibiscus rosa sinensis|Chemical|1|[5, 8]|500|-1|_|_|_|_|_|_|_|19761039
hibiscus rosa sinensis|Chemical|3|[31, 34]|500|-1|_|_|_|_|_|_|_|19761039
hibiscus rosa sinensis|Chemical|6|[8, 11]|500|-1|_|_|_|_|_|_|_|19761039
reserpine|Chemical|0|[6, 7]|1|-1|_|_|_|_|_|_|_|19761039
reserpine|Chemical|1|[19, 20]|1|-1|_|_|_|_|_|_|_|19761039
reserpine|Chemical|2|[6, 7]|1|-1|_|_|_|_|_|_|_|19761039
reserpine|Chemical|3|[16, 17]|1|-1|_|_|_|_|_|_|_|19761039
reserpine|Chemical|3|[16, 17]|1|-1|_|_|_|_|_|_|_|19761039
reserpine|Chemical|4|[7, 8]|1|-1|_|_|_|_|_|_|_|19761039
reserpine|Chemical|6|[16, 17]|1|-1|_|_|_|_|_|_|_|19761039
methanolic extract of hibiscus rosa sinensis|Chemical|1|[2, 8]|500|-1|_|_|_|_|_|_|_|19761039
superoxide dismutase (sod)|Chemical|4|[17, 22]|11|-1|_|_|_|_|_|_|_|19761039
catalase (cat)|Chemical|4|[23, 27]|12|-1|_|_|_|_|_|_|_|19761039
glutathione reductase (gsh)|Chemical|4|[28, 33]|13|-1|_|_|_|_|_|_|_|19761039
glaucoma|Disease|0|[22, 23]|0|H|_|_|_|_|_|_|_|11704023
open-angle glaucoma|Disease|4|[9, 13]|4|-1|_|_|_|_|_|_|_|11704023
ocular hypertension|Disease|4|[14, 16]|5|H|_|_|_|_|_|_|_|11704023
bradycardia|Disease|11|[5, 6]|6|-1|_|_|_|_|_|_|_|11704023
timolol|Chemical|0|[6, 7]|1|-1|_|_|_|_|_|_|_|11704023
heart rate|Physiology|0|[14, 16]|2|-1|_|_|_|_|_|_|_|11704023
bradycardia|Physiology|11|[5, 6]|7|-1|_|_|_|_|_|_|_|11704023
exercise performance|Physiology|12|[1, 3]|8|-1|_|_|_|_|_|_|_|11704023
topical beta-blocker treatment|Treat|1|[2, 7]|3|-1|_|_|_|_|_|_|_|11704023
apical ballooning syndrome|Disease|0|[4, 7]|500|-1|_|_|_|_|_|_|_|19300240
coronary disease|Disease|1|[43, 45]|501|H|_|_|_|_|_|_|_|19300240
hyperkinesis|Disease|1|[30, 31]|3|H|_|_|_|_|_|_|_|19300240
epicardial coronary disease|Disease|1|[42, 45]|501|H|_|_|_|_|_|_|_|19300240
abs|Disease|3|[7, 8]|500|-1|_|_|_|_|_|_|_|19300240
abs|Disease|13|[28, 29]|500|-1|_|_|_|_|_|_|_|19300240
chest pain|Disease|5|[11, 13]|7|H|_|_|_|_|_|_|_|19300240
colorectal cancer|Disease|6|[8, 10]|8|-1|_|_|_|_|_|_|_|19300240
wall-motion abnormality|Disease|7|[3, 7]|500|-1|_|_|_|_|_|_|_|19300240
apical akinesis|Disease|11|[11, 13]|500|-1|_|_|_|_|_|_|_|19300240
coronary vasospasm|Disease|12|[11, 13]|13|-1|_|_|_|_|_|_|_|19300240
thrombus|Disease|12|[18, 19]|14|-1|_|_|_|_|_|_|_|19300240
5 flourouracil|Chemical|0|[0, 2]|1|-1|_|_|_|_|_|_|_|19300240
fluorouracil|Chemical|6|[5, 6]|9|-1|_|_|_|_|_|_|_|19300240
chemotherapy|Treat|4|[12, 13]|6|-1|_|_|_|_|_|_|_|19300240
medical therapy|Treat|9|[5, 7]|11|-1|_|_|_|_|_|_|_|19300240
propofol|Chemical|0|[9, 10]|0|-1|_|_|_|_|_|_|_|18006530
remifentanil|Chemical|0|[11, 12]|1|-1|_|_|_|_|_|_|_|18006530
pain|Disease|0|[2, 3]|2|-1|_|_|_|_|_|_|_|18006530
fetal pulmonary hypertension|Disease|0|[5, 8]|0|H|_|_|_|_|_|_|_|17702969
fetal pulmonary hypertension|Disease|7|[9, 12]|0|H|_|_|_|_|_|_|_|17702969
pulmonary hypertension|Disease|0|[6, 8]|1|H|_|_|_|_|_|_|_|17702969
pulmonary arterial smooth muscle cell proliferation|Disease|10|[10, 16]|9|-1|_|_|_|_|_|_|_|17702969
fluoxetine|Chemical|0|[3, 4]|2|-1|_|_|_|_|_|_|_|17702969
serotonin|Chemical|1|[6, 7]|3|-1|_|_|_|_|_|_|_|17702969
pulmonary vascular smooth muscle mechanical properties|Physiology|4|[10, 16]|4|-1|_|_|_|_|_|_|_|17702969
weight ratio of the right ventricle to the left ventricle plus septum|Physiology|7|[19, 31]|6|-1|_|_|_|_|_|_|_|17702969
pulmonary arterial medial thickness|Physiology|7|[43, 47]|7|-1|_|_|_|_|_|_|_|17702969
arterial oxygen saturation|Physiology|8|[9, 12]|8|-1|_|_|_|_|_|_|_|17702969
vascular smooth muscle proliferation|Physiology|11|[29, 33]|10|-1|_|_|_|_|_|_|_|17702969
methadone|Chemical|0|[8, 9]|0|-1|_|_|_|_|_|_|_|17344330
methadone|Chemical|0|[8, 9]|0|-1|_|_|_|_|_|_|_|17344330
methadone|Chemical|1|[2, 3]|0|-1|_|_|_|_|_|_|_|17344330
methadone|Chemical|1|[2, 3]|0|-1|_|_|_|_|_|_|_|17344330
methadone|Chemical|2|[21, 22]|0|-1|_|_|_|_|_|_|_|17344330
methadone|Chemical|3|[53, 54]|0|-1|_|_|_|_|_|_|_|17344330
methadone|Chemical|4|[25, 26]|0|-1|_|_|_|_|_|_|_|17344330
methadone|Chemical|8|[9, 10]|0|-1|_|_|_|_|_|_|_|17344330
methadone|Chemical|9|[2, 3]|0|-1|_|_|_|_|_|_|_|17344330
methadone|Chemical|9|[2, 3]|0|-1|_|_|_|_|_|_|_|17344330
methadone|Chemical|11|[5, 6]|0|-1|_|_|_|_|_|_|_|17344330
methadone|Chemical|13|[4, 5]|0|-1|_|_|_|_|_|_|_|17344330
methadone|Chemical|14|[2, 3]|0|-1|_|_|_|_|_|_|_|17344330
methadone|Chemical|14|[2, 3]|0|-1|_|_|_|_|_|_|_|17344330
heroin|Chemical|3|[1, 2]|10|-1|_|_|_|_|_|_|_|17344330
buprenorphine|Chemical|4|[27, 28]|12|-1|_|_|_|_|_|_|_|17344330
syncope|Disease|0|[0, 1]|1|H|_|_|_|_|_|_|_|17344330
qt prolongation|Disease|0|[2, 4]|2|H|_|_|_|_|_|_|_|17344330
qt prolongation|Disease|14|[6, 8]|2|H|_|_|_|_|_|_|_|17344330
torsade de pointes (tdp)|Disease|2|[11, 17]|501|-1|_|_|_|_|_|_|_|17344330
tdp|Disease|3|[28, 29]|501|-1|_|_|_|_|_|_|_|17344330
qtc|Disease|10|[5, 6]|17|H|_|_|_|_|_|_|_|17344330
prolonged qtc interval|Disease|11|[13, 16]|19|-1|_|_|_|_|_|_|_|17344330
qt interval|Physiology|9|[8, 10]|16|-1|_|_|_|_|_|_|_|17344330
qtc interval|Physiology|12|[8, 10]|20|-1|_|_|_|_|_|_|_|17344330
cytosine arabinoside|Chemical|0|[7, 9]|0|-1|_|_|_|_|_|_|_|16826348
methylprednisolone|Chemical|6|[38, 39]|7|-1|_|_|_|_|_|_|_|16826348
central nervous system toxicity|Disease|1|[1, 5]|1|-1|_|_|_|_|_|_|_|16826348
myeloid leukemia|Disease|2|[12, 14]|2|-1|_|_|_|_|_|_|_|16826348
neuropathy|Disease|6|[1, 2]|4|-1|_|_|_|_|_|_|_|16826348
graft-versus-host disease|Disease|6|[25, 31]|5|-1|_|_|_|_|_|_|_|16826348
consolidation therapy|Treat|3|[34, 36]|3|-1|_|_|_|_|_|_|_|16826348
allogeneic bone marrow transplantation|Treat|6|[12, 16]|6|-1|_|_|_|_|_|_|_|16826348
therapy|Treat|7|[17, 18]|8|-1|_|_|_|_|_|_|_|16826348
hypertension|Disease|0|[7, 8]|0|-1|_|_|_|_|_|_|_|16820346
atorvastatin|Chemical|1|[6, 7]|501|-1|_|_|_|_|_|_|_|16820346
dexamethasone|Chemical|1|[11, 12]|502|-1|_|_|_|_|_|_|_|16820346
atorva|Chemical|3|[8, 9]|501|-1|_|_|_|_|_|_|_|16820346
dex|Chemical|3|[10, 11]|502|-1|_|_|_|_|_|_|_|16820346
dex|Chemical|3|[40, 41]|502|-1|_|_|_|_|_|_|_|16820346
nitrate|Chemical|5|[1, 2]|8|-1|_|_|_|_|_|_|_|16820346
hypertension|Physiology|1|[17, 18]|3|-1|_|_|_|_|_|_|_|16820346
blood pressure|Physiology|2|[3, 5]|4|-1|_|_|_|_|_|_|_|16820346
plasma nitrate/nitrite|Physiology|5|[0, 4]|10|-1|_|_|_|_|_|_|_|16820346
plasma|Physiology|6|[3, 4]|11|-1|_|_|_|_|_|_|_|16820346
dex-treated|Treat|5|[10, 13]|9|-1|_|_|_|_|_|_|_|16820346
thymus weight|Immune|6|[6, 8]|12|-1|_|_|_|_|_|_|_|16820346
pain|Disease|0|[16, 17]|0|H|_|_|_|_|_|_|_|15974569
ka|Disease|1|[12, 13]|3|-1|_|_|_|_|_|_|_|15974569
mechanical hyperalgesia|Disease|2|[33, 35]|6|-1|_|_|_|_|_|_|_|15974569
thermal hyperalgesia|Disease|2|[26, 28]|8|-1|_|_|_|_|_|_|_|15974569
glur5 kainate receptor antagonists|Chemical|0|[6, 10]|1|H|_|_|_|_|_|_|_|15974569
amino acids|Chemical|1|[0, 2]|2|H|_|_|_|_|_|_|_|15974569
glur5 ka|Chemical|1|[11, 13]|4|-1|_|_|_|_|_|_|_|15974569
carrageenan|Chemical|2|[23, 24]|5|-1|_|_|_|_|_|_|_|15974569
capsaicin|Chemical|2|[30, 31]|7|-1|_|_|_|_|_|_|_|15974569
sirolimus|Chemical|0|[0, 1]|500|-1|_|_|_|_|_|_|_|11583940
mycophenolate mofetil|Chemical|0|[2, 4]|1|-1|_|_|_|_|_|_|_|11583940
cyclosporine|Chemical|1|[5, 6]|3|-1|_|_|_|_|_|_|_|11583940
tacrolimus|Chemical|1|[7, 8]|4|-1|_|_|_|_|_|_|_|11583940
rapamycin|Chemical|5|[11, 12]|500|-1|_|_|_|_|_|_|_|11583940
immunosuppression|Immune|0|[8, 9]|2|-1|_|_|_|_|_|_|_|11583940
immunosuppressive therapy|Immune|6|[19, 21]|11|-1|_|_|_|_|_|_|_|11583940
nephrotoxicity|Disease|2|[21, 22]|5|-1|_|_|_|_|_|_|_|11583940
nephrotoxicity|Disease|3|[1, 2]|5|-1|_|_|_|_|_|_|_|11583940
nephrotoxicity|Disease|3|[22, 23]|5|-1|_|_|_|_|_|_|_|11583940
nephrotoxicity|Disease|4|[3, 4]|5|-1|_|_|_|_|_|_|_|11583940
nephrotoxicity|Disease|5|[16, 17]|5|-1|_|_|_|_|_|_|_|11583940
anemia|Disease|0|[3, 4]|0|-1|_|_|_|_|_|_|_|11245434
anemia|Disease|2|[0, 1]|0|-1|_|_|_|_|_|_|_|11245434
sarcoma|Disease|5|[10, 11]|5|H|_|_|_|_|_|_|_|11245434
ds-sarcoma|Disease|5|[8, 11]|6|-1|_|_|_|_|_|_|_|11245434
cyclophosphamide|Chemical|0|[8, 9]|1|-1|_|_|_|_|_|_|_|11245434
carboplatin|Chemical|2|[8, 9]|3|-1|_|_|_|_|_|_|_|11245434
hemoglobin concentration|Physiology|2|[31, 33]|4|-1|_|_|_|_|_|_|_|11245434
rhuepo treatment|Treat|10|[8, 10]|7|-1|_|_|_|_|_|_|_|11245434
convulsion|Disease|0|[9, 10]|500|-1|_|_|_|_|_|_|_|11243580
convulsions|Disease|1|[41, 42]|500|-1|_|_|_|_|_|_|_|11243580
lidocaine|Chemical|0|[6, 7]|1|-1|_|_|_|_|_|_|_|11243580
l-name|Chemical|1|[14, 17]|502|-1|_|_|_|_|_|_|_|11243580
l-name|Chemical|2|[33, 36]|502|-1|_|_|_|_|_|_|_|11243580
l-name|Chemical|2|[33, 36]|502|-1|_|_|_|_|_|_|_|11243580
l-name|Chemical|5|[0, 3]|502|-1|_|_|_|_|_|_|_|11243580
l-name|Chemical|5|[0, 3]|502|-1|_|_|_|_|_|_|_|11243580
n-nitro-l-arginine-methyl ester (l-name)|Chemical|1|[3, 18]|502|-1|_|_|_|_|_|_|_|11243580
nitric oxide (no)|Chemical|1|[19, 24]|502|-1|_|_|_|_|_|_|_|11243580
diazepam|Chemical|2|[48, 49]|7|-1|_|_|_|_|_|_|_|11243580
diazepam|Chemical|5|[15, 16]|7|-1|_|_|_|_|_|_|_|11243580
no|Chemical|7|[5, 6]|502|-1|_|_|_|_|_|_|_|11243580
injections|Treat|4|[22, 23]|9|-1|_|_|_|_|_|_|_|11243580
myocardial ischemia|Disease|0|[13, 15]|0|-1|_|_|_|_|_|_|_|11079278
myocardial ischemia|Disease|12|[13, 15]|0|-1|_|_|_|_|_|_|_|11079278
reversible perfusion defects|Disease|4|[8, 11]|5|-1|_|_|_|_|_|_|_|11079278
metoprolol|Chemical|0|[6, 7]|1|-1|_|_|_|_|_|_|_|11079278
metoprolol|Chemical|0|[3, 4]|1|-1|_|_|_|_|_|_|_|11079278
metoprolol|Chemical|7|[0, 1]|1|-1|_|_|_|_|_|_|_|11079278
metoprolol|Chemical|8|[5, 6]|1|-1|_|_|_|_|_|_|_|11079278
metoprolol|Chemical|9|[0, 1]|1|-1|_|_|_|_|_|_|_|11079278
dobutamine|Chemical|0|[10, 11]|3|H|_|_|_|_|_|_|_|11079278
technetium-99m sestamibi|Chemical|1|[14, 18]|4|-1|_|_|_|_|_|_|_|11079278
predobutamine|Chemical|7|[7, 8]|6|-1|_|_|_|_|_|_|_|11079278
heart rate|Physiology|7|[8, 10]|8|-1|_|_|_|_|_|_|_|11079278
atrophy|Disease|0|[9, 10]|500|-1|_|_|_|_|_|_|_|10910842
atrophy|Disease|13|[19, 20]|500|-1|_|_|_|_|_|_|_|10910842
atrophy|Disease|15|[15, 16]|500|-1|_|_|_|_|_|_|_|10910842
muscle dysfunction|Disease|0|[3, 5]|500|H|_|_|_|_|_|_|_|10910842
tetanic|Disease|5|[12, 13]|7|-1|_|_|_|_|_|_|_|10910842
tetanic|Disease|8|[5, 6]|7|-1|_|_|_|_|_|_|_|10910842
neuromuscular dysfunction|Disease|13|[5, 7]|500|H|_|_|_|_|_|_|_|10910842
muscle atrophy|Disease|13|[18, 20]|500|-1|_|_|_|_|_|_|_|10910842
chronic glucocorticoid therapy|Disease|14|[6, 9]|500|-1|_|_|_|_|_|_|_|10910842
prednisolone|Chemical|0|[0, 1]|2|-1|_|_|_|_|_|_|_|10910842
acetylcholine receptor expression|Physiology|0|[13, 16]|3|-1|_|_|_|_|_|_|_|10910842
muscle physiology|Physiology|1|[6, 8]|4|-1|_|_|_|_|_|_|_|10910842
muscle function|Physiology|2|[12, 14]|5|-1|_|_|_|_|_|_|_|10910842
tension|Physiology|8|[23, 24]|10|-1|_|_|_|_|_|_|_|10910842
acetylcholine receptor (achr)|Gene|2|[26, 31]|6|-1|_|_|_|_|_|_|_|10910842
achrs|Gene|5|[45, 46]|8|-1|_|_|_|_|_|_|_|10910842
achr|Gene|10|[0, 1]|11|-1|_|_|_|_|_|_|_|10910842
achr|Gene|13|[27, 28]|11|-1|_|_|_|_|_|_|_|10910842
tetany|Disease|0|[9, 10]|0|-1|_|_|_|_|_|_|_|10533019
calcium chloride|Chemical|0|[11, 13]|1|-1|_|_|_|_|_|_|_|10533019
diltiazem|Chemical|0|[6, 7]|2|-1|_|_|_|_|_|_|_|10533019
administration of calcium chloride|Treat|2|[1, 5]|3|-1|_|_|_|_|_|_|_|10533019
aneurysmal|Disease|0|[12, 13]|500|-1|_|_|_|_|_|_|_|10414674
aneurysmal|Disease|3|[2, 3]|500|-1|_|_|_|_|_|_|_|10414674
aneurysmal|Disease|3|[58, 59]|500|-1|_|_|_|_|_|_|_|10414674
aneurysmal subarachnoid hemorrhage|Disease|0|[12, 15]|501|-1|_|_|_|_|_|_|_|10414674
sah|Disease|3|[6, 7]|501|H|_|_|_|_|_|_|_|10414674
sah|Disease|3|[59, 60]|501|H|_|_|_|_|_|_|_|10414674
sah|Disease|11|[10, 11]|501|H|_|_|_|_|_|_|_|10414674
sah|Disease|11|[10, 11]|501|H|_|_|_|_|_|_|_|10414674
platelet aggregation|Disease|6|[1, 3]|12|-1|_|_|_|_|_|_|_|10414674
platelet aggregation|Disease|8|[4, 6]|12|-1|_|_|_|_|_|_|_|10414674
platelet aggregation|Disease|8|[21, 23]|12|-1|_|_|_|_|_|_|_|10414674
hematoma|Disease|9|[10, 11]|17|-1|_|_|_|_|_|_|_|10414674
artery aneurysms|Disease|12|[8, 10]|501|-1|_|_|_|_|_|_|_|10414674
hemorrhage|Disease|12|[19, 20]|501|H|_|_|_|_|_|_|_|10414674
platelet function|Physiology|1|[0, 2]|2|-1|_|_|_|_|_|_|_|10414674
platelet aggregation|Physiology|8|[4, 6]|15|-1|_|_|_|_|_|_|_|10414674
platelet aggregation|Physiology|8|[21, 23]|15|-1|_|_|_|_|_|_|_|10414674
ketoprofen|Chemical|3|[13, 14]|7|-1|_|_|_|_|_|_|_|10414674
ketoprofen|Chemical|3|[23, 24]|7|-1|_|_|_|_|_|_|_|10414674
ketoprofen|Chemical|11|[0, 1]|7|-1|_|_|_|_|_|_|_|10414674
acetaminophen|Chemical|3|[35, 36]|9|-1|_|_|_|_|_|_|_|10414674
acetaminophen|Chemical|3|[45, 46]|9|-1|_|_|_|_|_|_|_|10414674
acetaminophen|Chemical|11|[3, 4]|9|-1|_|_|_|_|_|_|_|10414674
fibrinogen|Chemical|10|[16, 17]|18|-1|_|_|_|_|_|_|_|10414674
treatment|Treat|4|[0, 1]|11|-1|_|_|_|_|_|_|_|10414674
arthralgia|Disease|0|[7, 8]|500|-1|_|_|_|_|_|_|_|9523850
arthralgia|Disease|2|[7, 8]|500|-1|_|_|_|_|_|_|_|9523850
arthralgia|Disease|9|[18, 19]|500|-1|_|_|_|_|_|_|_|9523850
reactions|Disease|6|[20, 21]|500|-1|_|_|_|_|_|_|_|9523850
methylprednisolone|Chemical|0|[2, 3]|502|-1|_|_|_|_|_|_|_|9523850
iron dextran|Chemical|0|[18, 20]|2|-1|_|_|_|_|_|_|_|9523850
methylprednisolone (mp)|Chemical|3|[25, 29]|502|-1|_|_|_|_|_|_|_|9523850
mp|Chemical|4|[54, 55]|502|-1|_|_|_|_|_|_|_|9523850
mp|Chemical|4|[36, 37]|502|-1|_|_|_|_|_|_|_|9523850
mp|Chemical|9|[6, 7]|502|-1|_|_|_|_|_|_|_|9523850
infusion|Treat|0|[16, 17]|3|-1|_|_|_|_|_|_|_|9523850
treated patients|Treat|2|[3, 5]|5|-1|_|_|_|_|_|_|_|9523850
tdi of iron dextran|Treat|10|[17, 21]|12|-1|_|_|_|_|_|_|_|9523850
vincristine|Chemical|0|[5, 6]|0|-1|_|_|_|_|_|_|_|8384253
non-hodgkin's lymphoma|Disease|1|[3, 9]|1|-1|_|_|_|_|_|_|_|8384253
neuropathic symptoms|Disease|2|[7, 9]|501|-1|_|_|_|_|_|_|_|8384253
vincristine neuropathy|Disease|12|[15, 17]|501|-1|_|_|_|_|_|_|_|8384253
vincristine treatment|Treat|3|[27, 29]|3|-1|_|_|_|_|_|_|_|8384253
therapy|Treat|8|[8, 9]|4|-1|_|_|_|_|_|_|_|8384253
reflexes|Physiology|10|[1, 2]|5|-1|_|_|_|_|_|_|_|8384253
d-penicillamine|Chemical|0|[13, 16]|0|-1|_|_|_|_|_|_|_|8268147
d-penicillamine|Chemical|0|[13, 16]|0|-1|_|_|_|_|_|_|_|8268147
d-penicillamine|Chemical|1|[1, 4]|0|-1|_|_|_|_|_|_|_|8268147
d-penicillamine|Chemical|1|[1, 4]|0|-1|_|_|_|_|_|_|_|8268147
d-penicillamine|Chemical|2|[12, 15]|0|-1|_|_|_|_|_|_|_|8268147
d-penicillamine|Chemical|2|[12, 15]|0|-1|_|_|_|_|_|_|_|8268147
d-penicillamine|Chemical|3|[14, 17]|0|-1|_|_|_|_|_|_|_|8268147
d-penicillamine|Chemical|3|[14, 17]|0|-1|_|_|_|_|_|_|_|8268147
d-penicillamine|Chemical|5|[2, 5]|0|-1|_|_|_|_|_|_|_|8268147
d-penicillamine|Chemical|5|[2, 5]|0|-1|_|_|_|_|_|_|_|8268147
polymyositis|Disease|0|[3, 4]|1|-1|_|_|_|_|_|_|_|8268147
polymyositis|Disease|2|[0, 1]|1|-1|_|_|_|_|_|_|_|8268147
primary biliary cirrhosis|Disease|0|[8, 11]|2|-1|_|_|_|_|_|_|_|8268147
telangiectasia|Disease|0|[5, 6]|0|-1|_|_|_|_|_|_|_|8251368
flushing|Disease|2|[6, 7]|2|-1|_|_|_|_|_|_|_|8251368
nifedipine|Chemical|0|[1, 2]|1|-1|_|_|_|_|_|_|_|8251368
amlodipine|Chemical|4|[6, 7]|3|-1|_|_|_|_|_|_|_|8251368
nephrotoxicity|Disease|0|[0, 1]|500|H|_|_|_|_|_|_|_|7542793
degenerative changes of proximal tubular epithelium|Disease|1|[43, 49]|6|-1|_|_|_|_|_|_|_|7542793
nephrotoxic|Disease|6|[5, 6]|500|H|_|_|_|_|_|_|_|7542793
cyclosporin a|Chemical|0|[2, 4]|502|-1|_|_|_|_|_|_|_|7542793
cyclosporin a|Chemical|1|[0, 2]|502|-1|_|_|_|_|_|_|_|7542793
fk506|Chemical|0|[5, 6]|2|-1|_|_|_|_|_|_|_|7542793
fk506|Chemical|1|[13, 14]|2|-1|_|_|_|_|_|_|_|7542793
fk506|Chemical|2|[6, 7]|2|-1|_|_|_|_|_|_|_|7542793
fk506|Chemical|3|[15, 16]|2|-1|_|_|_|_|_|_|_|7542793
fk506|Chemical|3|[3, 4]|2|-1|_|_|_|_|_|_|_|7542793
fk506|Chemical|4|[22, 23]|2|-1|_|_|_|_|_|_|_|7542793
fk506|Chemical|5|[17, 18]|2|-1|_|_|_|_|_|_|_|7542793
fk506|Chemical|6|[10, 11]|2|-1|_|_|_|_|_|_|_|7542793
rapamycin|Chemical|1|[27, 28]|5|-1|_|_|_|_|_|_|_|7542793
rapamycin|Chemical|4|[27, 28]|5|-1|_|_|_|_|_|_|_|7542793
rapamycin|Chemical|5|[21, 22]|5|-1|_|_|_|_|_|_|_|7542793
csa|Chemical|2|[4, 5]|502|-1|_|_|_|_|_|_|_|7542793
csa|Chemical|3|[13, 14]|502|-1|_|_|_|_|_|_|_|7542793
csa|Chemical|4|[20, 21]|502|-1|_|_|_|_|_|_|_|7542793
csa|Chemical|5|[15, 16]|502|-1|_|_|_|_|_|_|_|7542793
csa|Chemical|6|[8, 9]|502|-1|_|_|_|_|_|_|_|7542793
overdose|Disease|0|[10, 11]|0|-1|_|_|_|_|_|_|_|7337133
edema|Disease|0|[2, 3]|1|H|_|_|_|_|_|_|_|7337133
edema|Disease|1|[1, 2]|1|H|_|_|_|_|_|_|_|7337133
edema|Disease|3|[19, 20]|1|H|_|_|_|_|_|_|_|7337133
cerebral edema|Disease|0|[1, 3]|2|-1|_|_|_|_|_|_|_|7337133
fulminant hepatic failure|Disease|0|[5, 8]|3|-1|_|_|_|_|_|_|_|7337133
acetaminophen|Chemical|0|[9, 10]|4|-1|_|_|_|_|_|_|_|7337133
cranial decompression|Treat|0|[15, 17]|5|-1|_|_|_|_|_|_|_|7337133
conventional therapy|Treat|2|[2, 4]|7|-1|_|_|_|_|_|_|_|7337133
conventional medical therapy|Treat|3|[23, 26]|9|-1|_|_|_|_|_|_|_|7337133
gentamicin|Chemical|0|[0, 1]|0|-1|_|_|_|_|_|_|_|4069770
periodic acid|Chemical|3|[1, 3]|2|-1|_|_|_|_|_|_|_|4069770
anuria|Disease|2|[9, 10]|1|-1|_|_|_|_|_|_|_|4069770
phenobarbital|Chemical|0|[5, 6]|500|-1|_|_|_|_|_|_|_|3780814
diethylnitrosamine|Chemical|0|[9, 10]|501|-1|_|_|_|_|_|_|_|3780814
den|Chemical|2|[9, 10]|501|H|_|_|_|_|_|_|_|3780814
den|Chemical|2|[13, 14]|501|H|_|_|_|_|_|_|_|3780814
den|Chemical|3|[27, 28]|501|H|_|_|_|_|_|_|_|3780814
den|Chemical|4|[14, 15]|501|H|_|_|_|_|_|_|_|3780814
den|Chemical|4|[22, 23]|501|H|_|_|_|_|_|_|_|3780814
den|Chemical|6|[1, 2]|501|H|_|_|_|_|_|_|_|3780814
den|Chemical|6|[23, 24]|501|H|_|_|_|_|_|_|_|3780814
den|Chemical|7|[13, 14]|501|H|_|_|_|_|_|_|_|3780814
den|Chemical|7|[24, 25]|501|H|_|_|_|_|_|_|_|3780814
pb|Chemical|2|[15, 16]|500|-1|_|_|_|_|_|_|_|3780814
pb|Chemical|3|[22, 23]|500|-1|_|_|_|_|_|_|_|3780814
pb|Chemical|4|[24, 25]|500|-1|_|_|_|_|_|_|_|3780814
pb|Chemical|6|[3, 4]|500|-1|_|_|_|_|_|_|_|3780814
pb|Chemical|7|[4, 5]|500|-1|_|_|_|_|_|_|_|3780814
pb|Chemical|9|[14, 15]|500|-1|_|_|_|_|_|_|_|3780814
anti-carcinogen|Chemical|8|[2, 5]|500|-1|_|_|_|_|_|_|_|3780814
hepatocarcinogenesis|Disease|2|[28, 29]|2|H|_|_|_|_|_|_|_|3780814
preneoplastic foci|Disease|3|[16, 18]|6|-1|_|_|_|_|_|_|_|3780814
treatment|Treat|3|[5, 6]|9|-1|_|_|_|_|_|_|_|3780814
rigidity|Disease|0|[3, 4]|0|-1|_|_|_|_|_|_|_|3780697
fentanyl|Chemical|0|[5, 6]|1|-1|_|_|_|_|_|_|_|3780697
naloxone|Chemical|2|[5, 6]|2|-1|_|_|_|_|_|_|_|3780697
bromocriptine|Chemical|0|[4, 5]|0|-1|_|_|_|_|_|_|_|3686155
bromocriptine|Chemical|2|[0, 1]|0|-1|_|_|_|_|_|_|_|3686155
psychosis|Disease|3|[7, 8]|2|-1|_|_|_|_|_|_|_|3686155
mitomycin c|Chemical|0|[11, 13]|500|-1|_|_|_|_|_|_|_|3137399
doxorubicin|Chemical|1|[21, 22]|2|-1|_|_|_|_|_|_|_|3137399
doxorubicin|Chemical|7|[21, 22]|2|-1|_|_|_|_|_|_|_|3137399
doxorubicin|Chemical|11|[49, 50]|2|-1|_|_|_|_|_|_|_|3137399
mitomycin c (mmc)|Chemical|1|[2, 7]|500|-1|_|_|_|_|_|_|_|3137399
mmc|Chemical|7|[13, 14]|500|-1|_|_|_|_|_|_|_|3137399
mmc|Chemical|11|[16, 17]|500|-1|_|_|_|_|_|_|_|3137399
cardiotoxic|Disease|1|[12, 13]|1|H|_|_|_|_|_|_|_|3137399
cardiac failure|Disease|7|[5, 7]|6|-1|_|_|_|_|_|_|_|3137399
left ventricular ejection fraction (ef)|Physiology|5|[20, 27]|4|-1|_|_|_|_|_|_|_|3137399
nephrotoxicity|Disease|0|[8, 9]|500|H|_|_|_|_|_|_|_|2709684
nephrotoxicity|Disease|2|[4, 5]|500|H|_|_|_|_|_|_|_|2709684
diabetes mellitus (dm)|Disease|1|[6, 11]|501|-1|_|_|_|_|_|_|_|2709684
renal failure (arf)|Disease|1|[45, 50]|500|H|_|_|_|_|_|_|_|2709684
dm|Disease|3|[0, 1]|501|-1|_|_|_|_|_|_|_|2709684
dm|Disease|5|[37, 38]|501|-1|_|_|_|_|_|_|_|2709684
nephrotoxic|Disease|6|[0, 1]|500|H|_|_|_|_|_|_|_|2709684
renal dysfunction|Disease|7|[35, 37]|501|H|_|_|_|_|_|_|_|2709684
tubular necrosis|Disease|7|[59, 61]|11|-1|_|_|_|_|_|_|_|2709684
arf|Disease|8|[10, 11]|501|H|_|_|_|_|_|_|_|2709684
phlorizin|Chemical|0|[0, 1]|1|-1|_|_|_|_|_|_|_|2709684
gentamicin|Chemical|0|[7, 8]|2|-1|_|_|_|_|_|_|_|2709684
streptozotocin|Chemical|1|[3, 4]|3|-1|_|_|_|_|_|_|_|2709684
ccr|Physiology|8|[15, 16]|13|-1|_|_|_|_|_|_|_|2709684
ccr|Physiology|9|[14, 15]|13|-1|_|_|_|_|_|_|_|2709684
levodopa|Chemical|0|[2, 3]|0|-1|_|_|_|_|_|_|_|458486
levodopa|Chemical|1|[12, 13]|0|-1|_|_|_|_|_|_|_|458486
levodopa|Chemical|1|[12, 13]|0|-1|_|_|_|_|_|_|_|458486
levodopa|Chemical|3|[5, 6]|0|-1|_|_|_|_|_|_|_|458486
levodopa|Chemical|4|[8, 9]|0|-1|_|_|_|_|_|_|_|458486
tiapride|Chemical|1|[0, 1]|3|-1|_|_|_|_|_|_|_|458486
metoclopramide|Chemical|1|[9, 10]|4|-1|_|_|_|_|_|_|_|458486
involuntary movements|Disease|0|[5, 7]|501|-1|_|_|_|_|_|_|_|458486
akinesia|Disease|2|[17, 18]|6|-1|_|_|_|_|_|_|_|458486
parkinsonism|Disease|2|[8, 9]|7|H|_|_|_|_|_|_|_|458486
dystonia|Disease|3|[17, 18]|9|-1|_|_|_|_|_|_|_|458486
dyskinesias|Disease|4|[11, 12]|501|-1|_|_|_|_|_|_|_|458486
epilepsy|Disease|0|[15, 16]|500|-1|_|_|_|_|_|_|_|21294084
epileptic activity|Disease|1|[13, 15]|500|-1|_|_|_|_|_|_|_|21294084
cortical epileptic activity|Disease|9|[15, 18]|500|-1|_|_|_|_|_|_|_|21294084
deep brain stimulation|Treat|0|[4, 7]|1|-1|_|_|_|_|_|_|_|21294084
penicillin g|Chemical|4|[43, 45]|3|H|_|_|_|_|_|_|_|21294084
penicillin-g|Chemical|6|[9, 12]|4|-1|_|_|_|_|_|_|_|21294084
cerebral bioelectrical activity|Physiology|8|[14, 17]|5|-1|_|_|_|_|_|_|_|21294084
ketamine|Chemical|0|[5, 6]|500|-1|_|_|_|_|_|_|_|20727411
ketamine|Chemical|2|[16, 17]|500|-1|_|_|_|_|_|_|_|20727411
ketamine|Chemical|3|[5, 6]|500|-1|_|_|_|_|_|_|_|20727411
ketamine|Chemical|4|[23, 24]|500|-1|_|_|_|_|_|_|_|20727411
ketamine|Chemical|6|[0, 1]|500|-1|_|_|_|_|_|_|_|20727411
ketamine|Chemical|6|[0, 1]|500|-1|_|_|_|_|_|_|_|20727411
ketamine|Chemical|7|[0, 1]|500|-1|_|_|_|_|_|_|_|20727411
ketamine|Chemical|8|[12, 13]|500|-1|_|_|_|_|_|_|_|20727411
ketamine|Chemical|9|[0, 1]|500|-1|_|_|_|_|_|_|_|20727411
ketamine|Chemical|9|[0, 1]|500|-1|_|_|_|_|_|_|_|20727411
ketamine|Chemical|10|[0, 1]|500|-1|_|_|_|_|_|_|_|20727411
s-ketamine|Chemical|0|[3, 6]|500|-1|_|_|_|_|_|_|_|20727411
s-ketamine|Chemical|4|[21, 24]|500|-1|_|_|_|_|_|_|_|20727411
n-methyl-d-aspartate (nmda)|Chemical|1|[2, 12]|3|H|_|_|_|_|_|_|_|20727411
psychosis|Disease|0|[7, 8]|502|-1|_|_|_|_|_|_|_|20727411
psychopathological symptoms|Disease|6|[3, 5]|502|-1|_|_|_|_|_|_|_|20727411
bold responses|Physiology|4|[28, 30]|8|-1|_|_|_|_|_|_|_|20727411
neurotoxicity|Disease|0|[11, 12]|500|-1|_|_|_|_|_|_|_|20533999
neurotoxicity|Disease|3|[30, 31]|500|-1|_|_|_|_|_|_|_|20533999
neurotoxicity|Disease|4|[16, 17]|500|-1|_|_|_|_|_|_|_|20533999
neurotoxicity|Disease|6|[19, 20]|500|-1|_|_|_|_|_|_|_|20533999
da neurotoxicity|Disease|3|[29, 31]|500|-1|_|_|_|_|_|_|_|20533999
dopaminergic deficits|Disease|5|[19, 21]|500|-1|_|_|_|_|_|_|_|20533999
dopaminergic neurotoxicity|Disease|6|[18, 20]|500|-1|_|_|_|_|_|_|_|20533999
dopamine|Chemical|0|[0, 1]|502|-1|_|_|_|_|_|_|_|20533999
methamphetamine|Chemical|0|[8, 9]|503|-1|_|_|_|_|_|_|_|20533999
meth|Chemical|1|[12, 13]|503|-1|_|_|_|_|_|_|_|20533999
meth|Chemical|3|[26, 27]|503|-1|_|_|_|_|_|_|_|20533999
meth|Chemical|3|[26, 27]|503|-1|_|_|_|_|_|_|_|20533999
meth|Chemical|4|[15, 16]|503|-1|_|_|_|_|_|_|_|20533999
meth|Chemical|4|[25, 26]|503|-1|_|_|_|_|_|_|_|20533999
meth|Chemical|4|[15, 16]|503|-1|_|_|_|_|_|_|_|20533999
meth|Chemical|4|[25, 26]|503|-1|_|_|_|_|_|_|_|20533999
meth|Chemical|5|[16, 17]|503|-1|_|_|_|_|_|_|_|20533999
meth|Chemical|5|[16, 17]|503|-1|_|_|_|_|_|_|_|20533999
meth|Chemical|6|[15, 16]|503|-1|_|_|_|_|_|_|_|20533999
meth|Chemical|6|[15, 16]|503|-1|_|_|_|_|_|_|_|20533999
dopamine (da)|Chemical|1|[5, 9]|502|-1|_|_|_|_|_|_|_|20533999
methamphetamine (meth)|Chemical|1|[10, 14]|503|-1|_|_|_|_|_|_|_|20533999
tyrosine|Chemical|3|[24, 25]|6|H|_|_|_|_|_|_|_|20533999
l-dihydroxyphenylalanine|Chemical|3|[9, 12]|8|-1|_|_|_|_|_|_|_|20533999
l-dihydroxyphenylalanine|Chemical|3|[9, 12]|8|-1|_|_|_|_|_|_|_|20533999
alpha-methyl-para-tyrosine|Chemical|3|[18, 25]|13|-1|_|_|_|_|_|_|_|20533999
body temperature|Physiology|3|[38, 40]|14|-1|_|_|_|_|_|_|_|20533999
da|Gene|5|[13, 14]|23|-1|_|_|_|_|_|_|_|20533999
cocaine|Chemical|0|[8, 9]|0|-1|_|_|_|_|_|_|_|20304337
cocaine|Chemical|1|[10, 11]|0|-1|_|_|_|_|_|_|_|20304337
cocaine|Chemical|3|[19, 20]|0|-1|_|_|_|_|_|_|_|20304337
cocaine abuse|Disease|1|[10, 12]|2|H|_|_|_|_|_|_|_|20304337
multiple cranial-nerve involvement|Disease|3|[6, 11]|3|-1|_|_|_|_|_|_|_|20304337
streptozotocin|Chemical|0|[6, 7]|0|-1|_|_|_|_|_|_|_|20103708
streptozotocin|Chemical|4|[26, 27]|0|-1|_|_|_|_|_|_|_|20103708
streptozotocin|Chemical|6|[13, 14]|0|-1|_|_|_|_|_|_|_|20103708
reactive oxygen species (ros)|Chemical|1|[21, 27]|5|-1|_|_|_|_|_|_|_|20103708
nrf2|Chemical|5|[16, 17]|16|-1|_|_|_|_|_|_|_|20103708
transforming growth factor-beta1 (tgf-beta1)|Chemical|8|[29, 39]|24|-1|_|_|_|_|_|_|_|20103708
diabetic nephropathy|Disease|0|[9, 11]|1|-1|_|_|_|_|_|_|_|20103708
diabetic nephropathy|Disease|1|[2, 4]|1|-1|_|_|_|_|_|_|_|20103708
diabetic nephropathy|Disease|1|[2, 4]|1|-1|_|_|_|_|_|_|_|20103708
diabetic nephropathy|Disease|3|[13, 15]|1|-1|_|_|_|_|_|_|_|20103708
diabetic nephropathy|Disease|4|[29, 31]|1|-1|_|_|_|_|_|_|_|20103708
diabetic nephropathy|Disease|4|[13, 15]|1|-1|_|_|_|_|_|_|_|20103708
diabetic nephropathy|Disease|4|[21, 23]|1|-1|_|_|_|_|_|_|_|20103708
diabetic nephropathy|Disease|5|[6, 8]|1|-1|_|_|_|_|_|_|_|20103708
diabetic nephropathy|Disease|8|[18, 20]|1|-1|_|_|_|_|_|_|_|20103708
diabetic nephropathy|Disease|11|[37, 39]|1|-1|_|_|_|_|_|_|_|20103708
diabetic nephropathy|Disease|11|[12, 14]|1|-1|_|_|_|_|_|_|_|20103708
renal damage|Disease|6|[16, 18]|18|-1|_|_|_|_|_|_|_|20103708
renal injury|Disease|7|[23, 25]|20|-1|_|_|_|_|_|_|_|20103708
nrf2|Gene|0|[4, 5]|2|-1|_|_|_|_|_|_|_|20103708
nrf2|Gene|2|[0, 1]|2|-1|_|_|_|_|_|_|_|20103708
nrf2|Gene|3|[11, 12]|2|-1|_|_|_|_|_|_|_|20103708
nrf2|Gene|4|[11, 12]|2|-1|_|_|_|_|_|_|_|20103708
nrf2|Gene|4|[33, 34]|2|-1|_|_|_|_|_|_|_|20103708
nrf2|Gene|6|[5, 6]|2|-1|_|_|_|_|_|_|_|20103708
nrf2|Gene|7|[4, 5]|2|-1|_|_|_|_|_|_|_|20103708
nrf2|Gene|7|[27, 28]|2|-1|_|_|_|_|_|_|_|20103708
nrf2|Gene|8|[13, 14]|2|-1|_|_|_|_|_|_|_|20103708
nrf2|Gene|9|[15, 16]|2|-1|_|_|_|_|_|_|_|20103708
nrf2|Gene|10|[6, 7]|2|-1|_|_|_|_|_|_|_|20103708
nrf2|Gene|10|[25, 26]|2|-1|_|_|_|_|_|_|_|20103708
nrf2|Gene|11|[10, 11]|2|-1|_|_|_|_|_|_|_|20103708
nrf2|Gene|11|[22, 23]|2|-1|_|_|_|_|_|_|_|20103708
tgf-beta1|Gene|10|[29, 32]|29|-1|_|_|_|_|_|_|_|20103708
tgf-beta1|Gene|10|[12, 15]|29|-1|_|_|_|_|_|_|_|20103708
seizures|Disease|0|[10, 11]|0|-1|_|_|_|_|_|_|_|19996135
cerebral ischemic injury|Disease|6|[15, 18]|4|-1|_|_|_|_|_|_|_|19996135
ischemic brain injury|Disease|6|[25, 28]|5|-1|_|_|_|_|_|_|_|19996135
cardiopulmonary bypass|Disease|9|[7, 9]|7|-1|_|_|_|_|_|_|_|19996135
brain ischemic|Disease|10|[3, 5]|9|H|_|_|_|_|_|_|_|19996135
hyperthermia|Disease|10|[9, 10]|10|-1|_|_|_|_|_|_|_|19996135
metabolic|Disease|10|[6, 7]|11|H|_|_|_|_|_|_|_|19996135
tranexamic acid|Chemical|0|[3, 5]|501|-1|_|_|_|_|_|_|_|19996135
txa|Chemical|3|[19, 20]|501|-1|_|_|_|_|_|_|_|19996135
txa|Chemical|8|[9, 10]|501|-1|_|_|_|_|_|_|_|19996135
txa|Chemical|11|[11, 12]|501|-1|_|_|_|_|_|_|_|19996135
cardiac surgery|Treat|3|[24, 26]|3|-1|_|_|_|_|_|_|_|19996135
cardiopulmonary bypass|Treat|9|[7, 9]|8|-1|_|_|_|_|_|_|_|19996135
open-chamber cardiac surgery|Treat|11|[21, 26]|13|-1|_|_|_|_|_|_|_|19996135
dysosmia|Disease|0|[1, 2]|500|-1|_|_|_|_|_|_|_|19674115
hepatic toxicity|Disease|1|[7, 9]|2|-1|_|_|_|_|_|_|_|19674115
olfactory disorder|Disease|3|[6, 8]|500|-1|_|_|_|_|_|_|_|19674115
pyrazinamide|Chemical|0|[4, 5]|1|-1|_|_|_|_|_|_|_|19674115
colorectal adenomas|Disease|0|[20, 22]|500|-1|_|_|_|_|_|_|_|19139001
adenomatous polyps|Disease|1|[9, 11]|500|-1|_|_|_|_|_|_|_|19139001
hearing loss|Disease|2|[1, 3]|4|-1|_|_|_|_|_|_|_|19139001
hearing loss|Disease|9|[20, 22]|4|-1|_|_|_|_|_|_|_|19139001
ototoxicity|Disease|10|[5, 6]|11|-1|_|_|_|_|_|_|_|19139001
sulindac|Chemical|0|[15, 16]|1|-1|_|_|_|_|_|_|_|19139001
difluoromethylornithine (dfmo)|Chemical|1|[17, 21]|3|-1|_|_|_|_|_|_|_|19139001
treatment with dfmo|Treat|2|[8, 11]|5|-1|_|_|_|_|_|_|_|19139001
placebo|Treat|4|[27, 28]|7|-1|_|_|_|_|_|_|_|19139001
treatment|Treat|8|[13, 14]|8|-1|_|_|_|_|_|_|_|19139001
treatment|Treat|8|[45, 46]|8|-1|_|_|_|_|_|_|_|19139001
dfmo plus sulindac|Treat|11|[13, 16]|12|-1|_|_|_|_|_|_|_|19139001
air conduction pure tone thresholds|Physiology|3|[17, 22]|6|-1|_|_|_|_|_|_|_|19139001
trihexyphenidyl|Chemical|0|[10, 11]|0|-1|_|_|_|_|_|_|_|18239197
mental slowing|Physiology|0|[1, 3]|1|-1|_|_|_|_|_|_|_|18239197
mental slowness|Physiology|6|[18, 20]|6|-1|_|_|_|_|_|_|_|18239197
apoe|Gene|0|[6, 7]|2|-1|_|_|_|_|_|_|_|18239197
apoe|Gene|2|[14, 15]|2|-1|_|_|_|_|_|_|_|18239197
apoe|Gene|6|[24, 25]|2|-1|_|_|_|_|_|_|_|18239197
apoe|Gene|7|[37, 38]|2|-1|_|_|_|_|_|_|_|18239197
apoe epsilon4|Gene|1|[13, 15]|4|-1|_|_|_|_|_|_|_|18239197
epsilon4 allele|Gene|9|[3, 5]|9|-1|_|_|_|_|_|_|_|18239197
confusion|Disease|1|[25, 26]|3|-1|_|_|_|_|_|_|_|18239197
steroid|Chemical|0|[6, 7]|500|-1|_|_|_|_|_|_|_|17194457
steroid|Chemical|1|[15, 16]|500|-1|_|_|_|_|_|_|_|17194457
anabolic androgenic steroid (aas)|Chemical|1|[13, 19]|500|-1|_|_|_|_|_|_|_|17194457
serotonin|Chemical|1|[22, 23]|501|H|_|_|_|_|_|_|_|17194457
5-hydroxytryptamine, 5-ht|Chemical|1|[24, 31]|501|H|_|_|_|_|_|_|_|17194457
testosterone|Chemical|3|[22, 23]|500|-1|_|_|_|_|_|_|_|17194457
5-hydroxyindoleacetic acid (5-hiaa)|Chemical|6|[10, 19]|8|-1|_|_|_|_|_|_|_|17194457
t|Chemical|11|[6, 7]|500|H|_|_|_|_|_|_|_|17194457
irritability|Disease|4|[5, 6]|6|-1|_|_|_|_|_|_|_|17194457
irritability|Disease|9|[11, 12]|6|-1|_|_|_|_|_|_|_|17194457
irritability|Disease|10|[8, 9]|6|-1|_|_|_|_|_|_|_|17194457
aggressive behavior|Disease|12|[25, 27]|13|-1|_|_|_|_|_|_|_|17194457
locomotion|Physiology|4|[3, 4]|7|-1|_|_|_|_|_|_|_|17194457
chronic t treatment|Treat|8|[0, 3]|9|-1|_|_|_|_|_|_|_|17194457
glioblastoma|Disease|0|[13, 14]|500|-1|_|_|_|_|_|_|_|16132524
malignant brain tumors|Disease|1|[1, 4]|500|-1|_|_|_|_|_|_|_|16132524
glioblastoma multiforme|Disease|5|[10, 12]|500|-1|_|_|_|_|_|_|_|16132524
edema|Disease|6|[17, 18]|501|-1|_|_|_|_|_|_|_|16132524
edema|Disease|7|[6, 7]|501|-1|_|_|_|_|_|_|_|16132524
brain edema|Disease|6|[16, 18]|501|-1|_|_|_|_|_|_|_|16132524
paclitaxel|Chemical|0|[3, 4]|1|-1|_|_|_|_|_|_|_|16132524
carboplatin|Chemical|0|[5, 6]|2|-1|_|_|_|_|_|_|_|16132524
intracavitary chemotherapy|Treat|0|[0, 2]|3|-1|_|_|_|_|_|_|_|16132524
intracavitary chemotherapy|Treat|8|[0, 2]|3|-1|_|_|_|_|_|_|_|16132524
surgery|Treat|1|[11, 12]|5|-1|_|_|_|_|_|_|_|16132524
radiation therapy|Treat|1|[13, 15]|6|-1|_|_|_|_|_|_|_|16132524
re-resection|Treat|5|[13, 16]|8|-1|_|_|_|_|_|_|_|16132524
obsessive-compulsive symptoms|Disease|0|[3, 7]|500|-1|_|_|_|_|_|_|_|12907924
treatment-resistant depression|Disease|1|[8, 12]|2|-1|_|_|_|_|_|_|_|12907924
alzheimer's disease|Disease|1|[14, 18]|3|-1|_|_|_|_|_|_|_|12907924
depression|Disease|1|[11, 12]|4|H|_|_|_|_|_|_|_|12907924
obsessive-compulsive behavior|Disease|2|[1, 5]|500|-1|_|_|_|_|_|_|_|12907924
obsessive-compulsive disorder|Disease|3|[14, 18]|500|-1|_|_|_|_|_|_|_|12907924
methylphenidate|Chemical|0|[0, 1]|1|-1|_|_|_|_|_|_|_|12907924
fluvoxamine|Chemical|2|[16, 17]|5|-1|_|_|_|_|_|_|_|12907924
cardiac arrest|Disease|0|[0, 2]|0|H|_|_|_|_|_|_|_|12139551
cardiac arrest|Disease|0|[18, 20]|0|H|_|_|_|_|_|_|_|12139551
asystole|Disease|1|[13, 14]|4|-1|_|_|_|_|_|_|_|12139551
metoclopramide|Chemical|0|[13, 14]|2|-1|_|_|_|_|_|_|_|12139551
metoclopramide|Chemical|0|[4, 5]|2|-1|_|_|_|_|_|_|_|12139551
atropine|Chemical|4|[3, 4]|5|-1|_|_|_|_|_|_|_|12139551
dopamine|Chemical|6|[13, 14]|6|-1|_|_|_|_|_|_|_|12139551
hemolytic anemia|Disease|0|[2, 4]|0|-1|_|_|_|_|_|_|_|10411803
hemolytic anemia|Disease|1|[20, 22]|0|-1|_|_|_|_|_|_|_|10411803
hemolytic anemia|Disease|3|[7, 9]|0|-1|_|_|_|_|_|_|_|10411803
cefotetan|Chemical|0|[9, 10]|1|-1|_|_|_|_|_|_|_|10411803
prophylactically|Treat|2|[21, 22]|3|-1|_|_|_|_|_|_|_|10411803
cauda equina syndrome|Disease|0|[0, 3]|0|-1|_|_|_|_|_|_|_|10225068
cauda equina syndrome|Disease|0|[17, 20]|0|-1|_|_|_|_|_|_|_|10225068
anaesthesia|Disease|3|[7, 8]|3|-1|_|_|_|_|_|_|_|10225068
neurotoxicity|Disease|5|[10, 11]|4|-1|_|_|_|_|_|_|_|10225068
neurotoxicity|Disease|6|[7, 8]|4|-1|_|_|_|_|_|_|_|10225068
compressive aetiology|Disease|6|[23, 25]|6|-1|_|_|_|_|_|_|_|10225068
neurological deficits|Disease|7|[4, 6]|7|H|_|_|_|_|_|_|_|10225068
lignocaine|Chemical|0|[9, 10]|2|-1|_|_|_|_|_|_|_|10225068
l-dopa|Chemical|0|[7, 10]|0|-1|_|_|_|_|_|_|_|9549528
l-dopa|Chemical|0|[7, 10]|0|-1|_|_|_|_|_|_|_|9549528
l-dopa|Chemical|1|[40, 43]|0|-1|_|_|_|_|_|_|_|9549528
l-dopa|Chemical|1|[49, 52]|0|-1|_|_|_|_|_|_|_|9549528
l-dopa|Chemical|1|[40, 43]|0|-1|_|_|_|_|_|_|_|9549528
l-dopa|Chemical|1|[49, 52]|0|-1|_|_|_|_|_|_|_|9549528
l-dopa|Chemical|4|[15, 18]|0|-1|_|_|_|_|_|_|_|9549528
l-dopa|Chemical|4|[15, 18]|0|-1|_|_|_|_|_|_|_|9549528
parkinsonian|Disease|0|[4, 5]|501|-1|_|_|_|_|_|_|_|9549528
parkinsonian|Disease|1|[37, 38]|501|-1|_|_|_|_|_|_|_|9549528
parkinsonian|Disease|3|[2, 3]|501|-1|_|_|_|_|_|_|_|9549528
parkinsonian|Disease|3|[23, 24]|501|-1|_|_|_|_|_|_|_|9549528
dyskinesia|Disease|0|[15, 16]|501|-1|_|_|_|_|_|_|_|9549528
dyskinetic parkinsonian|Disease|3|[22, 24]|501|-1|_|_|_|_|_|_|_|9549528
dyskinetic parkinsonian|Disease|3|[1, 3]|501|-1|_|_|_|_|_|_|_|9549528
hyperkinetic|Disease|4|[9, 10]|16|H|_|_|_|_|_|_|_|9549528
l-dopa medication|Treat|1|[40, 44]|9|-1|_|_|_|_|_|_|_|9549528
regional cerebral blood flow (rcbf)|Physiology|1|[4, 11]|10|-1|_|_|_|_|_|_|_|9549528
motor cortex|Physiology|4|[34, 36]|18|-1|_|_|_|_|_|_|_|9549528
ocular hypertension|Disease|0|[3, 5]|0|-1|_|_|_|_|_|_|_|7843916
ocular hypertension|Disease|1|[10, 12]|0|-1|_|_|_|_|_|_|_|7843916
ocular hypertension|Disease|12|[17, 19]|0|-1|_|_|_|_|_|_|_|7843916
hypertensive|Disease|10|[7, 8]|8|-1|_|_|_|_|_|_|_|7843916
dexamethasone|Chemical|0|[0, 1]|501|-1|_|_|_|_|_|_|_|7843916
corticosteroid|Chemical|1|[13, 14]|501|-1|_|_|_|_|_|_|_|7843916
corticosteroid|Chemical|13|[15, 16]|501|-1|_|_|_|_|_|_|_|7843916
steroid|Chemical|13|[0, 1]|11|H|_|_|_|_|_|_|_|7843916
steroid|Chemical|14|[16, 17]|11|H|_|_|_|_|_|_|_|7843916
hypertension|Physiology|0|[4, 5]|2|-1|_|_|_|_|_|_|_|7843916
outflow facility|Physiology|2|[15, 17]|6|-1|_|_|_|_|_|_|_|7843916
intraocular pressure|Physiology|5|[0, 2]|7|-1|_|_|_|_|_|_|_|7843916
glucocorticoid treatment|Treat|2|[9, 11]|5|-1|_|_|_|_|_|_|_|7843916
dexamethasone treatment|Treat|12|[2, 4]|10|-1|_|_|_|_|_|_|_|7843916
cognitive deterioration|Disease|0|[0, 2]|0|-1|_|_|_|_|_|_|_|7803371
nausea|Disease|4|[15, 16]|3|-1|_|_|_|_|_|_|_|7803371
restlessness|Disease|4|[17, 18]|4|-1|_|_|_|_|_|_|_|7803371
nystagmus|Disease|4|[26, 27]|5|-1|_|_|_|_|_|_|_|7803371
aggressive behavior|Disease|4|[38, 40]|6|-1|_|_|_|_|_|_|_|7803371
insomnia|Disease|4|[19, 20]|7|-1|_|_|_|_|_|_|_|7803371
ataxia|Disease|4|[21, 22]|8|-1|_|_|_|_|_|_|_|7803371
slurred speech|Disease|4|[23, 25]|9|-1|_|_|_|_|_|_|_|7803371
dm|Disease|5|[8, 9]|10|H|_|_|_|_|_|_|_|7803371
dm|Disease|7|[13, 14]|10|H|_|_|_|_|_|_|_|7803371
dextromethorphan|Chemical|0|[8, 9]|1|-1|_|_|_|_|_|_|_|7803371
antitussives|Treat|1|[33, 34]|2|-1|_|_|_|_|_|_|_|7803371
lithium|Chemical|0|[3, 4]|0|-1|_|_|_|_|_|_|_|7437994
long-term lithium treatment|Treat|0|[0, 5]|1|-1|_|_|_|_|_|_|_|7437994
glomerular filtration|Physiology|4|[8, 10]|2|-1|_|_|_|_|_|_|_|7437994
polyuria|Disease|8|[0, 1]|3|-1|_|_|_|_|_|_|_|7437994
polyuria|Disease|8|[0, 1]|3|-1|_|_|_|_|_|_|_|7437994
trazodone|Chemical|0|[8, 9]|0|-1|_|_|_|_|_|_|_|6496797
heart block|Disease|1|[15, 17]|1|-1|_|_|_|_|_|_|_|6496797
quinidine phenylethylbarbiturate|Chemical|0|[0, 2]|0|-1|_|_|_|_|_|_|_|3411101
quinidine|Chemical|4|[0, 1]|2|-1|_|_|_|_|_|_|_|3411101
phenylethylbarbiturate|Chemical|4|[3, 4]|3|H|_|_|_|_|_|_|_|3411101
liver transplantation|Treat|2|[7, 9]|1|-1|_|_|_|_|_|_|_|3411101
flank pain syndrome|Disease|0|[5, 8]|0|-1|_|_|_|_|_|_|_|2598570
inflammatory|Disease|1|[7, 8]|3|H|_|_|_|_|_|_|_|2598570
hay fever|Disease|5|[31, 33]|4|-1|_|_|_|_|_|_|_|2598570
asthma|Disease|5|[34, 35]|5|-1|_|_|_|_|_|_|_|2598570
kidney stones|Disease|6|[25, 27]|7|-1|_|_|_|_|_|_|_|2598570
gout|Disease|6|[31, 32]|8|-1|_|_|_|_|_|_|_|2598570
suprofen|Chemical|0|[9, 10]|1|-1|_|_|_|_|_|_|_|2598570
suprofen|Chemical|1|[0, 1]|1|-1|_|_|_|_|_|_|_|2598570
alcohol|Chemical|5|[100, 101]|6|-1|_|_|_|_|_|_|_|2598570
hemolytic-uremic syndrome|Disease|0|[0, 4]|500|-1|_|_|_|_|_|_|_|1415380
hemolytic-uremic syndrome|Disease|1|[0, 4]|500|-1|_|_|_|_|_|_|_|1415380
reaction|Disease|8|[6, 7]|500|-1|_|_|_|_|_|_|_|1415380
reaction|Disease|8|[19, 20]|500|-1|_|_|_|_|_|_|_|1415380
quinine|Chemical|0|[8, 9]|1|-1|_|_|_|_|_|_|_|1415380
dipyridamole|Chemical|4|[13, 14]|4|-1|_|_|_|_|_|_|_|1415380
prednisone|Chemical|4|[8, 9]|5|-1|_|_|_|_|_|_|_|1415380
aspirin|Chemical|4|[10, 11]|6|-1|_|_|_|_|_|_|_|1415380
antibodies|Immune|3|[9, 10]|3|-1|_|_|_|_|_|_|_|1415380
plasma exchange|Treat|4|[5, 7]|7|-1|_|_|_|_|_|_|_|1415380
pharmacological treatment|Treat|6|[6, 8]|8|-1|_|_|_|_|_|_|_|1415380
pyeloureteritis cystica|Disease|1|[3, 5]|0|-1|_|_|_|_|_|_|_|1255900
pelvic thrombophlebitis|Disease|4|[12, 14]|1|-1|_|_|_|_|_|_|_|1255900
heparin therapy|Treat|4|[8, 10]|2|-1|_|_|_|_|_|_|_|1255900
hepatoma|Disease|0|[7, 8]|500|-1|_|_|_|_|_|_|_|85485
hepatomas|Disease|1|[2, 3]|500|-1|_|_|_|_|_|_|_|85485
alpha-benzene hexachloride|Chemical|0|[12, 16]|502|-1|_|_|_|_|_|_|_|85485
ethyl-alpha-p-chlorophenoxyisobutyrate|Chemical|2|[25, 32]|3|-1|_|_|_|_|_|_|_|85485
carcinogen|Chemical|3|[5, 6]|502|H|_|_|_|_|_|_|_|85485
peroxisomes|Chemical|5|[17, 18]|5|-1|_|_|_|_|_|_|_|85485
lactic acid|Chemical|1|[17, 19]|0|-1|_|_|_|_|_|_|_|48362
lactic acid|Chemical|4|[18, 20]|0|-1|_|_|_|_|_|_|_|48362
quinidine|Chemical|1|[5, 6]|1|-1|_|_|_|_|_|_|_|48362
hepatic toxicity|Disease|6|[14, 16]|3|-1|_|_|_|_|_|_|_|48362
acetaminophen|Chemical|0|[10, 11]|0|-1|_|_|_|_|_|_|_|9067481
adriamycin|Chemical|0|[12, 13]|1|-1|_|_|_|_|_|_|_|9067481
carbon tetrachloride|Chemical|0|[14, 16]|500|H|_|_|_|_|_|_|_|9067481
chloroform|Chemical|0|[17, 18]|501|-1|_|_|_|_|_|_|_|9067481
galactosamine|Chemical|0|[19, 20]|4|-1|_|_|_|_|_|_|_|9067481
cholesteryl hemisuccinate|Chemical|0|[0, 2]|502|-1|_|_|_|_|_|_|_|9067481
ccl4|Chemical|1|[37, 38]|500|-1|_|_|_|_|_|_|_|9067481
ccl4|Chemical|4|[36, 37]|500|-1|_|_|_|_|_|_|_|9067481
cs|Chemical|2|[30, 31]|502|-1|_|_|_|_|_|_|_|9067481
cs|Chemical|2|[8, 9]|502|-1|_|_|_|_|_|_|_|9067481
cs|Chemical|2|[21, 22]|502|-1|_|_|_|_|_|_|_|9067481
cs|Chemical|3|[7, 8]|502|-1|_|_|_|_|_|_|_|9067481
cs|Chemical|4|[15, 16]|502|-1|_|_|_|_|_|_|_|9067481
cs|Chemical|5|[1, 2]|502|-1|_|_|_|_|_|_|_|9067481
cs|Chemical|6|[4, 5]|502|-1|_|_|_|_|_|_|_|9067481
cs|Chemical|8|[15, 16]|502|-1|_|_|_|_|_|_|_|9067481
cs|Chemical|9|[5, 6]|502|-1|_|_|_|_|_|_|_|9067481
cs|Chemical|9|[18, 19]|502|-1|_|_|_|_|_|_|_|9067481
cs|Chemical|9|[29, 30]|502|-1|_|_|_|_|_|_|_|9067481
gamma-cholesteryloxybutyric acid|Chemical|2|[32, 36]|502|-1|_|_|_|_|_|_|_|9067481
cse|Chemical|2|[40, 41]|502|-1|_|_|_|_|_|_|_|9067481
cse|Chemical|9|[24, 25]|502|-1|_|_|_|_|_|_|_|9067481
chcl3|Chemical|4|[38, 39]|501|-1|_|_|_|_|_|_|_|9067481
hepatotoxic|Disease|1|[31, 32]|6|-1|_|_|_|_|_|_|_|9067481
cardiotoxic|Disease|4|[50, 51]|14|-1|_|_|_|_|_|_|_|9067481
hepatotoxicity|Disease|7|[31, 32]|20|-1|_|_|_|_|_|_|_|9067481
myeloma|Disease|0|[23, 24]|500|-1|_|_|_|_|_|_|_|19274460
multiple myeloma|Disease|1|[31, 33]|500|-1|_|_|_|_|_|_|_|19274460
hematological and gastrointestinal toxicities|Disease|7|[6, 10]|6|-1|_|_|_|_|_|_|_|19274460
neuropathy|Disease|7|[13, 14]|7|-1|_|_|_|_|_|_|_|19274460
mm|Disease|8|[29, 30]|500|-1|_|_|_|_|_|_|_|19274460
cyclophosphamide|Chemical|0|[8, 9]|1|-1|_|_|_|_|_|_|_|19274460
bortezomib|Chemical|0|[12, 13]|2|-1|_|_|_|_|_|_|_|19274460
dexamethasone|Chemical|0|[14, 15]|3|-1|_|_|_|_|_|_|_|19274460
stem cell transplantation|Treat|1|[22, 25]|5|-1|_|_|_|_|_|_|_|19274460
amlodipine|Chemical|0|[36, 37]|0|-1|_|_|_|_|_|_|_|18201582
amlodipine|Chemical|0|[38, 39]|0|-1|_|_|_|_|_|_|_|18201582
amlodipine|Chemical|1|[39, 40]|0|-1|_|_|_|_|_|_|_|18201582
amlodipine|Chemical|1|[29, 30]|0|-1|_|_|_|_|_|_|_|18201582
telmisartan|Chemical|0|[34, 35]|3|-1|_|_|_|_|_|_|_|18201582
t+a|Chemical|3|[7, 10]|7|-1|_|_|_|_|_|_|_|18201582
t+a|Chemical|6|[38, 41]|7|-1|_|_|_|_|_|_|_|18201582
t+a|Chemical|12|[14, 17]|7|-1|_|_|_|_|_|_|_|18201582
hypertension|Disease|0|[46, 47]|2|-1|_|_|_|_|_|_|_|18201582
edema|Disease|10|[1, 2]|12|-1|_|_|_|_|_|_|_|18201582
cough|Disease|10|[36, 37]|13|-1|_|_|_|_|_|_|_|18201582
headache|Disease|11|[3, 4]|14|-1|_|_|_|_|_|_|_|18201582
dizziness|Disease|11|[5, 6]|15|-1|_|_|_|_|_|_|_|18201582
diarrhea|Disease|11|[8, 9]|16|-1|_|_|_|_|_|_|_|18201582
blood pressure|Physiology|3|[19, 21]|6|-1|_|_|_|_|_|_|_|18201582
t+a|Treat|8|[13, 16]|9|-1|_|_|_|_|_|_|_|18201582
a|Treat|8|[15, 16]|10|-1|_|_|_|_|_|_|_|18201582
a|Treat|8|[28, 29]|10|-1|_|_|_|_|_|_|_|18201582
cutaneous leucocytoclastic vasculitis|Disease|0|[0, 3]|500|H|_|_|_|_|_|_|_|11337188
necrotic blisters|Disease|2|[0, 2]|500|-1|_|_|_|_|_|_|_|11337188
leucocytoclastic vasculitis|Disease|3|[6, 8]|500|H|_|_|_|_|_|_|_|11337188
leucocytoclastic vasculitis|Disease|6|[0, 2]|500|H|_|_|_|_|_|_|_|11337188
rash|Disease|5|[1, 2]|500|H|_|_|_|_|_|_|_|11337188
renal involvement|Disease|6|[19, 21]|6|-1|_|_|_|_|_|_|_|11337188
arthralgia|Disease|6|[16, 17]|7|H|_|_|_|_|_|_|_|11337188
abdominal pain|Disease|6|[13, 15]|9|H|_|_|_|_|_|_|_|11337188
palpable purpura|Disease|6|[4, 6]|500|-1|_|_|_|_|_|_|_|11337188
collagen vascular disease|Disease|7|[10, 13]|11|H|_|_|_|_|_|_|_|11337188
neoplasia|Disease|7|[14, 15]|12|-1|_|_|_|_|_|_|_|11337188
self-limited disorder|Disease|9|[4, 8]|14|H|_|_|_|_|_|_|_|11337188
oxacillin|Chemical|0|[5, 6]|1|-1|_|_|_|_|_|_|_|11337188
oxacillin|Chemical|10|[0, 1]|1|-1|_|_|_|_|_|_|_|11337188
corticosteroid|Chemical|9|[10, 11]|502|-1|_|_|_|_|_|_|_|11337188
corticosteroids|Chemical|9|[24, 25]|502|-1|_|_|_|_|_|_|_|11337188
corticosteroids|Treat|4|[8, 9]|4|-1|_|_|_|_|_|_|_|11337188
corticosteroid therapy|Treat|9|[10, 12]|16|-1|_|_|_|_|_|_|_|11337188
naloxazone|Chemical|0|[0, 1]|0|-1|_|_|_|_|_|_|_|6308526
morphine|Chemical|0|[11, 12]|1|-1|_|_|_|_|_|_|_|6308526
cardiorespiratory|Physiology|0|[3, 4]|2|-1|_|_|_|_|_|_|_|6308526
temperature|Physiology|0|[5, 6]|3|-1|_|_|_|_|_|_|_|6308526
cardiorespiratory responses|Physiology|1|[2, 4]|4|-1|_|_|_|_|_|_|_|6308526
hypothermia|Disease|2|[10, 11]|5|-1|_|_|_|_|_|_|_|6308526
catalepsy|Disease|2|[8, 9]|6|-1|_|_|_|_|_|_|_|6308526
hypotension|Disease|3|[9, 10]|7|-1|_|_|_|_|_|_|_|6308526
bradycardia|Disease|3|[18, 19]|8|-1|_|_|_|_|_|_|_|6308526
doxorubicin|Chemical|0|[16, 17]|0|-1|_|_|_|_|_|_|_|15897593
doxorubicin|Chemical|1|[6, 7]|0|-1|_|_|_|_|_|_|_|15897593
doxorubicin|Chemical|3|[41, 42]|0|-1|_|_|_|_|_|_|_|15897593
doxorubicin|Chemical|4|[15, 16]|0|-1|_|_|_|_|_|_|_|15897593
doxorubicin|Chemical|5|[43, 44]|0|-1|_|_|_|_|_|_|_|15897593
doxorubicin|Chemical|6|[18, 19]|0|-1|_|_|_|_|_|_|_|15897593
dexrazoxane|Chemical|0|[0, 1]|1|-1|_|_|_|_|_|_|_|15897593
etoposide|Chemical|0|[11, 12]|2|-1|_|_|_|_|_|_|_|15897593
daunorubicin|Chemical|0|[13, 14]|3|-1|_|_|_|_|_|_|_|15897593
epipodophyllotoxin|Chemical|1|[9, 10]|4|H|_|_|_|_|_|_|_|15897593
hematologic toxicity|Disease|3|[10, 12]|7|-1|_|_|_|_|_|_|_|15897593
hematologic toxicity|Disease|8|[24, 26]|7|-1|_|_|_|_|_|_|_|15897593
weight loss|Disease|5|[9, 11]|10|-1|_|_|_|_|_|_|_|15897593
weight loss|Disease|5|[34, 36]|10|-1|_|_|_|_|_|_|_|15897593
metastases|Disease|8|[6, 7]|13|-1|_|_|_|_|_|_|_|15897593
pharmacologic regulation|Treat|9|[9, 11]|15|-1|_|_|_|_|_|_|_|15897593
aniracetam (ro 13-5057)|Chemical|0|[5, 12]|500|-1|_|_|_|_|_|_|_|6817363
pyrrolidinone|Chemical|1|[16, 17]|3|H|_|_|_|_|_|_|_|6817363
pyrrolidinone|Chemical|5|[3, 4]|3|H|_|_|_|_|_|_|_|6817363
scopolamine|Chemical|1|[83, 84]|6|-1|_|_|_|_|_|_|_|6817363
aniracetam|Chemical|1|[3, 4]|500|-1|_|_|_|_|_|_|_|6817363
chloramphenicol|Chemical|1|[145, 146]|8|-1|_|_|_|_|_|_|_|6817363
piracetam|Chemical|5|[0, 1]|10|-1|_|_|_|_|_|_|_|6817363
hypercapnia|Disease|1|[61, 62]|1|-1|_|_|_|_|_|_|_|6817363
hypercapnia|Disease|1|[212, 213]|1|-1|_|_|_|_|_|_|_|6817363
amnesia|Disease|1|[89, 90]|4|-1|_|_|_|_|_|_|_|6817363
amnesia|Disease|1|[102, 103]|4|-1|_|_|_|_|_|_|_|6817363
catalepsy|Disease|0|[6, 7]|0|-1|_|_|_|_|_|_|_|11900788
nicotine|Chemical|0|[0, 1]|1|-1|_|_|_|_|_|_|_|11900788
morphine|Chemical|0|[3, 4]|2|-1|_|_|_|_|_|_|_|11900788
atropine|Chemical|4|[3, 4]|3|-1|_|_|_|_|_|_|_|11900788
naloxone|Chemical|4|[5, 6]|4|-1|_|_|_|_|_|_|_|11900788
mecamylamine|Chemical|4|[7, 8]|5|-1|_|_|_|_|_|_|_|11900788
hexamethonium|Chemical|4|[10, 11]|6|-1|_|_|_|_|_|_|_|11900788
doxorubicin|Chemical|0|[10, 11]|500|-1|_|_|_|_|_|_|_|11230490
doxorubicin|Chemical|0|[16, 17]|500|-1|_|_|_|_|_|_|_|11230490
doxorubicin|Chemical|1|[10, 11]|500|-1|_|_|_|_|_|_|_|11230490
doxorubicin|Chemical|1|[29, 30]|500|-1|_|_|_|_|_|_|_|11230490
doxorubicin|Chemical|2|[38, 39]|500|-1|_|_|_|_|_|_|_|11230490
doxorubicin|Chemical|6|[2, 3]|500|-1|_|_|_|_|_|_|_|11230490
doxorubicin|Chemical|9|[8, 9]|500|-1|_|_|_|_|_|_|_|11230490
cyclophosphamide|Chemical|0|[12, 13]|3|H|_|_|_|_|_|_|_|11230490
cyclophosphamide|Chemical|0|[18, 19]|3|H|_|_|_|_|_|_|_|11230490
myocet|Chemical|1|[5, 6]|500|-1|_|_|_|_|_|_|_|11230490
myocet|Chemical|2|[32, 33]|500|-1|_|_|_|_|_|_|_|11230490
mc|Chemical|5|[5, 6]|500|-1|_|_|_|_|_|_|_|11230490
mc|Chemical|5|[5, 6]|500|-1|_|_|_|_|_|_|_|11230490
mc|Chemical|6|[19, 20]|500|-1|_|_|_|_|_|_|_|11230490
mc|Chemical|6|[19, 20]|500|-1|_|_|_|_|_|_|_|11230490
mc|Chemical|7|[0, 1]|500|-1|_|_|_|_|_|_|_|11230490
mc|Chemical|8|[3, 4]|500|-1|_|_|_|_|_|_|_|11230490
mc|Chemical|8|[3, 4]|500|-1|_|_|_|_|_|_|_|11230490
ac|Chemical|6|[29, 30]|500|-1|_|_|_|_|_|_|_|11230490
ac|Chemical|8|[5, 6]|500|-1|_|_|_|_|_|_|_|11230490
metastatic breast cancer|Disease|0|[26, 29]|502|-1|_|_|_|_|_|_|_|11230490
mbc|Disease|2|[11, 12]|502|-1|_|_|_|_|_|_|_|11230490
mbc|Disease|9|[35, 36]|502|-1|_|_|_|_|_|_|_|11230490
congestive heart failure|Disease|3|[21, 24]|503|-1|_|_|_|_|_|_|_|11230490
congestive heart failure (chf)|Disease|3|[21, 27]|503|-1|_|_|_|_|_|_|_|11230490
chf|Disease|5|[14, 15]|503|-1|_|_|_|_|_|_|_|11230490
neutropenia|Disease|7|[7, 8]|21|-1|_|_|_|_|_|_|_|11230490
bn 52021|Chemical|0|[11, 13]|0|-1|_|_|_|_|_|_|_|2594614
bn 52021|Chemical|2|[13, 15]|0|-1|_|_|_|_|_|_|_|2594614
bn 52021|Chemical|3|[9, 11]|0|-1|_|_|_|_|_|_|_|2594614
bn 52021|Chemical|4|[1, 3]|0|-1|_|_|_|_|_|_|_|2594614
bn 52021|Chemical|5|[17, 19]|0|-1|_|_|_|_|_|_|_|2594614
bupivacaine|Chemical|0|[15, 16]|1|-1|_|_|_|_|_|_|_|2594614
decrease of mbp and hr|Disease|2|[40, 45]|501|H|_|_|_|_|_|_|_|2594614
decrease of mbp and hr|Disease|4|[30, 35]|501|H|_|_|_|_|_|_|_|2594614
ecg alterations|Disease|5|[7, 9]|7|-1|_|_|_|_|_|_|_|2594614
cardiovascular alterations|Disease|7|[19, 21]|501|H|_|_|_|_|_|_|_|2594614
cardiovascular alterations|Physiology|7|[19, 21]|10|-1|_|_|_|_|_|_|_|2594614
immunodeficiency|Disease|0|[13, 14]|0|H|_|_|_|_|_|_|_|2257294
immunodeficiency|Disease|1|[36, 37]|0|H|_|_|_|_|_|_|_|2257294
marrow suppression|Disease|0|[5, 7]|1|H|_|_|_|_|_|_|_|2257294
anemia|Disease|2|[27, 28]|7|-1|_|_|_|_|_|_|_|2257294
leukopenia|Disease|2|[29, 30]|8|-1|_|_|_|_|_|_|_|2257294
azt|Disease|5|[13, 14]|20|-1|_|_|_|_|_|_|_|2257294
azt|Disease|5|[3, 4]|20|-1|_|_|_|_|_|_|_|2257294
benzylacyclouridine|Chemical|0|[0, 1]|501|-1|_|_|_|_|_|_|_|2257294
azidothymidine|Chemical|0|[2, 3]|502|-1|_|_|_|_|_|_|_|2257294
uridine (urd)|Chemical|1|[4, 8]|501|-1|_|_|_|_|_|_|_|2257294
azidothymidine (azt)|Chemical|1|[17, 21]|502|-1|_|_|_|_|_|_|_|2257294
azt|Chemical|2|[24, 25]|502|-1|_|_|_|_|_|_|_|2257294
azt|Chemical|4|[44, 45]|502|-1|_|_|_|_|_|_|_|2257294
azt|Chemical|4|[30, 31]|502|-1|_|_|_|_|_|_|_|2257294
azt|Chemical|4|[10, 11]|502|-1|_|_|_|_|_|_|_|2257294
azt|Chemical|5|[13, 14]|502|-1|_|_|_|_|_|_|_|2257294
azt|Chemical|5|[3, 4]|502|-1|_|_|_|_|_|_|_|2257294
azt|Chemical|6|[27, 28]|502|-1|_|_|_|_|_|_|_|2257294
bau|Chemical|2|[16, 17]|502|-1|_|_|_|_|_|_|_|2257294
bau|Chemical|4|[33, 34]|502|-1|_|_|_|_|_|_|_|2257294
bau|Chemical|5|[11, 12]|502|-1|_|_|_|_|_|_|_|2257294
bau|Chemical|6|[12, 13]|502|-1|_|_|_|_|_|_|_|2257294
urd|Chemical|2|[8, 9]|502|-1|_|_|_|_|_|_|_|2257294
urd|Chemical|3|[15, 16]|502|-1|_|_|_|_|_|_|_|2257294
urd|Chemical|3|[24, 25]|502|-1|_|_|_|_|_|_|_|2257294
urd|Chemical|3|[3, 4]|502|-1|_|_|_|_|_|_|_|2257294
reticulocytes|Physiology|4|[60, 61]|19|-1|_|_|_|_|_|_|_|2257294
visceral pain|Disease|0|[18, 20]|500|H|_|_|_|_|_|_|_|10840460
visceral pain|Disease|1|[7, 9]|500|H|_|_|_|_|_|_|_|10840460
visceral pain|Disease|25|[25, 27]|500|H|_|_|_|_|_|_|_|10840460
cystitis|Disease|0|[3, 4]|1|-1|_|_|_|_|_|_|_|10840460
edema|Disease|16|[21, 22]|15|-1|_|_|_|_|_|_|_|10840460
painful syndromes|Disease|25|[34, 36]|500|H|_|_|_|_|_|_|_|10840460
painful|Disease|25|[34, 35]|21|H|_|_|_|_|_|_|_|10840460
cyclophosphamide|Chemical|0|[0, 1]|502|H|_|_|_|_|_|_|_|10840460
cyclophosphamide|Chemical|2|[0, 1]|502|H|_|_|_|_|_|_|_|10840460
acrolein|Chemical|2|[22, 23]|5|-1|_|_|_|_|_|_|_|10840460
cp|Chemical|3|[4, 5]|502|H|_|_|_|_|_|_|_|10840460
cp|Chemical|8|[11, 12]|502|H|_|_|_|_|_|_|_|10840460
cp|Chemical|8|[21, 22]|502|H|_|_|_|_|_|_|_|10840460
cp|Chemical|12|[6, 7]|502|H|_|_|_|_|_|_|_|10840460
cp|Chemical|14|[23, 24]|502|H|_|_|_|_|_|_|_|10840460
cp|Chemical|17|[4, 5]|502|H|_|_|_|_|_|_|_|10840460
cp|Chemical|20|[2, 3]|502|H|_|_|_|_|_|_|_|10840460
cp|Chemical|21|[8, 9]|502|H|_|_|_|_|_|_|_|10840460
cp|Chemical|25|[12, 13]|502|H|_|_|_|_|_|_|_|10840460
morphine|Chemical|5|[3, 4]|7|-1|_|_|_|_|_|_|_|10840460
morphine|Chemical|13|[0, 1]|7|-1|_|_|_|_|_|_|_|10840460
naloxone|Chemical|6|[17, 18]|8|-1|_|_|_|_|_|_|_|10840460
mg./kg.|Chemical|11|[7, 12]|11|-1|_|_|_|_|_|_|_|10840460
myoclonus|Disease|0|[2, 3]|0|-1|_|_|_|_|_|_|_|8278214
hyperesthesia|Disease|3|[6, 7]|4|H|_|_|_|_|_|_|_|8278214
neuralgia|Disease|4|[7, 8]|5|-1|_|_|_|_|_|_|_|8278214
morphine|Chemical|0|[11, 12]|1|-1|_|_|_|_|_|_|_|8278214
continuous intravenous morphine|Treat|0|[9, 12]|2|-1|_|_|_|_|_|_|_|8278214
intravenous morphine|Treat|1|[15, 17]|3|-1|_|_|_|_|_|_|_|8278214
vancomycin|Chemical|0|[8, 9]|0|-1|_|_|_|_|_|_|_|3934126
vancomycin|Chemical|2|[0, 1]|0|-1|_|_|_|_|_|_|_|3934126
proteinuria|Disease|4|[24, 25]|2|-1|_|_|_|_|_|_|_|3934126
rash|Disease|4|[10, 11]|3|-1|_|_|_|_|_|_|_|3934126
nephrotoxicity|Disease|4|[17, 18]|4|H|_|_|_|_|_|_|_|3934126
nephrotoxicity|Disease|5|[9, 10]|4|H|_|_|_|_|_|_|_|3934126
nephrotoxicity|Disease|5|[9, 10]|4|H|_|_|_|_|_|_|_|3934126
thrombophlebitis|Disease|4|[2, 3]|5|-1|_|_|_|_|_|_|_|3934126
thrombophlebitis|Disease|5|[0, 1]|5|-1|_|_|_|_|_|_|_|3934126
ototoxicity|Disease|4|[31, 32]|6|-1|_|_|_|_|_|_|_|3934126
ototoxicity|Disease|5|[11, 12]|6|-1|_|_|_|_|_|_|_|3934126
catalepsy|Disease|0|[14, 15]|0|-1|_|_|_|_|_|_|_|1687392
dopamine|Chemical|0|[10, 11]|1|H|_|_|_|_|_|_|_|1687392
fluphenazine|Chemical|3|[4, 5]|2|H|_|_|_|_|_|_|_|1687392
sch 23390|Chemical|3|[10, 12]|501|-1|_|_|_|_|_|_|_|1687392
sch 23390|Chemical|5|[2, 4]|501|-1|_|_|_|_|_|_|_|1687392
sch 23390|Chemical|6|[21, 23]|501|-1|_|_|_|_|_|_|_|1687392
sulpiride|Chemical|3|[17, 18]|4|-1|_|_|_|_|_|_|_|1687392
skf 38393|Chemical|6|[6, 8]|501|-1|_|_|_|_|_|_|_|1687392
skf 38393|Chemical|7|[4, 6]|501|-1|_|_|_|_|_|_|_|1687392
quinpirole|Chemical|6|[13, 14]|7|-1|_|_|_|_|_|_|_|1687392
d-1 receptor|Chemical|9|[17, 21]|501|-1|_|_|_|_|_|_|_|1687392
etodolac|Chemical|0|[2, 3]|500|H|_|_|_|_|_|_|_|19719056
etodolac|Chemical|5|[0, 1]|500|H|_|_|_|_|_|_|_|19719056
etodolac (e)|Chemical|1|[0, 4]|500|H|_|_|_|_|_|_|_|19719056
dextran|Chemical|2|[15, 16]|2|H|_|_|_|_|_|_|_|19719056
dextran|Chemical|2|[3, 4]|2|H|_|_|_|_|_|_|_|19719056
eai|Chemical|3|[15, 16]|4|-1|_|_|_|_|_|_|_|19719056
mark-howink-sakurada equation|Chemical|6|[10, 16]|6|-1|_|_|_|_|_|_|_|19719056
carrageenan|Chemical|10|[17, 18]|7|-1|_|_|_|_|_|_|_|19719056
writhing|Disease|10|[11, 12]|8|-1|_|_|_|_|_|_|_|19719056
edema|Disease|10|[22, 23]|9|-1|_|_|_|_|_|_|_|19719056
eosinophilic myocarditis|Disease|1|[7, 9]|500|-1|_|_|_|_|_|_|_|15266362
eosinophilic myocarditis|Disease|7|[0, 2]|500|-1|_|_|_|_|_|_|_|15266362
left ventricular dysfunction|Disease|3|[7, 10]|3|H|_|_|_|_|_|_|_|15266362
myocarditis|Disease|4|[13, 14]|500|-1|_|_|_|_|_|_|_|15266362
myocarditis|Disease|5|[0, 1]|500|-1|_|_|_|_|_|_|_|15266362
myocarditis|Disease|5|[5, 6]|500|-1|_|_|_|_|_|_|_|15266362
hypersensitivity (eosinophilic) myocarditis|Disease|6|[5, 10]|500|-1|_|_|_|_|_|_|_|15266362
dobutamine|Chemical|2|[24, 25]|1|-1|_|_|_|_|_|_|_|15266362
heart transplantation|Treat|2|[33, 35]|2|-1|_|_|_|_|_|_|_|15266362
erythema nodosum|Disease|0|[8, 10]|500|-1|_|_|_|_|_|_|_|14648024
erythema nodosum|Disease|1|[0, 2]|500|-1|_|_|_|_|_|_|_|14648024
promyelocytic leukemia|Disease|0|[14, 16]|501|-1|_|_|_|_|_|_|_|14648024
acute promyelocytic leukemia (apl)|Disease|1|[14, 20]|501|-1|_|_|_|_|_|_|_|14648024
apl|Disease|2|[6, 7]|501|H|_|_|_|_|_|_|_|14648024
painful|Disease|3|[4, 5]|500|-1|_|_|_|_|_|_|_|14648024
fever|Disease|3|[0, 1]|9|H|_|_|_|_|_|_|_|14648024
erythematous nodules|Disease|3|[5, 7]|500|-1|_|_|_|_|_|_|_|14648024
skin lesions|Disease|6|[5, 7]|500|-1|_|_|_|_|_|_|_|14648024
atra|Disease|8|[0, 1]|501|-1|_|_|_|_|_|_|_|14648024
all-trans-retinoic acid (atra)|Chemical|1|[4, 13]|503|-1|_|_|_|_|_|_|_|14648024
atra|Chemical|2|[12, 13]|503|-1|_|_|_|_|_|_|_|14648024
atra|Chemical|3|[23, 24]|503|-1|_|_|_|_|_|_|_|14648024
atra|Chemical|7|[8, 9]|503|-1|_|_|_|_|_|_|_|14648024
steroid|Chemical|9|[5, 6]|16|-1|_|_|_|_|_|_|_|14648024
atra therapy|Treat|2|[12, 14]|7|-1|_|_|_|_|_|_|_|14648024
steroids|Treat|5|[6, 7]|12|-1|_|_|_|_|_|_|_|14648024
thrombocytopenia|Disease|0|[6, 7]|0|-1|_|_|_|_|_|_|_|11827497
thrombocytopenia|Disease|1|[5, 6]|0|-1|_|_|_|_|_|_|_|11827497
thrombocytopenia|Disease|2|[8, 9]|0|-1|_|_|_|_|_|_|_|11827497
thrombocytopenia|Disease|3|[21, 22]|0|-1|_|_|_|_|_|_|_|11827497
thrombocytopenia|Disease|6|[16, 17]|0|-1|_|_|_|_|_|_|_|11827497
thrombocytopenia|Disease|8|[20, 21]|0|-1|_|_|_|_|_|_|_|11827497
thrombocytopenia|Disease|15|[8, 9]|0|-1|_|_|_|_|_|_|_|11827497
thrombocytopenia|Disease|16|[11, 12]|0|-1|_|_|_|_|_|_|_|11827497
arterial or venous thromboemboli|Disease|1|[18, 22]|500|H|_|_|_|_|_|_|_|11827497
thromboembolism|Disease|7|[9, 10]|500|H|_|_|_|_|_|_|_|11827497
pulmonary emboli|Disease|9|[9, 11]|8|-1|_|_|_|_|_|_|_|11827497
therapeutic heparin|Treat|11|[6, 8]|9|-1|_|_|_|_|_|_|_|11827497
therapy|Treat|16|[21, 22]|14|-1|_|_|_|_|_|_|_|11827497
platelet count|Physiology|11|[25, 27]|10|-1|_|_|_|_|_|_|_|11827497
warfarin|Chemical|13|[29, 30]|11|-1|_|_|_|_|_|_|_|11827497
amlodipine|Chemical|0|[23, 24]|0|-1|_|_|_|_|_|_|_|8841157
amlodipine|Chemical|1|[21, 22]|0|-1|_|_|_|_|_|_|_|8841157
amlodipine|Chemical|2|[33, 34]|0|-1|_|_|_|_|_|_|_|8841157
amlodipine|Chemical|3|[16, 17]|0|-1|_|_|_|_|_|_|_|8841157
amlodipine|Chemical|7|[5, 6]|0|-1|_|_|_|_|_|_|_|8841157
amlodipine|Chemical|10|[16, 17]|0|-1|_|_|_|_|_|_|_|8841157
amlodipine|Chemical|12|[48, 49]|0|-1|_|_|_|_|_|_|_|8841157
amlodipine|Chemical|12|[13, 14]|0|-1|_|_|_|_|_|_|_|8841157
amlodipine|Chemical|12|[56, 57]|0|-1|_|_|_|_|_|_|_|8841157
amlodipine|Chemical|12|[40, 41]|0|-1|_|_|_|_|_|_|_|8841157
amlodipine|Chemical|13|[13, 14]|0|-1|_|_|_|_|_|_|_|8841157
valsartan|Chemical|0|[0, 1]|1|-1|_|_|_|_|_|_|_|8841157
hypertension|Disease|2|[13, 14]|4|-1|_|_|_|_|_|_|_|8841157
edema|Disease|12|[7, 8]|15|-1|_|_|_|_|_|_|_|8841157
blood pressure|Physiology|3|[9, 11]|6|-1|_|_|_|_|_|_|_|8841157
therapy|Treat|3|[4, 5]|7|-1|_|_|_|_|_|_|_|8841157
therapy|Treat|3|[22, 23]|7|-1|_|_|_|_|_|_|_|8841157
kf17837|Chemical|0|[0, 1]|0|-1|_|_|_|_|_|_|_|8045270
kf17837|Chemical|1|[0, 1]|0|-1|_|_|_|_|_|_|_|8045270
kf17837|Chemical|2|[3, 4]|0|-1|_|_|_|_|_|_|_|8045270
kf17837|Chemical|3|[0, 1]|0|-1|_|_|_|_|_|_|_|8045270
kf17837|Chemical|5|[2, 3]|0|-1|_|_|_|_|_|_|_|8045270
kf17837|Chemical|6|[4, 5]|0|-1|_|_|_|_|_|_|_|8045270
kf17837|Chemical|7|[2, 3]|0|-1|_|_|_|_|_|_|_|8045270
adenosine|Chemical|1|[5, 6]|2|H|_|_|_|_|_|_|_|8045270
cgs 21680|Chemical|2|[36, 38]|5|-1|_|_|_|_|_|_|_|8045270
haloperidol|Chemical|3|[7, 8]|6|-1|_|_|_|_|_|_|_|8045270
reserpine|Chemical|3|[20, 21]|7|-1|_|_|_|_|_|_|_|8045270
mg/kg p.o.|Chemical|4|[17, 24]|10|H|_|_|_|_|_|_|_|8045270
l-dopa|Chemical|5|[32, 35]|11|-1|_|_|_|_|_|_|_|8045270
benserazide|Chemical|5|[46, 47]|12|-1|_|_|_|_|_|_|_|8045270
cataleptic responses|Disease|2|[23, 25]|3|-1|_|_|_|_|_|_|_|8045270
catalepsy|Disease|3|[4, 5]|8|H|_|_|_|_|_|_|_|8045270
parkinsonism|Disease|7|[12, 13]|16|-1|_|_|_|_|_|_|_|8045270
dopaminergic function|Physiology|6|[16, 18]|15|-1|_|_|_|_|_|_|_|8045270
fluvoxamine|Chemical|0|[7, 8]|0|-1|_|_|_|_|_|_|_|2576810
fluvoxamine|Chemical|1|[8, 9]|0|-1|_|_|_|_|_|_|_|2576810
fluvoxamine|Chemical|2|[4, 5]|0|-1|_|_|_|_|_|_|_|2576810
fluvoxamine|Chemical|3|[10, 11]|0|-1|_|_|_|_|_|_|_|2576810
fluvoxamine|Chemical|4|[16, 17]|0|-1|_|_|_|_|_|_|_|2576810
fluvoxamine|Chemical|5|[3, 4]|0|-1|_|_|_|_|_|_|_|2576810
fluvoxamine|Chemical|6|[4, 5]|0|-1|_|_|_|_|_|_|_|2576810
serotonin|Chemical|1|[12, 13]|2|H|_|_|_|_|_|_|_|2576810
methoxamine|Chemical|1|[22, 23]|3|-1|_|_|_|_|_|_|_|2576810
amphetamine|Chemical|2|[22, 23]|5|-1|_|_|_|_|_|_|_|2576810
nomifensine|Chemical|3|[4, 5]|9|-1|_|_|_|_|_|_|_|2576810
citalopram|Chemical|6|[10, 11]|14|-1|_|_|_|_|_|_|_|2576810
repeated treatment|Treat|2|[1, 3]|6|-1|_|_|_|_|_|_|_|2576810
hyperactivity|Disease|3|[1, 2]|8|-1|_|_|_|_|_|_|_|2576810
locomotor activity|Physiology|4|[3, 5]|11|-1|_|_|_|_|_|_|_|2576810
congestive heart failure|Disease|0|[1, 4]|500|-1|_|_|_|_|_|_|_|20635749
congestive heart failure|Disease|1|[19, 22]|500|-1|_|_|_|_|_|_|_|20635749
myxedemic coma|Disease|0|[9, 11]|501|-1|_|_|_|_|_|_|_|20635749
myxedema coma|Disease|1|[6, 8]|501|-1|_|_|_|_|_|_|_|20635749
myxedema coma|Disease|3|[0, 2]|501|-1|_|_|_|_|_|_|_|20635749
hypothyroidism|Disease|1|[13, 14]|4|H|_|_|_|_|_|_|_|20635749
congestive heart failure (chf)|Disease|1|[19, 25]|500|-1|_|_|_|_|_|_|_|20635749
chf|Disease|5|[2, 3]|500|-1|_|_|_|_|_|_|_|20635749
chf|Disease|6|[15, 16]|500|-1|_|_|_|_|_|_|_|20635749
chf|Disease|7|[22, 23]|500|-1|_|_|_|_|_|_|_|20635749
hypotension|Disease|7|[26, 27]|13|-1|_|_|_|_|_|_|_|20635749
amiodarone|Chemical|1|[10, 11]|6|-1|_|_|_|_|_|_|_|20635749
thyroxine (t4)|Chemical|4|[6, 10]|9|H|_|_|_|_|_|_|_|20635749
tri-iodo-thyronine (t3)|Chemical|4|[12, 20]|10|-1|_|_|_|_|_|_|_|20635749
treatment|Treat|3|[17, 18]|8|-1|_|_|_|_|_|_|_|20635749
hypotension|Physiology|7|[26, 27]|15|-1|_|_|_|_|_|_|_|20635749
startle|Disease|0|[10, 11]|0|-1|_|_|_|_|_|_|_|20394767
startle|Disease|0|[3, 4]|0|-1|_|_|_|_|_|_|_|20394767
startle|Disease|1|[8, 9]|0|-1|_|_|_|_|_|_|_|20394767
startle|Disease|2|[7, 8]|0|-1|_|_|_|_|_|_|_|20394767
startle|Disease|7|[26, 27]|0|-1|_|_|_|_|_|_|_|20394767
startle|Disease|7|[15, 16]|0|-1|_|_|_|_|_|_|_|20394767
startle|Disease|7|[5, 6]|0|-1|_|_|_|_|_|_|_|20394767
anxiety|Disease|1|[17, 18]|3|-1|_|_|_|_|_|_|_|20394767
yohimbine|Chemical|5|[17, 18]|5|-1|_|_|_|_|_|_|_|20394767
mcpp|Chemical|6|[10, 11]|6|-1|_|_|_|_|_|_|_|20394767
mcpp|Chemical|7|[12, 13]|6|-1|_|_|_|_|_|_|_|20394767
ptz|Chemical|7|[23, 24]|14|-1|_|_|_|_|_|_|_|20394767
les|Physiology|6|[7, 8]|7|-1|_|_|_|_|_|_|_|20394767
fps|Physiology|6|[13, 14]|8|-1|_|_|_|_|_|_|_|20394767
fps|Physiology|6|[18, 19]|8|-1|_|_|_|_|_|_|_|20394767
glomerulonephritis|Disease|0|[14, 15]|500|-1|_|_|_|_|_|_|_|19203554
glomerulonephritis|Disease|2|[9, 10]|500|-1|_|_|_|_|_|_|_|19203554
glomerulonephritis|Disease|7|[13, 14]|500|-1|_|_|_|_|_|_|_|19203554
proteinase 3-antineutrophil cytoplasmic antibody-(pr3-anca) positive necrotizing glomerulonephritis|Disease|0|[0, 15]|500|-1|_|_|_|_|_|_|_|19203554
red eyes|Disease|1|[11, 13]|3|-1|_|_|_|_|_|_|_|19203554
red eyes|Disease|5|[11, 13]|3|-1|_|_|_|_|_|_|_|19203554
urinary abnormalities|Disease|1|[19, 21]|4|H|_|_|_|_|_|_|_|19203554
ulcerative colitis|Disease|1|[8, 10]|5|-1|_|_|_|_|_|_|_|19203554
pleural effusion|Disease|1|[14, 16]|501|-1|_|_|_|_|_|_|_|19203554
segmental necrotizing glomerulonephritis|Disease|2|[7, 10]|500|-1|_|_|_|_|_|_|_|19203554
antineutrophil cytoplasmic antibody|Disease|3|[3, 6]|500|-1|_|_|_|_|_|_|_|19203554
chest pain|Disease|5|[14, 16]|10|-1|_|_|_|_|_|_|_|19203554
pleural effusions|Disease|5|[27, 29]|501|-1|_|_|_|_|_|_|_|19203554
necrotizing glomerulonephritis|Disease|7|[12, 14]|500|-1|_|_|_|_|_|_|_|19203554
sulphasalazine|Chemical|0|[17, 18]|2|-1|_|_|_|_|_|_|_|19203554
steroid|Chemical|5|[32, 33]|11|-1|_|_|_|_|_|_|_|19203554
steroid|Chemical|6|[3, 4]|11|-1|_|_|_|_|_|_|_|19203554
steroid therapy|Treat|5|[32, 34]|14|-1|_|_|_|_|_|_|_|19203554
c-reactive protein|Physiology|5|[19, 23]|15|-1|_|_|_|_|_|_|_|19203554
pr3-anca|Immune|5|[36, 39]|16|-1|_|_|_|_|_|_|_|19203554
phenytoin|Chemical|0|[1, 2]|0|-1|_|_|_|_|_|_|_|17049862
chiari malformation|Disease|1|[5, 7]|1|-1|_|_|_|_|_|_|_|17049862
hypothermic|Disease|2|[9, 10]|501|-1|_|_|_|_|_|_|_|17049862
seizure|Disease|3|[12, 13]|3|-1|_|_|_|_|_|_|_|17049862
bradycardia|Disease|4|[9, 10]|4|-1|_|_|_|_|_|_|_|17049862
hypothermia|Disease|5|[7, 8]|501|-1|_|_|_|_|_|_|_|17049862
hypothermia|Disease|6|[7, 8]|501|-1|_|_|_|_|_|_|_|17049862
schizophrenic|Disease|0|[9, 10]|0|H|_|_|_|_|_|_|_|16225977
schizophrenic|Disease|3|[9, 10]|0|H|_|_|_|_|_|_|_|16225977
tic-like symptoms|Disease|0|[2, 6]|500|-1|_|_|_|_|_|_|_|16225977
tic disorders|Disease|1|[0, 2]|500|-1|_|_|_|_|_|_|_|16225977
involuntary eye-blinking movements|Disease|3|[13, 18]|500|-1|_|_|_|_|_|_|_|16225977
psychosis|Disease|5|[3, 4]|11|H|_|_|_|_|_|_|_|16225977
amisulpride|Chemical|0|[0, 1]|1|-1|_|_|_|_|_|_|_|16225977
ziprasidone|Chemical|1|[15, 16]|3|-1|_|_|_|_|_|_|_|16225977
risperidone|Chemical|1|[11, 12]|5|-1|_|_|_|_|_|_|_|16225977
olanzapine|Chemical|1|[13, 14]|6|-1|_|_|_|_|_|_|_|16225977
quetiapine|Chemical|2|[24, 25]|7|-1|_|_|_|_|_|_|_|16225977
clozapine|Chemical|2|[26, 27]|8|-1|_|_|_|_|_|_|_|16225977
combined medications|Treat|7|[8, 10]|12|-1|_|_|_|_|_|_|_|16225977
role function|Physiology|7|[19, 21]|13|-1|_|_|_|_|_|_|_|16225977
aspirin|Chemical|0|[5, 6]|500|-1|_|_|_|_|_|_|_|12852481
acetylsalicylic acid|Chemical|0|[7, 9]|500|-1|_|_|_|_|_|_|_|12852481
asa|Chemical|2|[5, 6]|500|-1|_|_|_|_|_|_|_|12852481
asa|Chemical|5|[65, 66]|500|-1|_|_|_|_|_|_|_|12852481
asa|Chemical|5|[20, 21]|500|-1|_|_|_|_|_|_|_|12852481
asa|Chemical|6|[2, 3]|500|-1|_|_|_|_|_|_|_|12852481
asa|Chemical|13|[6, 7]|500|-1|_|_|_|_|_|_|_|12852481
asa|Chemical|14|[38, 39]|500|-1|_|_|_|_|_|_|_|12852481
developmental anomalies|Disease|1|[21, 23]|502|H|_|_|_|_|_|_|_|12852481
malformations|Disease|5|[63, 64]|502|H|_|_|_|_|_|_|_|12852481
malformations|Disease|13|[2, 3]|502|H|_|_|_|_|_|_|_|12852481
ventricular septal defects (vsds)|Disease|8|[9, 15]|8|-1|_|_|_|_|_|_|_|12852481
midline defects (mds)|Disease|8|[16, 21]|503|H|_|_|_|_|_|_|_|12852481
diaphragmatic hernia (dh)|Disease|8|[24, 29]|10|-1|_|_|_|_|_|_|_|12852481
dh|Disease|9|[5, 6]|11|-1|_|_|_|_|_|_|_|12852481
dh|Disease|11|[3, 4]|11|-1|_|_|_|_|_|_|_|12852481
md|Disease|9|[7, 8]|503|H|_|_|_|_|_|_|_|12852481
md|Disease|11|[5, 6]|503|H|_|_|_|_|_|_|_|12852481
vsd|Disease|9|[10, 11]|13|-1|_|_|_|_|_|_|_|12852481
vsd|Disease|10|[0, 1]|13|-1|_|_|_|_|_|_|_|12852481
vsd|Disease|11|[23, 24]|13|-1|_|_|_|_|_|_|_|12852481
vsd|Disease|12|[19, 20]|13|-1|_|_|_|_|_|_|_|12852481
hydrocephalus|Disease|12|[25, 26]|20|-1|_|_|_|_|_|_|_|12852481
treatment|Treat|10|[5, 6]|15|-1|_|_|_|_|_|_|_|12852481
torsade de pointes|Disease|0|[0, 3]|0|-1|_|_|_|_|_|_|_|11858397
left bundle branch block|Disease|0|[13, 17]|1|-1|_|_|_|_|_|_|_|11858397
metoclopramide|Chemical|0|[5, 6]|2|-1|_|_|_|_|_|_|_|11858397
metoclopramide|Chemical|7|[0, 1]|2|-1|_|_|_|_|_|_|_|11858397
procainamide|Chemical|2|[29, 30]|3|-1|_|_|_|_|_|_|_|11858397
erythromycin|Chemical|4|[10, 11]|4|-1|_|_|_|_|_|_|_|11858397
cisapride|Chemical|4|[8, 9]|5|-1|_|_|_|_|_|_|_|11858397
class ib drugs|Chemical|5|[13, 16]|6|H|_|_|_|_|_|_|_|11858397
administering class ib drugs|Treat|5|[12, 16]|7|-1|_|_|_|_|_|_|_|11858397
apomorphine|Chemical|0|[0, 1]|0|-1|_|_|_|_|_|_|_|11009181
apomorphine|Chemical|0|[0, 1]|0|-1|_|_|_|_|_|_|_|11009181
apomorphine|Chemical|1|[0, 1]|0|-1|_|_|_|_|_|_|_|11009181
apomorphine|Chemical|1|[0, 1]|0|-1|_|_|_|_|_|_|_|11009181
apomorphine|Chemical|2|[25, 26]|0|-1|_|_|_|_|_|_|_|11009181
apomorphine|Chemical|3|[13, 14]|0|-1|_|_|_|_|_|_|_|11009181
apomorphine|Chemical|3|[29, 30]|0|-1|_|_|_|_|_|_|_|11009181
apomorphine|Chemical|3|[13, 14]|0|-1|_|_|_|_|_|_|_|11009181
apomorphine|Chemical|3|[29, 30]|0|-1|_|_|_|_|_|_|_|11009181
apomorphine|Chemical|4|[2, 3]|0|-1|_|_|_|_|_|_|_|11009181
apomorphine|Chemical|5|[17, 18]|0|-1|_|_|_|_|_|_|_|11009181
apomorphine|Chemical|6|[13, 14]|0|-1|_|_|_|_|_|_|_|11009181
apomorphine|Chemical|7|[6, 7]|0|-1|_|_|_|_|_|_|_|11009181
apomorphine|Chemical|8|[8, 9]|0|-1|_|_|_|_|_|_|_|11009181
levodopa|Chemical|3|[26, 27]|8|-1|_|_|_|_|_|_|_|11009181
levodopa|Chemical|3|[26, 27]|8|-1|_|_|_|_|_|_|_|11009181
levodopa|Chemical|6|[22, 23]|8|-1|_|_|_|_|_|_|_|11009181
dopamine agonists|Chemical|4|[38, 40]|13|H|_|_|_|_|_|_|_|11009181
comt inhibitors|Chemical|4|[41, 43]|14|-1|_|_|_|_|_|_|_|11009181
subcutaneous administration of apomorphine|Treat|2|[22, 26]|5|-1|_|_|_|_|_|_|_|11009181
subcutaneous apomorphine treatment|Treat|8|[7, 10]|22|-1|_|_|_|_|_|_|_|11009181
dyskinesias|Disease|6|[25, 26]|18|-1|_|_|_|_|_|_|_|11009181
psychiatric complications|Disease|7|[18, 20]|20|-1|_|_|_|_|_|_|_|11009181
cocaine|Chemical|0|[15, 16]|0|H|_|_|_|_|_|_|_|8988571
cocaine|Chemical|0|[4, 5]|0|H|_|_|_|_|_|_|_|8988571
cocaine|Chemical|1|[7, 8]|0|H|_|_|_|_|_|_|_|8988571
cocaine|Chemical|2|[5, 6]|0|H|_|_|_|_|_|_|_|8988571
cocaine|Chemical|2|[29, 30]|0|H|_|_|_|_|_|_|_|8988571
cocaine|Chemical|5|[4, 5]|0|H|_|_|_|_|_|_|_|8988571
cocaine|Chemical|6|[11, 12]|0|H|_|_|_|_|_|_|_|8988571
cocaine|Chemical|6|[22, 23]|0|H|_|_|_|_|_|_|_|8988571
benzoylecgonine|Chemical|5|[6, 7]|8|-1|_|_|_|_|_|_|_|8988571
overdose|Disease|2|[30, 31]|3|-1|_|_|_|_|_|_|_|8988571
hyperthermia|Disease|4|[42, 43]|6|-1|_|_|_|_|_|_|_|8988571
sudden death|Disease|6|[37, 39]|9|H|_|_|_|_|_|_|_|8988571
rhabdomyolysis|Disease|6|[34, 35]|12|-1|_|_|_|_|_|_|_|8988571
delirium|Disease|6|[29, 30]|13|H|_|_|_|_|_|_|_|8988571
thrombocytopenia|Disease|0|[3, 4]|0|-1|_|_|_|_|_|_|_|6615052
thrombocytopenia|Disease|1|[9, 10]|0|-1|_|_|_|_|_|_|_|6615052
thrombosis|Disease|0|[5, 6]|1|-1|_|_|_|_|_|_|_|6615052
hemorrhage|Disease|0|[8, 9]|500|-1|_|_|_|_|_|_|_|6615052
thromboembolic events|Disease|2|[12, 14]|501|H|_|_|_|_|_|_|_|6615052
hemorrhagic and thromboembolic complications|Disease|5|[5, 9]|5|-1|_|_|_|_|_|_|_|6615052
hemorrhagic|Disease|5|[5, 6]|500|-1|_|_|_|_|_|_|_|6615052
thromboembolic|Disease|5|[7, 8]|501|-1|_|_|_|_|_|_|_|6615052
platelet aggregation|Disease|7|[21, 23]|8|-1|_|_|_|_|_|_|_|6615052
5-fluorouracil|Chemical|0|[3, 6]|500|-1|_|_|_|_|_|_|_|3952818
5-fluorouracil|Chemical|1|[18, 21]|500|-1|_|_|_|_|_|_|_|3952818
5-fluorouracil (5-fu)|Chemical|1|[18, 26]|500|-1|_|_|_|_|_|_|_|3952818
nifedipine|Chemical|2|[20, 21]|9|-1|_|_|_|_|_|_|_|3952818
5-fu|Chemical|3|[32, 35]|500|-1|_|_|_|_|_|_|_|3952818
5-fu|Chemical|3|[14, 17]|500|-1|_|_|_|_|_|_|_|3952818
angina|Disease|0|[13, 14]|502|-1|_|_|_|_|_|_|_|3952818
chest pain|Disease|1|[15, 17]|502|-1|_|_|_|_|_|_|_|3952818
chest pain|Disease|2|[15, 17]|502|-1|_|_|_|_|_|_|_|3952818
metastasis|Disease|1|[12, 13]|3|-1|_|_|_|_|_|_|_|3952818
colon carcinoma|Disease|1|[8, 10]|5|-1|_|_|_|_|_|_|_|3952818
prinzmetal's angina|Disease|2|[9, 13]|502|-1|_|_|_|_|_|_|_|3952818
coronary spasm|Disease|3|[4, 6]|502|-1|_|_|_|_|_|_|_|3952818
arthritis|Disease|0|[8, 9]|500|H|_|_|_|_|_|_|_|3084782
arthritis|Disease|1|[6, 7]|500|H|_|_|_|_|_|_|_|3084782
rheumatoid arthritis|Disease|0|[7, 9]|500|H|_|_|_|_|_|_|_|3084782
dermatitis|Disease|2|[9, 10]|4|-1|_|_|_|_|_|_|_|3084782
dermatitis|Disease|2|[31, 32]|4|-1|_|_|_|_|_|_|_|3084782
nephritis|Disease|2|[7, 8]|8|-1|_|_|_|_|_|_|_|3084782
ra|Disease|3|[13, 14]|500|H|_|_|_|_|_|_|_|3084782
hla|Gene|1|[32, 33]|3|-1|_|_|_|_|_|_|_|3084782
gold|Chemical|2|[34, 35]|6|-1|_|_|_|_|_|_|_|3084782
d-penicillamine|Chemical|2|[15, 18]|7|H|_|_|_|_|_|_|_|3084782
d-penicillamine|Chemical|2|[15, 18]|7|H|_|_|_|_|_|_|_|3084782
tiopronin|Chemical|2|[12, 13]|9|-1|_|_|_|_|_|_|_|3084782
tiopronin|Chemical|3|[17, 18]|9|-1|_|_|_|_|_|_|_|3084782
hemiparesis|Disease|0|[1, 2]|500|-1|_|_|_|_|_|_|_|430165
hemiparesis|Disease|3|[7, 8]|500|-1|_|_|_|_|_|_|_|430165
transient hemiparesis|Disease|0|[0, 2]|500|-1|_|_|_|_|_|_|_|430165
overdose|Disease|1|[10, 11]|3|H|_|_|_|_|_|_|_|430165
overdose|Disease|3|[11, 12]|3|H|_|_|_|_|_|_|_|430165
cerebellar dysfunction|Disease|1|[21, 23]|4|-1|_|_|_|_|_|_|_|430165
brain surgery|Disease|4|[2, 4]|9|-1|_|_|_|_|_|_|_|430165
cerebral damage|Disease|5|[7, 9]|11|H|_|_|_|_|_|_|_|430165
diphenylhydantoin|Chemical|0|[7, 8]|502|-1|_|_|_|_|_|_|_|430165
diphenylhydantoin (dph)|Chemical|1|[6, 10]|502|-1|_|_|_|_|_|_|_|430165
dph|Chemical|3|[10, 11]|502|-1|_|_|_|_|_|_|_|430165
dph|Chemical|5|[13, 14]|502|-1|_|_|_|_|_|_|_|430165
dph treatment|Treat|4|[5, 7]|10|-1|_|_|_|_|_|_|_|430165
overactive bladder|Disease|0|[12, 14]|500|-1|_|_|_|_|_|_|_|16600756
oab|Disease|2|[11, 12]|500|-1|_|_|_|_|_|_|_|16600756
oab|Disease|3|[11, 12]|500|-1|_|_|_|_|_|_|_|16600756
oab|Disease|7|[16, 17]|500|-1|_|_|_|_|_|_|_|16600756
oab|Disease|8|[14, 15]|500|-1|_|_|_|_|_|_|_|16600756
oab|Disease|9|[12, 13]|500|-1|_|_|_|_|_|_|_|16600756
oab|Disease|10|[3, 4]|500|-1|_|_|_|_|_|_|_|16600756
oab|Disease|11|[15, 16]|500|-1|_|_|_|_|_|_|_|16600756
oab|Disease|12|[12, 13]|500|-1|_|_|_|_|_|_|_|16600756
oab symptoms|Disease|13|[12, 14]|500|-1|_|_|_|_|_|_|_|16600756
pgs|Chemical|2|[7, 8]|2|H|_|_|_|_|_|_|_|16600756
pgs|Chemical|12|[4, 5]|2|H|_|_|_|_|_|_|_|16600756
pge2|Chemical|6|[2, 3]|4|-1|_|_|_|_|_|_|_|16600756
pge2|Chemical|8|[5, 6]|4|-1|_|_|_|_|_|_|_|16600756
pge2|Chemical|10|[5, 6]|4|-1|_|_|_|_|_|_|_|16600756
pgf2alpha|Chemical|6|[4, 5]|5|-1|_|_|_|_|_|_|_|16600756
pgf2alpha|Chemical|8|[7, 8]|5|-1|_|_|_|_|_|_|_|16600756
pgf2alpha|Chemical|11|[3, 4]|5|-1|_|_|_|_|_|_|_|16600756
pgi2|Chemical|6|[6, 7]|6|-1|_|_|_|_|_|_|_|16600756
pgi2|Chemical|11|[5, 6]|6|-1|_|_|_|_|_|_|_|16600756
amiodarone|Chemical|0|[8, 9]|0|-1|_|_|_|_|_|_|_|15686794
amiodarone|Chemical|1|[0, 1]|0|-1|_|_|_|_|_|_|_|15686794
atrial fibrillation (af)|Disease|1|[12, 17]|501|-1|_|_|_|_|_|_|_|15686794
atrial fibrillation|Disease|2|[10, 12]|501|-1|_|_|_|_|_|_|_|15686794
low back pain|Disease|2|[18, 21]|4|-1|_|_|_|_|_|_|_|15686794
parenteral administration|Treat|4|[11, 13]|5|-1|_|_|_|_|_|_|_|15686794
postoperative myalgia|Disease|0|[0, 2]|500|-1|_|_|_|_|_|_|_|12760988
postoperative myalgia|Disease|1|[8, 10]|500|-1|_|_|_|_|_|_|_|12760988
postoperative myalgia|Disease|10|[21, 23]|500|-1|_|_|_|_|_|_|_|12760988
postoperative myalgia|Disease|11|[8, 10]|500|-1|_|_|_|_|_|_|_|12760988
postoperative myalgia|Disease|12|[8, 10]|500|-1|_|_|_|_|_|_|_|12760988
myalgia|Disease|0|[1, 2]|500|-1|_|_|_|_|_|_|_|12760988
succinylcholine|Chemical|0|[3, 4]|2|-1|_|_|_|_|_|_|_|12760988
dexamethasone|Chemical|4|[18, 19]|4|-1|_|_|_|_|_|_|_|12760988
inflammation|Immune|7|[16, 17]|5|-1|_|_|_|_|_|_|_|12760988
levodopa|Chemical|0|[0, 1]|0|-1|_|_|_|_|_|_|_|12691807
levodopa|Chemical|1|[0, 1]|0|-1|_|_|_|_|_|_|_|12691807
levodopa|Chemical|1|[0, 1]|0|-1|_|_|_|_|_|_|_|12691807
levodopa|Chemical|3|[10, 11]|0|-1|_|_|_|_|_|_|_|12691807
dystonia|Disease|0|[4, 5]|501|-1|_|_|_|_|_|_|_|12691807
dystonia|Disease|3|[14, 15]|501|-1|_|_|_|_|_|_|_|12691807
progressive supranuclear palsy|Disease|0|[6, 9]|502|-1|_|_|_|_|_|_|_|12691807
atrophy|Disease|1|[15, 16]|3|-1|_|_|_|_|_|_|_|12691807
multiple system atrophy|Disease|1|[13, 16]|5|-1|_|_|_|_|_|_|_|12691807
dystonias|Disease|2|[1, 2]|501|-1|_|_|_|_|_|_|_|12691807
progressive supranuclear palsy (psp)|Disease|2|[7, 13]|502|-1|_|_|_|_|_|_|_|12691807
psp|Disease|3|[36, 37]|502|-1|_|_|_|_|_|_|_|12691807
psp|Disease|3|[20, 21]|502|-1|_|_|_|_|_|_|_|12691807
vestibulotoxicity|Disease|0|[8, 9]|0|-1|_|_|_|_|_|_|_|12600698
cerebral infarction|Disease|2|[21, 23]|3|-1|_|_|_|_|_|_|_|12600698
edaravone|Chemical|1|[10, 11]|1|-1|_|_|_|_|_|_|_|12600698
edaravone|Chemical|2|[0, 1]|1|-1|_|_|_|_|_|_|_|12600698
edaravone|Chemical|3|[15, 16]|1|-1|_|_|_|_|_|_|_|12600698
streptomycin|Chemical|1|[5, 6]|2|-1|_|_|_|_|_|_|_|12600698
streptomycin|Chemical|3|[0, 1]|2|-1|_|_|_|_|_|_|_|12600698
osmotic pump|Treat|3|[8, 10]|7|-1|_|_|_|_|_|_|_|12600698
vestibulo-ocular reflex|Physiology|4|[3, 7]|8|-1|_|_|_|_|_|_|_|12600698
ketamine|Chemical|0|[0, 1]|0|-1|_|_|_|_|_|_|_|12091028
ketamine|Chemical|0|[0, 1]|0|-1|_|_|_|_|_|_|_|12091028
ketamine|Chemical|1|[7, 8]|0|-1|_|_|_|_|_|_|_|12091028
ketamine|Chemical|3|[16, 17]|0|-1|_|_|_|_|_|_|_|12091028
ketamine|Chemical|3|[31, 32]|0|-1|_|_|_|_|_|_|_|12091028
ketamine|Chemical|5|[14, 15]|0|-1|_|_|_|_|_|_|_|12091028
ketamine|Chemical|5|[14, 15]|0|-1|_|_|_|_|_|_|_|12091028
diazepam|Chemical|3|[3, 4]|7|-1|_|_|_|_|_|_|_|12091028
diazepam|Chemical|5|[0, 1]|7|-1|_|_|_|_|_|_|_|12091028
diazepam|Chemical|5|[0, 1]|7|-1|_|_|_|_|_|_|_|12091028
glycopyrrolate|Chemical|3|[5, 6]|8|-1|_|_|_|_|_|_|_|12091028
local anaesthetic|Chemical|6|[0, 2]|16|-1|_|_|_|_|_|_|_|12091028
anaesthesia|Treat|1|[5, 6]|3|-1|_|_|_|_|_|_|_|12091028
local anaesthetic blocks|Treat|6|[0, 3]|17|-1|_|_|_|_|_|_|_|12091028
ventilation|Physiology|2|[24, 25]|4|-1|_|_|_|_|_|_|_|12091028
heart rate|Physiology|4|[12, 14]|9|-1|_|_|_|_|_|_|_|12091028
cardiovascular response|Physiology|5|[19, 21]|15|-1|_|_|_|_|_|_|_|12091028
hallucinations|Disease|5|[31, 32]|10|-1|_|_|_|_|_|_|_|12091028
steroid|Chemical|0|[0, 1]|500|H|_|_|_|_|_|_|_|11860495
steroid|Chemical|2|[6, 7]|500|H|_|_|_|_|_|_|_|11860495
pregnenolone sulphate|Chemical|0|[12, 14]|500|-1|_|_|_|_|_|_|_|11860495
pregnenolone sulphate (pregs)|Chemical|1|[0, 5]|500|-1|_|_|_|_|_|_|_|11860495
pregs|Chemical|3|[6, 7]|500|-1|_|_|_|_|_|_|_|11860495
pregs|Chemical|4|[2, 3]|500|-1|_|_|_|_|_|_|_|11860495
pregs|Chemical|5|[20, 21]|500|-1|_|_|_|_|_|_|_|11860495
pregs|Chemical|6|[69, 70]|500|-1|_|_|_|_|_|_|_|11860495
pregs|Chemical|6|[62, 63]|500|-1|_|_|_|_|_|_|_|11860495
pregs|Chemical|8|[1, 2]|500|-1|_|_|_|_|_|_|_|11860495
pregs|Chemical|9|[6, 7]|500|-1|_|_|_|_|_|_|_|11860495
pregs|Chemical|9|[38, 39]|500|-1|_|_|_|_|_|_|_|11860495
pregs|Chemical|10|[10, 11]|500|-1|_|_|_|_|_|_|_|11860495
gamma-aminobutyric acid|Chemical|3|[29, 33]|501|-1|_|_|_|_|_|_|_|11860495
nmdar|Chemical|4|[13, 14]|7|-1|_|_|_|_|_|_|_|11860495
nmdar|Chemical|5|[28, 29]|7|-1|_|_|_|_|_|_|_|11860495
gaba(a)r|Chemical|4|[15, 20]|501|-1|_|_|_|_|_|_|_|11860495
gaba(a)r|Chemical|5|[32, 37]|501|-1|_|_|_|_|_|_|_|11860495
11-ketopregnenolone sulphate|Chemical|6|[5, 9]|13|-1|_|_|_|_|_|_|_|11860495
epipregnanolone|Chemical|6|[25, 26]|500|-1|_|_|_|_|_|_|_|11860495
[3beta-hydroxy-5beta-pregnan-20-one] sulphate|Chemical|6|[27, 41]|500|-1|_|_|_|_|_|_|_|11860495
(-) pregs enantiomer|Chemical|6|[59, 64]|500|-1|_|_|_|_|_|_|_|11860495
scopolamine|Chemical|7|[21, 22]|20|-1|_|_|_|_|_|_|_|11860495
scopolamine|Chemical|8|[12, 13]|20|-1|_|_|_|_|_|_|_|11860495
scopolamine|Chemical|9|[21, 22]|20|-1|_|_|_|_|_|_|_|11860495
scopolamine|Chemical|10|[25, 26]|20|-1|_|_|_|_|_|_|_|11860495
epipregnanolone sulphate|Chemical|9|[13, 15]|500|-1|_|_|_|_|_|_|_|11860495
neuroactive steroids|Chemical|11|[14, 16]|500|H|_|_|_|_|_|_|_|11860495
memory formation|Physiology|2|[8, 10]|4|-1|_|_|_|_|_|_|_|11860495
amnesia|Disease|7|[24, 25]|19|-1|_|_|_|_|_|_|_|11860495
amnesia|Disease|10|[28, 29]|19|-1|_|_|_|_|_|_|_|11860495
adenosine|Chemical|0|[11, 12]|0|-1|_|_|_|_|_|_|_|11752998
capsaicin|Chemical|2|[27, 28]|5|-1|_|_|_|_|_|_|_|11752998
capsaicin|Chemical|4|[26, 27]|5|-1|_|_|_|_|_|_|_|11752998
capsaicin|Chemical|5|[24, 25]|5|-1|_|_|_|_|_|_|_|11752998
capsaicin|Chemical|6|[22, 23]|5|-1|_|_|_|_|_|_|_|11752998
intrathecal injection|Treat|0|[4, 6]|1|-1|_|_|_|_|_|_|_|11752998
intrathecal adenosine doses|Treat|3|[35, 38]|6|-1|_|_|_|_|_|_|_|11752998
chronic pain|Disease|1|[18, 20]|2|H|_|_|_|_|_|_|_|11752998
pain|Disease|1|[19, 20]|3|H|_|_|_|_|_|_|_|11752998
hypersensitivity|Disease|1|[42, 43]|4|H|_|_|_|_|_|_|_|11752998
mechanical hyperalgesia|Disease|4|[20, 22]|7|-1|_|_|_|_|_|_|_|11752998
mechanical hyperalgesia|Disease|5|[18, 20]|7|-1|_|_|_|_|_|_|_|11752998
allodynia|Disease|4|[23, 24]|9|-1|_|_|_|_|_|_|_|11752998
chronic neuropathic pain|Disease|7|[16, 19]|13|H|_|_|_|_|_|_|_|11752998
lithium|Chemical|0|[2, 3]|0|-1|_|_|_|_|_|_|_|10354657
maintenance therapy|Treat|0|[3, 5]|1|-1|_|_|_|_|_|_|_|10354657
lithium maintenance therapy|Treat|5|[18, 21]|3|-1|_|_|_|_|_|_|_|10354657
lithium treatment|Treat|11|[5, 7]|5|-1|_|_|_|_|_|_|_|10354657
bipolar disorder|Disease|5|[15, 17]|2|-1|_|_|_|_|_|_|_|10354657
hypothyroidism|Disease|8|[2, 3]|4|-1|_|_|_|_|_|_|_|10354657
hypercalcemia|Disease|14|[12, 13]|8|-1|_|_|_|_|_|_|_|10354657
magnesium levels|Physiology|11|[0, 2]|6|-1|_|_|_|_|_|_|_|10354657
plasma calcium levels|Physiology|13|[8, 11]|7|-1|_|_|_|_|_|_|_|10354657
capillary leak syndrome|Disease|0|[15, 18]|0|-1|_|_|_|_|_|_|_|10328196
psoriasis|Disease|0|[11, 12]|1|-1|_|_|_|_|_|_|_|10328196
fever|Disease|5|[8, 9]|7|H|_|_|_|_|_|_|_|10328196
anemia|Disease|5|[10, 11]|8|-1|_|_|_|_|_|_|_|10328196
sirolimus|Chemical|0|[5, 6]|501|-1|_|_|_|_|_|_|_|10328196
sirolimus|Chemical|1|[2, 3]|501|-1|_|_|_|_|_|_|_|10328196
rapamycin|Chemical|1|[5, 6]|501|-1|_|_|_|_|_|_|_|10328196
dexamethasone|Chemical|4|[15, 16]|6|-1|_|_|_|_|_|_|_|10328196
t-cell activation|Immune|1|[14, 18]|5|-1|_|_|_|_|_|_|_|10328196
t lymphocytes|Immune|6|[17, 19]|9|-1|_|_|_|_|_|_|_|10328196
immune modulators|Immune|7|[27, 29]|10|-1|_|_|_|_|_|_|_|10328196
muscle tone|Physiology|0|[22, 24]|0|-1|_|_|_|_|_|_|_|9630698
electromyographic activity|Physiology|4|[61, 63]|8|-1|_|_|_|_|_|_|_|9630698
haloperidol|Chemical|3|[5, 6]|1|-1|_|_|_|_|_|_|_|9630698
haloperidol|Chemical|4|[50, 51]|1|-1|_|_|_|_|_|_|_|9630698
haloperidol|Chemical|5|[34, 35]|1|-1|_|_|_|_|_|_|_|9630698
5,7-dcka|Chemical|4|[7, 12]|500|-1|_|_|_|_|_|_|_|9630698
5,7-dcka|Chemical|5|[0, 5]|500|-1|_|_|_|_|_|_|_|9630698
5,7-dcka|Chemical|5|[0, 5]|500|-1|_|_|_|_|_|_|_|9630698
5,7-dichlorokynurenic acid|Chemical|4|[0, 6]|500|-1|_|_|_|_|_|_|_|9630698
muscle rigidity|Disease|3|[0, 2]|2|-1|_|_|_|_|_|_|_|9630698
muscle rigidity|Disease|3|[0, 2]|2|-1|_|_|_|_|_|_|_|9630698
muscle rigidity|Disease|4|[53, 55]|2|-1|_|_|_|_|_|_|_|9630698
hypercholesterolemia|Disease|0|[10, 11]|0|-1|_|_|_|_|_|_|_|8480959
myopathy|Disease|9|[0, 1]|10|-1|_|_|_|_|_|_|_|8480959
myopathy|Disease|9|[0, 1]|10|-1|_|_|_|_|_|_|_|8480959
lovastatin|Chemical|0|[4, 5]|1|-1|_|_|_|_|_|_|_|8480959
lovastatin|Chemical|2|[38, 39]|1|-1|_|_|_|_|_|_|_|8480959
lovastatin|Chemical|2|[7, 8]|1|-1|_|_|_|_|_|_|_|8480959
lovastatin|Chemical|9|[31, 32]|1|-1|_|_|_|_|_|_|_|8480959
lovastatin|Chemical|11|[2, 3]|1|-1|_|_|_|_|_|_|_|8480959
cholesterol|Chemical|5|[21, 22]|4|H|_|_|_|_|_|_|_|8480959
creatine|Chemical|9|[7, 8]|9|-1|_|_|_|_|_|_|_|8480959
ldl cholesterol|Physiology|6|[39, 41]|5|-1|_|_|_|_|_|_|_|8480959
hdl cholesterol|Physiology|6|[57, 59]|6|-1|_|_|_|_|_|_|_|8480959
triglycerides|Physiology|6|[47, 48]|7|-1|_|_|_|_|_|_|_|8480959
ldl cholesterol levels|Physiology|7|[22, 25]|8|-1|_|_|_|_|_|_|_|8480959
rem sleep deprivation|Disease|0|[0, 3]|0|-1|_|_|_|_|_|_|_|7197363
rem sleep deprivation|Disease|1|[3, 6]|0|-1|_|_|_|_|_|_|_|7197363
aggressiveness|Disease|1|[13, 14]|1|-1|_|_|_|_|_|_|_|7197363
aggressiveness|Disease|2|[10, 11]|1|-1|_|_|_|_|_|_|_|7197363
head twitches|Disease|1|[18, 20]|2|-1|_|_|_|_|_|_|_|7197363
head twitches|Disease|2|[34, 36]|2|-1|_|_|_|_|_|_|_|7197363
antidepressive treatments|Disease|3|[12, 14]|10|H|_|_|_|_|_|_|_|7197363
apomorphine|Chemical|1|[10, 11]|3|-1|_|_|_|_|_|_|_|7197363
apomorphine|Chemical|2|[7, 8]|3|-1|_|_|_|_|_|_|_|7197363
quipazine|Chemical|1|[15, 16]|4|-1|_|_|_|_|_|_|_|7197363
quipazine|Chemical|2|[31, 32]|4|-1|_|_|_|_|_|_|_|7197363
antidepressive treatments|Treat|3|[12, 14]|11|-1|_|_|_|_|_|_|_|7197363
haloperidol|Chemical|0|[5, 6]|0|-1|_|_|_|_|_|_|_|7161250
haloperidol|Chemical|0|[5, 6]|0|-1|_|_|_|_|_|_|_|7161250
haloperidol|Chemical|1|[16, 17]|0|-1|_|_|_|_|_|_|_|7161250
haloperidol|Chemical|2|[10, 11]|0|-1|_|_|_|_|_|_|_|7161250
haloperidol|Chemical|6|[19, 20]|0|-1|_|_|_|_|_|_|_|7161250
lorazepam|Chemical|5|[6, 7]|7|-1|_|_|_|_|_|_|_|7161250
eps|Disease|1|[7, 8]|2|H|_|_|_|_|_|_|_|7161250
eps|Disease|6|[16, 17]|2|H|_|_|_|_|_|_|_|7161250
eps|Disease|6|[16, 17]|2|H|_|_|_|_|_|_|_|7161250
parkinsonism|Disease|2|[3, 4]|5|-1|_|_|_|_|_|_|_|7161250
akathisia|Disease|5|[0, 1]|6|-1|_|_|_|_|_|_|_|7161250
prophylactic antiparkinsonians|Treat|5|[15, 17]|8|-1|_|_|_|_|_|_|_|7161250
hepatic veno-occlusive disease|Disease|0|[0, 5]|500|-1|_|_|_|_|_|_|_|7053705
lymphocytic leukemia|Disease|1|[20, 22]|2|-1|_|_|_|_|_|_|_|7053705
sinusoidal engorgement|Disease|2|[10, 12]|500|-1|_|_|_|_|_|_|_|7053705
6-thioguanine|Chemical|0|[7, 10]|1|-1|_|_|_|_|_|_|_|7053705
maintenance therapy|Treat|1|[26, 28]|3|-1|_|_|_|_|_|_|_|7053705
urothelial toxicity|Disease|0|[5, 7]|0|H|_|_|_|_|_|_|_|6402369
lung cancer|Disease|0|[23, 25]|3|-1|_|_|_|_|_|_|_|6402369
haematuria|Disease|3|[17, 18]|7|-1|_|_|_|_|_|_|_|6402369
haematuria|Disease|3|[23, 24]|7|-1|_|_|_|_|_|_|_|6402369
polychemotherapy|Disease|5|[7, 8]|10|H|_|_|_|_|_|_|_|6402369
cystitis|Disease|6|[32, 33]|12|-1|_|_|_|_|_|_|_|6402369
pollakisuria|Disease|6|[34, 35]|13|-1|_|_|_|_|_|_|_|6402369
systemic toxicity|Disease|7|[20, 22]|14|H|_|_|_|_|_|_|_|6402369
ifosfamide|Chemical|0|[2, 3]|501|-1|_|_|_|_|_|_|_|6402369
sodium 2-mercaptoethane sulphonate (mesna)|Chemical|0|[11, 19]|502|-1|_|_|_|_|_|_|_|6402369
sodium 2-mercaptoethane sulphonate (mesna)|Chemical|1|[10, 18]|502|-1|_|_|_|_|_|_|_|6402369
ifosfamide (if)|Chemical|1|[23, 27]|501|-1|_|_|_|_|_|_|_|6402369
mesna|Chemical|2|[0, 1]|502|-1|_|_|_|_|_|_|_|6402369
mesna|Chemical|4|[9, 10]|502|-1|_|_|_|_|_|_|_|6402369
mesna|Chemical|7|[7, 8]|502|-1|_|_|_|_|_|_|_|6402369
mesna|Chemical|8|[6, 7]|502|-1|_|_|_|_|_|_|_|6402369
mesna|Chemical|9|[3, 4]|502|-1|_|_|_|_|_|_|_|6402369
prophylactic measures|Treat|5|[14, 16]|11|-1|_|_|_|_|_|_|_|6402369
cytostatic treatment|Treat|7|[24, 26]|16|-1|_|_|_|_|_|_|_|6402369
protection|Treat|9|[0, 1]|19|-1|_|_|_|_|_|_|_|6402369
hypaque 76|Chemical|0|[8, 10]|0|-1|_|_|_|_|_|_|_|3973521
hypaque 76|Chemical|1|[25, 27]|0|-1|_|_|_|_|_|_|_|3973521
qtc interval|Physiology|0|[4, 6]|1|-1|_|_|_|_|_|_|_|3973521
hypotension|Physiology|3|[14, 15]|6|-1|_|_|_|_|_|_|_|3973521
cardiac output|Physiology|3|[18, 20]|7|-1|_|_|_|_|_|_|_|3973521
hypotension|Disease|3|[14, 15]|3|-1|_|_|_|_|_|_|_|3973521
qtc prolongation|Disease|3|[1, 3]|4|-1|_|_|_|_|_|_|_|3973521
qtc prolongation|Disease|3|[1, 3]|4|-1|_|_|_|_|_|_|_|3973521
prostate cancer|Disease|0|[3, 5]|500|-1|_|_|_|_|_|_|_|3461217
prostate adenocarcinomas|Disease|1|[18, 20]|500|-1|_|_|_|_|_|_|_|3461217
pa|Disease|3|[14, 15]|500|-1|_|_|_|_|_|_|_|3461217
n-nitroso-n-methylurea|Chemical|0|[13, 20]|1|-1|_|_|_|_|_|_|_|3461217
n-nitroso-n-methylurea|Chemical|1|[26, 33]|1|-1|_|_|_|_|_|_|_|3461217
testosterone|Chemical|0|[21, 22]|502|-1|_|_|_|_|_|_|_|3461217
testosterone propionate|Chemical|1|[43, 45]|502|-1|_|_|_|_|_|_|_|3461217
tp|Chemical|3|[19, 20]|502|-1|_|_|_|_|_|_|_|3461217
tp|Chemical|4|[6, 7]|502|-1|_|_|_|_|_|_|_|3461217
treatments with n-nitroso-n-methylurea and testosterone|Treat|0|[11, 22]|3|-1|_|_|_|_|_|_|_|3461217
msh|Chemical|0|[8, 9]|500|-1|_|_|_|_|_|_|_|2840807
msh/acth|Chemical|0|[8, 11]|500|-1|_|_|_|_|_|_|_|2840807
dystonia|Disease|0|[1, 2]|1|-1|_|_|_|_|_|_|_|2840807
dystonia|Disease|1|[15, 16]|1|-1|_|_|_|_|_|_|_|2840807
long-term depression|Physiology|3|[59, 63]|4|-1|_|_|_|_|_|_|_|2840807
muscle rigidity|Disease|0|[14, 16]|0|-1|_|_|_|_|_|_|_|2569282
muscle rigidity|Disease|2|[2, 4]|0|-1|_|_|_|_|_|_|_|2569282
muscle rigidity|Disease|4|[16, 18]|0|-1|_|_|_|_|_|_|_|2569282
muscle rigidity|Disease|9|[10, 12]|0|-1|_|_|_|_|_|_|_|2569282
rigidity|Disease|3|[7, 8]|4|H|_|_|_|_|_|_|_|2569282
startle|Disease|11|[16, 17]|18|-1|_|_|_|_|_|_|_|2569282
dexmedetomidine|Chemical|0|[0, 1]|501|-1|_|_|_|_|_|_|_|2569282
dexmedetomidine (d-med)|Chemical|1|[9, 15]|501|-1|_|_|_|_|_|_|_|2569282
alfentanil|Chemical|4|[23, 24]|6|-1|_|_|_|_|_|_|_|2569282
d-med|Chemical|4|[11, 14]|501|-1|_|_|_|_|_|_|_|2569282
d-med|Chemical|5|[90, 93]|501|-1|_|_|_|_|_|_|_|2569282
d-med|Chemical|5|[39, 42]|501|-1|_|_|_|_|_|_|_|2569282
d-med|Chemical|5|[50, 53]|501|-1|_|_|_|_|_|_|_|2569282
d-med|Chemical|5|[61, 64]|501|-1|_|_|_|_|_|_|_|2569282
d-med|Chemical|9|[3, 6]|501|-1|_|_|_|_|_|_|_|2569282
d-med|Chemical|10|[10, 13]|501|-1|_|_|_|_|_|_|_|2569282
d-med|Chemical|11|[4, 7]|501|-1|_|_|_|_|_|_|_|2569282
medetomidine|Chemical|5|[29, 30]|501|-1|_|_|_|_|_|_|_|2569282
alf|Chemical|7|[8, 9]|13|-1|_|_|_|_|_|_|_|2569282
emg values|Physiology|10|[2, 4]|17|-1|_|_|_|_|_|_|_|2569282
cerebral vascular accident (cva)|Disease|1|[8, 14]|0|-1|_|_|_|_|_|_|_|2343592
seizures|Disease|1|[24, 25]|2|-1|_|_|_|_|_|_|_|2343592
seizure-like activity|Disease|2|[7, 11]|3|-1|_|_|_|_|_|_|_|2343592
imipenem/cilastatin|Chemical|1|[30, 33]|501|-1|_|_|_|_|_|_|_|2343592
anticonvulsant agents|Chemical|2|[14, 16]|4|H|_|_|_|_|_|_|_|2343592
phenytoin|Chemical|3|[8, 9]|5|-1|_|_|_|_|_|_|_|2343592
beta-lactam|Chemical|4|[8, 11]|501|-1|_|_|_|_|_|_|_|2343592
beta-lactam antibiotics|Chemical|4|[8, 12]|501|-1|_|_|_|_|_|_|_|2343592
streptozotocin|Chemical|0|[17, 18]|0|-1|_|_|_|_|_|_|_|2055425
streptozotocin|Chemical|2|[15, 16]|0|-1|_|_|_|_|_|_|_|2055425
streptozotocin|Chemical|9|[7, 8]|0|-1|_|_|_|_|_|_|_|2055425
bethanechol|Chemical|4|[25, 26]|5|-1|_|_|_|_|_|_|_|2055425
bethanechol|Chemical|7|[22, 23]|5|-1|_|_|_|_|_|_|_|2055425
diabetes mellitus|Disease|0|[20, 22]|501|-1|_|_|_|_|_|_|_|2055425
diabetes|Disease|3|[2, 3]|501|-1|_|_|_|_|_|_|_|2055425
diabetes|Disease|5|[2, 3]|501|-1|_|_|_|_|_|_|_|2055425
insulin treatment|Treat|0|[3, 5]|2|-1|_|_|_|_|_|_|_|2055425
contractile responses|Physiology|7|[6, 8]|8|-1|_|_|_|_|_|_|_|2055425
urinary bladder function|Physiology|9|[12, 15]|10|-1|_|_|_|_|_|_|_|2055425
edema|Disease|0|[12, 13]|500|-1|_|_|_|_|_|_|_|1711760
edema|Disease|1|[22, 23]|500|-1|_|_|_|_|_|_|_|1711760
edema|Disease|10|[16, 17]|500|-1|_|_|_|_|_|_|_|1711760
edema|Disease|12|[25, 26]|500|-1|_|_|_|_|_|_|_|1711760
edema|Disease|12|[16, 17]|500|-1|_|_|_|_|_|_|_|1711760
hypertension|Disease|0|[3, 4]|501|-1|_|_|_|_|_|_|_|1711760
brain edema|Disease|0|[11, 13]|500|-1|_|_|_|_|_|_|_|1711760
middle cerebral artery occlusion (mcao)|Disease|1|[13, 20]|502|-1|_|_|_|_|_|_|_|1711760
hypertensive|Disease|2|[9, 10]|501|-1|_|_|_|_|_|_|_|1711760
hypertensive|Disease|4|[2, 3]|501|-1|_|_|_|_|_|_|_|1711760
hypertensive|Disease|10|[21, 22]|501|-1|_|_|_|_|_|_|_|1711760
hypertensive|Disease|11|[23, 24]|501|-1|_|_|_|_|_|_|_|1711760
mcao|Disease|5|[3, 4]|502|-1|_|_|_|_|_|_|_|1711760
mcao|Disease|6|[14, 15]|502|-1|_|_|_|_|_|_|_|1711760
mcao|Disease|12|[12, 13]|502|-1|_|_|_|_|_|_|_|1711760
neuronal dysfunction|Disease|12|[42, 44]|16|H|_|_|_|_|_|_|_|1711760
isoflurane|Chemical|2|[1, 2]|6|-1|_|_|_|_|_|_|_|1711760
2,3,5-triphenyltetrazolium|Chemical|8|[8, 15]|12|-1|_|_|_|_|_|_|_|1711760
phenylephrine|Chemical|12|[4, 5]|17|-1|_|_|_|_|_|_|_|1711760
arterial pressure|Physiology|3|[12, 14]|7|-1|_|_|_|_|_|_|_|1711760
map|Physiology|4|[11, 12]|9|-1|_|_|_|_|_|_|_|1711760
hypertension|Physiology|12|[7, 8]|21|-1|_|_|_|_|_|_|_|1711760
amiodarone|Chemical|0|[0, 1]|0|-1|_|_|_|_|_|_|_|1595783
amiodarone|Chemical|1|[0, 1]|0|-1|_|_|_|_|_|_|_|1595783
steroid|Chemical|6|[4, 5]|8|-1|_|_|_|_|_|_|_|1595783
pneumonitis|Disease|1|[20, 21]|501|H|_|_|_|_|_|_|_|1595783
hypersensitivity pneumonitis|Disease|2|[24, 26]|3|-1|_|_|_|_|_|_|_|1595783
pulmonary toxicity|Disease|3|[9, 11]|501|-1|_|_|_|_|_|_|_|1595783
heart failure|Disease|4|[11, 13]|5|-1|_|_|_|_|_|_|_|1595783
malignancy|Disease|4|[17, 18]|6|-1|_|_|_|_|_|_|_|1595783
withdrawal|Treat|5|[1, 2]|7|-1|_|_|_|_|_|_|_|1595783
proteinuria|Disease|0|[2, 3]|0|-1|_|_|_|_|_|_|_|804391
proteinuria|Disease|1|[2, 3]|0|-1|_|_|_|_|_|_|_|804391
tuberculosis|Disease|0|[12, 13]|500|-1|_|_|_|_|_|_|_|804391
tuberculous|Disease|4|[8, 9]|500|-1|_|_|_|_|_|_|_|804391
rifampin|Chemical|0|[8, 9]|2|-1|_|_|_|_|_|_|_|804391
cellular mediated immunity|Immune|0|[4, 7]|3|-1|_|_|_|_|_|_|_|804391
lymphocyte|Immune|5|[26, 27]|6|-1|_|_|_|_|_|_|_|804391
hypokalaemia|Disease|0|[4, 5]|0|-1|_|_|_|_|_|_|_|28952
chlorthalidone|Chemical|0|[6, 7]|501|-1|_|_|_|_|_|_|_|28952
chlorthalidone|Chemical|2|[0, 1]|501|-1|_|_|_|_|_|_|_|28952
diuretic|Chemical|1|[36, 37]|501|-1|_|_|_|_|_|_|_|28952
diuretic|Chemical|1|[16, 17]|501|-1|_|_|_|_|_|_|_|28952
diuretic|Chemical|9|[8, 9]|501|-1|_|_|_|_|_|_|_|28952
total body potassium|Physiology|4|[6, 9]|5|-1|_|_|_|_|_|_|_|28952
weight|Physiology|5|[4, 5]|6|-1|_|_|_|_|_|_|_|28952
plasma renin activity|Physiology|5|[9, 12]|7|-1|_|_|_|_|_|_|_|28952
aldosterone secretion rate|Physiology|5|[14, 17]|8|-1|_|_|_|_|_|_|_|28952
potassium secretion|Physiology|9|[42, 44]|10|-1|_|_|_|_|_|_|_|28952
dynamic response of blood vessel|Physiology|0|[0, 5]|0|-1|_|_|_|_|_|_|_|19893084
blood vessels|Physiology|1|[19, 21]|2|-1|_|_|_|_|_|_|_|19893084
blood vessels|Physiology|1|[36, 38]|2|-1|_|_|_|_|_|_|_|19893084
blood urea|Physiology|4|[20, 22]|5|-1|_|_|_|_|_|_|_|19893084
potassium|Physiology|4|[28, 29]|6|-1|_|_|_|_|_|_|_|19893084
pressure|Physiology|5|[11, 12]|7|-1|_|_|_|_|_|_|_|19893084
pressure|Physiology|5|[1, 2]|7|-1|_|_|_|_|_|_|_|19893084
gentamicin|Chemical|1|[12, 13]|1|-1|_|_|_|_|_|_|_|19893084
vitamin c|Chemical|4|[4, 6]|4|-1|_|_|_|_|_|_|_|19893084
vitamin c|Chemical|6|[0, 2]|4|-1|_|_|_|_|_|_|_|19893084
vitamin c|Chemical|7|[39, 41]|4|-1|_|_|_|_|_|_|_|19893084
vitamin c administration|Treat|7|[39, 42]|11|-1|_|_|_|_|_|_|_|19893084
oxytocin|Chemical|0|[3, 4]|0|-1|_|_|_|_|_|_|_|18513945
neuraxial anesthesia|Treat|0|[9, 11]|1|-1|_|_|_|_|_|_|_|18513945
hemodynamics|Physiology|0|[1, 2]|2|-1|_|_|_|_|_|_|_|18513945
hypotension|Physiology|1|[13, 14]|4|-1|_|_|_|_|_|_|_|18513945
heart rate|Physiology|3|[22, 24]|8|-1|_|_|_|_|_|_|_|18513945
stroke volume|Physiology|3|[25, 27]|9|-1|_|_|_|_|_|_|_|18513945
blood pressure|Physiology|5|[40, 42]|11|-1|_|_|_|_|_|_|_|18513945
systemic vascular resistance|Physiology|7|[11, 14]|15|-1|_|_|_|_|_|_|_|18513945
cardiac output|Physiology|7|[25, 27]|16|-1|_|_|_|_|_|_|_|18513945
hypotension|Disease|1|[13, 14]|3|-1|_|_|_|_|_|_|_|18513945
hypotension|Disease|2|[2, 3]|3|-1|_|_|_|_|_|_|_|18513945
hypotension|Disease|3|[16, 17]|3|-1|_|_|_|_|_|_|_|18513945
hypotension|Disease|4|[3, 4]|3|-1|_|_|_|_|_|_|_|18513945
hypotension|Disease|7|[0, 1]|3|-1|_|_|_|_|_|_|_|18513945
hypotension|Disease|7|[0, 1]|3|-1|_|_|_|_|_|_|_|18513945
hypotension|Disease|8|[13, 14]|3|-1|_|_|_|_|_|_|_|18513945
stroke|Disease|3|[25, 26]|7|-1|_|_|_|_|_|_|_|18513945
stroke|Disease|7|[19, 20]|7|-1|_|_|_|_|_|_|_|18513945
cystitis|Disease|0|[24, 25]|500|-1|_|_|_|_|_|_|_|18483878
bladder inflammation|Disease|9|[13, 15]|500|-1|_|_|_|_|_|_|_|18483878
cyclophosphamide|Chemical|0|[18, 19]|1|-1|_|_|_|_|_|_|_|18483878
vasoactive intestinal polypeptide (vip)|Chemical|1|[0, 6]|3|-1|_|_|_|_|_|_|_|18483878
cyp|Chemical|4|[36, 37]|7|-1|_|_|_|_|_|_|_|18483878
cyp|Chemical|5|[9, 10]|7|-1|_|_|_|_|_|_|_|18483878
cyp|Chemical|5|[24, 25]|7|-1|_|_|_|_|_|_|_|18483878
cyp|Chemical|5|[59, 60]|7|-1|_|_|_|_|_|_|_|18483878
cyp|Chemical|5|[45, 46]|7|-1|_|_|_|_|_|_|_|18483878
cyp|Chemical|8|[0, 1]|7|-1|_|_|_|_|_|_|_|18483878
cyp|Chemical|8|[46, 47]|7|-1|_|_|_|_|_|_|_|18483878
cyp|Chemical|9|[26, 27]|7|-1|_|_|_|_|_|_|_|18483878
vasoactive intestinal polypeptide|Gene|0|[6, 9]|2|-1|_|_|_|_|_|_|_|18483878
vip|Gene|2|[0, 1]|4|-1|_|_|_|_|_|_|_|18483878
vip|Gene|3|[15, 16]|4|-1|_|_|_|_|_|_|_|18483878
vip|Gene|3|[1, 2]|4|-1|_|_|_|_|_|_|_|18483878
vip|Gene|4|[26, 27]|4|-1|_|_|_|_|_|_|_|18483878
vip|Gene|5|[52, 53]|4|-1|_|_|_|_|_|_|_|18483878
vip|Gene|5|[34, 35]|4|-1|_|_|_|_|_|_|_|18483878
vip|Gene|5|[16, 17]|4|-1|_|_|_|_|_|_|_|18483878
vip|Gene|9|[5, 6]|4|-1|_|_|_|_|_|_|_|18483878
vip|Gene|10|[11, 12]|4|-1|_|_|_|_|_|_|_|18483878
il-1beta|Gene|7|[11, 14]|20|-1|_|_|_|_|_|_|_|18483878
cxcl1|Gene|7|[15, 16]|21|-1|_|_|_|_|_|_|_|18483878
cyp treatment|Treat|5|[9, 11]|16|-1|_|_|_|_|_|_|_|18483878
cyp treatment|Treat|5|[24, 26]|16|-1|_|_|_|_|_|_|_|18483878
cyp treatment|Treat|5|[59, 61]|16|-1|_|_|_|_|_|_|_|18483878
cyp treatment|Treat|5|[45, 47]|16|-1|_|_|_|_|_|_|_|18483878
cyp treatment|Treat|8|[0, 2]|16|-1|_|_|_|_|_|_|_|18483878
cyp treatment|Treat|8|[46, 48]|16|-1|_|_|_|_|_|_|_|18483878
uveitis|Disease|0|[5, 6]|0|-1|_|_|_|_|_|_|_|17923537
elevated intraocular pressure|Disease|1|[9, 12]|4|-1|_|_|_|_|_|_|_|17923537
hypotony|Disease|6|[3, 4]|11|-1|_|_|_|_|_|_|_|17923537
fluocinolone acetonide|Chemical|0|[8, 10]|1|-1|_|_|_|_|_|_|_|17923537
iop-lowering medication|Chemical|4|[1, 5]|7|-1|_|_|_|_|_|_|_|17923537
intraocular pressure|Physiology|0|[0, 2]|2|-1|_|_|_|_|_|_|_|17923537
iop|Physiology|3|[46, 47]|5|-1|_|_|_|_|_|_|_|17923537
iop|Physiology|3|[19, 20]|5|-1|_|_|_|_|_|_|_|17923537
iop|Physiology|4|[1, 2]|5|-1|_|_|_|_|_|_|_|17923537
iop|Physiology|4|[16, 17]|5|-1|_|_|_|_|_|_|_|17923537
iop|Physiology|6|[14, 15]|5|-1|_|_|_|_|_|_|_|17923537
iop|Physiology|6|[5, 6]|5|-1|_|_|_|_|_|_|_|17923537
iop|Physiology|7|[3, 4]|5|-1|_|_|_|_|_|_|_|17923537
implants|Treat|0|[10, 11]|3|-1|_|_|_|_|_|_|_|17923537
trabeculectomies|Treat|4|[25, 26]|8|-1|_|_|_|_|_|_|_|17923537
medication and surgery|Treat|7|[18, 21]|15|-1|_|_|_|_|_|_|_|17923537
pallidal stimulation|Treat|0|[0, 2]|0|-1|_|_|_|_|_|_|_|15096016
pallidotomy|Treat|1|[22, 23]|1|-1|_|_|_|_|_|_|_|15096016
ventrolateral thalamotomy|Treat|3|[4, 6]|3|-1|_|_|_|_|_|_|_|15096016
bilateral pallidal stimulation|Treat|8|[35, 38]|12|-1|_|_|_|_|_|_|_|15096016
pd|Disease|2|[11, 12]|500|H|_|_|_|_|_|_|_|15096016
pd|Disease|5|[12, 13]|500|H|_|_|_|_|_|_|_|15096016
pallidal stimulation|Disease|4|[0, 2]|500|-1|_|_|_|_|_|_|_|15096016
dyskinesias|Disease|5|[16, 17]|501|-1|_|_|_|_|_|_|_|15096016
rigidity|Disease|5|[29, 30]|7|-1|_|_|_|_|_|_|_|15096016
bradykinesia|Disease|5|[31, 32]|8|-1|_|_|_|_|_|_|_|15096016
hyper- or dyskinetic|Disease|7|[7, 11]|501|-1|_|_|_|_|_|_|_|15096016
dyskinetic|Disease|7|[10, 11]|501|-1|_|_|_|_|_|_|_|15096016
levodopa|Chemical|6|[20, 21]|9|-1|_|_|_|_|_|_|_|15096016
myocardial infarction|Disease|0|[11, 13]|0|-1|_|_|_|_|_|_|_|12734532
hypertensive|Disease|2|[6, 7]|3|-1|_|_|_|_|_|_|_|12734532
overdose|Disease|3|[14, 15]|4|-1|_|_|_|_|_|_|_|12734532
myocardial injury|Disease|3|[9, 11]|5|H|_|_|_|_|_|_|_|12734532
ppa|Disease|5|[10, 11]|8|-1|_|_|_|_|_|_|_|12734532
cardiac risk|Disease|6|[9, 11]|9|H|_|_|_|_|_|_|_|12734532
phenylpropanolamine|Chemical|0|[5, 6]|501|-1|_|_|_|_|_|_|_|12734532
phenylpropanolamine (ppa)|Chemical|1|[0, 4]|501|-1|_|_|_|_|_|_|_|12734532
ppa|Chemical|3|[7, 8]|501|-1|_|_|_|_|_|_|_|12734532
ppa|Chemical|4|[9, 10]|501|-1|_|_|_|_|_|_|_|12734532
ppa|Chemical|6|[16, 17]|501|-1|_|_|_|_|_|_|_|12734532
schizophrenic|Disease|0|[9, 10]|0|H|_|_|_|_|_|_|_|12013711
schizophrenic|Disease|1|[1, 2]|0|H|_|_|_|_|_|_|_|12013711
eps|Disease|1|[17, 18]|4|-1|_|_|_|_|_|_|_|12013711
eps|Disease|1|[17, 18]|4|-1|_|_|_|_|_|_|_|12013711
visual disturbances|Disease|4|[6, 8]|8|-1|_|_|_|_|_|_|_|12013711
risperidone|Chemical|0|[0, 1]|1|-1|_|_|_|_|_|_|_|12013711
risperidone|Chemical|4|[0, 1]|1|-1|_|_|_|_|_|_|_|12013711
lsd|Chemical|0|[16, 17]|2|-1|_|_|_|_|_|_|_|12013711
lsd|Chemical|1|[10, 11]|2|-1|_|_|_|_|_|_|_|12013711
lsd|Chemical|3|[14, 15]|2|-1|_|_|_|_|_|_|_|12013711
treatment|Treat|6|[29, 30]|10|-1|_|_|_|_|_|_|_|12013711
poly(adp-ribose)|Chemical|0|[2, 8]|0|H|_|_|_|_|_|_|_|11861791
poly(adp-ribose)|Chemical|1|[5, 11]|0|H|_|_|_|_|_|_|_|11861791
poly(adp-ribose)|Chemical|1|[5, 11]|0|H|_|_|_|_|_|_|_|11861791
doxorubicin|Chemical|0|[13, 14]|500|-1|_|_|_|_|_|_|_|11861791
doxorubicin|Chemical|2|[12, 13]|500|-1|_|_|_|_|_|_|_|11861791
dox|Chemical|3|[13, 14]|500|-1|_|_|_|_|_|_|_|11861791
dox|Chemical|4|[38, 39]|500|-1|_|_|_|_|_|_|_|11861791
dox|Chemical|5|[19, 20]|500|-1|_|_|_|_|_|_|_|11861791
dox|Chemical|6|[3, 4]|500|-1|_|_|_|_|_|_|_|11861791
dox|Chemical|9|[6, 7]|500|-1|_|_|_|_|_|_|_|11861791
dox|Chemical|10|[9, 10]|500|-1|_|_|_|_|_|_|_|11861791
dox|Chemical|11|[16, 17]|500|-1|_|_|_|_|_|_|_|11861791
pj34|Chemical|4|[21, 22]|501|-1|_|_|_|_|_|_|_|11861791
pj34|Chemical|7|[11, 12]|501|-1|_|_|_|_|_|_|_|11861791
pj34|Chemical|8|[3, 4]|501|-1|_|_|_|_|_|_|_|11861791
pj34|Chemical|9|[2, 3]|501|-1|_|_|_|_|_|_|_|11861791
creatine|Chemical|9|[16, 17]|21|-1|_|_|_|_|_|_|_|11861791
parp inhibitors|Chemical|11|[0, 2]|501|-1|_|_|_|_|_|_|_|11861791
heart failure|Disease|0|[16, 18]|2|-1|_|_|_|_|_|_|_|11861791
cardiac dysfunction|Disease|4|[34, 36]|8|-1|_|_|_|_|_|_|_|11861791
parp|Gene|1|[13, 14]|5|-1|_|_|_|_|_|_|_|11861791
parp-1|Gene|5|[7, 10]|12|-1|_|_|_|_|_|_|_|11861791
parp-1|Gene|5|[0, 3]|12|-1|_|_|_|_|_|_|_|11861791
parp-1|Gene|6|[13, 16]|12|-1|_|_|_|_|_|_|_|11861791
parp-1|Gene|6|[28, 31]|12|-1|_|_|_|_|_|_|_|11861791
injection|Treat|5|[17, 18]|14|-1|_|_|_|_|_|_|_|11861791
vehicle|Treat|7|[13, 14]|19|-1|_|_|_|_|_|_|_|11861791
torsade de pointes|Disease|0|[3, 6]|500|-1|_|_|_|_|_|_|_|11302406
congestive heart failure|Disease|2|[44, 47]|2|-1|_|_|_|_|_|_|_|11302406
tdp|Disease|2|[35, 36]|500|-1|_|_|_|_|_|_|_|11302406
tdp|Disease|2|[62, 63]|500|-1|_|_|_|_|_|_|_|11302406
tdp|Disease|2|[20, 21]|500|-1|_|_|_|_|_|_|_|11302406
tdp|Disease|3|[52, 53]|500|-1|_|_|_|_|_|_|_|11302406
tdp|Disease|3|[1, 2]|500|-1|_|_|_|_|_|_|_|11302406
tdp|Disease|5|[16, 17]|500|-1|_|_|_|_|_|_|_|11302406
tdp|Disease|6|[24, 25]|500|-1|_|_|_|_|_|_|_|11302406
cardiomyopathy|Disease|2|[42, 43]|6|-1|_|_|_|_|_|_|_|11302406
ventricular tachycardia|Disease|3|[20, 22]|500|H|_|_|_|_|_|_|_|11302406
premature ventricular contractions|Disease|3|[15, 18]|500|H|_|_|_|_|_|_|_|11302406
nonsustained ventricular tachycardia (nsvt)|Disease|3|[19, 25]|501|H|_|_|_|_|_|_|_|11302406
qt prolongation|Disease|5|[13, 15]|500|H|_|_|_|_|_|_|_|11302406
nsvt|Disease|5|[21, 22]|501|-1|_|_|_|_|_|_|_|11302406
ventricular arrhythmias|Disease|7|[17, 19]|501|H|_|_|_|_|_|_|_|11302406
fluconazole|Chemical|0|[0, 1]|1|-1|_|_|_|_|_|_|_|11302406
spinal cord injury|Disease|0|[9, 12]|0|-1|_|_|_|_|_|_|_|11058428
myopathy|Disease|2|[14, 15]|2|-1|_|_|_|_|_|_|_|11058428
myopathy|Disease|5|[27, 28]|2|-1|_|_|_|_|_|_|_|11058428
myopathy|Disease|5|[3, 4]|2|-1|_|_|_|_|_|_|_|11058428
myopathy|Disease|6|[22, 23]|2|-1|_|_|_|_|_|_|_|11058428
methylprednisolone|Chemical|0|[3, 4]|501|-1|_|_|_|_|_|_|_|11058428
corticosteroid|Chemical|2|[13, 14]|501|-1|_|_|_|_|_|_|_|11058428
corticosteroid|Chemical|6|[21, 22]|501|-1|_|_|_|_|_|_|_|11058428
steroid|Chemical|5|[2, 3]|501|-1|_|_|_|_|_|_|_|11058428
steroid|Chemical|5|[26, 27]|501|-1|_|_|_|_|_|_|_|11058428
steroids|Treat|3|[14, 15]|4|-1|_|_|_|_|_|_|_|11058428
alzheimer's disease|Disease|1|[31, 35]|0|-1|_|_|_|_|_|_|_|11022397
impairment in word recall|Disease|12|[18, 22]|9|-1|_|_|_|_|_|_|_|11022397
impairment in word recall|Disease|15|[14, 18]|9|-1|_|_|_|_|_|_|_|11022397
pilocarpine|Chemical|2|[31, 32]|1|-1|_|_|_|_|_|_|_|11022397
pilocarpine|Chemical|9|[27, 28]|1|-1|_|_|_|_|_|_|_|11022397
pilocarpine|Chemical|12|[13, 14]|1|-1|_|_|_|_|_|_|_|11022397
pilocarpine|Chemical|14|[7, 8]|1|-1|_|_|_|_|_|_|_|11022397
pilocarpine|Chemical|16|[11, 12]|1|-1|_|_|_|_|_|_|_|11022397
pilocarpine|Chemical|17|[2, 3]|1|-1|_|_|_|_|_|_|_|11022397
tropicamide|Chemical|2|[13, 14]|2|-1|_|_|_|_|_|_|_|11022397
scopolamine|Chemical|3|[0, 1]|3|-1|_|_|_|_|_|_|_|11022397
scopolamine|Chemical|3|[0, 1]|3|-1|_|_|_|_|_|_|_|11022397
scopolamine|Chemical|11|[9, 10]|3|-1|_|_|_|_|_|_|_|11022397
scopolamine|Chemical|12|[15, 16]|3|-1|_|_|_|_|_|_|_|11022397
scopolamine|Chemical|15|[11, 12]|3|-1|_|_|_|_|_|_|_|11022397
central cholinergic functioning|Physiology|3|[14, 17]|5|-1|_|_|_|_|_|_|_|11022397
pupil diameter|Physiology|6|[2, 4]|6|-1|_|_|_|_|_|_|_|11022397
pupil size|Physiology|12|[3, 5]|12|-1|_|_|_|_|_|_|_|11022397
pupillary response|Physiology|13|[13, 15]|13|-1|_|_|_|_|_|_|_|11022397
central cholinergic function|Physiology|17|[10, 13]|19|-1|_|_|_|_|_|_|_|11022397
gerstmann syndrome|Disease|0|[3, 5]|0|-1|_|_|_|_|_|_|_|10692744
gerstmann syndrome|Disease|2|[8, 10]|0|-1|_|_|_|_|_|_|_|10692744
renal impairment|Disease|1|[15, 17]|2|-1|_|_|_|_|_|_|_|10692744
confusion|Disease|1|[1, 2]|3|-1|_|_|_|_|_|_|_|10692744
acetazolamide|Chemical|0|[0, 1]|1|-1|_|_|_|_|_|_|_|10692744
olanzapine|Chemical|0|[6, 7]|0|-1|_|_|_|_|_|_|_|10565806
hypomania|Disease|1|[22, 23]|1|-1|_|_|_|_|_|_|_|10565806
liver failure|Disease|0|[10, 12]|500|H|_|_|_|_|_|_|_|9061311
bacterial infections|Disease|1|[15, 17]|2|-1|_|_|_|_|_|_|_|9061311
overdose|Disease|2|[15, 16]|3|-1|_|_|_|_|_|_|_|9061311
overdose|Disease|8|[11, 12]|3|-1|_|_|_|_|_|_|_|9061311
alf|Disease|2|[11, 12]|500|-1|_|_|_|_|_|_|_|9061311
alf|Disease|3|[15, 16]|500|-1|_|_|_|_|_|_|_|9061311
alf|Disease|3|[3, 4]|500|-1|_|_|_|_|_|_|_|9061311
alf|Disease|6|[23, 24]|500|-1|_|_|_|_|_|_|_|9061311
alf|Disease|7|[8, 9]|500|-1|_|_|_|_|_|_|_|9061311
alf|Disease|8|[7, 8]|500|-1|_|_|_|_|_|_|_|9061311
defect|Disease|5|[1, 2]|500|-1|_|_|_|_|_|_|_|9061311
hydrogen peroxide|Chemical|0|[3, 5]|1|-1|_|_|_|_|_|_|_|9061311
paracetamol|Chemical|2|[14, 15]|4|-1|_|_|_|_|_|_|_|9061311
paracetamol|Chemical|8|[10, 11]|4|-1|_|_|_|_|_|_|_|9061311
oxygen|Chemical|2|[5, 6]|6|H|_|_|_|_|_|_|_|9061311
fmlp|Chemical|6|[17, 18]|502|-1|_|_|_|_|_|_|_|9061311
formyl-methionyl-leucyl-phenylalanine (fmlp)|Chemical|6|[9, 19]|502|-1|_|_|_|_|_|_|_|9061311
haloperidol|Chemical|0|[14, 15]|0|-1|_|_|_|_|_|_|_|8617710
haloperidol|Chemical|1|[15, 16]|0|-1|_|_|_|_|_|_|_|8617710
haloperidol|Chemical|1|[18, 19]|0|-1|_|_|_|_|_|_|_|8617710
haloperidol|Chemical|2|[10, 11]|0|-1|_|_|_|_|_|_|_|8617710
haloperidol|Chemical|5|[15, 16]|0|-1|_|_|_|_|_|_|_|8617710
haloperidol|Chemical|6|[4, 5]|0|-1|_|_|_|_|_|_|_|8617710
haloperidol|Chemical|7|[11, 12]|0|-1|_|_|_|_|_|_|_|8617710
haloperidol|Chemical|11|[2, 3]|0|-1|_|_|_|_|_|_|_|8617710
haloperidol|Chemical|11|[2, 3]|0|-1|_|_|_|_|_|_|_|8617710
sertraline|Chemical|0|[4, 5]|2|-1|_|_|_|_|_|_|_|8617710
sertraline|Chemical|11|[16, 17]|2|-1|_|_|_|_|_|_|_|8617710
cognitive impairment|Disease|0|[11, 13]|1|-1|_|_|_|_|_|_|_|8617710
nephrotoxicity|Disease|0|[3, 4]|0|H|_|_|_|_|_|_|_|8494478
nephrotoxicity|Disease|1|[0, 1]|0|H|_|_|_|_|_|_|_|8494478
interstitial nephritis|Disease|4|[1, 3]|3|-1|_|_|_|_|_|_|_|8494478
renal biopsy|Disease|5|[5, 7]|4|-1|_|_|_|_|_|_|_|8494478
ciprofloxacin|Chemical|0|[0, 1]|1|-1|_|_|_|_|_|_|_|8494478
renal function|Physiology|6|[3, 5]|5|-1|_|_|_|_|_|_|_|8494478
ventricular tachycardia|Disease|0|[6, 8]|500|H|_|_|_|_|_|_|_|8475949
torsade de pointes|Disease|1|[10, 13]|500|-1|_|_|_|_|_|_|_|8475949
torsade de pointes|Disease|4|[0, 3]|500|-1|_|_|_|_|_|_|_|8475949
torsade de pointes|Disease|6|[0, 3]|500|-1|_|_|_|_|_|_|_|8475949
qtc interval prolongation|Disease|7|[1, 4]|9|-1|_|_|_|_|_|_|_|8475949
pentamidine|Chemical|0|[3, 4]|502|-1|_|_|_|_|_|_|_|8475949
pentamidine|Chemical|3|[0, 1]|502|-1|_|_|_|_|_|_|_|8475949
pentamidine isethionate|Chemical|1|[0, 2]|502|-1|_|_|_|_|_|_|_|8475949
magnesium levels|Physiology|3|[11, 13]|5|-1|_|_|_|_|_|_|_|8475949
treatment with pentamidine|Treat|4|[11, 14]|7|-1|_|_|_|_|_|_|_|8475949
cerebral ischemia|Disease|0|[12, 14]|500|-1|_|_|_|_|_|_|_|7710775
ischemia|Disease|4|[1, 2]|500|-1|_|_|_|_|_|_|_|7710775
hypotensive|Disease|6|[52, 53]|8|-1|_|_|_|_|_|_|_|7710775
ischemic phenomena|Disease|7|[30, 32]|500|-1|_|_|_|_|_|_|_|7710775
malondialdehyde|Chemical|0|[4, 5]|1|-1|_|_|_|_|_|_|_|7710775
oxypurines|Chemical|0|[6, 7]|2|-1|_|_|_|_|_|_|_|7710775
nucleosides|Chemical|0|[9, 10]|3|-1|_|_|_|_|_|_|_|7710775
nitroprusside|Chemical|6|[54, 55]|9|-1|_|_|_|_|_|_|_|7710775
acetylsalicylate|Chemical|6|[33, 34]|10|-1|_|_|_|_|_|_|_|7710775
plasma|Physiology|5|[0, 1]|5|-1|_|_|_|_|_|_|_|7710775
plasma|Physiology|5|[19, 20]|5|-1|_|_|_|_|_|_|_|7710775
plasma|Physiology|5|[52, 53]|5|-1|_|_|_|_|_|_|_|7710775
ischemia|Physiology|6|[66, 67]|11|-1|_|_|_|_|_|_|_|7710775
ischemia|Physiology|6|[37, 38]|11|-1|_|_|_|_|_|_|_|7710775
echothiophate iodide|Chemical|0|[7, 9]|0|-1|_|_|_|_|_|_|_|7650771
muscle weakness|Disease|1|[19, 21]|1|-1|_|_|_|_|_|_|_|7650771
myasthenia gravis|Disease|1|[28, 30]|2|-1|_|_|_|_|_|_|_|7650771
acute renal failure|Disease|0|[0, 3]|0|-1|_|_|_|_|_|_|_|7565311
acute renal failure|Disease|3|[0, 3]|0|-1|_|_|_|_|_|_|_|7565311
embryonal rhabdomyosarcoma|Disease|2|[23, 25]|3|-1|_|_|_|_|_|_|_|7565311
carboplatin|Chemical|0|[6, 7]|1|-1|_|_|_|_|_|_|_|7565311
carboplatin|Chemical|1|[0, 1]|1|-1|_|_|_|_|_|_|_|7565311
endometrial carcinoma|Disease|0|[0, 2]|500|-1|_|_|_|_|_|_|_|7421734
hodgkin disease|Disease|0|[3, 5]|1|-1|_|_|_|_|_|_|_|7421734
hodgkin disease|Disease|1|[12, 14]|1|-1|_|_|_|_|_|_|_|7421734
hodgkin disease|Disease|2|[10, 12]|1|-1|_|_|_|_|_|_|_|7421734
ovarian failure|Disease|2|[2, 4]|4|-1|_|_|_|_|_|_|_|7421734
endometrial cancer|Disease|2|[25, 27]|500|-1|_|_|_|_|_|_|_|7421734
estrogens|Chemical|2|[16, 17]|6|-1|_|_|_|_|_|_|_|7421734
chemotherapy|Treat|2|[8, 9]|7|-1|_|_|_|_|_|_|_|7421734
obstructive sleep apnea syndrome|Disease|0|[3, 7]|500|-1|_|_|_|_|_|_|_|6732043
obstructive sleep apnea|Disease|1|[31, 34]|500|-1|_|_|_|_|_|_|_|6732043
sleep apnea|Disease|4|[12, 14]|500|-1|_|_|_|_|_|_|_|6732043
androgen|Chemical|0|[12, 13]|502|-1|_|_|_|_|_|_|_|6732043
androgens|Chemical|1|[38, 39]|502|-1|_|_|_|_|_|_|_|6732043
hypertensive|Disease|0|[14, 15]|0|H|_|_|_|_|_|_|_|6454943
hypertensive|Disease|1|[9, 10]|0|H|_|_|_|_|_|_|_|6454943
proteinuria|Disease|0|[11, 12]|1|-1|_|_|_|_|_|_|_|6454943
proteinuria|Disease|1|[0, 1]|1|-1|_|_|_|_|_|_|_|6454943
proteinuria|Disease|3|[15, 16]|1|-1|_|_|_|_|_|_|_|6454943
proteinuria|Disease|4|[12, 13]|1|-1|_|_|_|_|_|_|_|6454943
captopril|Chemical|0|[2, 3]|2|-1|_|_|_|_|_|_|_|6454943
puromycin aminonucleoside|Chemical|4|[15, 17]|8|-1|_|_|_|_|_|_|_|6454943
ketone|Chemical|6|[2, 3]|11|-1|_|_|_|_|_|_|_|6454943
hypertensive|Physiology|0|[14, 15]|3|-1|_|_|_|_|_|_|_|6454943
electrolyte concentrations|Physiology|5|[9, 11]|9|-1|_|_|_|_|_|_|_|6454943
endogenous creatinine clearance|Physiology|5|[20, 23]|10|-1|_|_|_|_|_|_|_|6454943
enflurane|Chemical|0|[3, 4]|0|-1|_|_|_|_|_|_|_|6153967
seizures|Disease|2|[15, 16]|1|-1|_|_|_|_|_|_|_|6153967
nephrectomy|Treat|2|[9, 10]|2|-1|_|_|_|_|_|_|_|6153967
surgically ablated|Treat|5|[8, 10]|3|-1|_|_|_|_|_|_|_|6153967
cerebral lesions|Disease|0|[1, 3]|500|-1|_|_|_|_|_|_|_|3183120
cerebral abnormalities|Disease|2|[13, 15]|500|-1|_|_|_|_|_|_|_|3183120
tiazofurin|Chemical|0|[5, 6]|1|-1|_|_|_|_|_|_|_|3183120
tiazofurin|Chemical|1|[0, 1]|1|-1|_|_|_|_|_|_|_|3183120
chemotherapeutic agent|Treat|1|[4, 6]|3|-1|_|_|_|_|_|_|_|3183120
diazepam|Chemical|0|[2, 3]|0|-1|_|_|_|_|_|_|_|3120485
diazepam|Chemical|1|[19, 20]|0|-1|_|_|_|_|_|_|_|3120485
diazepam|Chemical|2|[7, 8]|0|-1|_|_|_|_|_|_|_|3120485
diazepam|Chemical|3|[2, 3]|0|-1|_|_|_|_|_|_|_|3120485
ro15-1788|Chemical|0|[8, 11]|1|-1|_|_|_|_|_|_|_|3120485
ro15-1788|Chemical|1|[11, 14]|1|-1|_|_|_|_|_|_|_|3120485
ro15-1788|Chemical|1|[39, 42]|1|-1|_|_|_|_|_|_|_|3120485
ro15-1788|Chemical|3|[7, 10]|1|-1|_|_|_|_|_|_|_|3120485
ro15-1788|Chemical|6|[1, 4]|1|-1|_|_|_|_|_|_|_|3120485
lumbar epidural block|Treat|0|[16, 19]|2|-1|_|_|_|_|_|_|_|3120485
epidural block|Treat|1|[26, 28]|7|-1|_|_|_|_|_|_|_|3120485
epidural anaesthesia|Treat|2|[11, 13]|9|-1|_|_|_|_|_|_|_|3120485
sedative effects|Physiology|0|[5, 7]|3|-1|_|_|_|_|_|_|_|3120485
mood rating|Physiology|4|[7, 9]|13|-1|_|_|_|_|_|_|_|3120485
amnesia|Disease|4|[19, 20]|12|-1|_|_|_|_|_|_|_|3120485
amnesia|Disease|5|[13, 14]|12|-1|_|_|_|_|_|_|_|3120485
hypertensive|Disease|0|[10, 11]|0|-1|_|_|_|_|_|_|_|2886572
epinephrine|Chemical|0|[7, 8]|1|-1|_|_|_|_|_|_|_|2886572
catecholamine|Chemical|4|[2, 3]|5|H|_|_|_|_|_|_|_|2886572
propranolol|Chemical|7|[0, 1]|6|-1|_|_|_|_|_|_|_|2886572
phentolamine|Chemical|8|[0, 1]|7|-1|_|_|_|_|_|_|_|2886572
neurotransmitter overflow|Physiology|0|[4, 6]|2|-1|_|_|_|_|_|_|_|2886572
6-day epinephrine treatment|Treat|1|[7, 12]|3|-1|_|_|_|_|_|_|_|2886572
epinephrine treatment|Treat|3|[2, 4]|4|-1|_|_|_|_|_|_|_|2886572
arthritis|Disease|0|[5, 6]|500|H|_|_|_|_|_|_|_|1079693
arthritis|Disease|1|[7, 8]|500|H|_|_|_|_|_|_|_|1079693
arthritis|Disease|3|[23, 24]|500|H|_|_|_|_|_|_|_|1079693
juvenile rheumatoid arthritis|Disease|0|[3, 6]|500|H|_|_|_|_|_|_|_|1079693
iridocyclitis|Disease|2|[13, 14]|501|H|_|_|_|_|_|_|_|1079693
iridocyclitis|Disease|3|[0, 1]|501|H|_|_|_|_|_|_|_|1079693
uveitis|Disease|4|[7, 8]|501|-1|_|_|_|_|_|_|_|1079693
cataract|Disease|10|[0, 1]|13|-1|_|_|_|_|_|_|_|1079693
cataract|Disease|10|[0, 1]|13|-1|_|_|_|_|_|_|_|1079693
band keratopathy|Disease|10|[2, 4]|15|-1|_|_|_|_|_|_|_|1079693
chorioretinopathy|Disease|11|[16, 17]|17|-1|_|_|_|_|_|_|_|1079693
keratoconjunctivitis|Disease|13|[1, 2]|19|-1|_|_|_|_|_|_|_|1079693
jra|Disease|14|[5, 6]|500|H|_|_|_|_|_|_|_|1079693
glaucoma|Disease|15|[9, 10]|21|-1|_|_|_|_|_|_|_|1079693
red eye|Symptom|7|[19, 21]|7|-1|_|_|_|_|_|_|_|1079693
ocular pain|Symptom|7|[22, 24]|8|-1|_|_|_|_|_|_|_|1079693
decreased visual acuity|Symptom|7|[25, 28]|9|-1|_|_|_|_|_|_|_|1079693
photophobia|Symptom|7|[30, 31]|10|-1|_|_|_|_|_|_|_|1079693
corticosteroids|Chemical|8|[26, 27]|11|H|_|_|_|_|_|_|_|1079693
chloroquine|Chemical|11|[2, 3]|16|H|_|_|_|_|_|_|_|1079693
hydroxychloroquine|Chemical|11|[4, 5]|18|-1|_|_|_|_|_|_|_|1079693
intensive topical treatment|Treat|8|[22, 25]|12|-1|_|_|_|_|_|_|_|1079693
water intoxication|Disease|0|[0, 2]|0|-1|_|_|_|_|_|_|_|803783
asthenia|Disease|3|[47, 48]|4|-1|_|_|_|_|_|_|_|803783
irritability|Disease|3|[50, 51]|5|-1|_|_|_|_|_|_|_|803783
oxytocin|Chemical|0|[4, 5]|1|-1|_|_|_|_|_|_|_|803783
dextrose|Chemical|4|[21, 22]|6|-1|_|_|_|_|_|_|_|803783
abortion|Treat|0|[10, 11]|2|-1|_|_|_|_|_|_|_|803783
abortions|Treat|1|[14, 15]|3|-1|_|_|_|_|_|_|_|803783
urinary output|Physiology|5|[1, 3]|7|-1|_|_|_|_|_|_|_|803783
urinary output|Physiology|5|[18, 20]|7|-1|_|_|_|_|_|_|_|803783
